Title,Title_URL,Image,Tag_URL,Tag,jsteaserstandfirstlink,jsteaserstandfirstlink1,Time
NHS watchdog blocks AstraZeneca breast cancer drug,https://www.ft.com/content/d831c865-ae82-40f3-86a3-de43b53d25f0,https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2F04e2babf-2610-495b-92a2-c7dd78a070fd.jpg?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/disease-control-prevention,Disease control and prevention,"...Costs of the drug are covered in 17 countries across Europe, according to AstraZeneca....",AstraZeneca,"JULY 29, 2024"
AstraZeneca calls on UK to change rules on innovative drug pricing,https://www.ft.com/content/466a4d1d-e559-4695-ba77-92364c6b3447,https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2Fd4789915-cc5c-4d20-ada4-852aef0b9986.jpg?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,"...Sales of AstraZeneca’s cancer medicines, which make up 41 per cent of total sales, grew 22 per cent....",AstraZeneca’s,"JULY 25, 2024"
"GSK, Pfizer and Moderna face RSV vaccine sales slump",https://www.ft.com/content/8c21c662-b5c7-401a-b880-17905e15e2a5,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...Infants can receive Beyfortus, an antibody treatment developed by AstraZeneca and Sanofi....",AstraZeneca,"JULY 24, 2024"
The club of City executives plotting a revival for the UK’s capital markets,https://www.ft.com/content/557d71f5-c3c1-4e9f-b4e5-c5d4e36d73e0,,https://www.ft.com/content/bd843235-bf49-4910-85e2-e027d9f8155a,Rebooting Britain’s capital markets,...“They’re creating an unbalanced debate where good corporate governance is pitted against a thriving UK plc.”...,plc,"JUNE 24, 2024"
Tesco boss says he is ‘well paid’ as investors back £10mn package,https://www.ft.com/content/599326d2-b7d6-432e-9a73-c78f07aad582,,https://www.ft.com/stream/c5d45126-9952-466f-91fe-3525deb78b2d,Tesco PLC,"...FTSE boards have come under pressure to raise chief executive remuneration in order to compete with their transatlantic rivals, with shareholders at companies including AstraZeneca recently voting through...",AstraZeneca,"JUNE 14, 2024"
AstraZeneca’s next big target can cement its sector darling status,https://www.ft.com/content/9b2238eb-0a5b-4315-bc57-c4f74ce1ce37,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,...AstraZeneca reckons successful medicines from these trials could generate $20bn in revenue by 2030....,AstraZeneca,"JUNE 10, 2024"
BHP-Anglo: when ‘final’ no longer means final,https://www.ft.com/content/4a2dd050-bca5-4d14-89b9-46fe9c9a8c8e,,https://www.ft.com/due-diligence,Due Diligence,"...(Famously, then Pfizer boss Ian Read botched his £70bn pursuit of AstraZeneca in 2014 when he didn’t realise that final really meant final under the UK code....",AstraZeneca,"MAY 23, 2024"
AstraZeneca to build Chinese supply chain as US-Sino tensions increase,https://www.ft.com/content/e54ac617-9869-4ba2-8933-8cc91942044e,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,...The comments came as AstraZeneca announced plans to almost double revenue to $80bn by 2030....,AstraZeneca,"MAY 21, 2024"
AstraZeneca to build $1.5bn manufacturing site in Singapore,https://www.ft.com/content/fe6f6155-46ce-4153-88da-1c3ccdf89bd2,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,...AstraZeneca said on Monday that the move was supported by Singapore’s Economic Development Board but neither AstraZeneca nor the EDB disclosed what incentives it would receive from the Singaporean government...,AstraZeneca,"MAY 20, 2024"
AstraZeneca withdraws Covid-19 vaccine,https://www.ft.com/content/c1b391c0-bdc7-4b93-884a-8ec4866a7272,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,"...AstraZeneca signed its first for-profit deals in late 2021, as the company said the pandemic had moved into an “endemic phase”....",AstraZeneca,"MAY 8, 2024"
Smith & Nephew grants CEO 30% pay rise despite shareholder revolt,https://www.ft.com/content/60f4a5b8-4fa9-4170-bf06-712073fadca2,,https://www.ft.com/executive-pay,Executive Pay,"...The medical devices company is the latest FTSE company to withstand a shareholder revolt on large hikes to chief executive pay, after AstraZeneca, the London Stock Exchange Group and Ocado all faced down...",AstraZeneca,"MAY 1, 2024"
GSK pushes back on FTC ‘junk patents’ claim as it raises profit outlook,https://www.ft.com/content/3910ca6e-074d-4f25-a43a-a994fd5495d3,,https://www.ft.com/stream/7e27074f-ef2c-45ed-a6e3-04f0a93451f4,GSK PLC,"...GSK, AstraZeneca, Novo Nordisk and Novartis were among 10 companies to receive letters from the FTC on Tuesday informing them that the agency had disputed a number of patents with the Food and Drug Administration...",AstraZeneca,"MAY 1, 2024"
"Europe falling behind US and China in pharma innovation, warns AstraZeneca chief",https://www.ft.com/content/2c0d4917-f837-4aad-be54-6a727800c3e4,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,...Soriot said on Thursday that AstraZeneca’s deal activity would continue but “at a slower pace”....,AstraZeneca’s,"APRIL 25, 2024"
Ex-Smiths chief set for pay bump after quitting UK conglomerate for smaller US group,https://www.ft.com/content/6fec80ac-dee5-41e2-ad6b-3e4781582631,,https://www.ft.com/executive-pay,Executive Pay,...London Stock Exchange Group and Smith & Nephew are among the FTSE 100 companies hoping to follow AstraZeneca by pushing through pay increases for their executives at upcoming annual meetings....,AstraZeneca,"APRIL 22, 2024"
"Proxy advisers inflict ‘serious harm’ to UK, says AstraZeneca chair",https://www.ft.com/content/838177cd-af87-4b86-ac47-ecfc45665020,,https://www.ft.com/executive-pay,Executive Pay,...AstraZeneca has a market capitalisation of £171bn....,AstraZeneca,"APRIL 14, 2024"
AstraZeneca chair: UK business needs a level playing field to compete,https://www.ft.com/content/86524f70-b121-4432-9403-94cd1c26f266,,https://www.ft.com/stream/6c5dce72-0fdd-4261-aed6-15c6f01c1f52,Michel Demaré,"...The writer is chair of AstraZeneca

The AGM season is in full swing, and with it comes the usual set of controversies around remuneration....",AstraZeneca,"APRIL 14, 2024"
AstraZeneca shareholders approve CEO Soriot’s £18.7mn pay despite revolt,https://www.ft.com/content/5b88670f-1e29-45f5-b6d7-6c0157bcd427,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,"...“Some of our loyal shareholders do expect cash dividends as an important part of total returns,” said AstraZeneca chair Michel Demaré at the AGM....",AstraZeneca,"APRIL 11, 2024"
Smith & Nephew investors urged to oppose ‘excessive’ pay rise for boss,https://www.ft.com/content/d68cdcb8-f05f-4703-ac04-831340665d90,,https://www.ft.com/executive-pay,Executive Pay,...Companies including the London Stock Exchange Group and AstraZeneca are proposing pay increases for their bosses against a backdrop of concerns about the UK’s international competitiveness....,AstraZeneca,"APRIL 11, 2024"
Shell has a London problem,https://www.ft.com/content/f4ff7170-d1e1-47ef-90b2-466b6addaeca,,https://www.ft.com/due-diligence,Due Diligence,"...groups consider overseas headquarters to hedge against Chinese attack (FT)

HSBC to take $1bn hit on sale of Argentina unit (FT)

European ports turned into ‘car parks’ as vehicle imports pile up (FT)

AstraZeneca...",AstraZeneca,"APRIL 10, 2024"
"AstraZeneca’s Soriot ‘massively underpaid’ at £16.9mn, says top shareholder",https://www.ft.com/content/c7226781-b45b-4502-ba38-129dea5e960e,,https://www.ft.com/executive-pay,Executive Pay,"...Emma Walmsley, chief executive of AstraZeneca’s British rival GSK, earned £12.7mn in 2023....",AstraZeneca’s,"APRIL 9, 2024"
"A decade after Pfizer, AstraZeneca needs to find its growth again",https://www.ft.com/content/dace7169-67d0-4d11-b2fa-e3b013bc82c1,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,...AstraZeneca is starting its next 10-year cycle from a very different place....,AstraZeneca,"APRIL 1, 2024"
AstraZeneca shareholders urged to oppose pay plan for CEO Soriot,https://www.ft.com/content/6c0fa244-2096-4490-996b-8ee1ce2240df,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,"...Since taking the helm in 2012, Soriot has turned AstraZeneca into the second-largest company on the FTSE 100 index behind Shell....",AstraZeneca,"MARCH 30, 2024"
AstraZeneca strikes $2.4bn deal for radiotherapy biotech Fusion,https://www.ft.com/content/cf6b8ab8-03ef-43fa-9523-9c7d026830c5,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,...Shares in AstraZeneca dipped 1.1 per cent in morning trading....,AstraZeneca,"MARCH 19, 2024"
How Britain’s biggest aquarium chain keeps its animal records under wraps ,https://www.ft.com/content/8eb474b1-e1c3-4e8f-b4fb-b4ee8e53f052,,https://www.ft.com/stream/5be5d956-f0da-45f8-98a3-be58897aea5f,Merlin Entertainments PLC,"...a bid to gain good publicity for its penguins, the company has named them after public figures, including tennis player Emma Raducanu, diver Tom Daley and Dame Sarah Gilbert, who led development of the AstraZeneca...",AstraZeneca,"MARCH 12, 2024"
UK boards and investors push for higher CEO pay to bridge gap with US,https://www.ft.com/content/e3599807-bfb0-4ad6-9db0-99fbba67677f,,https://www.ft.com/executive-pay,Executive Pay,"...UK bank HSBC, pharmaceutical company AstraZeneca, consumer group Unilever and publisher Pearson are among those that have raised their leaders’ pay or are lobbying investors for support to do so....",AstraZeneca,"MARCH 2, 2024"
Europe’s ‘Granolas’ fuel record stock market surge,https://www.ft.com/content/b87e7bd6-b2be-43ca-bf03-a221383a8a92,https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2Febcc1b61-3e65-4780-8406-2dbab99db77d.jpg?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/european-equities,European equities,"...crunchy acronym was coined by Goldman Sachs for pharma companies GSK and Roche, Dutch chip company ASML, Switzerland’s Nestlé and Novartis, Danish drugmaker Novo Nordisk, France’s L’Oréal and LVMH, the UK’s AstraZeneca...",AstraZeneca,"FEBRUARY 23, 2024"
AstraZeneca unveils successes in treatment of lung cancer,https://www.ft.com/content/b845e8ab-9cbc-482c-aa22-0b5c020be099,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,"...These data reinforce that message,” said Susan Galbraith, executive vice-president of oncology R&D at AstraZeneca....",AstraZeneca,"FEBRUARY 19, 2024"
New drug launches weigh on AstraZeneca profits,https://www.ft.com/content/65338772-1fff-4fec-bb6b-ab63a2d1930a,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,"...AstraZeneca’s jab developed with Oxford university was widely used across the world, but sales fell more than 99 per cent to just $12mn in 2023....",AstraZeneca’s,"FEBRUARY 8, 2024"
"AstraZeneca wrongfully dismissed senior scientist, tribunal finds",https://www.ft.com/content/dc71612d-3408-4de8-b8f0-6b117c792f28,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,"...Muir had worked at AstraZeneca, which has more than 8,700 employees in the UK, since 1998....",AstraZeneca,"JANUARY 31, 2024"
GSK’s new RSV jab set to achieve blockbuster status,https://www.ft.com/content/c8f907b7-c263-4345-9cc5-f951a6a93088,,https://www.ft.com/stream/7e27074f-ef2c-45ed-a6e3-04f0a93451f4,GSK PLC,"...While rival AstraZeneca’s share price has soared almost 90 per cent over the past 5 years, GSK’s stands only 3 per cent higher....",AstraZeneca’s,"JANUARY 29, 2024"
UK government eyes AstraZeneca factory expansion deal,https://www.ft.com/content/d9916629-af1e-421e-a9fd-faa3ea767beb,,https://www.ft.com/uk-manufacturing,UK manufacturing,"...Late last year, AstraZeneca agreed to buy its first vaccine company, Icosovax, in a deal worth up to $1.1bn....",AstraZeneca,"JANUARY 24, 2024"
GSK agrees to buy respiratory medicine specialist Aiolos Bio for $1.4bn,https://www.ft.com/content/54103851-a3fe-4468-81ac-5d3717713914,,https://www.ft.com/stream/7e27074f-ef2c-45ed-a6e3-04f0a93451f4,GSK PLC,"...The £64bn company has long lagged behind £168bn Anglo-Swedish rival AstraZeneca, with investors raising questions over GSK’s pipeline of products and its growth plans....",AstraZeneca,"JANUARY 9, 2024"
AstraZeneca set to make one of its first acquisitions in China,https://www.ft.com/content/42ab62e9-f9b7-48f0-ac72-a9caf925a65d,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,"...In August, AstraZeneca signed a deal with China’s CanSino Biologics for the production of its potential mRNA vaccines....",AstraZeneca,"DECEMBER 26, 2023"
GSK on hunt for drug deals in China,https://www.ft.com/content/fbeb83e5-1880-4a9a-92fe-f57032760338,,https://www.ft.com/stream/7e27074f-ef2c-45ed-a6e3-04f0a93451f4,GSK PLC,"...Shares in GSK have fallen 5 per cent in the past five years, while many of its European rivals including Novo Nordisk, AstraZeneca and Novartis have soared....",AstraZeneca,"DECEMBER 17, 2023"
AstraZeneca strikes $1bn deal to acquire its first vaccine company,https://www.ft.com/content/1ededcba-dd40-455e-8fe0-fc3084389184,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,"...The deal is expected to close in the first quarter of next year, AstraZeneca said....",AstraZeneca,"DECEMBER 12, 2023"
AstraZeneca ties up with AI biologics company to develop cancer drug,https://www.ft.com/content/3d8a0ec6-5b04-486f-af2b-15de1486ffaf,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,...The agreement is part of AstraZeneca’s ambitious plans to replace traditional chemotherapy with a new generation of targeted drugs....,AstraZeneca’s,"DECEMBER 3, 2023"
Directors’ Deals: Strategy refresh spurs Unilever directors,https://www.ft.com/content/36f7c1d2-c04e-4454-a86b-5e6ab026b8ed,,https://www.ft.com/investments,Investments,"...AstraZeneca chair sees past vaccine headwinds

Michel Demaré, non-executive chair of the AstraZeneca board, appears bullish about the company’s prospects....",AstraZeneca,"DECEMBER 1, 2023"
AstraZeneca fights accusations its Covid-19 jab was ‘defective’,https://www.ft.com/content/e605325b-00c0-4c94-aa45-551076d52785,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,...AstraZeneca updated the label to warn recipients of the concern on April 7 and April 15....,AstraZeneca,"NOVEMBER 22, 2023"
AstraZeneca signs deal for oral obesity drug and lifts profit outlook,https://www.ft.com/content/c96bafc8-0ba9-4a24-9239-c5d5ee0d5051,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,"...Shares in AstraZeneca climbed 3 per cent on Thursday, having lost 9.2 per cent in the year to date period....",AstraZeneca,"NOVEMBER 9, 2023"
AstraZeneca hails ‘clinically meaningful’ cancer drug trial results,https://www.ft.com/content/0cb609da-f6b0-4d79-aa84-c972dd60b34e,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,...Galbraith did not comment on whether AstraZeneca had bid to partner on the next drugs in the pipeline....,AstraZeneca,"OCTOBER 23, 2023"
GSK signs £2.5bn shingles vaccine deal with China’s Zhifei,https://www.ft.com/content/fcf72c1d-b26f-45b4-b4c7-98cae0ea94df,,https://www.ft.com/stream/7e27074f-ef2c-45ed-a6e3-04f0a93451f4,GSK PLC,"...While AstraZeneca has built its brand in China and has a large unit that has deep roots beyond Beijing and Shanghai, GSK has had to navigate a trickier path since a corruption scandal in 2015....",AstraZeneca,"OCTOBER 9, 2023"
Ikea and BT among 130 companies to push COP28 for a timeline to ditch fossil fuels,https://www.ft.com/content/653560ff-6706-4e18-a7c0-36b8f6b8f282,,https://www.ft.com/stream/a4c60784-ec51-4e77-8814-93c1b8af82c7,COP28,"...Signatories to the letter also include AstraZeneca, BT Group, Nestlé, Unilever, Bayer, Ørsted, Iberdrola and Vodafone....",AstraZeneca,"OCTOBER 23, 2023"
AstraZeneca settles heartburn drug lawsuits for $425mn,https://www.ft.com/content/b430c9ca-9c48-46ff-afd7-f63e8b501f0c,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,...AstraZeneca shares are down about 4.5 per cent in the year so far....,AstraZeneca,"OCTOBER 3, 2023"
Oxford BioMedica shares soar as vaccine maker raises earnings guidance,https://www.ft.com/content/c4fb01d6-47c1-405f-88e8-5dca41bf71d0,,https://www.ft.com/stream/3e1788b4-0333-4616-9203-5b84eaf49e80,Oxford BioMedica PLC,...The AstraZeneca vaccine has fallen far behind its mRNA rivals from BioNTech/Pfizer and Moderna....,AstraZeneca,"SEPTEMBER 20, 2023"
AstraZeneca sues US government over drug price reforms,https://www.ft.com/content/1be1ec43-7464-4cab-998f-06db633e2b87,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,...AstraZeneca bought a rare disease business when it acquired Alexion in a $39bn deal in 2020....,AstraZeneca,"AUGUST 25, 2023"
"If the UK stock market is cheap, why doesn’t it go up?",https://www.ft.com/content/726a6188-f04c-40e4-b7d1-a055d75e772c,,https://www.ft.com/investments,Investments,...A Morgan Stanley analysis published last month found that core UK plc assets — equities and corporate bonds — “are arguably the cheapest asset classes in the world”....,plc,"AUGUST 25, 2023"
AstraZeneca signs vaccine deal with China’s CanSino,https://www.ft.com/content/89a2e92b-6771-44fe-8958-b4b21f8bbe3d,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,...AstraZeneca said at the time it did “not comment on rumours or speculations around future strategy or M&A”....,AstraZeneca,"AUGUST 9, 2023"
AstraZeneca beats estimates with strong cancer and diabetes drug sales,https://www.ft.com/content/430604de-be9a-4296-a8d9-aaa5702ed1b3,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,...Shares in AstraZeneca rose 4 per cent to £111.54 in morning trading in London....,AstraZeneca,"JULY 28, 2023"
AstraZeneca shares fall after cancer drug trial disappoints investors,https://www.ft.com/content/5eb6f262-4841-4f77-bed9-bd80269a08a4,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,...Shares in AstraZeneca were down 5 per cent to £107.41 in early trading in London....,AstraZeneca,"JULY 3, 2023"
What is happening with Abramovich’s frozen cash?,https://www.ft.com/content/56a2c5dc-fb63-4b33-a64a-30c290e24492,,https://www.ft.com/due-diligence,Due Diligence,"...News round-up

SVB Financial to sell investment banking unit to management team (FT)

PwC, KPMG drawn deeper into Brazilian retailer’s accounting scandal (FT)

AstraZeneca drafts plan to spin off China business...",AstraZeneca,"JUNE 20, 2023"
AstraZeneca/China: break-up deal would reflect necessity not choice,https://www.ft.com/content/92092f54-62e0-4c32-82a8-c11bffe43d56,https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2F83ce6e3f-adff-4629-a388-c33bc9c3973f.jpg?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...As tensions heighten between the US and China, AstraZeneca may offer its own twist by carving out its Chinese business....",AstraZeneca,"JUNE 19, 2023"
AstraZeneca could spin off China business,https://www.ft.com/content/cbedb2a1-10b1-40ba-8ac0-157419a75f19,,https://www.ft.com/ft-news-briefing,FT News Briefing podcast,"...AstraZeneca has drawn up plans to break out its China business, and France is challenging a German-led plan to build up Europe’s air defences....",AstraZeneca,"JUNE 19, 2023"
AstraZeneca drafts plan to spin off China business amid tensions,https://www.ft.com/content/d195f3d0-0101-414e-b190-9691e6c5661d,,https://www.ft.com/chinese-business-finance,Chinese business & finance,...AstraZeneca has also said it is interested in doing deals with Chinese biotechs....,AstraZeneca,"JUNE 18, 2023"
AstraZeneca defies geopolitics to bet on China,https://www.ft.com/content/4f9c5b6a-203a-49ed-8be7-2fd41de1fcd7,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,...AstraZeneca declined to comment on Wang’s statement....,AstraZeneca,"JUNE 4, 2023"
Veteran UK stockpicker Richard Buxton bows out of Jupiter,https://www.ft.com/content/6b776477-9ae1-4bf6-8d6b-2b760e639db2,,https://www.ft.com/stream/34a6c3e7-5a92-4087-89c4-c08a5ad0e3dc,Richard Buxton,"...Top holdings in his Jupiter UK Alpha fund, which manages £585mn, include pharmaceutical company AstraZeneca, power generation business Drax, natural resources group Glencore and Lloyds Banking Group....",AstraZeneca,"JUNE 2, 2023"
Directors’ Deals: AstraZeneca chair bets on upward momentum,https://www.ft.com/content/e82ca397-194d-4019-8414-eb7d7e878ab7,,https://www.ft.com/investments,Investments,...AstraZeneca is the jewel in the FTSE 100’s crown. The pharmaceutical group now has a market capitalisation of £182bn....,AstraZeneca,"MAY 12, 2023"
Europe’s energy majors have a black box problem,https://www.ft.com/content/6e45306d-17cd-4f60-b62d-b6f147df9612,,https://www.ft.com/david-sheppard,David Sheppard,"...Shell’s estimated earnings from trading in 2022 were even larger than the ebitda in the year to March 31 of AstraZeneca, the only company with a bigger market capitalisation in the FTSE 100....",AstraZeneca,"MAY 11, 2023"
AstraZeneca chair says it is paying CEO enough to ward off US rivals,https://www.ft.com/content/fb9f6c33-c745-468b-bb21-cd253b448e44,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,...AstraZeneca also has a secondary listing in New York....,AstraZeneca,"MAY 4, 2023"
GSK struggles to make investors believe its growth story ,https://www.ft.com/content/a0bd6cba-fef4-4186-9a48-cc5dc6a322f4,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,...GSK shares are down 3 per cent over the past five years while AstraZeneca’s have soared more than 125 per cent....,AstraZeneca’s,"APRIL 30, 2023"
AstraZeneca hunts for more China deals after signing partnerships,https://www.ft.com/content/bbd528e9-610d-432e-9fd6-3157ca850992,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,...AstraZeneca is the largest foreign pharmaceutical company by sales in China....,AstraZeneca,"APRIL 27, 2023"
GSK sales fall after demand for Covid treatment plummets ,https://www.ft.com/content/f20ae6ec-8207-4709-9bf9-99613c76980e,,https://www.ft.com/stream/7e27074f-ef2c-45ed-a6e3-04f0a93451f4,GSK PLC,"...Roche shares fell 1.3 per cent in early trading, while AstraZeneca was down 1.7 per cent by mid-morning....",AstraZeneca,"APRIL 26, 2023"
GSK/Bellus Health: biotech M&A is picking up,https://www.ft.com/content/061f7beb-a7d9-44f3-92a3-dbce489d2686,,https://www.ft.com/stream/7e27074f-ef2c-45ed-a6e3-04f0a93451f4,GSK PLC,"...AstraZeneca may end up paying more than a 200 per cent premium for blood pressure biotech CinCor agreed in January.

Bargains are rare. Premia averaged 125 per cent for seven $1bn plus deals this year....",AstraZeneca,"APRIL 18, 2023"
Rolls-Royce closes AI start-up after talks with buyers collapse,https://www.ft.com/content/bc175349-57f2-4473-b3a6-e41ff8974f6b,,https://www.ft.com/uk-companies,UK companies,"...Recent clients included pharmaceutical group AstraZeneca, which wanted to improve its data analytics and artificial intelligence capabilities in its factory processes....",AstraZeneca,"MARCH 17, 2023"
AstraZeneca chief says industry should not pay for NHS Covid costs,https://www.ft.com/content/70a9188d-2efa-49cf-bbb3-da3f28857ba6,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,...He also blamed a “discouraging tax rate” for AstraZeneca’s decision to build a $360mn factory in Ireland rather than the UK....,AstraZeneca’s,"FEBRUARY 9, 2023"
RQ Bio partners with AstraZeneca in Covid antibody fight,https://www.ft.com/content/af9174df-2d5d-4452-ba91-bf1ab1714f1a,,https://www.ft.com/drugs-research,Drugs research,"...“This is a really good model because we suddenly boosted the economy, freed up money from AstraZeneca and invested in employing people . . . if we can bottle this and do it across UK plc it would be amazing...",AstraZeneca,"JANUARY 29, 2023"
"UK/FTSE 100: elated, decorrelated and just a bit inflated",https://www.ft.com/content/e8fd5a3c-4458-43c5-ae17-14d481ad6acf,,https://www.ft.com/stream/fb9dbfea-969b-4e54-893f-ff148c57573c,FTSE 100,"...For example, AstraZeneca, the UK’s largest pharma group, made less than a tenth of its revenues in the UK in 2021....",AstraZeneca,"JANUARY 18, 2023"
AstraZeneca/CinCor: deal may herald start of biotech buying spree,https://www.ft.com/content/dac6a209-ebf6-4676-8493-3f4b563b5514,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...But AstraZeneca has built some buffer into the price. It is paying $1.3bn upfront, or roughly $800mn excluding the cash on CinCor’s balance sheet....",AstraZeneca,"JANUARY 9, 2023"
AstraZeneca to buy US biotech CinCor in $1.8bn deal,https://www.ft.com/content/9ee6ff98-81df-4c7e-a779-76de108fc6c2,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,"...AstraZeneca said baxdrostat could also be combined with Farxiga, its drug for chronic kidney disease....",AstraZeneca,"JANUARY 9, 2023"
A pharma partnership that brought a breakthrough in breast cancer,https://www.ft.com/content/37edd17b-145c-42ef-a725-c16c4f8861b0,,https://www.ft.com/drugs-research,Drugs research,"...In his first week at AstraZeneca, he pushed the idea that AstraZeneca should have a partnership with Daiichi....",AstraZeneca,"JANUARY 6, 2023"
CEO resolutions: ways for GSK’s Walmsley to warm up investors,https://www.ft.com/content/0b806af5-3fd9-456b-8f68-a8385bd5b662,,https://www.ft.com/stream/1ff9508f-e522-4acc-aeb6-fa319c914a97,Emma Walmsley,...It is late to the party in growth areas of oncology and immunotherapy — where rival AstraZeneca delivers hit after hit....,AstraZeneca,"DECEMBER 30, 2022"
GSK on hunt for attractive biotechs ‘hiding in plain sight’ ,https://www.ft.com/content/16017258-368d-49eb-8555-4603a63b6726,,https://www.ft.com/stream/7e27074f-ef2c-45ed-a6e3-04f0a93451f4,GSK PLC,"...Miels said these hires boosted GSK’s capability, especially in oncology, where AstraZeneca has far outperformed the company....",AstraZeneca,"DECEMBER 30, 2022"
GSK/Zantac: heartburn treatment avoids legal remedies,https://www.ft.com/content/f3b7ffea-938a-460e-bd8d-523094deedf4,,https://www.ft.com/stream/7e27074f-ef2c-45ed-a6e3-04f0a93451f4,GSK PLC,"...That is about half the multiple of AstraZeneca, which is admittedly growing faster. GSK looks mispriced for a company committed to more than 10 per cent annual profit growth through 2026....",AstraZeneca,"DECEMBER 7, 2022"
AstraZeneca drops submission to US regulators for Covid-19 vaccine approval,https://www.ft.com/content/85bec048-f0b8-4170-927a-5461cd02070a,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,"...AstraZeneca distributed the vaccine on a non-profit basis during the pandemic, and sold 3bn doses....",AstraZeneca,"NOVEMBER 10, 2022"
GSK: Zantac liabilities overshadow turnround efforts,https://www.ft.com/content/d44bcbdb-8e2f-4e51-b90b-2dde0501655a,,https://www.ft.com/stream/7e27074f-ef2c-45ed-a6e3-04f0a93451f4,GSK PLC,"...The gap with rival AstraZeneca, which has a leading immunotherapy portfolio, is growing wider. Despite strength in vaccines, GSK was nowhere in the fight against Covid....",AstraZeneca,"NOVEMBER 2, 2022"
GSK hails respiratory virus jab after trial results,https://www.ft.com/content/b7d40a54-3417-47b0-ba0f-22d329d1d09d,,https://www.ft.com/stream/7e27074f-ef2c-45ed-a6e3-04f0a93451f4,GSK PLC,"...It provided its adjuvant, which can improve the immune system’s response to vaccine, to other companies including Sanofi that were far behind Pfizer, BioNTech, Moderna, and Oxford/AstraZeneca....",AstraZeneca,"OCTOBER 13, 2022"
Nasal version of Oxford/AstraZeneca Covid vaccine fails in trial,https://www.ft.com/content/4ab29e80-12c0-44a0-8c48-908ab4ebaa55,https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2F82785d46-cdc8-49f4-9b50-ff95aec64cfc.png?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...AstraZeneca, Oxford’s partner for the Covid-19 vaccine, funded the study....",AstraZeneca,"OCTOBER 10, 2022"
Malaria/vaccine development: injection of hope,https://www.ft.com/content/39362d00-0a3f-4024-abd0-ba5cfdddb43c,https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2F33d34aa8-ba7a-4353-9521-5d3774b4ad5c.png?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/medical-science,Medical science,"...The team, which previously developed a Covid-19 jab with AstraZeneca, showed the effectiveness of a booster shot in a study involving more than 400 west African children....",AstraZeneca,"SEPTEMBER 10, 2022"
AstraZeneca succeeds in last-ditch bid to stop former executive starting at GSK this week,https://www.ft.com/content/1660bd90-f232-41dd-9a71-8edf54cb82ca,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,...AstraZeneca declined to comment....,AstraZeneca,"AUGUST 31, 2022"
AstraZeneca sues former executive over move to rival GSK,https://www.ft.com/content/66cc50a5-fafa-48cf-8cac-b03042791e9b,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,...AstraZeneca and GSK declined to comment....,AstraZeneca,"AUGUST 16, 2022"
AstraZeneca to double number of countries where US biotech arm sells rare disease drugs,https://www.ft.com/content/0c6464ac-995a-457c-9388-e9b0573800cd,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,"...“The idea is to use the subsidiaries of AstraZeneca as a leverage to gain a greater reach around the world,” Dunoyer told the Financial Times....",AstraZeneca,"JULY 30, 2022"
AstraZeneca raises forecasts after strong Covid and cancer drug sales,https://www.ft.com/content/754327a5-921f-4d39-be06-17d39da5ad30,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,...AstraZeneca also announced that board member Michel Demaré would succeed Leif Johansson as chair in April 2023....,AstraZeneca,"JULY 29, 2022"
Covid-19 vaccines: shape-shifting virus puts agile manufacturers at an advantage,https://www.ft.com/content/c7f60b6a-a1bd-4896-897f-e4aa8aac7bd7,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...That is not the case with the vaccine made from a modified adenovirus by AstraZeneca/Oxford university.

Nonetheless, AstraZeneca’s jab comes second only to BioNTech/Pfizer’s shot in terms of orders....",AstraZeneca,"JULY 19, 2022"
"GSK split will help deal with ‘perennial underperformance’, says chief",https://www.ft.com/content/77e0a8de-bbf6-4a2d-9918-a199c398626e,,https://www.ft.com/stream/7e27074f-ef2c-45ed-a6e3-04f0a93451f4,GSK PLC,"...The pharmaceuticals division will have an estimated market capitalisation of about £70bn, according to one healthcare banker — smaller than rivals such as AstraZeneca and Sanofi — which could make it vulnerable...",AstraZeneca,"JULY 16, 2022"
Oxford BioMedica extends Covid vaccine deal with AstraZeneca,https://www.ft.com/content/d5a2cdb6-8138-4511-b6c5-a06f31a65e76,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...Before AstraZeneca partnered with Oxford university to develop its Covid vaccine, the pharmaceutical company did not have a significant vaccine business....",AstraZeneca,"JULY 1, 2022"
UK signs £1bn deal with Moderna for new vaccine centre,https://www.ft.com/content/aab5de46-6a30-44fb-9e9d-08b915059b6f,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...In 2020, the government bet heavily on the vaccine developed by AstraZeneca in partnership with Oxford university, which never achieved the efficacy levels of the mRNA jabs....",AstraZeneca,"JUNE 22, 2022"
Sanofi and GSK report ‘positive’ results from Covid booster,https://www.ft.com/content/8da80d74-9ba3-4e96-950f-d6501af39dd9,,https://www.ft.com/stream/35509ea0-bccd-41f1-80e7-d4e83ece7dc0,Sanofi SA,"...The companies only applied for regulatory approval for their first vaccine in February, more than a year after the shots from BioNTech/Pfizer, Moderna and Oxford/AstraZeneca were approved....",AstraZeneca,"JUNE 13, 2022"
"AstraZeneca-Daiichi drug sharply raises breast cancer survival rate, trial shows",https://www.ft.com/content/9a9a3650-4e5b-4dcb-aeb7-1aa8533fd6d5,,https://www.ft.com/medical-science,Medical science,"...Global sales of Enhertu outside the Japanese market were worth $426mn in 2021, according to AstraZeneca....",AstraZeneca,"JUNE 5, 2022"
"Investors’ Chronicle: Treatt, Virgin Money, Vertu Motors",https://www.ft.com/content/81620344-acc5-4b97-a3c0-b9e777b3a27b,,https://www.ft.com/investments,Investments,"...The All-Share index has been pushed up by big rises in a few huge stocks such as Shell, BP and AstraZeneca. Most shares have underperformed the market, which means that so too have most funds....",AstraZeneca,"MAY 13, 2022"
AstraZeneca sales beat forecasts on Covid jab demand,https://www.ft.com/content/55a28845-7361-4c4f-ba79-673cf73b561c,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,...AstraZeneca confirmed its full-year guidance at constant exchange rates....,AstraZeneca,"APRIL 29, 2022"
"Investors’ Chronicle: Oxford Biomedica, Wood Group, Just Eat",https://www.ft.com/content/306c007f-f764-4821-a0fe-059d19681deb,,https://www.ft.com/investments,Investments,"...Put simply, the trajectory of the share price remains intertwined with the clinical relationship with AstraZeneca....",AstraZeneca,"APRIL 22, 2022"
Oxford BioMedica warns revenue will be hit by AstraZeneca jab uncertainty,https://www.ft.com/content/5ef2709d-bb3d-473c-b5c1-9fcf11170387,,https://www.ft.com/stream/3e1788b4-0333-4616-9203-5b84eaf49e80,Oxford BioMedica PLC,...about a very rare side effect with the Oxford/AstraZeneca jab....,AstraZeneca,"APRIL 20, 2022"
GSK to buy Sierra Oncology for £1.5bn to boost cancer drug pipeline,https://www.ft.com/content/d26ea24f-1ea9-4b09-842d-4708090bfe42,,https://www.ft.com/stream/7e27074f-ef2c-45ed-a6e3-04f0a93451f4,GSK PLC,"...“I think we are still very much in the foothills of oncology but what is striking is that these things can change very quickly,” Miels said, pointing to the rapid success of his former employer AstraZeneca...",AstraZeneca,"APRIL 13, 2022"
Breast cancer: precision drugs make inroads against stubborn tumours,https://www.ft.com/content/4cc34cff-1cd0-44ee-bc92-72ee18e35cd5,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,...AstraZeneca in 2019 bought a share in rights to the drug for up to $6.9bn. Positive trial results in February pushed the equity of the Anglo-Swedish company up 4 per cent....,AstraZeneca,"APRIL 6, 2022"
AstraZeneca prepared to ditch effort to secure US approval for Covid vaccine,https://www.ft.com/content/e1edb2b2-0e12-4c83-9257-eeeb2ba29267,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...Roughly 2.6bn doses of AstraZeneca’s cheap and easy to deliver Covid vaccine have been administered globally....,AstraZeneca’s,"MARCH 17, 2022"
WPP chief confident in outlook despite Ukraine conflict ,https://www.ft.com/content/37eb3405-8970-465e-8ebc-f2d637208973,,https://www.ft.com/stream/b445134d-4023-471f-8f0b-17a4b8e6b80a,WPP PLC,"...WPP signed global deals with Coca-Cola and Google during the period and won assignments from clients including AstraZeneca, L’Oréal and J Sainsbury....",AstraZeneca,"FEBRUARY 24, 2022"
Sanofi and GSK to seek approval for delayed Covid vaccine,https://www.ft.com/content/1d0ee887-0c98-4bb2-9d6b-b4c231af31ef,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...It boosted neutralising antibodies by 18- to 30-fold when used as a third dose after an initial series of an mRNA shot, or an adenovirus jab, like those made by Oxford/AstraZeneca and Johnson & Johnson....",AstraZeneca,"FEBRUARY 23, 2022"
Covid vaccine helps push AstraZeneca to record revenues,https://www.ft.com/content/2227262f-b240-407c-b02c-597f481cc121,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,...The new guidance puts AstraZeneca on track to hit a $40bn revenue target a year ahead of schedule....,AstraZeneca,"FEBRUARY 10, 2022"
Taylor Wimpey names new chief in shadow of Elliott,https://www.ft.com/content/93ae1585-948f-4892-a7b9-fee5b074c9dc,,https://www.ft.com/city-bulletin,City Bulletin,"...Email me at citybulletin@ft.com

Briefly

It is all change in UK plc today....",plc,"FEBRUARY 7, 2022"
BHP poised for FTSE 100 exit after shareholders back unification,https://www.ft.com/content/d75f0bec-3694-44ed-babd-3facfe420418,,https://www.ft.com/stream/e63fea1c-5571-4cd7-8952-d02ef388acf0,BHP Group Ltd,...The £128bn company — currently the third biggest in the FTSE 100 behind Shell and AstraZeneca — says a simpler corporate structure will make it more agile and better able to seize on acquisition opportunities...,AstraZeneca,"JANUARY 20, 2022"
The challenge to GSK from Unilever’s blockbuster consumer bid,https://www.ft.com/content/d1ee325f-07e2-4e50-a1f5-1f5d917c9573,,https://www.ft.com/helen-thomas,Helen Thomas,"...No one remembers or cares about takeover premia at that point either: just ask Pascal Soriot at AstraZeneca, who spent years batting off questions about Pfizer’s £55-a-share offer for AstraZeneca (before...",AstraZeneca,"JANUARY 18, 2022"
Covid vaccine makers face investor pressure over global access,https://www.ft.com/content/948196b8-27c7-4dec-996b-c5a1587c6676,https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2F620006d5-eaf5-4c2b-a348-ce8a02613882.jpg?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...The letter was sent to the boards of Pfizer, Moderna, AstraZeneca and Johnson & Johnson....",AstraZeneca,"JANUARY 6, 2022"
Oxford/AstraZeneca vaccine: underdog provider needs to pass potency test,https://www.ft.com/content/bda616ee-8d6f-48d9-823d-74e2ef8c2c04,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...The Oxford/AstraZeneca Covid-19 vaccine may have saved more lives than any other. But it has been dogged by controversy and setbacks....,AstraZeneca,"DECEMBER 23, 2021"
"AstraZeneca booster raises antibodies against Omicron less than Pfizer, study shows",https://www.ft.com/content/55b7bdc6-5bd3-41b6-8d01-91e2f92cff4c,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...A third dose of the Oxford/AstraZeneca Covid-19 vaccine increases antibody levels against the Omicron coronavirus variant far less than a BioNTech/Pfizer booster, a study has shown....",AstraZeneca,"DECEMBER 23, 2021"
Oxford and AstraZeneca developing Omicron-targeted version of vaccine,https://www.ft.com/content/e61faf47-d563-4a87-8f0c-dcf7b8b28b43,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...AstraZeneca had not yet formally applied for an EU-wide booster, Cooke added.

The UK and the EU are mostly using mRNA shots in their booster campaigns....",AstraZeneca,"DECEMBER 21, 2021"
"Covid boosters essential to back up Oxford/AstraZeneca jabs, new study shows",https://www.ft.com/content/1d7371c2-c248-4833-b9c9-2f91f48a4725,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...Oxford and AstraZeneca did not respond to requests for comment....,AstraZeneca,"DECEMBER 20, 2021"
UK’s ‘mix and match’ booster jab strategy backed by new study,https://www.ft.com/content/e5be88c5-f32a-4bde-8ad9-19040b085f75,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...But the Oxford/AstraZeneca and Valneva jabs lagged....,AstraZeneca,"DECEMBER 2, 2021"
Pascal Soriot links AstraZeneca jab to low UK hospitalisations,https://www.ft.com/content/92e77bf1-2266-4534-a043-daa6c8bb413f,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,"...The UK used the Oxford/AstraZeneca jab heavily at the start of its vaccination campaign, as it began immunising older and more vulnerable people first....",AstraZeneca,"NOVEMBER 23, 2021"
AstraZeneca calls on UK to increase science investment,https://www.ft.com/content/b825a376-6e5b-4e2c-a769-5166a57e07d8,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,...The AstraZeneca vaccine powered much of the UK’s initial vaccination campaign....,AstraZeneca,"NOVEMBER 23, 2021"
"News updates from November 23: US to release 50m barrels of oil from reserves, thousands in England sign up for Covid booster, Apple sues Israeli spyware group NSO",https://www.ft.com/content/66724b3d-156d-4595-9494-b38a79507b51,,https://www.ft.com/ft-live-news,FT live news,,,
AstraZeneca’s vaccine hopes lie overseas as it runs out of road in UK,https://www.ft.com/content/35b659c7-af4f-4f60-a7ec-bb02f0c5041b,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,"...of 400,000 AstraZeneca shots were given....",AstraZeneca,"NOVEMBER 19, 2021"
Top scientist defends decision to sell AstraZeneca vaccine at a profit,https://www.ft.com/content/e289de88-2da9-45bc-ad86-093f03a66e49,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...“AstraZeneca has done more than any other company to address that,” he said....",AstraZeneca,"NOVEMBER 16, 2021"
AstraZeneca to take profits from Covid vaccine sales,https://www.ft.com/content/cae4eb5f-1369-4eec-88ec-6fd3afe352ab,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,...AstraZeneca did not have a significant vaccine business before its partnership with Oxford....,AstraZeneca,"NOVEMBER 12, 2021"
AstraZeneca commits to vaccines business with new division,https://www.ft.com/content/36cbdad9-7dd9-4ba5-a4ef-818c41cfadb3,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,...The European Medicines Agency is still reviewing use of the AstraZeneca shot as a booster....,AstraZeneca,"NOVEMBER 9, 2021"
"Covid vaccines associated with rare neurological complications, says study",https://www.ft.com/content/b2b74d63-7c94-4602-82eb-82e87ec5186f,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...AstraZeneca said patient safety was of the “utmost importance” and it worked with regulators to monitor safety information....,AstraZeneca,"OCTOBER 25, 2021"
Lowball investor offer has AstraZeneca on tender hooks,https://www.ft.com/content/0ac9dbac-a7be-47f3-bca7-0db697d9ab52,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,"...TRC tried the same tactic on AstraZeneca in 2004, as well as on dozens of others before and since....",AstraZeneca,"OCTOBER 22, 2021"
Valneva says Covid jab yields stronger immune response than AstraZeneca’s,https://www.ft.com/content/cfc924b5-8f7d-4a7d-8cb0-3a1c6d478c16,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...The vaccine was compared with the AstraZeneca shot because it is no longer seen as ethical to use a placebo since approved jabs became available....,AstraZeneca,"OCTOBER 18, 2021"
Mini-tenders/AstraZeneca: regulatory loophole creates trap for the unwary,https://www.ft.com/content/c4bb99da-8546-4213-b419-50609888b41f,,https://www.ft.com/mergers-acquisitions,Mergers & Acquisitions,...AstraZeneca on Monday urged holders of its American Depository shares to reject a below-market price approach. The offer was an example of a mini-tender....,AstraZeneca,"OCTOBER 18, 2021"
Why GSK investors might want to pass on private equity money,https://www.ft.com/content/95ba1ca6-935f-4a15-80a6-fe2542744535,,https://www.ft.com/cat-rutter-pooley,Cat Rutter Pooley,...Investors might trust AstraZeneca’s Pascal Soriot with such a war chest after the company’s recent outperformance....,AstraZeneca’s,"OCTOBER 14, 2021"
AstraZeneca says Covid drug cuts risk of severe disease or death by 50%,https://www.ft.com/content/17cf953b-38b5-4862-814f-ad51f1066f19,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,"...AstraZeneca’s Covid-19 antibody cocktail cuts the risk of severe disease or death in patients by half, the company said on Monday....",AstraZeneca’s,"OCTOBER 11, 2021"
Asos changes up its chief executive,https://www.ft.com/content/10544474-1c46-48af-8531-cf1a0f66653a,,https://www.ft.com/city-bulletin,City Bulletin,"...AstraZeneca said the latest trial of its antibody cocktail — as opposed to its vaccine — showed positive high-level results, with a “statistically significant reduction in severe Covid-19 or death compared...",AstraZeneca,"OCTOBER 11, 2021"
Yachts to yoghurt: inside the UK government’s venture capital portfolio,https://www.ft.com/content/351cf280-0009-46aa-98dd-797dda764aa7,,https://www.ft.com/uk-economy,UK economy,"...The Treasury has boasted of support for Vaccitech, a start-up involved in the Oxford/AstraZeneca vaccine....",AstraZeneca,"OCTOBER 8, 2021"
WHO backs deployment of first malaria vaccine for children,https://www.ft.com/content/f6d08998-4c25-468e-b99d-20b8e86f53e6,,https://www.ft.com/stream/a9e91132-a389-42c9-8b6a-d5ce24688bf1,World Health Organization,"...Both entities have developed safe and effective Covid-19 vaccines, with AstraZeneca and Pfizer, respectively....",AstraZeneca,"OCTOBER 6, 2021"
AstraZeneca partners with VaxEquity in RNA deal,https://www.ft.com/content/ad6cd548-9e8c-4e67-a819-a4c14b5b53fc,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,...AstraZeneca is taking a stake in the company in a deal that includes up to $195m in milestone payments plus royalties....,AstraZeneca,"SEPTEMBER 23, 2021"
National Express in talks to buy smaller rival Stagecoach,https://www.ft.com/content/8830df7d-01f3-4cb7-b0fe-c2f586aa0749,,https://www.ft.com/city-bulletin,City Bulletin,...AstraZeneca revealed plans to invest $360m to develop a manufacturing facility in Ireland to make primary ingredients for medicines....,AstraZeneca,"SEPTEMBER 21, 2021"
UK prepares for ‘mix and match’ Covid vaccine booster programme,https://www.ft.com/content/a03b8c21-7412-460f-9196-8c41ac80c6eb,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...who had two doses of AstraZeneca....,AstraZeneca,"SEPTEMBER 10, 2021"
EU ends dispute with AstraZeneca over vaccine deliveries,https://www.ft.com/content/7aab1fd5-2d8d-4e53-beba-c8f91298bfd5,https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2F179e14ba-ef63-4f23-acd8-818c40aaec8c.jpg?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...The EU ordered 300m doses of the AstraZeneca vaccine but has only administered 68m....,AstraZeneca,"SEPTEMBER 3, 2021"
GSK hopes for vaccine success as new shot enters late-stage trial,https://www.ft.com/content/81dc5251-a970-4713-aa6f-2b4586df20f8,,https://www.ft.com/stream/7e27074f-ef2c-45ed-a6e3-04f0a93451f4,GSK PLC,"...During phase 3 trials, the safety and effectiveness of the SK Bioscience GBP510 vaccine will be measured against the Oxford/AstraZeneca jab....",AstraZeneca,"AUGUST 31, 2021"
AstraZeneca to seek approval for Covid antibody cocktail,https://www.ft.com/content/4f71162d-125f-46cc-9993-65b47c7ad772,,https://www.ft.com/coronavirus-treatment,Coronavirus treatment,"...AstraZeneca has a deal with the US to supply up to 700,000 doses of the treatment for up to $726m....",AstraZeneca,"AUGUST 20, 2021"
BHP to shift main stock market listing from London to Sydney,https://www.ft.com/content/47e226aa-315c-48e3-aef3-44f83075dcc3,,https://www.ft.com/stream/e63fea1c-5571-4cd7-8952-d02ef388acf0,BHP Group Ltd,...Plc shareholders will receive shares Ltd on a one-to-one basis....,Plc,"AUGUST 17, 2021"
Vaccine patents battle intensifies as poor nations struggle in war on coronavirus,https://www.ft.com/content/cf12e1ba-ee25-4a0a-870d-53f5b66b0996,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...In the case of AstraZeneca, their fears would prove to be unfounded....",AstraZeneca,"AUGUST 16, 2021"
AstraZeneca reveals strong Covid vaccine sales but warns of US approval delays,https://www.ft.com/content/8e14257f-8bf8-4dc7-9680-9d489654d2b6,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,...Shares in AstraZeneca were flat on Thursday....,AstraZeneca,"JULY 29, 2021"
AstraZeneca admits ‘complicated’ Thai vaccine production launch,https://www.ft.com/content/1c54c222-98c6-4fc7-b43c-1b9115a27750,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...However, it is in line with a commitment floated by AstraZeneca in a leaked letter to Thailand’s Health Minister Anutin Charnvirakul....",AstraZeneca,"JULY 24, 2021"
"GSK to create up to 5,000 jobs as it plans huge biotech centre",https://www.ft.com/content/0e8a4cb7-020c-4d3c-91f9-8b2430d6b762,,https://www.ft.com/stream/7e27074f-ef2c-45ed-a6e3-04f0a93451f4,GSK PLC,"...The programme is advised by a scientific advisory council chaired by Sir John Bell, part of the team who developed the Oxford/AstraZeneca Covid-19 vaccine....",AstraZeneca,"JULY 16, 2021"
Burberry makes ‘excellent start’ to its new trading year,https://www.ft.com/content/4a3e989e-27e8-4199-81ac-47361fb0c08d,,https://www.ft.com/city-bulletin,City Bulletin,"...Briefly

The US health regulator rejected AstraZeneca’s application to approve its roxadustat drug for the treatment of anaemia in chronic kidney disease....",AstraZeneca’s,"JULY 16, 2021"
SSP chief executive to join private-equity backed business,https://www.ft.com/content/797d025f-7381-4550-9d52-3969e29c3e73,,https://www.ft.com/city-bulletin,City Bulletin,"...The Competition and Markets Authority gave final clearance to AstraZeneca’s proposed $39bn takeover of US peer Alexion, which is now expected to close on July 21....",AstraZeneca’s,"JULY 14, 2021"
Graduate jobs after the pandemic: ‘I’m only an email address to my team’ ,https://www.ft.com/content/0c4bf673-ab70-4d8f-98c7-9ab3b0f7e261,,https://www.ft.com/content/2424f04a-ccd5-4e62-a523-27c0dbe0deaf,Graduates: the class of 2021,"...Confidence and presentation skills may not have developed, says Tanya de Grunwald, founder of the Good + Fair Employers Club, a group of graduate employers that includes AstraZeneca, the pharmaceutical group...",AstraZeneca,"JULY 4, 2021"
Coronavirus: US automakers say vaccinated workers can ditch masks - as it happened,https://www.ft.com/content/d452224b-cb7b-4294-bfff-05255a391a83,,https://www.ft.com/coronavirus,Coronavirus,,,
What next for AstraZeneca vs the EU?,https://www.ft.com/content/59e5a856-ba37-4f57-91b5-eddca9709497,,https://www.ft.com/tom-braithwaite,Tom Braithwaite,...It looks a lot like the EU won in theory and AstraZeneca in practice....,AstraZeneca,"JUNE 25, 2021"
Morrisons bid highlights the tricky business of stakeholder M&A,https://www.ft.com/content/8e256d28-0193-4bd0-a5cd-46f34d10bc23,,https://www.ft.com/helen-thomas,Helen Thomas,...Pfizer’s interest in AstraZeneca wasn’t even official in 2014 before the then-shadow business secretary Chuka Umunna grabbed one to warn about “asset stripping” and how any deal would be a bad one for “British...,AstraZeneca,"JUNE 21, 2021"
GSK faces struggle to convince investors as activist Elliott lurks,https://www.ft.com/content/c8318b00-6102-4d7c-8b6e-92ea5ec2e11f,,https://www.ft.com/health,Health,"...Luke Miels, president of GSK, who runs the commercial business, compared the company to AstraZeneca, where he used to work, which was also behind in oncology but has now rocketed ahead....",AstraZeneca,"JUNE 19, 2021"
EU fails in legal bid to speed up AstraZeneca vaccine supply,https://www.ft.com/content/6c535f67-c154-4044-91d0-8ed375cab361,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,...But it did not order AstraZeneca to use UK production to fulfil the EU order....,AstraZeneca,"JUNE 18, 2021"
Delta variant tests UK guidance on under-40s and the AstraZeneca jab,https://www.ft.com/content/6e6d641c-087a-4429-be27-0342ef14ed7d,,https://www.ft.com/coronavirus,Coronavirus,"...In comparison, the one-off risk of developing so-called cerebral venous sinus thrombosis due to the AstraZeneca jab was about 1.5 per 100,000....",AstraZeneca,"JUNE 17, 2021"
AstraZeneca’s Thai deal brings renewed controversy,https://www.ft.com/content/e7c35384-6329-437f-86d0-07d81cc528ac,,https://www.ft.com/ft-view,The editorial board,"...Some rivals, meanwhile, are charging five times AstraZeneca and making hefty profits....",AstraZeneca,"JUNE 17, 2021"
Antibody screening could transform Covid-19 vaccine distribution,https://www.ft.com/content/4a7575ac-605a-4589-8ed2-19036ece7ced,,https://www.ft.com/stream/f14c6bcc-8e52-43d4-84cd-a2a8579a69f9,Ara Darzi,"...Indeed, AstraZeneca has licensed its Covid-19 vaccine to be produced at cost by the Serum Institute of India and others....",AstraZeneca,"JUNE 17, 2021"
AstraZeneca Covid antibody treatment fails to hit main targets in latest trial,https://www.ft.com/content/67066cb2-054e-4525-b884-546061a35d6a,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,"...AstraZeneca has agreed to supply up to 700,000 doses of the antibody treatment to the US government, worth up to $726m....",AstraZeneca,"JUNE 15, 2021"
Boohoo on course to deliver solid growth,https://www.ft.com/content/72f0b616-fe8a-4888-8fde-e37d65914ad5,,https://www.ft.com/city-bulletin,City Bulletin,"...Briefly

AstraZeneca said a late-stage clinical trial of its experimental Covid-19 antibody drug had failed to meet its primary goal....",AstraZeneca,"JUNE 15, 2021"
AstraZeneca,https://www.ft.com/content/71b52de0-4f8c-4a30-97cf-9bc1776faf03,,https://www.ft.com/stream/a534e712-f97c-44a9-ad2c-42a8e9da5682,FT Collections,,,"JUNE 10, 2021"
Thailand to launch mass vaccine drive as Covid cases surge,https://www.ft.com/content/9e85b179-8e31-4549-b0be-e349c1d0e273,,https://www.ft.com/thailand,Thailand,...“But AstraZeneca could do a lot by being more upfront.”...,AstraZeneca,"JUNE 6, 2021"
AstraZeneca appoints new finance director,https://www.ft.com/content/173b55cc-a6f7-4ccd-b001-13788734101f,,https://www.ft.com/city-bulletin,City Bulletin,"...The changes are conditional upon AstraZeneca finalising its purchase of Alexion, likely in the third quarter....",AstraZeneca,"JUNE 4, 2021"
AstraZeneca and Merck point to progress in fighting breast cancer,https://www.ft.com/content/aa6332fd-7ca2-4e01-91b2-928c4b2e77f5,,https://www.ft.com/medical-science,Medical science,...AstraZeneca’s innovation in oncology has helped turn round performance at the Anglo-Swedish drugmaker in recent years....,AstraZeneca’s,"JUNE 3, 2021"
Covid-19 vaccines burnt as shelf-life complicates global rollout,https://www.ft.com/content/8e1385cf-1569-4bf8-904e-fdc29367a758,https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2F39b2739d-e20e-4b32-ad5b-03bbf34a0673.jpg?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...“We were to get the 3.6m doses of AstraZeneca, but we’ve got only 1m,” Akhwale said....",AstraZeneca,"JUNE 1, 2021"
Does the AstraZeneca vaccine have a future?,https://www.ft.com/content/2bae4886-78e5-4586-aa6f-2d3154e6d936,,https://www.ft.com/content/71b52de0-4f8c-4a30-97cf-9bc1776faf03,AstraZeneca ,"...If supply is plentiful, AstraZeneca could be forced to compete on price....",AstraZeneca,"MAY 28, 2021"
Scientists claim to have solved Covid vaccine blood-clot puzzle,https://www.ft.com/content/f76eb802-ec05-4461-9956-b250115d0577,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...The rare blood-clotting reaction that has disrupted the rollout of the AstraZeneca and J&J shots has been recorded in 309 of the 33m people who have received the AstraZeneca vaccine in the UK, causing 56...",AstraZeneca,"MAY 26, 2021"
EU to demand billions in damages if AstraZeneca fails to hit vaccine target,https://www.ft.com/content/dd191c42-3509-42c6-8fd2-e617f16935ec,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...“AstraZeneca has to catch up with the agreed calendar as soon as possible.”...,AstraZeneca,"MAY 26, 2021"
UK regulator probes $39bn AstraZeneca tie-up with Alexion,https://www.ft.com/content/96d46d74-6e9b-4691-9384-2f28e637cc51,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,"...He said AstraZeneca could help Alexion expand in emerging markets, including China.

Shares in AstraZeneca fell 0.4 per cent to £81.20p in morning trading in London....",AstraZeneca,"MAY 25, 2021"
FirstFT: Today’s top stories,https://www.ft.com/content/87da4657-36df-4157-8302-c661e2f7f919,,https://www.ft.com/firstft,FirstFT,"...Pascal Soriot, the chief executive of AstraZeneca, has insisted its Covid-19 vaccine has a future, in his first interview following a string of setbacks....",AstraZeneca,"MAY 24, 2021"
"Vaccines work well against variant found in India, data show",https://www.ft.com/content/e7147144-11ff-45bc-96f1-236380c9df5d,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...Protection conferred by two doses of the Oxford/AstraZeneca vaccine was lower against both variants, at 66 per cent for B.1.1.7 and 60 per cent for B.1.617.2....",AstraZeneca,"MAY 22, 2021"
AstraZeneca chief says ‘vaccine has a future’ after setbacks,https://www.ft.com/content/02c543e0-45a6-4189-94cf-30a5c3d5499d,,https://www.ft.com/content/71b52de0-4f8c-4a30-97cf-9bc1776faf03,AstraZeneca ,"...AstraZeneca is in talks with governments, including the UK, about new contracts for booster doses, he said....",AstraZeneca,"MAY 21, 2021"
UK launches extensive trial of third booster shots of Covid vaccines,https://www.ft.com/content/f60b3201-8efd-494f-b4c7-afea6be3a4ba,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...Some participants will receive the same AstraZeneca or Pfizer shot as their original two....,AstraZeneca,"MAY 19, 2021"
"Oxford/AstraZeneca booster works well, study finds",https://www.ft.com/content/c5297d58-ad6d-490f-89e0-74f9c13377e4,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...Oxford and AstraZeneca did not comment. It is not known when they plan to publish the data....,AstraZeneca,"MAY 19, 2021"
Time for other vaccine makers to follow lead of Oxford and AstraZeneca,https://www.ft.com/content/65856fab-e394-4407-adf9-63edd8acdad3,,https://www.ft.com/stream/493014d4-58c6-4b0f-9533-336d3600ab9e,Louise Richardson,...Today AstraZeneca is administering vaccines around the world for $5 or under per dose and we account for 98 per cent of supplies to Covax....,AstraZeneca,"MAY 18, 2021"
UK trial points to mixed vaccines raising risk of side-effects,https://www.ft.com/content/b236171f-f478-4f7e-ad94-5b2c81e0e49e,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...For example, 34 per cent of people who received an AstraZeneca shot followed by a Pfizer jab felt feverish, compared with 10 per cent who got two AstraZeneca doses....",AstraZeneca,"MAY 12, 2021"
AstraZeneca chief suffers investor rebellion over pay,https://www.ft.com/content/14f8277f-7cd7-4e1d-938b-f73ad3da6473,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,"...Since Soriot took over in 2012, he has transformed AstraZeneca’s drug pipeline, more than doubling the company’s share price....",AstraZeneca’s,"MAY 11, 2021"
The real dangers in AstraZeneca’s blockbuster pay policy,https://www.ft.com/content/207622c5-7df7-453a-9fcf-e6d1538b70f1,,https://www.ft.com/helen-thomas,Helen Thomas,...AstraZeneca is facing a revolt at its shareholder meeting on Tuesday over the pay for chief executive Pascal Soriot....,AstraZeneca,"MAY 10, 2021"
UK to offer under-40s alternative to AstraZeneca vaccine,https://www.ft.com/content/8136478f-d447-4aef-8078-9b72e5ce5149,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...AstraZeneca did not respond to a request for comment....,AstraZeneca,"MAY 7, 2021"
Vaccitech slides in US stock market debut,https://www.ft.com/content/031b16f0-c80c-410f-8b09-8cff139fc454,,https://www.ft.com/ipos,IPOs,...It is also working on another Covid-19 vaccine that could be used as a booster for those who received the AstraZeneca shot....,AstraZeneca,"APRIL 30, 2021"
"AstraZeneca on track to submit data for US vaccine approval, says chief",https://www.ft.com/content/01d22a56-e606-45d4-a127-86ad03761993,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,"...Soriot has invested in rejuvenating AstraZeneca’s pipeline of drugs, particularly in oncology....",AstraZeneca’s,"APRIL 30, 2021"
Rare blood clots from AstraZeneca vaccine mostly affect younger people,https://www.ft.com/content/dfaff95b-8f64-4963-9483-494498c55863,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...the age of 40 are offered an alternative to the AstraZeneca vaccine....,AstraZeneca,"APRIL 29, 2021"
Covid has shown the subjective nature of risk perception,https://www.ft.com/content/852c28c7-8089-464f-98b5-e7a0fe14fa68,,https://www.ft.com/stream/29cd35b2-bbfb-4a4c-9b2a-5bddbcde7ee7,Jemima Kelly,"...When reports began to emerge that Britain’s AstraZeneca vaccine could be linked to rare but dangerous blood clots in the brain, I recall feeling a sense of doom....",AstraZeneca,"APRIL 28, 2021"
Factory troubles slow US move to share AstraZeneca vaccines,https://www.ft.com/content/8b6128fa-127d-4cdb-9ea2-900ec5abb013,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...AstraZeneca did not respond to a request to comment....,AstraZeneca,"APRIL 27, 2021"
US to share up to 60m doses of AstraZeneca’s Covid vaccine ,https://www.ft.com/content/db461dd7-b132-4f08-a94e-b23a6764bdb3,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...The US had previously said it would send several million AstraZeneca doses to Canada and Mexico....,AstraZeneca,"APRIL 26, 2021"
Biotech behind AstraZeneca vaccine aims to raise $117m at IPO,https://www.ft.com/content/3f41a41a-3c4a-4831-b922-2bd0bd3baea0,,https://www.ft.com/stream/de97ac77-7606-44c8-abe4-70ee0acb3cea,Vaccitech,"...Vaccitech, the company behind the Oxford/AstraZeneca vaccine platform, said it planned to raise as much as $117m in a US initial public offering that would value the company at about $613m....",AstraZeneca,"APRIL 26, 2021"
EU to sue AstraZeneca over vaccine supply shortfall,https://www.ft.com/content/78e8c248-4deb-4728-8b2b-d3cf60fbff1b,,https://www.ft.com/european-union,European Union,...AstraZeneca later downgraded its second quarter supply estimates from 180m shots to 70m....,AstraZeneca,"APRIL 26, 2021"
Big pay battles loom as investors say no to pandemic bonuses,https://www.ft.com/content/d18b99f1-d975-4f0a-ae92-29041f797218,,https://www.ft.com/executive-pay,Executive Pay,"...Other companies in the spotlight over pay include BAE Systems, which handed its chief executive £2m to stay at the business; AstraZeneca because of its decision to increase the maximum long-term incentive...",AstraZeneca,"APRIL 25, 2021"
Why GSK will struggle to mount AstraZeneca-style revival,https://www.ft.com/content/f411acf1-1d4e-4ecf-a902-6435b8924c90,,https://www.ft.com/helen-thomas,Helen Thomas,"...No, AstraZeneca eight years ago.

It’s easy to forget how tarnished the current golden child of UK pharmaceuticals was back then....",AstraZeneca,"APRIL 23, 2021"
Scientists split over advice on giving AstraZeneca jab to UK under-40s,https://www.ft.com/content/a3a487ec-4926-4941-b783-dcd27ca094c7,https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2Ffa3d0686-4aa5-425b-8a86-7c719561fcf2.jpg?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...AstraZeneca declined to comment....,AstraZeneca,"APRIL 22, 2021"
Covid vaccines and the race to understand blood clots,https://www.ft.com/content/42f57da1-577c-4685-952f-2630fb0fb01a,https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2Ffe5652a1-8484-4995-b49c-05bd58b8a2c4.jpg?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...The rare blood-clotting reaction that has disrupted the rollout of the Oxford/AstraZeneca and Johnson & Johnson coronavirus vaccines is now the focus of a heated scientific debate over why the shots may...,AstraZeneca,"APRIL 20, 2021"
Pipeline pressure and Elliott’s stake have GSK in a spin ,https://www.ft.com/content/f135e584-bda2-47ad-a414-38346abaec04,,https://www.ft.com/stream/7e27074f-ef2c-45ed-a6e3-04f0a93451f4,GSK PLC,"...While investors may be glad GSK has escaped the scrutiny that AstraZeneca is suffering, it has missed out on the billions of dollars of revenue forecast by Pfizer and Moderna....",AstraZeneca,"APRIL 16, 2021"
"Pregnant women can receive Covid vaccine, say UK health chiefs",https://www.ft.com/content/8d81f095-0885-4a55-be69-49cf617eca45,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...The AstraZeneca jab is based on different technology known as adenovirus....,AstraZeneca,"APRIL 16, 2021"
"Investors’ Chronicle: JD Sports, Oxford BioMedica, Tesco",https://www.ft.com/content/e3b0b6b8-fb33-4de9-a61d-fb0e97d051b3,,https://www.ft.com/investments,Investments,"...The Oxford university/AstraZeneca Covid-19 vaccine saga has had several plot twists in recent weeks, amid mounting fears about a suspected, extremely rare-side effect of blood clotting....",AstraZeneca,"APRIL 16, 2021"
‘Slow’ UK response to AstraZeneca side-effects alarms experts,https://www.ft.com/content/5251e1b9-b88d-4bfc-95fa-29dc34d37652,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...By March 15 eight European countries had suspended their AstraZeneca inoculation programmes....,AstraZeneca,"APRIL 15, 2021"
Norway delays AstraZeneca vaccine ruling to further probe risks,https://www.ft.com/content/fcc50938-4190-43c8-b8f9-d011b5f840e1,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...Hoie said: “If we now say no to AstraZeneca, it could have consequences for the opportunity to assess the use of Johnson & Johnson....",AstraZeneca,"APRIL 15, 2021"
Hedge fund Elliott builds multibillion-pound stake in GSK,https://www.ft.com/content/c1d64eff-7cfb-4f73-9a48-45857640f9a9,,https://www.ft.com/stream/7e27074f-ef2c-45ed-a6e3-04f0a93451f4,GSK PLC,"...In December, AstraZeneca agreed to buy Alexion in a $39bn deal....",AstraZeneca,"APRIL 15, 2021"
EU bets big on BioNTech/Pfizer jab as Danes stop giving AstraZeneca,https://www.ft.com/content/7b992d68-2814-4390-9d71-ff4c704c9f98,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...Norway is set to announce its decision on whether to permanently suspend the AstraZeneca jab on Thursday....,AstraZeneca,"APRIL 14, 2021"
AstraZeneca vaccine elicits stronger T-cell response in elderly than Pfizer jab,https://www.ft.com/content/4492746e-6a14-4993-9c21-cd9c9f37eca4,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...However, participants who received the AstraZeneca jab were more likely to also have a T-cell response....",AstraZeneca,"APRIL 14, 2021"
Can mixing Covid vaccines work?,https://www.ft.com/content/428d719a-b53e-4bd1-8cd6-ba796291120b,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...Snape said another mouse study combining the AstraZeneca and Pfizer vaccines in a course had also been “encouraging”....,AstraZeneca,"APRIL 13, 2021"
Vaccitech warns of blood clot risk in IPO filing,https://www.ft.com/content/06860275-4cbe-4cf3-9251-5e47e87ccf0d,,https://www.ft.com/stream/de97ac77-7606-44c8-abe4-70ee0acb3cea,Vaccitech,...The company received a one-off payment of $2.5m when it transferred the technology behind the Oxford/AstraZeneca vaccine last year....,AstraZeneca,"APRIL 9, 2021"
AstraZeneca cuts this week’s vaccine deliveries to EU by half,https://www.ft.com/content/df5020f4-461e-443e-8d55-f3234690d049,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,...AstraZeneca has previously pointed to this issue as one of the reasons behind its shortfalls....,AstraZeneca,"APRIL 9, 2021"
"People struggle to assess risk, especially in a pandemic",https://www.ft.com/content/07bf5293-3a06-4fa9-96b8-74406e6abf72,,https://www.ft.com/stream/d0d7d109-3297-4a05-ade1-8db25b4e9e49,Melinda Mills,"...We know that the risk of blood clots after the AstraZeneca jab is extremely low at four in a million, with chances of death at one in a million....",AstraZeneca,"APRIL 9, 2021"
France to offer mRNA jabs as second dose after AstraZeneca ,https://www.ft.com/content/db295bb9-d1fe-47f8-bc0f-eb40dfaf545f,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...Trials studying a combination of vaccines, including AstraZeneca’s and Russia’s Sputnik V shots, are under way....",AstraZeneca’s,"APRIL 9, 2021"
Are women at greater risk from blood clots linked to the AstraZeneca jab?,https://www.ft.com/content/45cb34d0-eb43-479c-aabf-2e3f537aa2bc,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...“I’m loath to say it’s 100 per cent AstraZeneca because we don’t know yet, but it does pretty much seem to be AstraZeneca,” she said....",AstraZeneca,"APRIL 9, 2021"
Experts back UK age limit for rollout of AstraZeneca vaccine,https://www.ft.com/content/5db4a13f-11b1-4f1e-891b-9f68c639a6f9,,https://www.ft.com/coronavirus-treatment,Coronavirus treatment,...The stark contrast between the UK’s approach for the use of the Oxford/AstraZeneca vaccine and many other countries became clear on Thursday morning....,AstraZeneca,"APRIL 8, 2021"
African Union halts AstraZeneca vaccine purchases over supply concerns,https://www.ft.com/content/869ba1e3-7805-47c2-b4ed-935da38ff028,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...The decision not to buy AstraZeneca is so as “not to duplicate efforts”, Nkengasong said....",AstraZeneca,"APRIL 8, 2021"
Maintaining trust in the AstraZeneca vaccine,https://www.ft.com/content/9be92acd-ad88-4432-acc7-ad3a655096d6,,https://www.ft.com/ft-view,The editorial board,...; African countries would still receive AstraZeneca vaccines through the global Covax initiative....,AstraZeneca,"APRIL 8, 2021"
Spain and Italy to restrict AstraZeneca’s Covid jab to over-60s,https://www.ft.com/content/3dd76041-d8ac-4465-99a5-4569e8b9706e,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...Of those, slightly more than 2m have received the AstraZeneca jab, whose use had been accelerating in recent weeks....",AstraZeneca,"APRIL 8, 2021"
Breton seeks to inject drive into EU’s stuttering vaccine push,https://www.ft.com/content/a816a6cd-030d-4258-9a48-23bc8ca75b7e,,https://www.ft.com/stream/043de40a-de05-4c1c-9b76-69e3a1bbdbfa,Thierry Breton,"...Since a big cut in AstraZeneca supply is already factored in, the target should be achievable....",AstraZeneca,"APRIL 8, 2021"
AstraZeneca vaccine guidance leaves UK facing challenges over supply and hesitancy,https://www.ft.com/content/adeda24a-52ca-499b-b747-905a6fd7ad3f,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...“AstraZeneca has had a rougher ride than the other vaccines — or has given itself a rougher ride — which has not helped the trajectory of confidence,” she added....",AstraZeneca,"APRIL 7, 2021"
UK advises under-30s to take offer of  alternative to AstraZeneca vaccine,https://www.ft.com/content/3870ba5b-3f71-4bb0-986f-47d8fa3c6842,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...Emer Cooke, head of the EMA, said unusual blood clottings “should be listed as possible side effects of the [AstraZeneca] vaccine”....",AstraZeneca,"APRIL 7, 2021"
Fresh questions for AstraZeneca over its vaccine,https://www.ft.com/content/aa3664d4-d06c-40e1-a276-e6f4a2b0d147,,https://www.ft.com/disrupted-times,Disrupted Times,"...The new advice came as the European Medicines Agency, the EU regulator, said it had established a link between rare blood clots in the brain and the AstraZeneca jab....",AstraZeneca,"APRIL 7, 2021"
India to restart Covid vaccine exports in June if local cases fall  ,https://www.ft.com/content/fcdffb8f-f86e-4bd9-adec-20256aeb0a07,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...The Serum Institute of India, the world’s largest vaccine manufacturer, will resume exports of the Oxford/AstraZeneca Covid-19 vaccine in June but only if domestic coronavirus cases decline....",AstraZeneca,"APRIL 7, 2021"
Moderna’s UK vaccine rollout begins in Wales,https://www.ft.com/content/f1ff80af-d204-4c33-b9a9-c3bf72a50cf2,https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2F26f9b600-083b-4caf-bfa8-1883b8bcae89.jpg?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...That’s why we have them, that’s why they are independent,” he said on Tuesday on a visit to an AstraZeneca plant....",AstraZeneca,"APRIL 6, 2021"
Oxford pauses AstraZeneca Covid vaccine study on children,https://www.ft.com/content/9748269c-3f40-40e5-9606-2d2cc0d4946f,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...Restrictions on imports of the AstraZeneca vaccine from India are another source of uncertainty....,AstraZeneca,"APRIL 6, 2021"
J&J takes over US Covid vaccine factory after 15m doses spoiled,https://www.ft.com/content/3906ee0c-8062-496c-9bb7-d1814a30bdf3,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...UK-based AstraZeneca said it would move Covid-19 vaccine production out of the facility to another location....,AstraZeneca,"APRIL 4, 2021"
Blood clots and the AstraZeneca Covid vaccine: is there a link?,https://www.ft.com/content/d5cd63c6-af01-4d29-a5e5-b69ade4f3803,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...AstraZeneca shots....,AstraZeneca,"APRIL 2, 2021"
UK reports 7 blood clot deaths among recipients of AstraZeneca jab,https://www.ft.com/content/2e52a5b0-29b9-4c7e-8cfb-97bf8edea865,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...Thirty cases of blood clots combined with low platelet counts equates to roughly one case in every 600,000 people who have received the AstraZeneca vaccine....",AstraZeneca,"APRIL 2, 2021"
EU warns ‘zero’ jabs shipped to UK until AstraZeneca meets bloc’s targets,https://www.ft.com/content/28158bed-5f07-4504-9a00-2f3d8f7519df,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...After initially pledging to deliver up to 120m doses to the EU in the first quarter of the year, AstraZeneca ended up slashing its commitment to 30m....",AstraZeneca,"MARCH 31, 2021"
Germany will only use AstraZeneca jab on over-60s,https://www.ft.com/content/6e1774a8-2e22-4d20-a31d-b83e47e8b880,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...The German government has decided that the Oxford/AstraZeneca vaccine should be used only on people over the age of 60 amid concerns over possible side-effects....,AstraZeneca,"MARCH 30, 2021"
GSK to help manufacture 60m doses of Novavax Covid vaccine in UK ,https://www.ft.com/content/55f1776f-84bb-45bd-83cc-bdc825817879,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...However, it hit a setback earlier this month when it emerged that supplies would be far lower in April than expected, in part because of delays in securing additional doses of the AstraZeneca vaccine from...",AstraZeneca,"MARCH 29, 2021"
Pascal Soriot: the pharma CEO navigating a vaccine storm,https://www.ft.com/content/2ce008f2-b5d2-4578-802d-d69b89d7036c,,https://www.ft.com/content/71b52de0-4f8c-4a30-97cf-9bc1776faf03,AstraZeneca ,"...Around midnight on Tuesday, battered by the latest furore over his company’s life-saving Covid vaccine, Pascal Soriot, chief executive of AstraZeneca, sent an email to a friend....",AstraZeneca,"MARCH 27, 2021"
Europe warns hospitals at ‘breaking point’ as third Covid wave hits ,https://www.ft.com/content/4c87ff52-4957-49b5-abf0-dacfa4ed5a41,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...With the pandemic threatening to run out of control, EU leaders have lashed out at AstraZeneca for holding up their vaccination campaigns after failing to deliver promised doses....",AstraZeneca,"MARCH 26, 2021"
India rethinks vaccine export plans as infections surge,https://www.ft.com/content/65f92a2f-edcc-4af0-ab18-4d38ca88a205,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...At the time, the company said the fire killed five workers and that it would not affect production of the AstraZeneca vaccine....",AstraZeneca,"MARCH 26, 2021"
EU regulator approves contested Dutch vaccine production site,https://www.ft.com/content/5673962a-a813-4a30-ba27-ee280e5022fa,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...EU officials have said it was the job of AstraZeneca to provide the necessary data to the EMA to secure official authorisation....,AstraZeneca,"MARCH 26, 2021"
Norway extends AstraZeneca jab suspension over blood clots fears,https://www.ft.com/content/40943f39-a9de-44ea-a7b3-2d45199d6ae1,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...“It is a difficult but correct decision to extend the pause for the AstraZeneca vaccine....,AstraZeneca,"MARCH 26, 2021"
Health scares test confidence of Europeans in AstraZeneca vaccine,https://www.ft.com/content/3dd22394-8dc2-4d34-b0cd-09e01ecdfd91,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...She finally secured an appointment to receive the AstraZeneca jab on April 6. “AstraZeneca or another vaccine, it doesn’t matter,” she said....",AstraZeneca,"MARCH 26, 2021"
EU leaders clash over vaccine distribution in tense summit,https://www.ft.com/content/486a65fe-0608-4230-b9d5-c990f10d5be8,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...Kurz was leading efforts to ensure that Austria is part of a group of EU countries given extra doses after being affected by AstraZeneca’s delivery shortfalls....,AstraZeneca’s,"MARCH 25, 2021"
Disputes leave AstraZeneca boss with chronic vaccine headache,https://www.ft.com/content/7df5e368-a1dd-409f-9363-5b2e623ce708,,https://www.ft.com/content/71b52de0-4f8c-4a30-97cf-9bc1776faf03,AstraZeneca ,"...On Sunday, Soriot’s friend José Baselga, AstraZeneca’s head of oncology R&D, died in Spain....",AstraZeneca’s,"MARCH 25, 2021"
Sweden clears AstraZeneca vaccine for use in over-65s,https://www.ft.com/content/a73d6bfd-662e-4055-b9b2-f2bf5d1d670d,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...Finland suspended the AstraZeneca vaccine last Friday but on Wednesday reinstated it for those aged 65 and over....,AstraZeneca,"MARCH 25, 2021"
Trial set to start of AstraZeneca Covid vaccine as nasal spray,https://www.ft.com/content/48fe2e97-f9e5-4291-b965-0728bfc42213,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...Oxford and AstraZeneca did not respond to requests for comment....,AstraZeneca,"MARCH 25, 2021"
India blocks vaccine exports in blow to dozens of nations,https://www.ft.com/content/5349389c-8313-41e0-9a67-58274e24a019,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...AstraZeneca did not immediately respond to requests for comment. India’s foreign ministry declined to comment....,AstraZeneca,"MARCH 25, 2021"
AstraZeneca and the lessons of vaccine hesitancy,https://www.ft.com/content/087cab8e-3587-49f9-8efc-de36c47803e3,,https://www.ft.com/david-pilling,David Pilling,"...The rollout of the AstraZeneca jab has appeared designed to shake faith in what is, almost certainly, an excellent vaccine....",AstraZeneca,"MARCH 25, 2021"
AstraZeneca revises down efficacy rate for US Covid vaccine trial,https://www.ft.com/content/5852349c-d4c5-4da5-9c02-031d751db89f,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...AstraZeneca is also mired in a conflict with the EU over alleged supply shortfalls....,AstraZeneca,"MARCH 25, 2021"
AstraZeneca/Pascal Soriot: good deed may go unpunished,https://www.ft.com/content/d3d021e5-5ab2-4624-890a-544ebb1d5543,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...Please tell us what you think of the dispute in the EU over AstraZeneca in the comments section below...,AstraZeneca,"MARCH 24, 2021"
AstraZeneca’s shot at redemption sows further confusion ,https://www.ft.com/content/bb69ecd8-323e-4848-bcdf-9117a2e26158,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...One global health official asked: “How does AstraZeneca manage to screw up every time?”...,AstraZeneca,"MARCH 23, 2021"
AstraZeneca to publish more Covid vaccine trial data after monitors raise alarm,https://www.ft.com/content/24090cf8-9b6c-45b9-9a8d-41ca2450194d,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...“AstraZeneca should provide the answer right now, not in 48 hours.”...",AstraZeneca,"MARCH 23, 2021"
Vaccine-friendly Britons puzzled by AstraZeneca jab’s EU troubles,https://www.ft.com/content/149e6dd3-15a2-4413-a1b3-64328f9b2d1c,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...Kathy Heffernan, a train driver, emerged from the vaccination centre in Brighton grateful to have received her first Oxford/AstraZeneca injection and grateful that — at least on this aspect of its handling...",AstraZeneca,"MARCH 23, 2021"
Coronavirus: Fed’s Powell pledges support ‘for as long as it takes’ — as it happened,https://www.ft.com/content/10a8ada7-6d1b-448c-8f3e-07d4bf4ca42e,https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2F5f859d1f-3d6b-47cd-af97-4b1e732c0451.jpg?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/coronavirus,Coronavirus,,,
Johnson sends envoy to seek vaccine deal with India to ease UK shortage,https://www.ft.com/content/0049a35c-7e5b-430c-9b1d-e884672298c7,https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2F2c73397f-789f-4dd6-b7ca-6992f4bce9d6.jpg?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...As well as issues with supply from the Serum Institute, a batch of 1.7m doses of AstraZeneca jabs is undergoing further testing....",AstraZeneca,"MARCH 22, 2021"
AstraZeneca US trial shows 79% efficacy against Covid,https://www.ft.com/content/7aa7f2cc-01ae-48c3-b3bf-6dee68f4d3e6,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...A fifth of the participants in the AstraZeneca trial were over 65 and the jab showed 80 per cent efficacy in these older participants....,AstraZeneca,"MARCH 22, 2021"
Nordic nations hold off on AstraZeneca jab as scientists probe safety concerns,https://www.ft.com/content/0ef3a623-f3a2-4e76-afbd-94a915b24ad5,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...No direct link to the AstraZeneca vaccine has been proved and the mechanism of such a severe reaction is unknown....,AstraZeneca,"MARCH 21, 2021"
Johnson lobbies EU leaders in bid to avert vaccine export blocks,https://www.ft.com/content/254fc733-1568-4ea7-9fdf-069285c7f9c1,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...One Dutch official urged the UK to reach a deal with the commission and AstraZeneca in order to avoid a “lose-lose scenario”....,AstraZeneca,"MARCH 21, 2021"
Scandinavian countries keep AstraZeneca vaccine on hold,https://www.ft.com/content/9424d00d-5700-48a6-8eda-7b519383b21a,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...It reiterated, as has the World Health Organization, that the benefits of the AstraZeneca vaccine far outweighed its risks....",AstraZeneca,"MARCH 19, 2021"
European pause in AstraZeneca jab risks rollout in developing states,https://www.ft.com/content/434e4909-c71d-4fbf-9ecd-fbb5c3af0f78,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...The linchpin of our campaign is AstraZeneca. But vaccine confidence is destroyed and conspiracy theories are running amok,” she added....",AstraZeneca,"MARCH 19, 2021"
Johnson urges EU to step back from coronavirus vaccine war,https://www.ft.com/content/2a332a32-26d2-493e-9c52-6c73f5106688,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...Some EU nations suspended use of the AstraZeneca vaccine because of concern about a possible link to blood clots, but the EMA said on Thursday the AstraZeneca jab was “safe and effective”....",AstraZeneca,"MARCH 18, 2021"
EU countries to restart use of ‘safe and effective’ AstraZeneca vaccine,https://www.ft.com/content/c83944d5-ad26-415f-bf34-1eba428beeb9,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...AstraZeneca welcomed the result of the assessment....,AstraZeneca,"MARCH 18, 2021"
US plans to send 4m AstraZeneca vaccine doses to Mexico and Canada,https://www.ft.com/content/64eace92-e98a-48ff-ab90-5269917970c4,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...The vaccines are part of a stockpile of 7m available doses that have accumulated while AstraZeneca continues its US clinical trials before applying for regulatory approval....,AstraZeneca,"MARCH 18, 2021"
EU threat to vaccine exports exposes mutual risks to global supply chain,https://www.ft.com/content/773245da-900a-468e-aaf3-96ec8c43341f,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...The scheme has the aim of forcing suppliers, notably AstraZeneca, to honour their contracts with the EU....",AstraZeneca,"MARCH 18, 2021"
NHS warns of ‘significant reduction’ in vaccine supplies,https://www.ft.com/content/0202f902-7e28-40a0-b127-1ad57d2fb55b,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...One senior government figure blamed AstraZeneca for failing to meet its supply commitments....,AstraZeneca,"MARCH 17, 2021"
Biotech start-up behind AstraZeneca jab raises $168m,https://www.ft.com/content/22f65d88-b3e3-4162-bef7-d94d0b5a5618,,https://www.ft.com/biotech,Biotech,...AstraZeneca has commercial rights to use Vaccitech’s platform for its Covid-19 vaccine....,AstraZeneca,"MARCH 17, 2021"
AstraZeneca and Catalent defend Covid vaccine manufacturing process,https://www.ft.com/content/6cae6639-5766-47af-8727-f1819082d6c7,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...One of AstraZeneca’s fill and finish facilities is the Anagni plant in Italy, run by US company Catalent....",AstraZeneca’s,"MARCH 17, 2021"
"Pharma is riding a vaccine high, but reputational risks loom",https://www.ft.com/content/7ad9d74e-f4e7-4b30-9391-0b934662b6ac,,https://www.ft.com/brooke-masters,Brooke Masters,...AstraZeneca and Johnson & Johnson have promised not to profit from their jabs “during the pandemic”....,AstraZeneca,"MARCH 17, 2021"
European capitals co-ordinated suspension of Oxford/AstraZeneca Covid jab,https://www.ft.com/content/a046e340-892b-4e68-bfae-4f5c40a5506a,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...AstraZeneca has defended the safety and efficacy of its vaccine....,AstraZeneca,"MARCH 16, 2021"
Side-effect fears should not derail vaccinations,https://www.ft.com/content/524cac6f-af30-4344-8fa8-f465f575a58b,,https://www.ft.com/ft-view,The editorial board,"...Letter in response to this editorial comment:

People want to know how AstraZeneca jab compares / From Khalid Ikram, Potomac, MD, US...",AstraZeneca,"MARCH 16, 2021"
Blood clot fears and the Oxford-AstraZeneca vaccine: what we know,https://www.ft.com/content/e1a99f4f-70ad-4477-a366-53a7cb5900d6,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...There was no evidence of a problem with blood clots during the Oxford/AstraZeneca trials, which found the vaccine was safe and effective....",AstraZeneca,"MARCH 15, 2021"
Countries across Europe suspend use of Oxford/AstraZeneca jab,https://www.ft.com/content/334abab8-bf24-49f4-aad9-cac4326ebc4c,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...Norway said one of three healthcare workers hospitalised with blood clots after taking AstraZeneca’s coronavirus vaccine had died....,AstraZeneca’s,"MARCH 15, 2021"
EU member states squabble over vaccine distribution ,https://www.ft.com/content/d14df110-cbb0-4652-98cb-15e716cfff7b,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...They are now lagging on deliveries because of AstraZeneca’s production problems....,AstraZeneca’s,"MARCH 14, 2021"
France raises prospect of mandatory Covid-19 jabs for healthcare staff ,https://www.ft.com/content/cebe8cf7-fe2c-4420-95d0-0eb32ddb1497,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...But only 27 per cent said they would accept the AstraZeneca shot, 34 per cent were unsure and 38 per cent said they would not....",AstraZeneca,"MARCH 14, 2021"
Brussels warns that AstraZeneca will miss already reduced targets,https://www.ft.com/content/f9e5b8d8-8153-474a-bd57-97f5adbeb638,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...AstraZeneca declined to comment on Breton’s statement....,AstraZeneca,"MARCH 11, 2021"
Covid-19 and the business of vaccines,https://www.ft.com/video/e6f487f4-a7d9-4e90-b9cb-ef8d25803bec,,https://www.ft.com/ft-film,FT Film,"...And its vaccine manufacturing partner, AstraZeneca, received up to $1.2bn for trials in manufacturing from the US government....",AstraZeneca,"MARCH 10, 2021"
The UK biotech racing to cash in on Covid vaccine success,https://www.ft.com/content/d8748c7a-e4c1-4b4b-9980-7d8571a7f4bf,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...Its 18-month contract with AstraZeneca is worth more than £50m. Dawson added: “We don’t make our normal margins on this work....,AstraZeneca,"MARCH 7, 2021"
EU turns to US in scramble for Oxford/AstraZeneca vaccine,https://www.ft.com/content/e4aaf7a8-3ccb-4223-b8e9-4cd069a9dbf2,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...AstraZeneca declined to comment on the EU effort to access its US production....,AstraZeneca,"MARCH 6, 2021"
France backs Italy’s decision to block vaccine exports to Australia,https://www.ft.com/content/999f20d3-105f-4b15-b382-8f5ef9882e73,https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2F08013d48-9450-41a8-aa44-e5b7ce18f907.jpg?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...Canberra insisted the government would have “more than enough” vaccines to distribute until local production of the Oxford/AstraZeneca vaccine begins in late March....,AstraZeneca,"MARCH 5, 2021"
Germany approves AstraZeneca jab for over-65s,https://www.ft.com/content/e8f35720-4965-4356-92d1-5971fa420c85,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...France has also changed its guidelines for the AstraZeneca shot....,AstraZeneca,"MARCH 4, 2021"
Italy blocks shipment of Oxford/AstraZeneca vaccines to Australia,https://www.ft.com/content/bed655ac-9285-486a-b5ad-b015284798c8,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...AstraZeneca in January revealed a big shortfall in its vaccine deliveries to the EU because of production problems in Europe....,AstraZeneca,"MARCH 4, 2021"
Covid vaccines show few serious side-effects after millions of jabs,https://www.ft.com/content/68a26565-6de1-44db-8569-50b64b20385a,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...Severe allergic reactions — so-called anaphylaxis — were reported 168 times for the Pfizer vaccine and 105 times for the AstraZeneca product....,AstraZeneca,"MARCH 2, 2021"
Germany loses Covid crown as vaccine campaign falters   ,https://www.ft.com/content/33f8ffd6-066b-449c-bf7e-edd51d661b19,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...No-shows for AstraZeneca appointments are widespread.

But even to get an appointment in the first place, users must navigate a digital platform that has become a byword for clunkiness....",AstraZeneca,"MARCH 2, 2021"
France lifts restrictions on Oxford/AstraZeneca jab for over-65s,https://www.ft.com/content/608681ab-ba63-4be0-962f-345773d4bb8c,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...The age restrictions had the unintended effect of slowing France’s vaccination campaign, leading to an accumulation of stockpiles of Oxford/AstraZeneca jabs....",AstraZeneca,"MARCH 1, 2021"
Johnson defends UK border regime amid hunt for Covid patient,https://www.ft.com/content/0cd86de9-148d-4617-bd6b-97f5e50c196c,,https://www.ft.com/coronavirus-treatment,Coronavirus treatment,"...But the UK’s vaccination programme was boosted by fresh data from Public Health England, which confirmed that a single dose of either the BioNTech/Pfizer or Oxford/AstraZeneca vaccines was more than 80 per...",AstraZeneca,"MARCH 1, 2021"
German health advisers signal end of Oxford/AstraZeneca age restrictions,https://www.ft.com/content/d6f5aff4-987f-4e36-9022-0da76766cf5c,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...He said the current regime restricting vaccines to the highest priority groups should be cancelled quickly with regard to the AstraZeneca jab....,AstraZeneca,"FEBRUARY 28, 2021"
Europe’s AstraZeneca stockpile mounts as citizens snub jab,https://www.ft.com/content/767fdd85-5329-479d-b565-4ec85d28b492,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...“I don’t have anything against the AstraZeneca vaccine,” said Jérôme Marty, who heads a French doctors’ union....",AstraZeneca,"FEBRUARY 27, 2021"
EU leaders vent fears over delays to vaccination drive ,https://www.ft.com/content/a8346439-d365-43a8-be5b-c53d0bdbdd7b,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...The issue for the EU is a first-quarter vaccine supply squeeze that is hard to remedy at this point and is being worsened by manufacturing production glitches, notably with the AstraZeneca jab it had relied...",AstraZeneca,"FEBRUARY 25, 2021"
Africa will pay more for Russian Covid vaccine than ‘western’ jabs,https://www.ft.com/content/ffe40c7d-c418-4a93-a202-5ee996434de7,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...The African Union will pay three times more for Russia’s Sputnik V jab than it is paying for the Oxford/AstraZeneca and Novavax vaccines, according to people familiar with the procurement process....",AstraZeneca,"FEBRUARY 25, 2021"
Ghana becomes first country to receive free Covax vaccines ,https://www.ft.com/content/d3609020-c786-47b4-8ccb-7412af61576a,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...Ghana will receive 600,000 doses of the Oxford/AstraZeneca jab from the Serum Institute of India....",AstraZeneca,"FEBRUARY 24, 2021"
"Covid vaccines slash risk of infection, illness and death, UK studies find",https://www.ft.com/content/20576254-422b-4545-91ab-20b4d005bbf3,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...“But the Oxford/AstraZeneca vaccine data are also showing signs of a good effect,” she added....",AstraZeneca,"FEBRUARY 22, 2021"
Why the three biggest vaccine makers failed on Covid-19,https://www.ft.com/content/657b123a-78ba-4fba-b18e-23c07e313331,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...In the event, it was AstraZeneca that worked with Oxford....",AstraZeneca,"FEBRUARY 16, 2021"
Airline industry alarm as vaccine-led recovery hopes take a dive ,https://www.ft.com/content/10ef7ab8-1c54-44af-9b7e-bfcc30a13386,,https://www.ft.com/airlines,Airlines,...A small trial that found the Oxford/AstraZeneca vaccine may be less effective at stopping milder and moderate cases of the South African variant only added to the pressure on the UK government to introduce...,AstraZeneca,"FEBRUARY 16, 2021"
AstraZeneca hands chief £15.4m pay package,https://www.ft.com/content/4e76871f-520c-4ed3-a24a-cb145a66ad11,,https://www.ft.com/executive-pay,Executive Pay,"...“The benefit of the increased share price has also been experienced by shareholders,” AstraZeneca noted in the report....",AstraZeneca,"FEBRUARY 15, 2021"
South African scientists on pandemic’s frontline,https://www.ft.com/content/644a898b-d878-4383-8b87-ff3178c10c21,,https://www.ft.com/south-africa,South Africa,...The South African suspension was based on a relatively small local trial of the AstraZeneca vaccine that did not examine effects on severe disease or death....,AstraZeneca,"FEBRUARY 15, 2021"
What’s the latest on the Covid vaccines? Q&A,https://www.ft.com/content/d2fb66c4-146d-4791-b7f1-2b88c5c96660,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...The latest research suggests that the Oxford/AstraZeneca vaccine may not stop transmission of the variant first detected in South Africa but what does this mean for people who have already been vaccinated...,AstraZeneca,"FEBRUARY 12, 2021"
African countries unsure whether to use Oxford/AstraZeneca jab,https://www.ft.com/content/89ab2393-02d0-4f6c-a86d-2bad4eb9f10f,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...“We will no longer be using the AstraZeneca-Oxford vaccine.”

South Africa has already halted the rollout of the Oxford/AstraZeneca vaccine, which had been due to begin this month....",AstraZeneca,"FEBRUARY 11, 2021"
AstraZeneca aims to accelerate adaptation of vaccine for new Covid variants,https://www.ft.com/content/1f951eb5-325f-423f-be98-7b26cac406e3,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...“You have to adjust the vaccine as you go,” like for flu shots, said Pascal Soriot, AstraZeneca’s chief executive....",AstraZeneca’s,"FEBRUARY 11, 2021"
AstraZeneca predicts pandemic will disrupt prescription sales,https://www.ft.com/content/d850c031-5361-47ea-b0a5-526f606c4e81,,https://www.ft.com/city-bulletin,City Bulletin,"...AstraZeneca cautioned of a tough year ahead as the pandemic disrupts prescription sales, with the drugmaker also planning for higher spending....",AstraZeneca,"FEBRUARY 11, 2021"
Vaccines vs variants: the race to immunise the developing world,https://www.ft.com/content/797e3d7b-0091-4bfd-8cae-c0b5be380772,,https://www.ft.com/the-big-read,The Big Read,"...“Instead of rolling out AstraZeneca vaccine, we’ll be rolling out the J&J vaccine.”...",AstraZeneca,"FEBRUARY 11, 2021"
AstraZeneca agrees German manufacturing deal to fill vaccine gap,https://www.ft.com/content/f654d813-5c4c-4d86-827f-c6a73eea9a30,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...AstraZeneca has enlisted German drug manufacturer IDT Biologika to help boost production of its Covid-19 vaccine and tackle supply shortages in Europe....,AstraZeneca,"FEBRUARY 10, 2021"
WHO recommends use of Oxford/AstraZeneca vaccine for all adults,https://www.ft.com/content/be33aa38-5eff-4069-b104-ba7bdb735c72,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...Oxford/AstraZeneca doses represent a large proportion of the vaccines procured by Covax so far....,AstraZeneca,"FEBRUARY 10, 2021"
Top UK scientist warns ‘unpredictable’ Covid evolution threatens vaccine success,https://www.ft.com/content/e17f18a5-25e8-451c-abdd-a2f65ec3da92,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...One of the UK government’s top scientific advisers has warned that early signs the Oxford/AstraZeneca vaccine is less effective at stopping mild and moderate cases of the South African coronavirus variant...,AstraZeneca,"FEBRUARY 9, 2021"
South Africa forced to overhaul vaccine plan over variant fears,https://www.ft.com/content/61f7d15c-e576-4d8f-a757-eb0653117e09,https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2F593d0721-1bb6-4f6c-b2f4-984ef1809635.jpg?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...However, even before the Oxford/Astrazeneca setback, several health experts, including Dr Shabir Madhi, leader of the Wits study, had called those plans unrealistic....",Astrazeneca,"FEBRUARY 9, 2021"
Boris Johnson confident in AstraZeneca vaccine after South Africa move,https://www.ft.com/content/a8c8923c-5bd5-4e81-988b-57b34ff2d03d,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...Johnson’s comments came after South Africa stopped using the AstraZeneca jab....,AstraZeneca,"FEBRUARY 8, 2021"
What we know about the most troublesome Covid mutations ,https://www.ft.com/content/71e53321-3719-4f10-9406-c614a5ddc1b8,,https://www.ft.com/coronavirus-treatment,Coronavirus treatment,...Pangalos said it would be one to three months before prototypes of a new Oxford/AstraZeneca vaccine would be ready and new clinical trials could begin....,AstraZeneca,"FEBRUARY 8, 2021"
AstraZeneca hit by more doubts over vaccine’s efficacy,https://www.ft.com/content/23c5d94d-1983-4aad-8568-43f796aa3b26,,https://www.ft.com/disrupted-times,Disrupted Times,...Today’s development is another setback for AstraZeneca....,AstraZeneca,"FEBRUARY 8, 2021"
Learning to live with coronavirus,https://www.ft.com/content/87d07f5e-6129-4d3e-a68e-906a5b78b127,,https://www.ft.com/ft-view,The editorial board,"...The emergence of mutated strains, particularly the South African variant and concerns over the effectiveness of the Oxford/AstraZeneca vaccine against it, has shifted the debate about how straight that path...",AstraZeneca,"FEBRUARY 8, 2021"
South Africa halts rollout of AstraZeneca vaccine,https://www.ft.com/content/82534b15-6f2d-41b9-9947-de674b11079c,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...However, initial data indicated those responses remained intact against the South African variant, AstraZeneca said....",AstraZeneca,"FEBRUARY 8, 2021"
"Oxford/AstraZeneca jab fails to prevent mild and moderate Covid from S African strain, study shows",https://www.ft.com/content/e9bbd4fe-e6bf-4383-bfd3-be64140a3f36,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...AstraZeneca initially declined to comment....,AstraZeneca,"FEBRUARY 7, 2021"
"How AstraZeneca’s vaccine was hit by flawed trials, defects and politics — but might still save the world",https://www.ft.com/content/d0fd6c4c-939a-43c7-a9b9-47c8d3cab253,,https://www.ft.com/content/71b52de0-4f8c-4a30-97cf-9bc1776faf03,AstraZeneca ,"...But after its data was published, AstraZeneca’s stock fell....",AstraZeneca’s,"FEBRUARY 5, 2021"
Sunak hails vaccine success as model for more nimble UK economy ,https://www.ft.com/content/16618624-9856-47ac-9b2a-8115dfe64c3d,,https://www.ft.com/uk-economy,UK economy,...Oxford/AstraZeneca also received help in kind as work was done to refine the manufacturing process for their vaccine and then to produce it at large volume....,AstraZeneca,"FEBRUARY 4, 2021"
Swiss medical regulator rejects Oxford/AstraZeneca Covid vaccine,https://www.ft.com/content/a6a6d64c-a337-4af4-9525-d194571c7887,,https://www.ft.com/content/25fc01a9-27f8-41d9-9103-04d8b9f6e292,This week in Covid vaccines: A collection of the FT’s essential reading,...Approval of the Oxford/AstraZeneca vaccine had been widely expected by many in Switzerland....,AstraZeneca,"FEBRUARY 3, 2021"
Vaccine milestone as global Covid jabs pass number of confirmed cases,https://www.ft.com/content/e29efb8b-46ec-4815-98aa-458deffcd896,,https://www.ft.com/content/25fc01a9-27f8-41d9-9103-04d8b9f6e292,This week in Covid vaccines: A collection of the FT’s essential reading,...Data released by Oxford university on Monday suggested that its vaccine developed with AstraZeneca would reduce transmission by 67 per cent....,AstraZeneca,"FEBRUARY 3, 2021"
Oxford/AstraZeneca study supports UK decision to delay second doses,https://www.ft.com/content/de00fe75-9ba1-4be7-8cf1-6e9fa55f09ce,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...A single dose of the Oxford/AstraZeneca coronavirus vaccine is 76 per cent effective from three weeks to 12 weeks after the injection, according to an analysis of trial data that could boost confidence in...",AstraZeneca,"FEBRUARY 2, 2021"
French panel advises against giving Oxford/AstraZeneca jab to over-65s,https://www.ft.com/content/081454a5-3190-48d0-8309-7c6eb588aab8,,https://www.ft.com/content/25fc01a9-27f8-41d9-9103-04d8b9f6e292,This week in Covid vaccines: A collection of the FT’s essential reading,"...Asked to comment on the French decision, AstraZeneca reiterated its confidence in the shot and the data behind it....",AstraZeneca,"FEBRUARY 2, 2021"
EU reverses course after Irish border curbs for vaccines trigger uproar  ,https://www.ft.com/content/c678dc02-c5f5-4717-a7ca-43c0ba3f2b44,,https://www.ft.com/brexit,Brexit,...AstraZeneca’s jab was on Friday cleared for use in EU by the bloc’s medical regulator....,AstraZeneca’s,"JANUARY 29, 2021"
EU clamps down on Covid vaccine exports,https://www.ft.com/content/24867d39-4507-4c48-be27-c34b581220b0,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...The tighter export rules revealed on Friday are coming into force as AstraZeneca has denied Brussels’ claims that it was unable to honour vaccine delivery commitments to the EU because it had diverted production...,AstraZeneca,"JANUARY 29, 2021"
Brussels publishes EU-AstraZeneca vaccine contract,https://www.ft.com/content/5a8a87b4-0ea8-4db3-acc4-8a72d3b8b64c,,https://www.ft.com/coronavirus-treatment,Coronavirus treatment,...Does the contract commit AstraZeneca to binding delivery schedules?...,AstraZeneca,"JANUARY 29, 2021"
EU regulator approves Oxford/AstraZeneca vaccine for all adults,https://www.ft.com/content/a7d38aba-aed0-44df-b4ec-efba6470505e,,https://www.ft.com/coronavirus-treatment,Coronavirus treatment,"...The European bloc has ordered 300m doses of the AstraZeneca drug, with an option to take 100m more....",AstraZeneca,"JANUARY 29, 2021"
Shortfall in jabs pushes EU vaccine drive to crisis point,https://www.ft.com/content/1b2afe60-b5e6-456d-98e0-313fe664d0b9,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...AstraZeneca rejected the recommendation.

The EMA is expected to reach a decision on Friday on approval of the Oxford/AstraZeneca vaccine for use in the EU....",AstraZeneca,"JANUARY 28, 2021"
Covid-19 vaccine exports face new EU restrictions as shortages bite,https://www.ft.com/content/b2a0f104-076b-48cb-9f34-6511ae344b45,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...Boris Johnson, the UK prime minister, has refused to be drawn into the dispute between the EU and AstraZeneca....",AstraZeneca,"JANUARY 28, 2021"
German panel advises against AstraZeneca vaccine for over-65s,https://www.ft.com/content/0190dae8-f751-4876-8404-68a34d9be716,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...The EMA is expected to reach a long-awaited decision on the approval of the Oxford/AstraZeneca vaccine for use in the EU on Friday....,AstraZeneca,"JANUARY 28, 2021"
AstraZeneca/Covid-19 vaccine: jab grab,https://www.ft.com/content/cfd5de3e-70a5-4bb3-b1bc-5108a996bd8f,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...Legal action, as threatened by Italy, could become a headache for AstraZeneca....",AstraZeneca,"JANUARY 28, 2021"
What the spat over AstraZeneca’s vaccine contract shows us,https://www.ft.com/content/c4cde78a-e769-44b3-8631-73be810249cf,,https://www.ft.com/david-allen-green,David Allen Green,"...Therefore, one can presume that the terms are also in the agreement with AstraZeneca....",AstraZeneca,"JANUARY 28, 2021"
EU and AstraZeneca fail to resolve vaccine supply dispute,https://www.ft.com/content/27221e59-e4ee-4c0a-b07a-a668a59978c6,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...The European Medicines Agency regulator could decide to give its long-awaited approval to the AstraZeneca vaccine at a meeting on Friday....,AstraZeneca,"JANUARY 28, 2021"
EU demands UK Covid vaccines from AstraZeneca to make up shortfall,https://www.ft.com/content/d814b2dc-a803-4680-b8c4-ffa2a4c370ad,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...AstraZeneca said it was committed to “even closer co-ordination” in that regard....,AstraZeneca,"JANUARY 27, 2021"
Brazilian companies discuss seeking direct vaccine supplies,https://www.ft.com/content/fb1b273d-1df2-4ec9-8aad-f4b79de5ee19,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...AstraZeneca has warned EU countries, too, to expect significant shortfalls to early deliveries of its coronavirus vaccine due to supply chain issues....",AstraZeneca,"JANUARY 26, 2021"
"If Covid vaccines stop working, how quickly can drugmakers respond?",https://www.ft.com/content/3bfe4375-ef37-4168-9a86-1c48be6cd5b1,https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2F4a6612ec-3dab-47fe-927c-72206e8d6cad.jpg?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...Mr Pangalos of AstraZeneca also conceded that mRNA vaccines “probably have a 4-6 week advantage”....,AstraZeneca,"JANUARY 26, 2021"
Germany presses EU for powers to block vaccine exports ,https://www.ft.com/content/ed0059c9-1ea5-4ba9-a1ff-88004b59e71d,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...The EU is struggling to get its vaccine rollout strategy back on track after AstraZeneca informed officials late last week that its production would sharply undershoot expectations....,AstraZeneca,"JANUARY 26, 2021"
Vaccine protectionism by the EU will backfire,https://www.ft.com/content/044ef5c8-d07e-47df-9264-769457130991,,https://www.ft.com/ft-view,The editorial board,...Then AstraZeneca said it may not be able to deliver up to 60 per cent of its order for the first quarter because of production problems....,AstraZeneca,"JANUARY 26, 2021"
Germany pushes back on AstraZeneca vaccine efficacy reports,https://www.ft.com/content/7d73b65f-0b37-4e3b-a841-ae95e2387e1c,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...The UK and EU bet heavily on the Oxford/AstraZeneca vaccine: the UK has ordered 100m doses and the EU up to 400m....,AstraZeneca,"JANUARY 26, 2021"
Brussels moves to tighten rules on Covid vaccine exports,https://www.ft.com/content/dab81697-ec25-4c14-9ac6-8bdafb474cc0,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,"...But Ms Kyriakides said AstraZeneca’s proposed new supply schedule was “not acceptable” and said the EU wanted to know “exactly which doses have been produced [and] where by AstraZeneca . . . and if, or to...",AstraZeneca’s,"JANUARY 25, 2021"
EU hit by delay to Oxford/AstraZeneca vaccine delivery,https://www.ft.com/content/3dbfe495-5947-4dd0-9f43-5edc5e6d6dc7,,https://www.ft.com/covid-19-vaccines,Covid-19 vaccines,...Oxford and AstraZeneca have both defended the integrity of their trials....,AstraZeneca,"JANUARY 22, 2021"
Thailand to charge opposition leader over ‘royal vaccine’ remarks,https://www.ft.com/content/28ed5f8a-882b-4c5b-8ac8-7046ee832967,,https://www.ft.com/thailand,Thailand,"...Thailand in November announced a deal with AstraZeneca to produce 26m doses of the drugmaker’s vaccine, which it aims to distribute by mid-year....",AstraZeneca,"JANUARY 20, 2021"
Burberry posts 9% sales drop despite Asia growth ,https://www.ft.com/content/da44182b-9e86-48a5-820b-19e0c905dccf,,https://www.ft.com/stream/2f2df645-7d9e-4241-bdba-36574edfcf96,Burberry Group PLC,"...The company expected tourist arrivals to pick up in the medium term as vaccines were rolled out; development of the AstraZeneca/Oxford vaccine was partly funded by a donation from Burberry, although Ms Brown...",AstraZeneca,"JANUARY 20, 2021"
Suspicion and tech glitches blight India’s vaccination campaign,https://www.ft.com/content/748b93c7-6725-4331-8a18-ed32d4729482,,https://www.ft.com/coronavirus-treatment,Coronavirus treatment,"...But Narendra Modi’s government appeared determined to launch an “Indian-developed” vaccine simultaneously with Covishield, a locally produced version of the Oxford/AstraZeneca jab, which has already been...",AstraZeneca,"JANUARY 19, 2021"
WHO head warns of global ‘moral failure’ on vaccines,https://www.ft.com/content/ca57c76c-f86a-4f2d-81ab-7f5970ad2dbd,,https://www.ft.com/coronavirus-treatment,Coronavirus treatment,"...South Africa, with a population of 58m, announced this month that it had reached an agreement to acquire 1.5m doses of AstraZeneca’s vaccine from India-based manufacturer Serum Institute....",AstraZeneca’s,"JANUARY 18, 2021"
Brazil approves AstraZeneca and Chinese coronavirus vaccines,https://www.ft.com/content/c53676de-bb20-4f7e-8a62-d8ed5386d9ca,,https://www.ft.com/brazil,Brazil,"...It covers 6m doses of CoronaVac imported from China and a batch of 2m Oxford/AstraZeneca jabs yet to be shipped from India, which has just started its own immunisation programme....",AstraZeneca,"JANUARY 17, 2021"
UK set to step up coronavirus vaccinations ,https://www.ft.com/content/818a5fcc-0b10-4cd1-8ed6-0ad06aabb9d0,,https://www.ft.com/coronavirus-treatment,Coronavirus treatment,"...The document, published online by the Scottish government on Wednesday, was later withdrawn, but it showed that vaccines supplied by Pfizer, AstraZeneca and Moderna are scheduled to arrive in significant...",AstraZeneca,"JANUARY 14, 2021"
Pharma lobby warns against extending Covid jab intervals,https://www.ft.com/content/fe796144-4570-4075-be86-b370436bdf1d,,https://www.ft.com/coronavirus-treatment,Coronavirus treatment,...AstraZeneca is a member of some of these lobby groups....,AstraZeneca,"JANUARY 13, 2021"
Australian scientists cast doubt on Oxford/AstraZeneca vaccine,https://www.ft.com/content/8def3a81-9b80-46a1-9742-f64b80bfc74f,,https://www.ft.com/coronavirus-treatment,Coronavirus treatment,...But it has not called for a pause in the rollout of the Oxford/AstraZeneca vaccine....,AstraZeneca,"JANUARY 13, 2021"
EU’s Covid vaccine chief defends procurement scheme ,https://www.ft.com/content/119cb18b-6b8a-4588-9d4a-b2cdce5aa8f6,,https://www.ft.com/coronavirus-treatment,Coronavirus treatment,"...She said she hoped the Oxford/AstraZeneca jab would, later this month, become the third Covid-19 vaccine to be approved by the European medical regulator....",AstraZeneca,"JANUARY 12, 2021"
Governments need to intervene to ramp up vaccine production,https://www.ft.com/content/4e94269b-5568-494d-bce5-99b56d0b6c21,,https://www.ft.com/stream/0068a6fb-9978-4261-a908-06b0e0134756,Gustav A. Oertzen,"...Most countries’ hopes therefore rest on the Oxford/AstraZeneca jab, which is also relatively cheap and easy to distribute.

This joint venture plans to ramp up production to 3bn jabs through 2021....",AstraZeneca,"JANUARY 6, 2021"
UK vaccine rollout hampered by red tape and lack of back-up stocks ,https://www.ft.com/content/64ba9bdd-32be-44b5-9e5d-b2aac1b8424c,,https://www.ft.com/coronavirus-treatment,Coronavirus treatment,...The government has promised to secure “tens of millions” of doses of the Oxford/AstraZeneca vaccine by the end of March....,AstraZeneca,"JANUARY 4, 2021"
India approves two vaccines but critics warn on lack of transparency,https://www.ft.com/content/d325d317-2acb-49c0-9669-668437b3254b,,https://www.ft.com/coronavirus-treatment,Coronavirus treatment,"...VG Somani, drugs controller general of India, also said the regulator had approved the vaccine made by Oxford university and AstraZeneca, which was given the green light by the UK last week....",AstraZeneca,"JANUARY 3, 2021"
UK’s chief medical officers warn over vaccine availability ,https://www.ft.com/content/d97c72c5-ed23-4c2b-bf1c-9cc10b21f007,,https://www.ft.com/coronavirus-treatment,Coronavirus treatment,"...They added that while the decision by the UK’s medicines regulator to approve the Oxford/AstraZeneca vaccine earlier this week would reduce the problem, it would not eradicate it completely....",AstraZeneca,"DECEMBER 31, 2020"
UK approves Oxford/AstraZeneca vaccine,https://www.ft.com/content/84b53ae7-fa05-4914-b7e5-8a2c5908d2f4,,https://www.ft.com/coronavirus-treatment,Coronavirus treatment,...AstraZeneca made clear that supplies of its vaccine would not be available for private purchase....,AstraZeneca,"DECEMBER 30, 2020"
AstraZeneca/UK vaccination: midsummer gladness,https://www.ft.com/content/0b51533e-2e77-4d72-a3a1-d69ff54e07d1,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,"...That implies over 40m may receive the Oxford/AstraZeneca shot by the end of June. Given 70 per cent efficacy, more than 28m people would be shielded....",AstraZeneca,"DECEMBER 30, 2020"
Oxford/AstraZeneca Covid vaccine to be approved by UK within days,https://www.ft.com/content/61938eba-0ca3-436d-a043-89ac80d5c87a,,https://www.ft.com/coronavirus-treatment,Coronavirus treatment,...AstraZeneca declined to comment....,AstraZeneca,"DECEMBER 27, 2020"
The ESG case for the Oxford/AstraZeneca vaccine,https://www.ft.com/content/0ad28950-cf97-4ae9-8b08-18fdc9ffbeb1,,https://www.ft.com/coronavirus,Coronavirus,"...When the dust settles, that may well be AstraZeneca....",AstraZeneca,"DECEMBER 23, 2020"
Anxiety clouds China’s rush to vaccinate parts of the world,https://www.ft.com/content/d8d9a691-831f-4942-a8f2-9b6f80f43b0b,,https://www.ft.com/coronavirus-treatment,Coronavirus treatment,"...Western frontrunners, such as Pfizer/BioNTech, AstraZeneca-Oxford and Moderna, have already completed phase 3 trials and publicly released data that has been reviewed by regulators in Europe, the UK and...",AstraZeneca,"DECEMBER 20, 2020"
GSK invests in new field of genetic rebalancing ,https://www.ft.com/content/8b98c361-4be1-4cc1-a07b-b4cd01fee538,,https://www.ft.com/biotech,Biotech,"...Prof Jackson’s earlier biotech company KuDOS developed one of the first treatments using synthetic lethality, the cancer drug now sold by AstraZeneca as Lynparza....",AstraZeneca,"DECEMBER 18, 2020"
The winners and losers from a pharma mega-deal,https://www.ft.com/content/bd940a2c-b460-423d-8be5-68d6a69e6a4d,https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2Fd07027c6-bf16-485c-b9d8-bc2f81898d84.jpg?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/due-diligence,Due Diligence,"...And among the losers:

AstraZeneca shareholders — for now....",AstraZeneca,"DECEMBER 15, 2020"
AstraZeneca shares fall on investor concern over $39bn deal,https://www.ft.com/content/ffde62b7-727d-4f63-8753-e575bdeb4ca3,https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2F8dc8f0ee-4fff-4296-9e25-dd6b9e714308.jpg?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,...Not all AstraZeneca shareholders were hostile to the deal....,AstraZeneca,"DECEMBER 14, 2020"
AstraZeneca’s $39bn Alexion deal marks shift from prey to predator ,https://www.ft.com/content/bcfee150-fd61-4694-bc61-97195758a750,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,"...On Saturday Mr Soriot struck the largest deal in AstraZeneca’s history, agreeing to buy US rare disease specialist Alexion in a $39bn cash-and-stock agreement....",AstraZeneca’s,"DECEMBER 14, 2020"
AstraZeneca/Alexion: the odd couple,https://www.ft.com/content/f23045bd-e9c7-40b2-80b3-b4c45f69f7b3,,https://www.ft.com/mergers-acquisitions,Mergers & Acquisitions,...Some of the gloss was knocked off AstraZeneca’s stock by its recent Covid-19 vaccine trial results. But the shares are still valued much more highly than those of most of its peers....,AstraZeneca’s,"DECEMBER 13, 2020"
AstraZeneca to buy Alexion in $39bn immunology deal,https://www.ft.com/content/a7444fd3-0044-4aab-ab23-60eb7a6572e5,,https://www.ft.com/mergers-acquisitions,Mergers & Acquisitions,"...Morgan Stanley, JPMorgan and Goldman Sachs will help AstraZeneca finance the deal. Freshfields was AstraZeneca’s legal adviser. Bank of America advised Alexion and Wachtell provided legal advice....",AstraZeneca,"DECEMBER 12, 2020"
Sanofi/GSK delay vaccine rollout and Australia ditches trial,https://www.ft.com/content/b7b5da3f-f863-4cf2-bd0d-2694dfe6ae1e,,https://www.ft.com/coronavirus-treatment,Coronavirus treatment,...The Australian government announced it had bought 31m extra doses of rival vaccines produced by AstraZeneca/Oxford university and Novavax. It had already signed an agreement with Pfizer/BioNTech....,AstraZeneca,"DECEMBER 11, 2020"
Efficacy data for Oxford/AstraZeneca vaccine confirmed,https://www.ft.com/content/e4404637-1fd0-4cc0-bf3f-10e971c944b0,,https://www.ft.com/coronavirus-treatment,Coronavirus treatment,"...“When people start to compare data, it is really important to bear in mind that we need several vaccines,” said Pascal Soriot, AstraZeneca chief executive....",AstraZeneca,"DECEMBER 8, 2020"
Output of Oxford-AstraZeneca doses held up,https://www.ft.com/content/651be7e7-2a4e-410f-8089-b4b7e887f6e8,,https://www.ft.com/coronavirus-treatment,Coronavirus treatment,...Mr McCubbin said at least 80m of the 100m doses of the Oxford-AstraZeneca ordered by the UK government would be made in Britain....,AstraZeneca,"DECEMBER 8, 2020"
Manufacturing delays leave UK with fewer vaccines than hoped ,https://www.ft.com/content/38fecae5-86d0-49a5-8a33-3bf4a64e57bb,,https://www.ft.com/coronavirus-treatment,Coronavirus treatment,"...One person familiar with government planning suggested that the delay in the supplies of the Pfizer/BioNTech vaccine could increase reliance on the version developed by Oxford university and AstraZeneca,...",AstraZeneca,"DECEMBER 4, 2020"
AstraZeneca sells Crestor rights for $350m,https://www.ft.com/content/b967dea0-4181-4401-a8c7-0418ea7dde89,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,...AstraZeneca said it would continue to manufacture and supply Crestor to Grünenthal during a transition period....,AstraZeneca,"DECEMBER 1, 2020"
City Bulletin: AstraZeneca sells rights to best-selling anti-cholesterol drug,https://www.ft.com/content/10dca8b2-2429-41ff-9051-550eefa5dd32,,https://www.ft.com/city-bulletin,City Bulletin,"...While the world awaits updates on AstraZeneca’s Covid-19 vaccine candidate, the company has been clearing out the cupboards....",AstraZeneca’s,"DECEMBER 1, 2020"
Vaccine breakthroughs set off investor rush for cyclical stocks,https://www.ft.com/content/64b5c0c2-cc44-4c55-8f58-ab0cae0c59aa,,https://www.ft.com/equities,Equities,"...Last week, Oxford university and AstraZeneca said their vaccine — which they have agreed to sell at cost to developing nations in perpetuity — had an average efficacy of 70 per cent....",AstraZeneca,"NOVEMBER 30, 2020"
Covid vaccines offer Big Pharma a chance of rehabilitation ,https://www.ft.com/content/75029036-13f3-4ca2-8954-5a7207c0c3db,,https://www.ft.com/the-big-read,The Big Read,"...That premise has been put to the test this year and the industry has over-delivered,” says Mr Mahony, who is co-head of healthcare for Polar Capital, which has an investment in AstraZeneca....",AstraZeneca,"NOVEMBER 27, 2020"
How AstraZeneca and Oxford found their vaccine under fire,https://www.ft.com/content/cc78aa2f-1b10-446a-88d9-86a78c5ce461,,https://www.ft.com/coronavirus-treatment,Coronavirus treatment,"...The controversy has shown up in AstraZeneca shares, which have tumbled nearly 7 per cent over the past week....",AstraZeneca,"NOVEMBER 27, 2020"
"Investors Chronicle: Virgin Money, Pets at Home, Daily Mail and General Trust",https://www.ft.com/content/8718f01f-901c-4c36-84ac-cb9332a61dce,,https://www.ft.com/investments,Investments,"...If that isn’t something to look forward to in itself, the achievements of the boffins at Pfizer, Moderna and AstraZeneca are suggestive of an industry that could be about to embark on a splurge of innovation...",AstraZeneca,"NOVEMBER 27, 2020"
Doubts raised over AstraZeneca-Oxford vaccine data,https://www.ft.com/content/4583fbf8-b47c-4e78-8253-22efcfa4903a,,https://www.ft.com/coronavirus-treatment,Coronavirus treatment,...Prof Dean contrasted the AstraZeneca disclosures with those from other trials....,AstraZeneca,"NOVEMBER 26, 2020"
Oxford-AstraZeneca vaccine results raise hopes for Covid fight,https://www.ft.com/content/2da97a56-23df-4345-9157-6dc8ec322c69,,https://www.ft.com/coronavirus-treatment,Coronavirus treatment,...AstraZeneca said it would work closely with the FDA to bring the vaccine to the US “as quickly as possible”....,AstraZeneca,"NOVEMBER 23, 2020"
Coronavirus/vaccines: safety in numbers,https://www.ft.com/content/409c8e7b-1602-4b05-8317-8e32f8570ac4,,https://www.ft.com/coronavirus-treatment,Coronavirus treatment,"...AstraZeneca has made production deals with Russian drugmaker R-Pharm, Fiocruz of Brazil and the Serum Institute of India....",AstraZeneca,"NOVEMBER 23, 2020"
How the Oxford-AstraZeneca vaccine works and why it matters,https://www.ft.com/content/49d4a7ff-a20c-4ac2-84f7-d9dbab1d431f,,https://www.ft.com/coronavirus-treatment,Coronavirus treatment,...How does the Oxford/AstraZeneca vaccine work?...,AstraZeneca,"NOVEMBER 23, 2020"
Vaccine contracts shrouded in secrecy despite massive public funding,https://www.ft.com/content/95c49b5a-f2c7-49a3-9ac5-3e7a66e3ad6b,,https://www.ft.com/coronavirus-treatment,Coronavirus treatment,"...AstraZeneca, which has promised not to profit from its jab during the pandemic, has — in at least one agreement — the contractual right to declare an end to the pandemic as soon as July 2021....",AstraZeneca,"NOVEMBER 23, 2020"
Oxford Covid vaccine trial confirms encouraging results for the elderly,https://www.ft.com/content/7ce02375-b66e-4e4d-a5d5-3084f1e83831,,https://www.ft.com/coronavirus-treatment,Coronavirus treatment,...No data have been published on whether the Oxford-AstraZeneca vaccine prevents people from developing Covid-19....,AstraZeneca,"NOVEMBER 19, 2020"
AstraZeneca still suffering growing pains,https://www.ft.com/content/74b66e18-8bf0-4758-abf1-3fb31fd72939,,https://www.ft.com/bryce-elder,Bryce Elder,...The vaccine is a standalone product that cannot explain AstraZeneca’s £112bn market value....,AstraZeneca’s,"NOVEMBER 5, 2020"
AstraZeneca expects Covid vaccine trial results this year,https://www.ft.com/content/f4e3505b-5b0c-4caf-a35a-a4ac57b943a3,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,"...But AstraZeneca executives said the company was ready to supply the vaccine as soon as feasible, keeping it in frozen form in an attempt to prolong its shelf life....",AstraZeneca,"NOVEMBER 5, 2020"
AstraZeneca misses target for delivery of UK Covid vaccine,https://www.ft.com/content/6ccff5f5-834d-43b7-84e4-82ec3bb3ab06,,https://www.ft.com/coronavirus-treatment,Coronavirus treatment,...AstraZeneca said it was making progress in readying its supply chain so it could begin supplying doses as soon as the vaccine is approved....,AstraZeneca,"NOVEMBER 4, 2020"
GSK/ESG funds: flower power,https://www.ft.com/content/de57828f-6ef4-48e5-80ce-5e1c6cf37fb7,,https://www.ft.com/esg-investing,ESG investing,"...They trade at 11 times forward earnings half of rival AstraZeneca which has a more promising pipeline of drugs.

It is easy to mock the flurries of jargon that accompany new ways of thinking....",AstraZeneca,"NOVEMBER 3, 2020"
Oxford Covid vaccine trials offer hope for elderly ,https://www.ft.com/content/b15446e5-66f7-4e6a-947a-1b638769ff79,https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2Fb432a7ca-6c64-41d7-bb79-6782afd4615a.jpg?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/coronavirus-treatment,Coronavirus treatment,"...The US arm of the Oxford/AstraZeneca study was given the go-ahead to resume on Friday, having been halted since September 6 after a participant developed neurological symptoms....",AstraZeneca,"OCTOBER 26, 2020"
AstraZeneca and J&J get go-ahead to resume Covid-19 vaccine trials,https://www.ft.com/content/2d2d0e8c-3560-456f-bf3e-59a869e6aa00,,https://www.ft.com/coronavirus-treatment,Coronavirus treatment,"...Pascal Soriot, AstraZeneca’s chief executive, said people should be “reassured by the care taken by independent regulators to protect the public”....",AstraZeneca’s,"OCTOBER 23, 2020"
Vaccine deal allows AstraZeneca to take up to 20% on top of costs,https://www.ft.com/content/e359159b-105c-407e-b1be-0c7a1ddb654b,,https://www.ft.com/coronavirus-treatment,Coronavirus treatment,"...UK-headquartered AstraZeneca has pledged to sell the vaccine “at cost” during the pandemic, eschewing profits. It has declined to say how much the vaccine costs to make....",AstraZeneca,"OCTOBER 23, 2020"
"Ministers handed £280,000 Covid contract to business of executive in voluntary public role",https://www.ft.com/content/a252e28e-d4cf-4a75-9782-693a6168423e,,https://www.ft.com/coronavirus,Coronavirus,"...Mrs White was an executive at Sodexo, another government outsourcer, and AstraZeneca, the pharmaceuticals giant, before joining struggling Interserve in 2017....",AstraZeneca,"OCTOBER 16, 2020"
AstraZeneca vaccine document shows limit of no-profit pledge,https://www.ft.com/content/c474f9e1-8807-4e57-9c79-6f4af145b686,,https://www.ft.com/coronavirus-treatment,Coronavirus treatment,...AstraZeneca declined to answer specific questions regarding its definition of the “Pandemic Period” or the Fiocruz agreement....,AstraZeneca,"OCTOBER 7, 2020"
FDA widens probe into AstraZeneca Covid vaccine,https://www.ft.com/content/2356aa1e-b862-405d-be41-e64ee14b41ba,,https://www.ft.com/coronavirus-treatment,Coronavirus treatment,"...AstraZeneca is in talks with MHRA over rolling reviews, according to one of the people briefed on the matter....",AstraZeneca,"OCTOBER 1, 2020"
City Bulletin: Scientists plead for clarity on AstraZeneca’s Covid-19 vaccine trial,https://www.ft.com/content/9c5f6a96-fc11-42f1-8f4e-f1c27cdfd089,,https://www.ft.com/city-bulletin,City Bulletin,"...Scientists are demanding to know why AstraZeneca’s trial of its Covid-19 vaccine is still on hold in the US while it has been restarted elsewhere, report our healthcare correspondents Hannah Kuchler and...",AstraZeneca’s,"SEPTEMBER 23, 2020"
Scientists call for clarity on AstraZeneca’s Covid vaccine trial,https://www.ft.com/content/06015bd9-ed4b-44ef-a243-2bd67557d2c0,,https://www.ft.com/coronavirus-treatment,Coronavirus treatment,...Neither AstraZeneca nor the US Food and Drug Administration would explain why the trial had not restarted....,AstraZeneca,"SEPTEMBER 22, 2020"
Oxford and AstraZeneca resume coronavirus vaccine trial | Free to read,https://www.ft.com/content/588cebbc-cbae-45ba-8b9a-e8ad2760c0ed,,https://www.ft.com/content/7c88016e-f025-4f7f-b68a-27efe56ffa1c,Coronavirus: free to read,...Oxford university and AstraZeneca are to resume the international clinical trial of their proposed coronavirus vaccine candidate....,AstraZeneca,"SEPTEMBER 13, 2020"
"Investors Chronicle: AstraZeneca, Halfords, Tullow Oil",https://www.ft.com/content/7b4edd89-8325-4eec-80f5-1fd85959ac7d,,https://www.ft.com/investments,Investments,...AstraZeneca wasn’t the only Plc under the spotlight on Wednesday....,AstraZeneca,"SEPTEMBER 11, 2020"
AstraZeneca ‘still on track’ to submit Covid vaccine data before end of year,https://www.ft.com/content/f92bdc4a-319a-47e7-8344-9a9fe224303c,,https://www.ft.com/coronavirus-treatment,Coronavirus treatment,"...As well as the AstraZeneca-Oxford university vaccine, two others — manufactured by Pfizer and Moderna — were “also advancing quite quickly”, he said....",AstraZeneca,"SEPTEMBER 10, 2020"
AstraZeneca’s Covid trial pause a reminder of huge challenges in race for vaccines,https://www.ft.com/content/c94b9497-5a3c-46b7-ba76-bdd093a56d46,,https://www.ft.com/content/7c88016e-f025-4f7f-b68a-27efe56ffa1c,Coronavirus: free to read,"...That possibility was behind AstraZeneca’s decision voluntarily to pause the trial, he said....",AstraZeneca’s,"SEPTEMBER 9, 2020"
AstraZeneca puts vaccine trial on hold after participant falls ill,https://www.ft.com/content/98fca6d4-fcd2-488c-bcfc-d47758740a1a,,https://www.ft.com/coronavirus-treatment,Coronavirus treatment,...AstraZeneca said it was reviewing the event to ensure it would not result in a significant delay....,AstraZeneca,"SEPTEMBER 9, 2020"
John Kay: a lifetime in investment trusts,https://www.ft.com/content/802486eb-a669-4341-921f-01f6b6d03842,,https://www.ft.com/john-kay,John Kay,"...If the largest holdings are AstraZeneca, Unilever, Shell and HSBC you are effectively paying active management fees for an index tracker, and will you do better to buy the indexed tracker....",AstraZeneca,"AUGUST 28, 2020"
Trump considers fast-tracking UK Covid-19 vaccine before US election,https://www.ft.com/content/b053f55b-2a8b-436c-8154-0e93dcdb3c1a,,https://www.ft.com/coronavirus,Coronavirus,"...A spokesperson for the Treasury secretary said: “Secretary Mnuchin did not make any comments regarding AstraZeneca, nor is he familiar with the specifics of the AstraZeneca vaccine candidate....",AstraZeneca,"AUGUST 24, 2020"
Why is the ‘anti-vaxxer’ movement growing during a pandemic?,https://www.ft.com/content/f1966dd4-1c21-4a92-b726-f3634d8d9f16,,https://www.ft.com/content/7c88016e-f025-4f7f-b68a-27efe56ffa1c,Coronavirus: free to read,"...She is also mistrustful of Operation Warp Speed, a sprawling federally-funded effort that has paid billions of dollars to drug companies — including $1.2bn to AstraZeneca and $1.6bn to Novavax — to manufacture...",AstraZeneca,"AUGUST 20, 2020"
Being boring helps Unilever clean up,https://www.ft.com/content/c6078f45-a291-4657-9cf4-e905f2a3450d,,https://www.ft.com/bryce-elder,Bryce Elder,...The Dove soap maker this month overtook drugmaker AstraZeneca to become the UK’s most valuable listed company....,AstraZeneca,"AUGUST 1, 2020"
AstraZeneca bucks industry trend with rise in first-half profits,https://www.ft.com/content/2def1ffd-186c-494c-b5e3-a9a9b2c429a8,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,"...AstraZeneca’s London-listed shares added 2.6 per cent on Thursday.

Earlier this month, AstraZeneca said its Covid-19 jab elicited a sustained immune response, and that a study showed it was safe....",AstraZeneca’s,"JULY 30, 2020"
GlaxoSmithKline warns of hit to vaccines business,https://www.ft.com/content/2e12bcbb-1b9f-4bd6-8ee1-5b0ae3793166,,https://www.ft.com/stream/7e27074f-ef2c-45ed-a6e3-04f0a93451f4,GSK PLC,"...Moderna is pitching its coronavirus vaccine to potential buyers in a range of about $50 to $60 per dose, higher than prices already disclosed for those being jointly developed by Pfizer and BioNTech, and by AstraZeneca...",AstraZeneca,"JULY 29, 2020"
UK strikes deal for 60m Covid-19 vaccine doses with Sanofi and GSK,https://www.ft.com/content/4fd94286-66d8-4c6b-b589-da87a92c3715,,https://www.ft.com/coronavirus-treatment,Coronavirus treatment,"...It earlier agreed to buy 100m doses of the Oxford university vaccine being developed with AstraZeneca, as well as 30m doses from Germany’s BioNTech and US group Pfizer....",AstraZeneca,"JULY 29, 2020"
AstraZeneca and Daiichi Sankyo join forces again in $6bn cancer deal,https://www.ft.com/content/9dddea94-9d36-4689-8369-18d4620ea1ef,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,"...AstraZeneca has agreed to pay Japan’s Daiichi Sankyo up to $6bn to develop and market a potential lung and breast cancer drug, the second large oncology deal between the companies in the past two years....",AstraZeneca,"JULY 27, 2020"
Forecast-beating Unilever becomes UK’s biggest listed company,https://www.ft.com/content/fb5273b0-c44b-491c-8ad0-de0b92163087,,https://www.ft.com/stream/54c1f96b-d68e-4ec3-92b4-87608a3e963d,Unilever PLC,"...maker of Dove soap, Ben & Jerry’s ice cream and Domestos bleach rose 8.75 per cent to £47.09 on the news, making it the largest company in the FTSE 100 by market capitalisation as it overtook drugmaker AstraZeneca...",AstraZeneca,"JULY 23, 2020"
"Coronavirus: California surpasses 400,000 cases, closes in on New York — as it happened",https://www.ft.com/content/cffbad8f-41a3-3f00-9585-0efc3169ffb9,,https://www.ft.com/coronavirus,Coronavirus,,,"JULY 21, 2020"
GSK shown up by AstraZeneca yet again,https://www.ft.com/content/6d406df6-8c33-409e-860c-6a38cc165568,,https://www.ft.com/cat-rutter-pooley,Cat Rutter Pooley,"...On Monday, AstraZeneca’s lead extended further with positive results from the trial it is conducting with Oxford university. GSK’s vaccine-related announcement was more modest....",AstraZeneca’s,"JULY 20, 2020"
Oxford coronavirus vaccine shows promise in early trial,https://www.ft.com/content/10c7306d-dbfa-4a5f-abe5-5748b4083d94,,https://www.ft.com/coronavirus-treatment,Coronavirus treatment,"...AstraZeneca’s share price jumped more than 3 per cent on the news, then fell back to below where it started....",AstraZeneca’s,"JULY 20, 2020"
Pharma can redeem itself through the pandemic,https://www.ft.com/content/a6dde4a6-c2a5-11ea-9b66-39ae33ea12cb,https://www.ft.com/__origami/service/image/v2/images/raw/http%3A%2F%2Fprod-upp-image-read.ft.com%2F9224d3ac-c2b5-11ea-a0f0-d00aaf61dffd?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/ft-view,The editorial board,...Companies such as AstraZeneca and GlaxoSmithKline have begun work on setting up supply chains for the global manufacture and supply of a vaccine....,AstraZeneca,"JULY 12, 2020"
Markets Now - Monday 8th June 2020,https://www.ft.com/content/7f5ed0fb-9332-4273-9797-2dc07c281bab,,https://www.ft.com/equities,Equities,"...AstraZeneca Plc has made a preliminary approach to rival drugmaker Gilead Sciences Inc. about a potential merger, according to people familiar with the matter, in what would be the biggest health-care deal...",AstraZeneca,"JUNE 8, 2020"
"Trump social media order, AstraZeneca turnround",https://www.ft.com/content/4a93301f-9aed-48ea-85ae-f3d8e2718013,,https://www.ft.com/ft-news-briefing,FT News Briefing podcast,"...Plus, the FT’s industry editor, Peggy Hollinger, unpacks the turnround that propelled pharmaceutical group AstraZeneca to the industry’s front ranks....",AstraZeneca,"MAY 29, 2020"
GSK targets production of 1bn doses of coronavirus vaccine booster,https://www.ft.com/content/30c6c6a7-dca7-40f4-9fc0-5b8835f1aab3,,https://www.ft.com/coronavirus,Coronavirus,...AstraZeneca’s partnership with the University of Oxford on its own candidate has attracted a promise of more than $1bn in funding from the US....,AstraZeneca’s,"MAY 28, 2020"
The lessons and consequences of a failed megadeal,https://www.ft.com/content/335d22dd-c45b-47f5-a6eb-aa6fa4cf1c4f,,https://www.ft.com/due-diligence,Due Diligence,"...That time Pfizer failed to clinch a deal for AstraZeneca

If Ian Read had his way, AstraZeneca would be a unit of US pharma group Pfizer right now....",AstraZeneca,"MAY 28, 2020"
Drug wars: how AstraZeneca overtook GSK in UK pharma,https://www.ft.com/content/20bd997e-d26a-4cf6-8f2e-3cf35784669e,,https://www.ft.com/the-big-read,The Big Read,"...Luke Miels, once Mr Soriot’s right-hand man at AstraZeneca, is GSK’s head of pharmaceuticals....",AstraZeneca,"MAY 27, 2020"
Race for a vaccine raises fears over unequal access,https://www.ft.com/content/fc40456e-9c36-11ea-adb1-529f96d8a00b,,https://www.ft.com/ft-view,The editorial board,...AstraZeneca last week said it was engaging with international bodies such as the World Health Organization “for the fair allocation and distribution of the vaccine around the world”....,AstraZeneca,"MAY 25, 2020"
Scientists vs politicians: the reality check for ‘warp speed’ vaccine research ,https://www.ft.com/content/1467b1da-28a5-47d4-a5e2-a6f4b68484c3,,https://www.ft.com/content/7c88016e-f025-4f7f-b68a-27efe56ffa1c,Coronavirus: free to read,"...They believe that before the end of the year we could see vaccines from Pfizer and their German partner BioNTech, and AstraZeneca and Oxford university....",AstraZeneca,"MAY 22, 2020"
City Bulletin: Retail sales plunge to record low,https://www.ft.com/content/82f70003-844e-4298-9c7d-964a47832b12,,https://www.ft.com/city-bulletin,City Bulletin,"...Lombard If UK plc needed a new national champion, AstraZeneca would not be a bad candidate (Swedish heritage aside).

Thanks for reading....",plc,"MAY 22, 2020"
Covid-19 has brought on a case of corporate good citizenship at AstraZeneca,https://www.ft.com/content/a008426d-79b2-4cfc-8ab4-39808e5d9a48,,https://www.ft.com/cat-rutter-pooley,Cat Rutter Pooley,"...If UK plc needed a new national champion, AstraZeneca would not be a bad candidate (Swedish heritage aside)....",plc,"MAY 21, 2020"
Markets Now - Thursday 21st May 2020,https://www.ft.com/content/7e055f67-be0e-4951-911d-93cab2e26b59,,https://www.ft.com/equities,Equities,"...Assuming nothing changes, UK PLC’s top tier will be swapping international travel and essential home comforts for gambling, incontinence and monetisable paranoia. That feels appropriate for 2020....",PLC’s,"MAY 21, 2020"
AstraZeneca books orders for 400m doses of Oxford vaccine,https://www.ft.com/content/4b216c2e-2558-4308-b9c2-bf805b08e949,,https://www.ft.com/coronavirus,Coronavirus,...Drugmaker AstraZeneca said on Thursday that it had secured orders for at least 400m doses of an as yet unproven Covid-19 vaccine being developed with Oxford university and would begin delivering them in...,AstraZeneca,"MAY 21, 2020"
Prostate cancer drugs: precisely done,https://www.ft.com/content/9a88b9f5-1ab3-4caf-91cf-1cff8a4daa82,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...US regulators have approved Lynparza, in a significant breakthrough for the drug’s developers — AstraZeneca of the UK and America’s Merck....",AstraZeneca,"MAY 20, 2020"
AstraZeneca’s rise to the FTSE top spot feels like a sell signal,https://www.ft.com/content/58433ba9-4122-471b-8fe6-77813e7f4530,,https://www.ft.com/bryce-elder,Bryce Elder,...AstraZeneca’s profit growth now leads the sector....,AstraZeneca’s,"MAY 16, 2020"
"Investors Chronicle: JD Sports, AstraZeneca, Virgin Money UK",https://www.ft.com/content/50bee04d-0bb6-4b63-ba2f-ca72008a52d8,,https://www.ft.com/investments,Investments,"...BUY: AstraZeneca (AZN)

AstraZeneca’s growth rates are moving in the right direction and the dividend assurance on offer is increasingly rare, writes Harriet Clarfelt....",AstraZeneca,"MAY 7, 2020"
Coronavirus vaccine: an epidemic of nationalism,https://www.ft.com/content/56899fab-94e7-49b5-bbc6-beda92df6ea7,,https://www.ft.com/coronavirus,Coronavirus,"...In the UK, a global tie-up between AstraZeneca and the University of Oxford aims to make 100m doses, with Britons getting priority....",AstraZeneca,"APRIL 30, 2020"
AstraZeneca and Oxford university agree deal to develop virus vaccine,https://www.ft.com/content/ddf8ec8c-dc30-43b3-847e-c412704a0296,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,"...The collaboration pushed shares in AstraZeneca 2.8 per higher, to a record of 229p a share....",AstraZeneca,"APRIL 30, 2020"
Next’s Wolfson shows his workings for a new socially distant world,https://www.ft.com/content/1398ba85-5051-4823-9ab8-86ae5185fa23,,https://www.ft.com/kate-burgess,Kate Burgess,"...Ad Astra

AstraZeneca is proving more Covid-19 immune than other pharma groups scrabbling to find a cure. Its efforts remain directed at cancer treatments, and investors approve....",AstraZeneca,"APRIL 29, 2020"
Can Matt Hancock’s 5-point plan solve the testing crisis?,https://www.ft.com/content/3c102ab6-4e0e-46e7-a515-124f4f046aea,,https://www.ft.com/uk-politics,UK politics,...remains to be seen whether his ambitious “five-pillar” plan — engaging the private sector in testing and trying to develop a “huge diagnostic industry” almost from scratch involving big companies like AstraZeneca...,AstraZeneca,"APRIL 2, 2020"
AstraZeneca: the right prescription,https://www.ft.com/content/46d0baed-60f2-40b2-a380-5df037e9b250,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,"...AstraZeneca makes it look almost easy. In the middle of the past decade, the Anglo-Swedish pharmaceutical company fell down the biggest patent cliff in the industry....",AstraZeneca,"MARCH 30, 2020"
AstraZeneca warns of coronavirus hit to growth,https://www.ft.com/content/b9fa5578-4ef7-11ea-95a0-43d18ec715f5,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,"...AstraZeneca has warned of the “unfavourable impact” on its business of the coronavirus outbreak, making clear that the unfolding epidemic has injected uncertainty into its growth forecasts....",AstraZeneca,"FEBRUARY 14, 2020"
The onetime Parisian street fighter who gave his company purpose,https://www.ft.com/content/227bee4e-1524-11ea-9ee4-11f260415385,,https://www.ft.com/how-to-lead,How to Lead,"...Growing up in the Parisian banlieues, Mr Soriot, now chief executive of Anglo-Swedish pharma group AstraZeneca, was not above resorting to fisticuffs as he and his friends defended themselves against rival...",AstraZeneca,"FEBRUARY 9, 2020"
Fear that governance code will spark wave of UK board departures,https://www.ft.com/content/6905336e-4442-11ea-a43a-c4b328d9061c,,https://www.ft.com/corporate-governance,Corporate governance,"...Pascal Soriot, chief executive of AstraZeneca, also questioned the need for rigid adherence to the nine-year rule....",AstraZeneca,"FEBRUARY 3, 2020"
AstraZeneca takes $100m hit after failed heart drug trial,https://www.ft.com/content/d11dd4e2-35d3-11ea-a6d3-9a26f8c3cba4,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,...AstraZeneca will take a $100m writedown after trials of a heart disease drug showed it to be ineffective in treating a particular cardiovascular condition....,AstraZeneca,"JANUARY 13, 2020"
Paul Hudson seeks to write new prescription for Sanofi,https://www.ft.com/content/08f1fcf8-1ce4-11ea-97df-cc63de1d73f4,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...Chris Brinsmead, the former UK head of AstraZeneca, described him as “a commercial animal”.

He added: “His DNA is business and commerce really, but he is a smart guy....",AstraZeneca,"DECEMBER 13, 2019"
AstraZeneca backs $1bn China biotech fund for smaller ventures,https://www.ft.com/content/5727e4fc-ffe1-11e9-be59-e49b2a136b8d,https://www.ft.com/__origami/service/image/v2/images/raw/http%3A%2F%2Fprod-upp-image-read.ft.com%2F068297c6-ffec-11e9-a530-16c6c29e70ca?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,"...Part of AstraZeneca’s plans involve doubling staff at its research centre in Shanghai to 1,000 over the next few years....",AstraZeneca’s,"NOVEMBER 5, 2019"
AstraZeneca lifts sales outlook on further boost from new drugs,https://www.ft.com/content/55c67e04-f62a-11e9-9ef3-eca8fc8f2d65,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,"...Speaking to reporters after the results were released, Mr Soriot emphasised the broad-based nature of AstraZeneca’s resurgence....",AstraZeneca’s,"OCTOBER 24, 2019"
Opening Quote: RBS returns to familiar losses,https://www.ft.com/content/67ea740a-f62f-11e9-a79c-bc9acae3b654,,https://www.ft.com/city-bulletin,City Bulletin,...Finally drugmaker AstraZeneca has upgraded sales guidance for the second quarter in a row....,AstraZeneca,"OCTOBER 24, 2019"
Data may widen market for AstraZeneca and GSK ovarian cancer drugs,https://www.ft.com/content/68056ab2-e176-11e9-9743-db5a370481bc,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...The UK’s two biggest drugmakers may have widened the market for their ovarian cancer treatments following positive results from clinical trials

AstraZeneca and GlaxoSmithKline both showcased striking outcomes...",AstraZeneca,"SEPTEMBER 28, 2019"
The UK’s unpredictable attitude to foreign bids,https://www.ft.com/content/00ad892c-cfe6-11e9-99a4-b5ded7a7fe3f,,https://www.ft.com/ft-view,The editorial board,"...The regulations were further reinforced after Pfizer made broad commitments to invest in the UK, during its abortive bid for AstraZeneca, the drugs company, in 2014....",AstraZeneca,"SEPTEMBER 9, 2019"
Marks and Spencer heads for relegation from FTSE 100,https://www.ft.com/content/11df570e-cd5a-11e9-99a4-b5ded7a7fe3f,,https://www.ft.com/uk-equities,UK equities,"...AstraZeneca led the day’s gainers, with the drugmaker hitting a record high in response to promising data from a pivotal trial of its diabetes drug Farxiga to treat cardiovascular problems....",AstraZeneca,"SEPTEMBER 2, 2019"
AstraZeneca faces setback in lung cancer drug trial,https://www.ft.com/content/dbc97422-c3dd-11e9-a8e9-296ca66511c9,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,"...The immunotherapy achieved sales of $633m in the first half of this year, a growth of nearly 250 per cent which helped AstraZeneca raise its sales outlook on booming revenues....",AstraZeneca,"AUGUST 21, 2019"
AstraZeneca climbs as it raises outlook on booming sales,https://www.ft.com/content/542168e4-aead-11e9-8030-530adfa879c2,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,...AstraZeneca shares were up almost 6 per cent at lunchtime in London to £67.35....,AstraZeneca,"JULY 25, 2019"
GSK: betting the pharm,https://www.ft.com/content/a97ab0a0-ae23-11e9-8030-530adfa879c2,,https://www.ft.com/stream/7e27074f-ef2c-45ed-a6e3-04f0a93451f4,GSK PLC,"...The latest is the newly announced chairman Jonathan Symonds, a former finance director at rival drugmakers AstraZeneca and Novartis....",AstraZeneca,"JULY 24, 2019"
AstraZeneca to pay millions of pounds to former staff,https://www.ft.com/content/d312cdba-a88f-11e9-984c-fac8325aaa04,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,"...AstraZeneca remained closely involved in helping secure a future for the site following the sale to Avara, which it said had been “made in good faith” in 2016....",AstraZeneca,"JULY 17, 2019"
Ovarian cancer treatment boosts GSK,https://www.ft.com/content/9afd687a-a6d4-11e9-984c-fac8325aaa04,,https://www.ft.com/stream/7e27074f-ef2c-45ed-a6e3-04f0a93451f4,GSK PLC,"...At the time of the Tesaro acquisition, some analysts had suggested that it might struggle against Lynparza, another ovarian cancer drug, that is being jointly developed and commercialised by AstraZeneca...",AstraZeneca,"JULY 15, 2019"
GSK to appoint Jonathan Symonds as chairman,https://www.ft.com/content/c6d73fd2-a645-11e9-984c-fac8325aaa04,,https://www.ft.com/stream/7e27074f-ef2c-45ed-a6e3-04f0a93451f4,GSK PLC,...A spokesman for GSK said: “GlaxoSmithKline plc announced in January 2019 that the board had started the process to find a successor to Sir Philip Hampton as non-executive chairman....,plc,"JULY 14, 2019"
AstraZeneca takes lessons from fast food to serve China,https://www.ft.com/content/1370a998-a3a1-11e9-974c-ad1c6ab5efd1,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,...AstraZeneca has been an early adopter of this approach since Mr Wang joined the company in 2013....,AstraZeneca,"JULY 11, 2019"
Smith & Nephew directors discussed US listing to boost CEO pay,https://www.ft.com/content/5ccdb134-9650-11e9-8cfb-30c211dcd229,,https://www.ft.com/stream/ea1f8c97-07cd-4de0-998b-ced2c8a3d742,Smith & Nephew PLC,"...If the plan were enacted, it would leave just three healthcare companies in the FTSE 100: GlaxoSmithKline, AstraZeneca and NMC Health....",AstraZeneca,"JUNE 25, 2019"
UK biotechs seek to speed up cancer detection,https://www.ft.com/content/d0a2225c-86e2-11e9-97ea-05ac2431f453,,https://www.ft.com/stream/95e1dc23-3922-3288-a702-efbb1a46c070,Small-cap focus,"...AstraZeneca, the Anglo-Swedish drugmaker, for example, showcased treatments intended to be administered at a much earlier stage, when the disease could still be cured....",AstraZeneca,"JUNE 7, 2019"
Pharma groups combine to promote drug discovery with AI,https://www.ft.com/content/ef7be832-86d0-11e9-a028-86cea8523dc2,,https://www.ft.com/medical-science,Medical science,"...In the UK, Genomics Plc, a spinout from the University of Oxford, signed a drug discovery deal with Vertex Pharmaceuticals, the biotech company....",Plc,"JUNE 4, 2019"
AstraZeneca reports encouraging results for early-stage cancer treatments,https://www.ft.com/content/304ea416-8448-11e9-a028-86cea8523dc2,,https://www.ft.com/uk-companies,UK companies,"...AstraZeneca has unveiled data suggesting that its push into early-stage treatments for cancer is yielding results, as the drugmaker seeks to lead a global race to increase survival rates....",AstraZeneca,"JUNE 2, 2019"
Neil Woodford sells stake in P2P Global to meet redemptions,https://www.ft.com/content/38496d6e-6b51-11e9-80c7-60ee53e6681d,,https://www.ft.com/stream/64d042d9-7c75-4a4d-8533-a5e4065bcbf5,Neil Woodford,...One of Mr Woodford’s top five holdings — biotech company Benevolent AI — on Tuesday announced a long-term collaboration with AstraZeneca to use artificial intelligence and machine learning to develop treatments...,AstraZeneca,"APRIL 30, 2019"
AstraZeneca cancer drugs drive growth in sales,https://www.ft.com/content/5e24cdb0-67e8-11e9-9adc-98bf1d35a056,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,"...AstraZeneca reported its third successive quarter of sales growth on the back of demand for its new cancer drugs and a strong showing in emerging markets, especially China....",AstraZeneca,"APRIL 26, 2019"
AstraZeneca chief claims vindication five years after Pfizer bid,https://www.ft.com/content/5be151ac-3eaf-11e9-9bee-efab61506f44,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...Five years ago this week, AstraZeneca boss Pascal Soriot was embarking on the fight of his life....",AstraZeneca,"APRIL 24, 2019"
"YouGov, AstraZeneca",https://www.ft.com/content/a349f1fa-5568-11e9-a3db-1fe89bedc16e,,https://www.ft.com/investments,Investments,...AstraZeneca has raised $3.5bn (£2.7bn) via a share placing to help fund a new partnership with Japanese pharma group Daiichi Sankyo....,AstraZeneca,"APRIL 5, 2019"
The UK executives helping Putin burnish Russia’s image,https://www.ft.com/content/0d58751a-5566-11e9-91f9-b6515a54c5b1,,https://www.ft.com/henry-foy,Henry Foy,"...The other foreign guests included Graeme Macdonald, chief executive of JCB, Ian Taylor of Vitol, Pascal Soriot of Swedish-British drugmaker AstraZeneca and former WPP chief Martin Sorrell....",AstraZeneca,"APRIL 4, 2019"
"Stocks to watch: EasyJet, WPP, Circassia, Royal Mail, Publicis",https://www.ft.com/content/7921ce88-545b-11e9-91f9-b6515a54c5b1,,https://www.ft.com/equities,Equities,"...Reaching the milestones means lossmaking Circassia has to pay $20m to AstraZeneca within 30 days, with a further $100m due by June 30....",AstraZeneca,"APRIL 1, 2019"
AstraZeneca: capital remedy,https://www.ft.com/content/e685b9ce-522d-11e9-9c76-bf4a0ce37d49,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,"...But AstraZeneca has earned credibility in recent years. With the latest drug adding to several other likely cancer blockbusters, expect AstraZeneca to outpace most of its peers....",AstraZeneca,"MARCH 29, 2019"
AstraZeneca in $6.9bn cancer deal with Daiichi Sankyo,https://www.ft.com/content/08cd39b0-51cc-11e9-b401-8d9ef1626294,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...Shares in Daiichi surged 16 per cent on news of the deal, which AstraZeneca will partly fund through a $3.5bn share sale....",AstraZeneca,"MARCH 29, 2019"
AstraZeneca places digital tech at core of blueprint for growth,https://www.ft.com/content/a38d9d02-41c6-11e9-9bee-efab61506f44,https://www.ft.com/__origami/service/image/v2/images/raw/http%3A%2F%2Fprod-upp-image-read.ft.com%2Fde7802de-48ad-11e9-bde6-79eaea5acb64?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,"...AstraZeneca is mounting a big push into digital technologies, which includes hiring a former Nasa artificial intelligence expert, as it seeks to accelerate drug discovery and show the value of its medicines...",AstraZeneca,"MARCH 17, 2019"
US drugmakers defend pricing under fire in Senate,https://www.ft.com/content/7df3a7e8-39e3-11e9-b72b-2c7f526ca5d0,,https://www.ft.com/drug-prices,Drug prices,"...Albert Bourla, the new chief executive of Pfizer, said the company would “not keep a single dollar” from the rebate reforms, while Pascal Soriot, chief executive of AstraZeneca, said removing the rebates...",AstraZeneca,"FEBRUARY 26, 2019"
Drugmakers face Senate over drug pricing,https://www.ft.com/content/2061c974-3651-11e9-bb0c-42459962a812,,https://www.ft.com/drug-prices,Drug prices,"...Pascal Soriot, chief executive of UK-based AstraZeneca, will try to make the case that pharma can play a role in reducing costs for the health system overall....",AstraZeneca,"FEBRUARY 24, 2019"
Purplebricks displays knack for turning faces purple,https://www.ft.com/content/62ec183c-35e6-11e9-bb0c-42459962a812,,https://www.ft.com/kate-burgess,Kate Burgess,"...Ten FTSE 100 groups account for more than half of dividend payments — Royal Dutch Shell, HSBC, BP, BAT, GlaxoSmithKline, Vodafone, Rio Tinto, AstraZeneca, Lloyds and Glencore....",AstraZeneca,"FEBRUARY 21, 2019"
New drugs help AstraZeneca sales rebound,https://www.ft.com/content/eee7f494-3020-11e9-8744-e7016697f225,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,"...Drugmaker AstraZeneca extended a sales rebound in the final quarter of last year, driven by the strong performance of new medicines and demand from emerging markets....",AstraZeneca,"FEBRUARY 14, 2019"
"Fast Europe Open: Germany GDP, Turkey current account",https://www.ft.com/content/2a12eaca-3020-11e9-8744-e7016697f225,,https://www.ft.com/markets,Markets,"...Expect a flurry of earnings on Thursday morning with AstraZeneca, Ashmore, Commerzbank, Credit Agricole, Credit Suisse, Renault, Nestle, Money Supermarket and Manchester United Plc lined up to report....",AstraZeneca,"FEBRUARY 14, 2019"
AstraZeneca hires controversial head of cancer R&D,https://www.ft.com/content/e821b2ea-126a-11e9-a581-4ff78404524e,,https://www.ft.com/content/a68b3582-43f2-11e8-803a-295c97e6fd0b,FT People: Consumer and retail,"...Pascal Soriot, chief executive of AstraZeneca, described Dr Baselga as “one of the top, if not the top, scientific leaders in oncology”....",AstraZeneca,"JANUARY 7, 2019"
"Emma Walmsley, a fast-talker shaking up GSK",https://www.ft.com/content/d5385f40-0481-11e9-99df-6183d3002ee1,,https://www.ft.com/columnists/person-in-the-news,Person in the News,"...She poached Luke Miels, AstraZeneca’s European head, to run the division, and Hal Barron from Calico by way of Genentech, to oversee research and development, presenting them as star signings....",AstraZeneca’s,"DECEMBER 21, 2018"
GlaxoSmithKline to break up after striking Pfizer joint venture,https://www.ft.com/content/3681be02-035d-11e9-9d01-cd4d49afbbe3,,https://www.ft.com/stream/7e27074f-ef2c-45ed-a6e3-04f0a93451f4,GSK PLC,"...The deal also comes four years after Mr Read failed in an attempt to take over AstraZeneca, the Anglo-Swedish company, and three years since he inquired about an acquisition of GSK....",AstraZeneca,"DECEMBER 19, 2018"
GlaxoSmithKline/Tesaro: hobby horse,https://www.ft.com/content/3a103fda-f71e-11e8-af46-2022a0b02a6c,,https://www.ft.com/mergers-acquisitions,Mergers & Acquisitions,"...But it faces competition from treatments from AstraZeneca, Merck and multiple biotech start-ups. *

Through the first nine months of the year, Tesaro generated $166m of revenue....",AstraZeneca,"DECEMBER 3, 2018"
GSK to boost cancer drugs pipeline with $5.1bn Tesaro purchase,https://www.ft.com/content/3da2b2d0-f6f7-11e8-8b7c-6fa24bd5409c,,https://www.ft.com/stream/7e27074f-ef2c-45ed-a6e3-04f0a93451f4,GSK PLC,...Credit Suisse noted the “extremely competitive area of PARP commercialisation given the [joint venture] between AstraZeneca and Merck over their medicine Lynparza” and “the more challenging tolerability...,AstraZeneca,"DECEMBER 3, 2018"
AstraZeneca Mystic lung cancer trial fails to deliver results,https://www.ft.com/content/aa773ade-e96e-11e8-a34c-663b3f553b35,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,"...AstraZeneca had hoped the medicine, whichis called Imfinzi, would eventually be adopted as a first line treatment for non-small cell lung cancer....",AstraZeneca,"NOVEMBER 16, 2018"
AstraZeneca diabetes drug cuts complications,https://www.ft.com/content/8020e04c-e413-11e8-a6e5-792428919cee,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...A drug developed by AstraZeneca has markedly reduced the chances of diabetic patients being hospitalised with heart failure, a condition associated with type 2 diabetes....",AstraZeneca,"NOVEMBER 10, 2018"
AstraZeneca: back from the abyss,https://www.ft.com/content/c3638808-e361-11e8-a6e5-792428919cee,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,"...But AstraZeneca’s white coats have outperformed. Their recent winning streak has produced the first quarter of core sales growth since 2014, pushing the shares up 2 per cent on Thursday....",AstraZeneca’s,"NOVEMBER 8, 2018"
AstraZeneca shares surge as new drugs spark hope of growth,https://www.ft.com/content/093224be-e332-11e8-a6e5-792428919cee,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,"...Despite Crestor woes, AstraZeneca said there were no major patent expiries looming in the near future....",AstraZeneca,"NOVEMBER 8, 2018"
AstraZeneca sells trio of respiratory drugs for $350m,https://www.ft.com/content/03eef9d6-e194-11e8-a6e5-792428919cee,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,...AstraZeneca has been searching for ways to offset a decline in sales from former blockbuster drugs such as Crestor as patents expire....,AstraZeneca,"NOVEMBER 6, 2018"
AstraZeneca strengthens cancer focus with Innate deal,https://www.ft.com/content/6848f540-d694-11e8-a854-33d6f82e62f8,,https://www.ft.com/stream/e800f5e3-f118-4859-90a1-6e5c1cc969f0,AstraZeneca PLC,"...The companies on Tuesday said that AstraZeneca would acquire a 9.8 per cent equity stake in Innate through the issue of 6,260,500 new shares to AstraZeneca at €10 each, more than double Monday’s closing...",AstraZeneca,"OCTOBER 23, 2018"
AstraZeneca gets cancer trial boost for Lynparza drug,https://www.ft.com/content/c099aafe-d44c-11e8-a854-33d6f82e62f8,,https://www.ft.com/drugs-research,Drugs research,...A treatment developed by AstraZeneca has shown strong benefits for women newly diagnosed with ovarian cancer in the latest boost for the Anglo-Swedish drugmaker’s research and development-led growth strategy...,AstraZeneca,"OCTOBER 21, 2018"
Unilever U-turn shows how angry shareholders are securing change,https://www.ft.com/content/d7211dba-ce21-11e8-9fe5-24ad351828ab,,https://www.ft.com/personal-household-goods,Personal & Household Goods,"...Rebellions over high executive pay at the UK’s largest companies, meanwhile, doubled this year, with businesses from AstraZeneca to BT and Shell suffering big protests at their AGMs....",AstraZeneca,"OCTOBER 14, 2018"
Respiratory illnesses prompt innovation at small UK pharma groups,https://www.ft.com/content/a552dbc0-c89f-11e8-ba8f-ee390057b8c9,,https://www.ft.com/uk-companies,UK companies,"...In 2017, the company also established a commercial collaboration with AstraZeneca in the US through which Circassia promotes the COPD (chronic obstructive pulmonary disease] treatment Tudorza and has the...",AstraZeneca,"OCTOBER 5, 2018"
AstraZeneca Imfinzi scores lung cancer success,https://www.ft.com/content/87024e50-bda8-11e8-8274-55b72926558f,,https://www.ft.com/uk-companies,UK companies,...Shares in AstraZeneca were 2 per cent higher in early afternoon trading after the announcement....,AstraZeneca,"SEPTEMBER 25, 2018"
Woodford finds all is not lost — and there’s hope on the Horizon,https://www.ft.com/content/046e8e00-ba7d-11e8-8274-55b72926558f,,https://www.ft.com/matthew-vincent,Matthew Vincent,...Its Crispr gene-editing technique has earned it an agreement with AstraZeneca and another unnamed “major” pharmaceutical company — and this is an end-market with a compound annual growth rate of 15-20 per...,AstraZeneca,"SEPTEMBER 17, 2018"
Big pharma takes a gamble on NHS experiment,https://www.ft.com/content/0951ab8c-a128-11e8-85da-eeb7a9ce36e4,,https://www.ft.com/sarah-neville,Sarah Neville,"...We have Pfizer, we have Chiesi, we have [AstraZeneca] . . .[ and] Bohringer Ingelheim in this COPD space with huge amounts to offer and huge skin in the game.”...",AstraZeneca,"AUGUST 28, 2018"
China health reforms help global pharma groups despite price cuts,https://www.ft.com/content/5aef7218-a50f-11e8-8ecf-a7ae1beff35b,,https://www.ft.com/chinese-politics-policy,Chinese politics & policy,"...“It’s suddenly a very nice performance,” AstraZeneca’s chief executive Pascal Soriot told investors on a conference call....",AstraZeneca’s,"AUGUST 26, 2018"
Diversify in your search for income,https://www.ft.com/content/6b698796-93df-11e8-95f8-8640db9060a7,,https://www.ft.com/maike-currie,Maike Currie,"...Shell, GSK and AstraZeneca have all maintained their dividends, even though, at times, those dividends weren’t covered, and the underlying business dynamics pointed towards a dividend cut....",AstraZeneca,"AUGUST 1, 2018"
UK earnings bonanza: a (brief) London stocks round-up,https://www.ft.com/content/41b020a8-90a2-11e8-bb8f-a6a2f7bca546,https://www.ft.com/__origami/service/image/v2/images/raw/http%3A%2F%2Fprod-upp-image-read.ft.com%2F9ee87a34-90a9-11e8-bb8f-a6a2f7bca546?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/uk-companies,UK companies,"...Also on Thursday pharma giant AstraZeneca reported strong sales growth but said new medicines had failed to offset the impact of patent expiries, broadcaster Sky beat expectations over the period in which...",AstraZeneca,"JULY 26, 2018"
"Opening Quote: Diageo, Astra, Shell, Sky . . . phew, what a scorcher",https://www.ft.com/content/b53fd718-90a0-11e8-b639-7680cedcc421,,https://www.ft.com/matthew-vincent,Matthew Vincent,...AstraZeneca has been trying to convince investors that newer drugs can make up for falling sales of Crestor and other ex blockbuster drugs that are coming off patent....,AstraZeneca,"JULY 26, 2018"
New drugs boost AstraZeneca sales but patent expiries still weigh,https://www.ft.com/content/b1c776ce-9099-11e8-bb8f-a6a2f7bca546,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...The decline of sales from Crestor, which at its 2011 peak generated annual sales of more than $6bn has hurt AstraZeneca quarter after quarter....",AstraZeneca,"JULY 26, 2018"
Emma Walmsley plots course out of ‘hobbyland’ for GSK,https://www.ft.com/content/41e49546-8c0f-11e8-bf9e-8771d5404543,,https://www.ft.com/uk-companies,UK companies,...Ms Walton noted with approval that AstraZeneca had “a good track record of fast development”....,AstraZeneca,"JULY 20, 2018"
Investors step up protests over excessive pay,https://www.ft.com/content/7052722a-7627-11e8-b326-75a27d27ea5f,,https://www.ft.com/corporate-governance,Corporate governance,"...Investors have stepped up protests against directors who back excessive pay or sit on too many boards as they increase scrutiny of some of Britain’s biggest groups including AstraZeneca, British American...",AstraZeneca,"JUNE 22, 2018"
FCA interviewed Finsbury chief’s driver in insider trading probe,https://www.ft.com/content/f662e4a0-7567-11e8-aa31-31da4279a601,,https://www.ft.com/uk-companies,UK companies,"...It represented Walmart in the sale of Asda to Sainsbury’s and also advises Sky, AstraZeneca and BAE Systems....",AstraZeneca,"JUNE 21, 2018"
Global pharma bleeds talent to China start-ups,https://www.ft.com/content/d3a2de0e-6fbb-11e8-92d3-6c13e5c92914,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...Former China executives at multinationals including Pfizer, AstraZeneca, GlaxoSmithKline and Johnson & Johnson have switched to local companies in recent months as the domestic industry develops drugs for...",AstraZeneca,"JUNE 17, 2018"
AstraZeneca and Eli Lilly scrap Alzheimer’s drug trial,https://www.ft.com/content/b07e1f70-6e07-11e8-852d-d8b934ff5ffa,,https://www.ft.com/dementia,Dementia,...AstraZeneca said the discontinuation of the trial was not expected to have a material impact on its 2018 financial guidance....,AstraZeneca,"JUNE 12, 2018"
Alzheimer’s cure: a fading hope,https://www.ft.com/content/689edad8-6e38-11e8-852d-d8b934ff5ffa,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,...On Tuesday a treatment from AstraZeneca and Eli Lilly joined the list. The partners halted a trial of a drug called Lanabecestat on the grounds it was unlikely to meet its goal....,AstraZeneca,"JUNE 12, 2018"
Drugmakers struggle to find immunotherapy combinations for cancer,https://www.ft.com/content/d39afa5e-6066-11e8-9334-2218e7146b04,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...The medicines, which wowed the audience at Asco in 2014, raked in $10bn in sales last year for Merck of the US, Bristol-Myers Squibb, Roche and AstraZeneca....",AstraZeneca,"MAY 30, 2018"
Balfour Beatty sees off investor pay unrest,https://www.ft.com/content/7ef0001a-6027-11e8-ad91-e01af256df68,,https://www.ft.com/remuneration,Remuneration,"...London-listed investment house Jupiter Fund Management, housebuilders Bovis Homes and Persimmon, drugmaker AstraZeneca and the consumer giant Unilever all faced substantial revolts over their pay packages...",AstraZeneca,"MAY 25, 2018"
Lloyds shareholders protest over Horta-Osório pay,https://www.ft.com/content/a104bee8-5f64-11e8-9334-2218e7146b04,,https://www.ft.com/uk-banks,UK banks,"...Thursday’s vote was the latest in a series of recent protests over pay at large groups such as Royal Dutch Shell, AstraZeneca and Unilever....",AstraZeneca,"MAY 24, 2018"
Royal Dutch Shell hit by protest over CEO’s pay,https://www.ft.com/content/7f945fc4-5dc6-11e8-9334-2218e7146b04,,https://www.ft.com/european-companies,European companies,"...But it added to sizeable pay protests this month against a series of large European companies, including AstraZeneca and Unilever, in a sign shareholders are becoming more assertive on the issue....",AstraZeneca,"MAY 22, 2018"
AstraZeneca: appliance of science,https://www.ft.com/content/df9d11be-5aaa-11e8-b8b2-d6ceb45fa9d0,,https://www.ft.com/uk-companies,UK companies,"...Sales dropped after a faster-than-expected decline in AstraZeneca’s cholesterol-zapping drug Crestor.

Boss Pascal Soriot says AstraZeneca is still on track to meet its 2023 revenue targets....",AstraZeneca’s,"MAY 18, 2018"
AstraZeneca chief Pascal Soriot suffers pay revolt,https://www.ft.com/content/cdd56fd4-5a60-11e8-bdb7-f6677d2e1ce8,,https://www.ft.com/uk-companies,UK companies,...AstraZeneca shares fell almost 2 per cent to close at £52.41....,AstraZeneca,"MAY 18, 2018"
"Stocks to watch: Vodafone, AstraZeneca, Glencore, Campbell Soup",https://www.ft.com/content/9f41c1b6-5a7b-11e8-b8b2-d6ceb45fa9d0,,https://www.ft.com/equities,Equities,"...AstraZeneca fell 2.5 per cent after the drugmaker’s earnings per share for the first quarter halved, hit by increased generic competition for its Crestor statin drug....",AstraZeneca,"MAY 18, 2018"
AstraZeneca shareholders urged to reject pay report,https://www.ft.com/content/a01e9de2-51f3-11e8-b3ee-41e0209208ec,,https://www.ft.com/uk-companies,UK companies,...AstraZeneca insiders suggested the different figures reflected adjustments to strip out the effect of currency movements....,AstraZeneca,"MAY 7, 2018"
The London Report: BAT slides to sharpest FTSE faller,https://www.ft.com/content/00842618-4d60-11e8-8a8e-22951a2d8493,,https://www.ft.com/retail-consumer,Retail & Consumer industry,"...Vague theories about a bid approach helped lift AstraZeneca, with US website Streetinsider naming Roche or Pfizer as potential buyers....",AstraZeneca,"MAY 1, 2018"
AstraZeneca receives regulatory boost for oncology drugs,https://www.ft.com/content/3b5f9b6c-374b-11e8-8b98-2f31af407cc8,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...AstraZeneca received a double boost for its oncology portfolio on Tuesday, after US and European regulators accepted regulatory submissions for its drugs, the first step towards winning approval for these...",AstraZeneca,"APRIL 3, 2018"
Immuno-oncology: on target,https://www.ft.com/content/cd2ec0e8-3748-11e8-8eee-e06bde01c544,,https://www.ft.com/uk-companies,UK companies,"...Roche, Pfizer and AstraZeneca are among those hoping to catch up fast....",AstraZeneca,"APRIL 3, 2018"
GKN vs Melrose poses key test for Britain’s national priorities,https://www.ft.com/content/d369ab34-31bd-11e8-b5bf-23cb17fd1498,,https://www.ft.com/us-companies,US & Canadian companies,...Pfizer promised in 2014 that it would protect jobs and investment at AstraZeneca....,AstraZeneca,"MARCH 27, 2018"
GKN debate reflects UK takeover regime’s flaws,https://www.ft.com/content/9ffafff6-31b2-11e8-ac48-10c6fdc22f03,,https://www.ft.com/uk-industrial-strategy,UK industrial strategy,"...Even deals that were turned away — by cost-slashers Pfizer and 3G for AstraZeneca and Unilever, respectively — created a sense that, left to its own devices, the deal market would leave Britain industrially...",AstraZeneca,"MARCH 27, 2018"
"Stocks to watch: Facebook, Henkel, WPP, Micro Focus, Sophos",https://www.ft.com/content/3dc37162-2b5c-11e8-9b4b-bc4b9f08f381,,https://www.ft.com/european-equities,European equities,"...Sellside Stories

● Jefferies upgrades AstraZeneca to “buy” with a £56 target price.

“AstraZeneca is at a turning point....",AstraZeneca,"MARCH 19, 2018"
Leaders under pressure,https://www.ft.com/content/5de4a96e-27d0-11e8-b27e-cc62a39d57a0,,https://www.ft.com/due-diligence,Due Diligence,"...Prudential plc will contain the Asian and US businesses, while M&G Prudential will house the UK operations....",plc,"MARCH 15, 2018"
AstraZeneca faces longer wait on key lung cancer drug test,https://www.ft.com/content/955c323e-25cf-11e8-b27e-cc62a39d57a0,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,...Key data on whether an AstraZeneca drug improves overall survival for those with non-small cell lung cancer that has spread elsewhere in the body will not now be released until the second half of the year...,AstraZeneca,"MARCH 12, 2018"
Immunotherapy: beyond melanoma and lung cancer treatment,https://www.ft.com/content/d9d91a4c-cece-11e7-947e-f1ea5435bcc7,https://www.ft.com/__origami/service/image/v2/images/raw/http%3A%2F%2Fprod-upp-image-read.ft.com%2F3a205b7e-1d7e-11e8-a748-5da7d696ccab?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/content/bfd3f044-8f0a-11e7-9084-d0c17942ba93,50 Ideas to Change the World,"...Other companies, including Roche and AstraZeneca, make competing versions....",AstraZeneca,"MARCH 5, 2018"
AstraZeneca: hoist the sales,https://www.ft.com/content/a6eb6582-1586-11e8-9e9c-25c814761640,https://www.ft.com/__origami/service/image/v2/images/raw/http%3A%2F%2Fprod-upp-image-read.ft.com%2F4026b618-1599-11e8-9e9c-25c814761640?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,...The implications of AstraZeneca’s namesake drug trial also take some fathoming....,AstraZeneca’s,"FEBRUARY 19, 2018"
AstraZeneca hails ‘milestone’ US approval for lung cancer drug,https://www.ft.com/content/c67f3b6a-1565-11e8-9e9c-25c814761640,,https://www.ft.com/uk-companies,UK companies,"...The news met a muted response from investors, with AstraZeneca shares up less than 1 per cent to £47.68p by mid-morning.

However, analysts reacted positively....",AstraZeneca,"FEBRUARY 19, 2018"
Opening Quote: Reckitt hopes for a healthier 2018; Astra’s win; Saga’s shake-up,https://www.ft.com/content/cd5b3fd6-1549-11e8-9376-4a6390addb44,,https://www.ft.com/matthew-vincent,Matthew Vincent,"...Dave Fredrickson, who heads the oncology business unit at AstraZeneca, decribed the approval as a “truly meaningful milestone for patients who, until now, had no FDA-approved treatment options following...",AstraZeneca,"FEBRUARY 19, 2018"
AstraZeneca wins FDA approval for key cancer drug,https://www.ft.com/content/3678e966-1543-11e8-9376-4a6390addb44,,https://www.ft.com/uk-companies,UK companies,"...The approval was based on positive results from AstraZeneca’s “Pacific” trial, which were published last year....",AstraZeneca’s,"FEBRUARY 19, 2018"
"Irish drugmaker Horizon Pharma raises painkiller price to $3,000 in US",https://www.ft.com/content/1922e424-11d4-11e8-940e-08320fc2a277,,https://www.ft.com/european-companies,European companies,"...When AstraZeneca was selling the drug in the US, the price was $138 per bottle....",AstraZeneca,"FEBRUARY 15, 2018"
Shire warns on competition from generic drugs,https://www.ft.com/content/5426b936-1190-11e8-8cb6-b9ccc4c4dbbb,,https://www.ft.com/european-companies,European companies,"...Nicholas Hyett, equity analyst at Hargreaves Lansdown said although Shire was small compared to rivals such as AstraZeneca and GlaxoSmithKline, patent expiries were a minor issue for it at the moment, nor...",AstraZeneca,"FEBRUARY 14, 2018"
Shield Therapeutics shows nothing is iron clad in biopharma,https://www.ft.com/content/8f810c32-0ce7-11e8-839d-41ca06376bf2,,https://www.ft.com/kate-burgess,Kate Burgess,"...Fortunately, it had raised £275m in 2015, which it used to pay for the distribution rights to two AstraZeneca drugs going through trials this year....",AstraZeneca,"FEBRUARY 11, 2018"
"Investors Chronicle: AstraZeneca, Ocado, Smurfit Kappa",https://www.ft.com/content/c69fd93c-0bfc-11e8-839d-41ca06376bf2,,https://www.ft.com/personal-finance,Personal Finance,"...For the first time since 2014, AstraZeneca has reported an increase in drugs sales....",AstraZeneca,"FEBRUARY 9, 2018"
GSK: complementary therapy,https://www.ft.com/content/990e2390-0c1d-11e8-8eb7-42f857ea9f09,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...GSK has good reasons to have opted for a diversified model, unlike “pure-play” drugmakers such as AstraZeneca....",AstraZeneca,"FEBRUARY 7, 2018"
The Woodford Hall of Contrarian Honour,https://www.ft.com/content/42699f64-1a7a-3d53-8dcd-e8c096ec90ee,,https://www.ft.com/passive-investing,Passive Investing,...AstraZeneca. The drug maker is Woodford’s second largest holding and had a wobble last year after one of its lung cancer treatments disappointed in a trial....,AstraZeneca,"FEBRUARY 5, 2018"
Cobham under fire over balance sheet fears,https://www.ft.com/content/978632f0-082c-11e8-9650-9c0ad2d7c5b5,,https://www.ft.com/uk-equities,UK equities,"...AstraZeneca gained 3.1 per cent to £50.36 after its first-quarter results beat expectations, albeit largely on one-off factors including a tax benefit....",AstraZeneca,"FEBRUARY 2, 2018"
AstraZeneca chief executive hails push into China,https://www.ft.com/content/d86c64ea-07e3-11e8-9650-9c0ad2d7c5b5,,https://www.ft.com/uk-companies,UK companies,"...The chief executive of AstraZeneca has hailed a big push into China, unveiling collaborations with two big Chinese technology companies and forecasting sales growth in the country of more than 20 per cent...",AstraZeneca,"FEBRUARY 2, 2018"
AstraZeneca logs fall in 2017 revenues on lower product sales,https://www.ft.com/content/aa880c90-07e9-11e8-9650-9c0ad2d7c5b5,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,...The past year has been one of mixed fortunes for AstraZeneca....,AstraZeneca,"FEBRUARY 2, 2018"
GSK leads drugmakers’ fight against superbugs,https://www.ft.com/content/ffa6af22-002f-11e8-9650-9c0ad2d7c5b5,,https://www.ft.com/uk-companies,UK companies,"...Entasis, a Massachusetts-based company spun out of AstraZeneca’s antibiotics business in 2015, is well ahead of this group with 17 points out of a possible 20....",AstraZeneca’s,"JANUARY 23, 2018"
"Investors Chronicle: Merck, Pearson, GKN",https://www.ft.com/content/c13eca8e-fb9e-11e7-a492-2c9be7f3120a,,https://www.ft.com/gold,Gold,"...But the hard work is not yet over for Merck: Bristol-Myers Squibb, AstraZeneca and Roche are all vying for its spot as the leader in lung cancer treatment....",AstraZeneca,"JANUARY 19, 2018"
US-based fund to invest $1bn in UK biotech,https://www.ft.com/content/3bdf4e92-d806-11e7-a039-c64b1c09b482,,https://www.ft.com/brexit,Brexit,"...Separately, the Business, Energy and Industrial Strategy committee has published submissions from almost 20 organisations and companies, including AstraZeneca, Lilly UK, MSD and Merck, as part of its inquiry...",AstraZeneca,"DECEMBER 4, 2017"
Roche shares lifted by positive drug trials,https://www.ft.com/content/b7abd968-ce02-11e7-9dbb-291a884dd8c6,,https://www.ft.com/european-companies,European companies,"...AstraZeneca closed flat.

Roche closed up 6 per cent at SFr243.60

This copy has been amended to correct the combination that atezolizumab was being compared to...",AstraZeneca,"NOVEMBER 20, 2017"
Roche boosted by haemophilia and cancer trials; shares in rivals slip,https://www.ft.com/content/079a289b-5d1b-3d60-9b07-1ccdbcd0b0ce,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...AstraZeneca fell 0.5 per cent.

Photo: Bloomberg...",AstraZeneca,"NOVEMBER 20, 2017"
AstraZeneca lifts earnings guidance as sales decline slows,https://www.ft.com/content/4d70528c-c53c-11e7-a1d2-6786f39ef675,,https://www.ft.com/uk-companies,UK companies,...AstraZeneca also said its annual profit would likely decline at a slower rate than it had predicted....,AstraZeneca,"NOVEMBER 9, 2017"
FT Opening Quote – Sainsbury highlights £100m savings,https://www.ft.com/content/f19cb832-787d-35ce-9252-5667f0b6fadd,,https://www.ft.com/chris-nuttall,Chris Nuttall,"...FastFT reports AstraZeneca said its profits are unlikely to fall as far as previously feared this year, after the decline in sales of its older drugs slowed in the third quarter....",AstraZeneca,"NOVEMBER 9, 2017"
AstraZeneca brightens forecasts as sales decline slows,https://www.ft.com/content/9c2d4666-333a-3283-971f-6dbdb01c7db7,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...AstraZeneca said its profits are unlikely to fall as far as previously feared this year, after the decline in sales of its older drugs slowed in the third quarter....",AstraZeneca,"NOVEMBER 9, 2017"
Why employers ignore abuse complaints,https://www.ft.com/content/b720d60c-c2e4-11e7-a1d2-6786f39ef675,,https://www.ft.com/michael-skapinker,Michael Skapinker,"...It followed a string of sexual abuse scandals at Mitsubishi, the US Army and the US branch of Astra, the pharmaceuticals company that is now part of AstraZeneca....",AstraZeneca,"NOVEMBER 7, 2017"
GSK’s chief scientist leaves for senior UK government job,https://www.ft.com/content/ee76ebfc-bf27-11e7-9836-b25f8adaa111,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...Since taking the helm at GSK in April, Emma Walmsley has restructured the R&D operation, poaching Luke Miels, previously head of AstraZeneca’s European business, as global head of pharma and giving him a...",AstraZeneca’s,"NOVEMBER 3, 2017"
AstraZeneca discloses ‘disappointing’ results from asthma drug trial,https://www.ft.com/content/2c9c8cec-df01-37fb-8424-8254522c7903,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,...AstraZeneca struck a $115m deal with Denmark’s Leo Pharma to manufacture and supply tralokinumab last July....,AstraZeneca,"NOVEMBER 1, 2017"
AstraZeneca takes stake in Aim-listed Mereo Biopharma,https://www.ft.com/content/400e91b0-2d59-3801-894c-42fc15e135a1,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...AstraZeneca is taking a stake in Mereo Biopharma, the Aim-listed group already backed by Novartis and Neil Woodford, as part of a deal to sell the commercial rights to one of the FTSE 100 drugmaker’s new...",AstraZeneca,"OCTOBER 30, 2017"
Elliott unit urges Smith & Nephew to slim down business,https://www.ft.com/content/e4f4a93e-b586-11e7-a398-73d59db9e399,https://www.ft.com/__origami/service/image/v2/images/raw/http%3A%2F%2Fprod-upp-image-read.ft.com%2F7070d982-ae9e-11e7-8076-0a4bdda92ca2?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/us-companies,US & Canadian companies,"...He added that the company had a credible management team, pointing to the appointment of Graham Baker, who began in March as chief finance officer from AstraZeneca, and a strong chairman in Roberto Quarta...",AstraZeneca,"OCTOBER 20, 2017"
Akzo/AstraZeneca: the chemical brothers,https://www.ft.com/content/400f725e-b3ed-11e7-a398-73d59db9e399,,https://www.ft.com/corporate-earnings-results,Corporate earnings and results,...It could be AstraZeneca. Or it could be Akzo Nobel....,AstraZeneca,"OCTOBER 18, 2017"
US veterans sue drug companies over Iraq bribes,https://www.ft.com/content/d5c1b734-b353-11e7-a398-73d59db9e399,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,...AstraZeneca and J&J did not immediately respond to requests for comment....,AstraZeneca,"OCTOBER 17, 2017"
China boost for miners fails to keep FTSE in black,https://www.ft.com/content/ede89cc4-b277-11e7-aa26-bb002965bce8,,https://www.ft.com/uk-equities,UK equities,"...AstraZeneca
 was upgraded by Credit Suisse to outperform on “significant earnings growth” ahead, moving 0.5 per cent higher to £51.55....",AstraZeneca,"OCTOBER 16, 2017"
Decoding cancer: hopes rise for a new age of precision medicine,https://www.ft.com/content/9e02a064-a9d1-11e7-93c5-648314d2c72c,,https://www.ft.com/the-big-read,The Big Read,"...Guardant has also signed deals with other large drugmakers like Merck and AstraZeneca, which want to use the test in their clinical trials....",AstraZeneca,"OCTOBER 10, 2017"
Pfizer weighs sale of consumer health business,https://www.ft.com/content/8b98ede6-adb1-11e7-aab9-abaa44b1e130,,https://www.ft.com/us-companies,US & Canadian companies,"...He has since tried to reshape the drugmaker through attempted acquisitions of Anglo-Swedish AstraZeneca and Dublin-based Allergan, although both tie-ups were thwarted by politicians worried about jobs and...",AstraZeneca,"OCTOBER 10, 2017"
AstraZeneca chief confident risks will pay off,https://www.ft.com/content/8013513c-97db-11e7-b83c-9588e51488a0,,https://www.ft.com/uk-companies,UK companies,"...AstraZeneca admits cancer trial setback

When the disappointing results of the Mystic trial were released, showing it was not superior to chemotherapy in extending “progression free survival”, AstraZeneca...",AstraZeneca,"OCTOBER 9, 2017"
Francis Crick Institute looks to turn discoveries into treatments,https://www.ft.com/content/1cc15854-a2ad-11e7-9e4f-7f5e6a7c98a2,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...The institute has also established a “rather open translational relationship” with the two largest UK drug companies, GlaxoSmithKline and AstraZeneca, Sir Paul said....",AstraZeneca,"OCTOBER 1, 2017"
AstraZeneca climbs as Bernstein backs takeover talk,https://www.ft.com/content/023b2cb8-9fa5-11e7-8cd4-932067fbf946,,https://www.ft.com/mergers-acquisitions,Mergers & Acquisitions,...AstraZeneca led the FTSE 100 higher on Friday after Bernstein Research said investors were wrong to write off the chances of another takeover approach....,AstraZeneca,"SEPTEMBER 22, 2017"
Experian jumps on optimism over Brazil reforms,https://www.ft.com/content/54171310-970f-11e7-b83c-9588e51488a0,,https://www.ft.com/uk-equities,UK equities,"...AstraZeneca gained 2.1 per cent to £48.90 after releasing data from clinical trials of its Tagrisso and Imfinzi treatments for lung cancer, which had already shown positive top-line results....",AstraZeneca,"SEPTEMBER 11, 2017"
"AstraZeneca, Merck and Inctye show cancer treatment advances",https://www.ft.com/content/8532671a-9651-11e7-b83c-9588e51488a0,,https://www.ft.com/european-companies,European companies,...Investor hopes of making money from cutting-edge cancer treatments were given a boost on Monday with particularly positive data from UK-based drugmaker AstraZeneca sending shares higher....,AstraZeneca,"SEPTEMBER 11, 2017"
Generic drug giant bypasses AstraZeneca’s Soriot,https://www.ft.com/content/5c9a90e2-2070-3424-9d09-92cbf96d31a9,,https://www.ft.com/uk-companies,UK companies,"...Related:

AstraZeneca chief defiant after drug disappointment (July 2017)...",AstraZeneca,"SEPTEMBER 11, 2017"
AstraZeneca looks for boost from positive trials,https://www.ft.com/content/0eb8512c-948e-11e7-bdfa-eda243196c2c,,https://www.ft.com/uk-companies,UK companies,"...AstraZeneca would need to generate $8.5bn in sales from pipeline drugs by the end of 2022, which they said was “unlikely”....",AstraZeneca,"SEPTEMBER 8, 2017"
Hopes for cancer treatment buoy AstraZeneca,https://www.ft.com/content/b071029c-93ea-11e7-bdfa-eda243196c2c,,https://www.ft.com/uk-equities,UK equities,...AstraZeneca is expected to release OS data from the Mystic trial during the first half of 2018....,AstraZeneca,"SEPTEMBER 7, 2017"
Circassia shares jump 10% after positive AstraZeneca trial results,https://www.ft.com/content/48947d4b-577a-3135-a4d2-03d8c7474610,,https://www.ft.com/world,World,"...AstraZeneca’s shares rose 0.9 per cent, to £46.19....",AstraZeneca’s,"SEPTEMBER 7, 2017"
Secretive Moderna yet to convince on $5bn valuation,https://www.ft.com/content/ab138504-8c2e-11e7-a352-e46f43c5825d,,https://www.ft.com/stream/f6ea19e6-cb8f-452e-8d0d-4298e8f38c55,Moderna,...Moderna has struck lucrative partnerships with companies including AstraZeneca and Merck to work on medicines for a wide range of illnesses from cancer and vaccines to rare diseases....,AstraZeneca,"SEPTEMBER 6, 2017"
Big investors step up rebellion at company meetings,https://www.ft.com/content/f26b22a6-8f10-11e7-a352-e46f43c5825d,,https://www.ft.com/corporate-governance,Corporate governance,"...Companies including GAM, the Swiss asset manager, AstraZeneca, the Anglo-Swiss drugmaker, Burberry, the fashion house, and Wells Fargo, the US bank, all suffered shareholder revolts this year....",AstraZeneca,"SEPTEMBER 2, 2017"
"Markets Live: Thursday, 31st August, 2017",https://www.ft.com/content/0107c568-16d0-3380-809c-bc9ec38398a6,,https://www.ft.com/paul-murphy,Paul Murphy,,,"AUGUST 31, 2017"
AstraZeneca sinks after Goldman urges caution,https://www.ft.com/content/acee5286-8da1-11e7-9084-d0c17942ba93,,https://www.ft.com/uk-equities,UK equities,...AstraZeneca was a laggard in a rising London market on Wednesday after Goldman Sachs advised selling....,AstraZeneca,"AUGUST 30, 2017"
AstraZeneca uses AI to tackle neurological disease,https://www.ft.com/content/6e0ec9d0-8a66-11e7-9084-d0c17942ba93,,https://www.ft.com/uk-companies,UK companies,"...AstraZeneca is teaming up with US biology and technology company Berg to search for new drugs to treat Parkinson’s Disease and other neurological disorders, using artificial intelligence....",AstraZeneca,"AUGUST 28, 2017"
AstraZeneca to announce plans for UK investment,https://www.ft.com/content/f171ba36-8b19-11e7-9084-d0c17942ba93,,https://www.ft.com/brexit,Brexit,...This article has been amended to clarify the nature of AstraZeneca’s investment...,AstraZeneca’s,"AUGUST 27, 2017"
GVC’s offer for Ladbrokes a calculated gamble amid state review,https://www.ft.com/content/3449f15c-8363-11e7-94e2-c5b903247afd,,https://www.ft.com/neil-collins,Neil Collins,"...Since moving from Invesco to run his own operation, his magic touch has deserted him, and the plunging value of his funds’ holdings in Provident Financial, Allied Minds and AstraZeneca have caused much schadenfreude...",AstraZeneca,"AUGUST 25, 2017"
Neil Woodford: inpatient capital,https://www.ft.com/content/0f99916e-8813-11e7-8bb1-5ba57d47eff7,,https://www.ft.com/world,World,"...AstraZeneca is off 12.4 per cent after a drug failed a clinical trial.

The value of the flagship Woodford Equity Income Fund has dropped 7.5 per cent since its June peak....",AstraZeneca,"AUGUST 24, 2017"
Small-cap focus: UK biotechs seek to prosper in immunotherapy,https://www.ft.com/content/5e49e822-828c-11e7-a4ce-15b2513cb3ff,,https://www.ft.com/uk-companies,UK companies,"...While AstraZeneca has suffered a serious setback in the hot field of cancer immunotherapy, a host of comparative minnows, undeterred, are pressing ahead with allied technologies that promise millions in...",AstraZeneca,"AUGUST 18, 2017"
Shares in drugmakers fall on Stada takeover,https://www.ft.com/content/5fc6c3f5-12a3-35cf-91a3-e8c57cda8824,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,...GlaxoSmithKline is down 1 per cent at £14.90 and AstraZeneca is falling 1.2 per cent at £44.27....,AstraZeneca,"AUGUST 18, 2017"
Shareholder anger at executive pay switches to FTSE 250,https://www.ft.com/content/997425ea-819a-11e7-a4ce-15b2513cb3ff,https://www.ft.com/__origami/service/image/v2/images/raw/http%3A%2F%2Fprod-upp-image-read.ft.com%2F85f809d4-81ed-11e7-94e2-c5b903247afd?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/fund-management,Fund management,"...However eight FTSE 100 companies faced significant investor anger, with large protest votes against Pearson, the education group, supermarket group Wm Morrison and drug company AstraZeneca....",AstraZeneca,"AUGUST 15, 2017"
Greggs proves a haven in weak London market,https://www.ft.com/content/3b51c1bc-7de8-11e7-ab01-a13271d1ee9c,,https://www.ft.com/uk-equities,UK equities,"...Most of the loss was because of heavyweight stocks including Royal Dutch Shell, AstraZeneca, BP, Diageo, Rio Tinto, BT and GlaxoSmithKline trading without rights to their most recent dividends....",AstraZeneca,"AUGUST 10, 2017"
GSK chief says her lack of ‘baggage’ in pharma is an advantage,https://www.ft.com/content/deec0e46-76bc-11e7-90c0-90a9d1bc9691,,https://www.ft.com/uk-companies,UK companies,"...Critics point out that this winnowing process was undertaken by some of GSK’s rivals, such as UK rival AstraZeneca, three or four years ago....",AstraZeneca,"AUGUST 6, 2017"
AstraZeneca is beginning to look a lot like Tesco,https://www.ft.com/content/50319614-75d9-11e7-a3e8-60495fe6ca71,,https://www.ft.com/terry-smith,Terry Smith,...Alongside the Tesco chart is one showing AstraZeneca’s ROCE for the period 2001-16....,AstraZeneca’s,"AUGUST 4, 2017"
AstraZeneca receives US FDA boost for cancer drug,https://www.ft.com/content/cec5c2de-75ed-11e7-90c0-90a9d1bc9691,,https://www.ft.com/uk-companies,UK companies,"...AstraZeneca’s share price rose almost 3 per cent to £46.14 on Monday, after a sharp fall last week....",AstraZeneca’s,"JULY 31, 2017"
Astra wins US regulatory breakthrough for cancer treatment Imfinzi,https://www.ft.com/content/e31f9f7c-7b24-3e0c-a7bb-33f94a167a82,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...AstraZeneca said Imfinzi was being studied in several trials, on its own and in combination with other medicines....",AstraZeneca,"JULY 31, 2017"
Faster path for drugs in UK ‘would spur investment and jobs’,https://www.ft.com/content/75701922-714d-11e7-aca6-c6bd07df1a3c,,https://www.ft.com/uk-economy,UK economy,"...Pascal Soriot, chief executive of AstraZeneca, also spoke out, saying that aside from the human imperative to ensure patients received the best treatment, there was “an industrial dimension,” with companies...",AstraZeneca,"JULY 31, 2017"
Woodford dented after AstraZeneca and Provident shares fall,https://www.ft.com/content/433308cc-7385-11e7-93ff-99f383b09ff9,,https://www.ft.com/fund-management,Fund management,"...Mr Woodford remained unperturbed by the troubles of AstraZeneca and Provident this week, issuing a note to reiterate his faith in the companies....",AstraZeneca,"JULY 30, 2017"
AstraZeneca chief demands clarity on post-Brexit landscape,https://www.ft.com/content/bc38b9f8-73b0-11e7-93ff-99f383b09ff9,,https://www.ft.com/brexit,Brexit,...The chief executive of AstraZeneca has said uncertainty over the regulatory regime post-Brexit meant the company would “wait to see” before taking some key decisions about further investment in the UK....,AstraZeneca,"JULY 29, 2017"
AstraZeneca hit with S&P downgrade after cancer drug setback,https://www.ft.com/content/d3eb3256-59cb-3088-9426-44a586c4714e,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...AstraZeneca was stripped of its A-minus rating from S&P Global on Friday, days after the pharmaceutical group suffered a setback with a lung cancer drug it had hoped would replace chemotherapy as a first-line...",AstraZeneca,"JULY 28, 2017"
AstraZeneca climbs after cancer drug reassessment,https://www.ft.com/content/0782f9de-7396-11e7-aca6-c6bd07df1a3c,,https://www.ft.com/uk-equities,UK equities,"...AstraZeneca closed 3.6 per cent higher at £44.82 in a weak wider market. The FTSE 100 closed 1 per cent lower, down 74.64 points at 7,368.37....",AstraZeneca,"JULY 28, 2017"
Corporate earnings: holiday rush,https://www.ft.com/content/3dca5af0-7382-11e7-93ff-99f383b09ff9,,https://www.ft.com/world,World,"...A few companies stood out, including AstraZeneca for all the wrong reasons, but wider stock indices ended the day almost flat.

Any camouflage effect is likely to be temporary, however....",AstraZeneca,"JULY 28, 2017"
Merck updates guidance to reflect June cyber attack,https://www.ft.com/content/3d7ac341-1742-3329-9a15-2dc269522d10,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,...*The copy has been amended from the original publication to reflect that headline profit cut was due to AstraZeneca partnership....,AstraZeneca,"JULY 28, 2017"
AstraZeneca shares tumble 15% on big drug trial setback,https://www.ft.com/content/eee32de4-627f-11e7-91a7-502f7ee26895,,https://www.ft.com/european-companies,European companies,...The speculation wiped more than £3bn off AstraZeneca shares at the time....,AstraZeneca,"JULY 27, 2017"
AstraZeneca chief strikes defiant tone after drug disappointment,https://www.ft.com/content/55a23aa8-72bf-11e7-93ff-99f383b09ff9,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...Pascal Soriot, chief executive of AstraZeneca, declared on Wednesday that he was no “quitter” after reports of an impending departure....",AstraZeneca,"JULY 27, 2017"
AstraZeneca: transcendental agitation,https://www.ft.com/content/2b7a6e30-72dd-11e7-aca6-c6bd07df1a3c,,https://www.ft.com/uk-companies,UK companies,...AstraZeneca’s Pascal Soriot has discovered his faith in the Mystic cancer drug trial really was misplaced....,AstraZeneca’s,"JULY 27, 2017"
Bristol-Myers slides with Wall St eyeing key cancer drug,https://www.ft.com/content/94ff447a-4508-3572-abb6-c6823e517275,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...The group’s shares dropped 6 per cent in New York trading, following a nearly 15 per cent fall in AstraZeneca’s US-listed shares....",AstraZeneca’s,"JULY 27, 2017"
AstraZeneca shares drop 15% on lung cancer drug setback,https://www.ft.com/content/d16d7753-a096-3089-a614-619dc37a40b9,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...Shares in AstraZeneca are on course for their worst ever day, dropping to a six-month low this morning after it suffered a setback in a much awaited lung cancer drug trial....",AstraZeneca,"JULY 27, 2017"
AstraZeneca suffers setback on ‘Mystic’ lung cancer drug trial,https://www.ft.com/content/76e35936-401d-3bc1-90e0-0f2d0ecb8975,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...AstraZeneca, the Anglo-Swedish pharmaceutical company, has suffered a big setback, after a much-awaited trial of a new lung cancer drug failed to show the benefits for which the company had hoped....",AstraZeneca,"JULY 27, 2017"
"Fast Europe Open: Spain unemployment, Turkey rates decision",https://www.ft.com/content/ba740c6c-e5c8-324a-94d9-a96d34245b60,,https://www.ft.com/european-banks,European banks,"...It’s a bumper corporate calendar this morning with Nokia, Telefonica, Total, Volkswagen, Deuttsche Bank, Repsol, Accor, Danone, Airbus, Orange, British American Tobacco, Shell,, AstraZeneca, Just Eat, Lloyds...",AstraZeneca,"JULY 27, 2017"
China slashes prices of patented western drugs by up to 70%,https://www.ft.com/content/ef1566be-6c7b-11e7-bfeb-33fe0c5b7eaa,,https://www.ft.com/stream/73421c5c-456d-426c-a125-60e03196f126,Audio articles,"...Prices for two drugs used to treat breast cancer, AstraZeneca’s Fulvestrant and GSK’s Lapatinib will fall by 56 per cent and 41 per cent respectively....",AstraZeneca’s,"JULY 19, 2017"
Pascal Soriot to remain at AstraZeneca,https://www.ft.com/content/16dad442-68ce-11e7-8526-7b38dcaef614,,https://www.ft.com/uk-companies,UK companies,"...Pascal Soriot is to remain as chief executive of AstraZeneca, scotching two days of rumours that he was leaving to head rival drugmaker Teva Pharmaceutical Industries and pushing AstraZeneca’s US-listed...",AstraZeneca,"JULY 14, 2017"
Pascal Soriot said to stay on as AstraZeneca’s CEO,https://www.ft.com/content/e2785599-1ac4-3a7b-afb6-261a82a7e722,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...Pascal Soriot is set to remain as chief executive of AstraZeneca, scotching two days of rumours that he was leaving to head rival drugmaker Teva Pharmaceutical Industries and pushing AstraZeneca’s US-listed...",AstraZeneca,"JULY 14, 2017"
AstraZeneca: mystique,https://www.ft.com/content/7b0b62fc-67d8-11e7-8526-7b38dcaef614,,https://www.ft.com/uk-companies,UK companies,...AstraZeneca has one of the latter herd. Pascal Soriot has run AstraZeneca since 2012. Reports on Thursday that he might move to Teva of Israel knocked more than 4 per cent off the former’s value....,AstraZeneca,"JULY 13, 2017"
Ocado gains on prospect of automation cutting costs,https://www.ft.com/content/e8d7f54a-67d6-11e7-8526-7b38dcaef614,https://www.ft.com/__origami/service/image/v2/images/raw/http%3A%2F%2Fprod-upp-image-read.ft.com%2F730b3884-67f1-11e7-9a66-93fb352ba1fe?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/uk-equities,UK equities,"...“If true, the optics around his departure would be terrible” given AstraZeneca is about to deliver results from a pivotal trial of its cancer drug, known as Mystic, said Leerink Partners....",AstraZeneca,"JULY 13, 2017"
AstraZeneca shares hit by report on chief’s departure,https://www.ft.com/content/11b5b1ee-6752-11e7-8526-7b38dcaef614,,https://www.ft.com/uk-companies,UK companies,"...Shares in AstraZeneca fell on Thursday following a report that its chief executive, Pascal Soriot, was leaving the Anglo-Swedish drugmaker after almost five years to take the top job at Teva Pharmaceutical...",AstraZeneca,"JULY 13, 2017"
AstraZeneca shares fall on reports of CEO departure,https://www.ft.com/content/b91a8d1f-3e19-396b-b5d7-062ac2e69877,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...AstraZeneca and Teva both declined to comment on “market speculation”.

Reporting by Sarah Neville and John Reed...",AstraZeneca,"JULY 13, 2017"
UK drugs groups seek court block on NHS price limits,https://www.ft.com/content/f0bfff9a-6539-11e7-9a66-93fb352ba1fe,,https://www.ft.com/uk-economy,UK economy,"...Anglo-Swedish AstraZeneca also made clear it had reservations, saying the company was continuing to “champion dialogue”....",AstraZeneca,"JULY 10, 2017"
Fears over a medical gold rush in cancer drug race,https://www.ft.com/content/00092dde-578c-11e7-9fed-c19e2700005f,,https://www.ft.com/us-companies,US & Canadian companies,"...Pascal Soriot, chief executive AstraZeneca, which is trialling its own immunotherapy combination, admitted as much in a recent interview with the Financial Times.

“The field is very competitive....",AstraZeneca,"JULY 2, 2017"
Provident Financial recovers from botched restructuring,https://www.ft.com/content/e459690a-576d-11e7-9fed-c19e2700005f,,https://www.ft.com/uk-equities,UK equities,"...The FTSE 100 edged 8.5 points lower at 7,439.29 but Shire jumped 3.7 per cent to £46.26 and AstraZeneca rose 2 per cent to £55.08, a record high....",AstraZeneca,"JUNE 22, 2017"
FT Health: Beware donor disillusionment,https://www.ft.com/content/c718d21a-51c6-11e7-a1f2-db19572361bb,,https://www.ft.com/health,Health,"...(FT)

Testing times for Astra 
Pascal Soriot, AstraZeneca’s chief executive, warned of a “substantial setback” if trials for Imfinzi, its new immunotherapy drug, fail....",AstraZeneca’s,"JUNE 16, 2017"
European takeover rules merit a sceptical response,https://www.ft.com/content/ec361c36-51cd-11e7-a1f2-db19572361bb,,https://www.ft.com/eu-business-regulation,EU business regulation,"...Did Pfizer, in its bid for AstraZeneca, plan to “invert” into Astra’s legal domicile, in a bid to reduce taxes?...",AstraZeneca,"JUNE 15, 2017"
AstraZeneca CEO warns of ‘substantial setback’ if new drug fails,https://www.ft.com/content/60810728-4a16-11e7-a3f4-c742b9791d43,,https://www.ft.com/uk-companies,UK companies,"...Unless AstraZeneca’s shares responded “massively to Mystic . . . I think we’re still exposed”, he added....",AstraZeneca’s,"JUNE 11, 2017"
AstraZeneca faces up to its year of living dangerously,https://www.ft.com/content/b3ff5598-4468-11e7-8d27-59b4dd6296b8,,https://www.ft.com/companies/byregion,Companies By Region,...Immunotherapy is a fast-moving field and AstraZeneca is racing to make up for a late start....,AstraZeneca,"JUNE 11, 2017"
UK defensive stocks: a house divided,https://www.ft.com/content/c15d7bc2-4d1c-11e7-a3f4-c742b9791d43,,https://www.ft.com/currencies,Currencies,...Shares in AstraZeneca and GSK have risen steeply since the referendum due partly to low sterling income....,AstraZeneca,"JUNE 9, 2017"
AstraZeneca pins hopes on novel breast cancer drug,https://www.ft.com/content/c369da12-47e7-11e7-8519-9f94ee97d996,,https://www.ft.com/us-companies,US & Canadian companies,"...But Pascal Soriot, AstraZeneca chief executive, said the trial results were a sign that the drug could help patients whose disease is not so advanced....",AstraZeneca,"JUNE 4, 2017"
FT Health: Funding the fight against disease,https://www.ft.com/content/5625567c-4781-11e7-8519-9f94ee97d996,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...Can AstraZeneca build an oncology powerhouse? (FT)

Tackling opioid addiction Last year more than 52,000 Americans died of drug overdoses, mostly from opioids such as heroin and fentanyl....",AstraZeneca,"JUNE 2, 2017"
The chemicals industry has lost its future,https://www.ft.com/content/423f0548-4530-11e7-8d27-59b4dd6296b8,,https://www.ft.com/stream/68fdc60e-43ee-4b05-a359-3881e3f78d5e,John Gapper,"...Akzo includes the old Imperial Chemical Industries, which split itself 25 years ago into ICI and Zeneca, the pharma group that is now part of AstraZeneca, under pressure from Hanson, a conglomerate raider...",AstraZeneca,"MAY 31, 2017"
It will cost more than a coffee to recast BA as a favourite flier,https://www.ft.com/content/687591d0-451e-11e7-8d27-59b4dd6296b8,,https://www.ft.com/kate-burgess,Kate Burgess,"...It is tempting to brand the offer from Pfizer of the US for AstraZeneca, the British drug company, in 2014 as an opportunist tilt at tax arbitrage and asset stripping....",AstraZeneca,"MAY 30, 2017"
Big pharma turns to immunotherapy combos to beat cancer,https://www.ft.com/content/06f54222-4224-11e7-82b6-896b95f30f58,,https://www.ft.com/us-companies,US & Canadian companies,...Can AstraZeneca build an oncology powerhouse?...,AstraZeneca,"MAY 30, 2017"
AstraZeneca sells Seloken European rights for $300m,https://www.ft.com/content/347f11ea-3efb-11e7-9d56-25f963e998b2,,https://www.ft.com/european-companies,European companies,...Shares in AstraZeneca closed flat on Monday at £51.27....,AstraZeneca,"MAY 22, 2017"
Opening Quote: Stage set for Goodwin’s RBS testimony,https://www.ft.com/content/f13a431d-af70-3cfb-8775-11614a49a544,,https://www.ft.com/markets,Markets,"...Having been called JRP since the deal, from this morning it will be known as Just Group plc. Or just Just.

Beyond the Square Mile

Asian markets were mostly higher on Monday....",plc,"MAY 22, 2017"
Opening Quote: Stage set for Goodwin’s RBS testimony; Barclays’ IT helpdesk,https://www.ft.com/content/0cd2a630-edaa-3c45-a44a-717280e83dc5,,https://www.ft.com/fastft,fastFT,"...Having been called JRP since the deal, from this morning it will be known as Just Group plc. Or just Just.

FT Opening Quote, with commentary by Matthew Vincent, is your early Square Mile briefing....",plc,"MAY 22, 2017"
AstraZeneca sells European rights to Seloken heart medicines for over $300m,https://www.ft.com/content/8478927b-7863-3d93-a5fc-bac11b820814,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...AstraZeneca will continue commercialise the medicines outside of Europe, where it still holds the rights....",AstraZeneca,"MAY 22, 2017"
Hikma shares hit after cutting sales forecasts,https://www.ft.com/content/73e82f2c-3c78-11e7-821a-6027b8a20f23,,https://www.ft.com/uk-companies,UK companies,"...Both GSK and AstraZeneca have warned that as their best selling drugs come off patent, they face increased competition from cheaper generics....",AstraZeneca,"MAY 19, 2017"
Big pharma hopes rule change will ease China sales pain,https://www.ft.com/content/84653126-306e-11e7-9555-23ef563ecf9a,,https://www.ft.com/chinese-politics-policy,Chinese politics & policy,...AstraZeneca said that its China sales had increased 7 per cent in the first quarter to $782m after sales growth of 10 per cent in 2016 and 15 per cent in 2015....,AstraZeneca,"MAY 16, 2017"
Forterra and Ibstock hit records on UK housing hopes,https://www.ft.com/content/8183a5a6-3734-11e7-99bd-13beb0903fa3,,https://www.ft.com/uk-equities,UK equities,"...AstraZeneca released the interim data earlier than expected, ahead of its keenly awaited Mystic trial....",AstraZeneca,"MAY 12, 2017"
AstraZeneca US shares set for biggest daily gain since July,https://www.ft.com/content/82f31da2-e24b-321d-a3a7-37894ae7ba80,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...US-listed shares of British drugmaker AstraZeneca are headed for their biggest one-day gain in more than nine months, following their UK-listed counterparts higher on news of successful trials involving...",AstraZeneca,"MAY 12, 2017"
FTSE companies avoid shareholder wrath on pay at AGMs,https://www.ft.com/content/2e001b72-36f7-11e7-99bd-13beb0903fa3,,https://www.ft.com/uk-companies,UK companies,"...There have been significant protest votes elsewhere, including at FTSE 100 pharmaceutical group AstraZeneca, satellite operator Inmarsat, and Drax, owner of the UK’s largest power plant....",AstraZeneca,"MAY 12, 2017"
AstraZeneca boosted by positive lung cancer drug trial,https://www.ft.com/content/48eba4de-36ec-11e7-99bd-13beb0903fa3,https://www.ft.com/__origami/service/image/v2/images/raw/http%3A%2F%2Fprod-upp-image-read.ft.com%2F178ecef8-2b2e-11e7-9ec8-168383da43b7?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/uk-companies,UK companies,...AstraZeneca’s shares bumped up nearly 5 per cent on Friday after the company announced strong results from a trial of a new treatment for lung cancer....,AstraZeneca’s,"MAY 12, 2017"
AstraZeneca shares jump after cancer trial success,https://www.ft.com/content/c582606f-d9aa-30b2-ba24-6e44168e7058,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,...AstraZeneca said Imfinzi is the first immuno-oncology medicine to show a “superior” impact on progression-free survival rates in this setting....,AstraZeneca,"MAY 12, 2017"
Pearson shareholders vote against CEO pay,https://www.ft.com/content/333019b2-3166-11e7-9555-23ef563ecf9a,,https://www.ft.com/uk-companies,UK companies,"...The vote at Pearson was the biggest investor revolt against executive pay at a major UK company so far this season, with the next nearest being a 40 per cent vote against the remuneration report at AstraZeneca...",AstraZeneca,"MAY 5, 2017"
AstraZeneca wins US approval for ‘cornerstone’ cancer drug,https://www.ft.com/content/b009df62-2f37-11e7-9555-23ef563ecf9a,,https://www.ft.com/uk-companies,UK companies,"...They predicted that results from the upcoming lung cancer trial, known as Mystic, could provoke an “extreme” reaction in AstraZeneca’s shares....",AstraZeneca’s,"MAY 2, 2017"
AstraZeneca wins FDA approval for key cancer drug,https://www.ft.com/content/1eebf731-3baa-3dfe-b134-6b6928e6cd28,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,...AstraZeneca has received its first US FDA approval for a new cancer treatment that the company hopes will be a “cornerstone” of its new immuno-oncology portfolio as it looks to return to growth....,AstraZeneca,"MAY 2, 2017"
Cancer fund failure highlights the dilemma of drug pricing,https://www.ft.com/content/35cee17c-2c06-11e7-bc4b-5528796fe35c,,https://www.ft.com/anjana-ahuja,Anjana Ahuja,"...Nice has threatened to stop recommending certain drugs unless companies slash prices, a tactic it deployed successfully with AstraZeneca’s ovarian cancer drug Olaparib....",AstraZeneca’s,"MAY 1, 2017"
Pearson defends CEO pay ahead of investor showdown,https://www.ft.com/content/dfe183a2-2d9d-11e7-9555-23ef563ecf9a,,https://www.ft.com/uk-companies,UK companies,"...Drugmaker AstraZeneca, for example, suffered a significant shareholder protest on pay last week, while investors also signalled concern at Credit Suisse....",AstraZeneca,"APRIL 30, 2017"
Credit Suisse pay report approved by just 58% of shareholders,https://www.ft.com/content/eae9be20-2c19-11e7-bc4b-5528796fe35c,,https://www.ft.com/european-companies,European companies,"....

——————–

Bankers never volunteer to take the blame 
WPP to limit Sorrell’s pay to just over £13m 
AstraZeneca suffers shareholder rebellion on pay 
GAM suffers shareholder revolt over pay

——————–

Meanwhile...",AstraZeneca,"APRIL 28, 2017"
Biotech and big pharma reap rewards from partnerships,https://www.ft.com/content/e8fccaf6-2c0c-11e7-bc4b-5528796fe35c,,https://www.ft.com/uk-companies,UK companies,"...AstraZeneca is taking a $50m stake, making it the company’s third-largest shareholder....",AstraZeneca,"APRIL 28, 2017"
AstraZeneca’s pivot point might not come until 2018,https://www.ft.com/content/1242d0aa-2b5d-11e7-bc4b-5528796fe35c,,https://www.ft.com/matthew-vincent,Matthew Vincent,"...Listening to Pascal Soriot describe 2017, one wonders if the AstraZeneca chief executive has swallowed a thesaurus. And misread the recommended dose....",AstraZeneca,"APRIL 27, 2017"
AstraZeneca suffers shareholder rebellion on pay,https://www.ft.com/content/87377a2a-2b29-11e7-9ec8-168383da43b7,,https://www.ft.com/uk-companies,UK companies,...Shares in AstraZeneca were largely flat in London at £46.98....,AstraZeneca,"APRIL 27, 2017"
Lloyds Bank shares jump while wider stock markets cool,https://www.ft.com/content/4d2710b6-9e63-3c53-bdda-fe9205a59874,,https://www.ft.com/us-equities,US equities,"...Airbus shares were down 1.1 per cent at publication time, while AstraZeneca’s were down 1 per cent....",AstraZeneca’s,"APRIL 27, 2017"
AstraZeneca revenues decline but CEO praises pipeline progress,https://www.ft.com/content/2e14ea43-4edf-36c1-be2a-fe56e5f23186,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,...Ratings agency Moody’s yesterday noted that AstraZeneca has one of the strongest pipelines of new products in development among global pharmaceuticals groups....,AstraZeneca,"APRIL 27, 2017"
"Fast Europe Open: UK retail sales, ECB and Riksbank rates decisions",https://www.ft.com/content/b31653fe-ae6c-3ddc-96c5-335aabc46426,,https://www.ft.com/markets,Markets,"...Corporate earnings reports out today include BBVA, Deutsche Bank, Bayer, Lufthansa, SNB, Nordea, WPP, Pret, AstraZeneca, Cobham, Meggitt, Renault, Schroders, SEB, Heathrow Airport, GAM and Dong Energy....",AstraZeneca,"APRIL 27, 2017"
GSK: continuity candidate,https://www.ft.com/content/20398414-2a96-11e7-9ec8-168383da43b7,,https://www.ft.com/uk-companies,UK companies,"...GSK previously boasted of having more drugs approved than AstraZeneca, but a host of smaller treatments is no match for a blockbuster....",AstraZeneca,"APRIL 26, 2017"
Circassia losses widen after failed clinical trials,https://www.ft.com/content/2dfb980e-29a5-11e7-bc4b-5528796fe35c,,https://www.ft.com/ipos,IPOs,"...The deal will include AstraZeneca taking a $50m stake in the group, making it the company’s third-largest shareholder....",AstraZeneca,"APRIL 25, 2017"
"Circassia losses grow after allergy drug failures, knocking shares",https://www.ft.com/content/5c9ffc23-b485-3e0f-a9ba-c78848963eec,,https://www.ft.com/ipos,IPOs,"...The deal will include AstraZeneca taking a $50m stake in the group, making it the company’s third-largest shareholder....",AstraZeneca,"APRIL 25, 2017"
Ashmore investors ignore Trump and trackers,https://www.ft.com/content/645ecbb4-244b-11e7-8691-d5f7e0cd0a16,,https://www.ft.com/matthew-vincent,Matthew Vincent,"...More pertinently, how patient will Neil Woodford and Touchstone be with a company that has few innovations left — and is now focused on nothing more revolutionary then selling drugs for AstraZeneca?...",AstraZeneca,"APRIL 18, 2017"
Circassia halts allergy programme after failed trials,https://www.ft.com/content/f22545e6-240e-11e7-a34a-538b4cb30025,,https://www.ft.com/uk-companies,UK companies,...The two drugs have been developed by AstraZeneca to treat chronic obstructive pulmonary disease....,AstraZeneca,"APRIL 18, 2017"
Circassia shares volatile after abandoning anti-allergy programme,https://www.ft.com/content/572a1624-e646-3035-ae63-aa165351744f,,https://www.ft.com/ipos,IPOs,"...Mr Harris said Circassia will make no further investment in its allergy programmes, and will instead focus on its wider respiratory business, particularly a collaboration with FTSE 100 group AstraZeneca...",AstraZeneca,"APRIL 18, 2017"
Small-cap focus: UK regions,https://www.ft.com/content/1cd346ce-2047-11e7-b7d3-163f5a7f229c,,https://www.ft.com/uk-companies,UK companies,"...Redx, which took on several former employees of AstraZeneca and moved to its old site in Alderley Park, said it would cut staff by 86.

The move should save approximately £4.2m....",AstraZeneca,"APRIL 14, 2017"
Gold miners retreat as Syria haven trade fades,https://www.ft.com/content/dcaff7f6-1df6-11e7-b7d3-163f5a7f229c,,https://www.ft.com/uk-equities,UK equities,"...Jefferies downgraded AstraZeneca’s rating from “buy” to “hold”, which resulted in its shares slipping 1.2 per cent to £47.38....",AstraZeneca’s,"APRIL 10, 2017"
AstraZeneca under pressure amid caution over cancer drug trial,https://www.ft.com/content/47f852a6-1a23-11e7-a266-12672483791a,,https://www.ft.com/uk-equities,UK equities,...AstraZeneca came under pressure on Wednesday after UBS turned cautious ahead of results from a pivotal lung cancer drug trial....,AstraZeneca,"APRIL 5, 2017"
Testing times for the UK’s university spin-off funds,https://www.ft.com/content/a0eaa08e-002a-11e7-8d8e-a5e3738f9ae4,,https://www.ft.com/content/e3254ca0-15ca-11e7-80f4-13e067d5072c,Tomorrow’s Global Business: Raising Capital,"...Oxford Nanopore Technologies, a gene sequencing company valued at more than £1.25bn, Circassia Pharmaceuticals, which recently agreed a $230m deal with AstraZeneca for its respiratory drugs, and PsiOxus...",AstraZeneca,"APRIL 5, 2017"
Next feels the chill after broker unpicks turnround assumptions,https://www.ft.com/content/c6ce9d56-188e-11e7-a53d-df09f373be87,,https://www.ft.com/uk-equities,UK equities,...Speculative demand saw AstraZeneca rally off a session low of £48.86 to close little changed at £49.08. The drugmaker has pivotal trial results of a cancer treatment due in mid-2017....,AstraZeneca,"APRIL 3, 2017"
Four big challenges Emma Walmsley faces at the helm of GSK,https://www.ft.com/content/ba55a992-0d72-11e7-a88c-50ba212dce4d,https://www.ft.com/__origami/service/image/v2/images/raw/http%3A%2F%2Fprod-upp-image-read.ft.com%2F6a32fb8c-1627-11e7-b0c1-37e417ee6c76?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...And much like AstraZeneca some years ago, they were badly burnt by several expensive, high risk, poorly thought through clinical trials.”...",AstraZeneca,"APRIL 1, 2017"
"DNA decoding initiative to involve 500,000 middle-aged Britons",https://www.ft.com/content/9a5c8472-0efc-11e7-a88c-50ba212dce4d,,https://www.ft.com/us-companies,US & Canadian companies,"...Last year, for example, AstraZeneca announced a collaboration with Human Longevity Inc, the US company run by genomics pioneer Craig Venter, and the Wellcome Trust Sanger Institute in Cambridge....",AstraZeneca,"MARCH 23, 2017"
AstraZeneca diabetes drug cuts death rates in real world trial,https://www.ft.com/content/0a7e762e-0a3f-11e7-97d1-5e720a26771b,,https://www.ft.com/uk-companies,UK companies,"...AstraZeneca’s cardio vascular and metabolic diseases division, which includes diabetes, generated more than $8.1bn in revenue, representing 38 per cent of total product sales for AstraZeneca....",AstraZeneca’s,"MARCH 19, 2017"
Circassia strikes drug collaboration deal with AstraZeneca,https://www.ft.com/content/41c519c2-0b1f-11e7-ac5a-903b21361b43,,https://www.ft.com/european-companies,European companies,"...Steve Harris, Circassia chief executive, said AstraZeneca “did a huge amount of diligence on the business”....",AstraZeneca,"MARCH 17, 2017"
Britain’s national champions can thrive without protection,https://www.ft.com/content/6b07db66-0a44-11e7-ac5a-903b21361b43,,https://www.ft.com/stream/ccfd9664-828d-4c02-bf03-1d07010dbb4d,Sir Geoffrey Owen,...This was implicit in Mrs May’s AstraZeneca reference....,AstraZeneca,"MARCH 17, 2017"
Circassia shares climb 30% after AstraZeneca deal,https://www.ft.com/content/b0b30dab-d032-36d9-a5ca-9e34efaa7da6,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...Mark Mallon, AstraZeneca executive vice president for global product and portfolio strategy, said:

Tudorza and Duaklir are important components of AstraZeneca’s respiratory franchise globally and this collaboration...",AstraZeneca,"MARCH 17, 2017"
AstraZeneca blood drug dealt fresh blow by US regulator,https://www.ft.com/content/eb396bc3-a6f6-3b0b-8194-238c475906fe,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,...The FDA rejection is the second in less than a year for AstraZeneca’s hyperkalaemia drug after it issued its first CRL in May 2016....,AstraZeneca’s,"MARCH 17, 2017"
AstraZeneca drug reduces risk of progression in ovarian cancer,https://www.ft.com/content/c8739c70-08c5-11e7-97d1-5e720a26771b,,https://www.ft.com/european-companies,European companies,"...A drug produced by AstraZeneca has reduced the risk of disease progression in ovarian cancer patients, in a boost for the Anglo-Swedish drugmaker as it seeks to meet ambitious growth targets....",AstraZeneca,"MARCH 14, 2017"
Brexit effect shakes up London dealmaking,https://www.ft.com/content/2f1358ec-f9f0-11e6-bd4e-68d53499ed71,,https://www.ft.com/brexit,Brexit,...Not since Pfizer’s abortive hostile bid for the Anglo-Swedish drugmaker AstraZeneca in 2014 have attempted deals caused such a fluttering in UK government ranks....,AstraZeneca,"FEBRUARY 27, 2017"
"Psst, Kraft-Heinz wasn’t bidding for Unilever because of the weak pound",https://www.ft.com/content/386d5711-2b74-31a7-942b-f4d8600c57e9,,https://www.ft.com/kadhim-shubber,Kadhim Shubber,...Gov must resist as we did over Pfizer bid for AstraZeneca. Theresa must act....,AstraZeneca,"FEBRUARY 20, 2017"
AstraZeneca sells US Zoladex cancer treatment rights for over $320m,https://www.ft.com/content/a789a195-6dfc-3bea-9d33-cb6352934995,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...AstraZeneca has sold the US and Canadian rights to its Zoladex cancer treatment to TerSera Therapeutics, in a deal worth more than $320m (£257m), as it looks to focus its efforts on developing new medicines...",AstraZeneca,"FEBRUARY 20, 2017"
Kraft case showed limits to UK’s power to intervene,https://www.ft.com/content/e24ca166-f694-11e6-bd4e-68d53499ed71,,https://www.ft.com/us-companies,US & Canadian companies,...The Kraft Heinz bid for Unilever had opened Mrs May to criticism that she was presiding over a fire sale of UK plc thanks to the sharp fall in the pound since the Brexit vote....,plc,"FEBRUARY 19, 2017"
Inmarsat loses altitude over dividend worries,https://www.ft.com/content/5b646718-f538-11e6-8758-6876151821a6,,https://www.ft.com/uk-equities,UK equities,...AstraZeneca took on 1.6 per cent to £45.95 on positive results from a trial of its Lynparza drug to treat a strain of breast cancer....,AstraZeneca,"FEBRUARY 17, 2017"
MPs hit out at post-Brexit ‘fire sale’ after approach for Unilever,https://www.ft.com/content/16109310-f530-11e6-95ee-f14e55513608,,https://www.ft.com/personal-household-goods,Personal & Household Goods,"...However, Mr Cable said there were mechanisms that the government could use to prevent any deal against the national interest — noting that a potential purchase of Unilever was “even bigger than Pfizer-AstraZeneca...",AstraZeneca,"FEBRUARY 17, 2017"
AstraZeneca boosted by positive breast cancer trial,https://www.ft.com/content/3164e684-f512-11e6-8758-6876151821a6,,https://www.ft.com/uk-companies,UK companies,...AstraZeneca shares rose more than 2 per cent on Friday....,AstraZeneca,"FEBRUARY 17, 2017"
Unilever/Kraft Heinz: knives out,https://www.ft.com/content/152957a4-f510-11e6-95ee-f14e55513608,,https://www.ft.com/us-companies,US & Canadian companies,"...Any deal is likely to face stiff political opposition, just as bids for Cadbury and AstraZeneca did....",AstraZeneca,"FEBRUARY 17, 2017"
AstraZeneca tops FTSE 100 after positive cancer drug trial,https://www.ft.com/content/2cd615fa-1843-324f-adec-b162abaf24c5,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,...Lynparza generated sales of $218m for AstraZeneca last year....,AstraZeneca,"FEBRUARY 17, 2017"
UK challenger banks in demand,https://www.ft.com/content/f3bb4c96-f46d-11e6-95ee-f14e55513608,,https://www.ft.com/uk-equities,UK equities,"...In a wider market that struggled for direction, the FTSE 100 closed lower by 0.3 per cent or 24.49 points to 7,277.92 as heavyweight stocks including AstraZeneca, BP and Royal Dutch Shell began trading ex...",AstraZeneca,"FEBRUARY 16, 2017"
Big pharma faces costly setback in cancer fight,https://www.ft.com/content/24441526-ede0-11e6-ba01-119a44939bb6,,https://www.ft.com/the-big-read,The Big Read,"...Investors have been unnerved too by the actions of AstraZeneca, which is studying a combination of two immunotherapies that is very similar to the one being investigated by Bristol-Myers....",AstraZeneca,"FEBRUARY 9, 2017"
GSK revenues beat forecasts but shares fall after competition warning,https://www.ft.com/content/e84c08ec-d8a6-340f-ba3a-9dba960872c0,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,...Last month GSK also poached former AstraZeneca executive vice president Luke Miels to head its pharmaceuticals business....,AstraZeneca,"FEBRUARY 8, 2017"
Aberdeen needs to change the script as well-worn tale wears thin,https://www.ft.com/content/2c9b5cb6-e962-11e6-893c-082c54a7f539,,https://www.ft.com/retail-consumer,Retail & Consumer industry,"...Astra’s pharma trials

Pascal Soriot, AstraZeneca’s chief executive, has a treatment for almost everything — except ALTSD, or acute long-term shareholder discomfort....",AstraZeneca’s,"FEBRUARY 2, 2017"
AstraZeneca: faith healer,https://www.ft.com/content/ed56239c-e957-11e6-893c-082c54a7f539,,https://www.ft.com/uk-companies,UK companies,"...Much rides on Mystic, a trial of two cancer drugs developed by AstraZeneca....",AstraZeneca,"FEBRUARY 2, 2017"
AstraZeneca hit by falling sales of its bestselling drugs,https://www.ft.com/content/319501ea-e91c-11e6-893c-082c54a7f539,,https://www.ft.com/uk-companies,UK companies,"...AstraZeneca has much riding on the drug, which analysts expect to deliver multibillion sales....",AstraZeneca,"FEBRUARY 2, 2017"
AstraZeneca sees annual drop in revenue of 5%,https://www.ft.com/content/9cb37b43-2d88-35d3-9b42-3455ef440b43,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...AstraZeneca recorded a 5 per cent drop in revenue last year, as competition from generics in the US hurt sales of the Anglo-Swedish drugmaker’s key product Crestor....",AstraZeneca,"FEBRUARY 2, 2017"
Pharma shares top FTSE after Trump pledge,https://www.ft.com/content/1188432d-2fdd-3039-81ad-6d7b62a14f9e,,https://www.ft.com/uk-equities,UK equities,"...Astrazeneca and Shire were also near the top of the index, with shares in both rising 2.2 per cent....",Astrazeneca,"FEBRUARY 1, 2017"
EasyJet slips amid fears of dividend cut,https://www.ft.com/content/3eadecee-e4bb-11e6-9645-c9357a75844a,https://www.ft.com/__origami/service/image/v2/images/raw/http%3A%2F%2Fprod-upp-image-read.ft.com%2Feec7efcc-c6dd-11e6-9043-7e34c07b46ef?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/uk-equities,UK equities,"...Ahead of results due Thursday, AstraZeneca faded 1.4 per cent to £42.39 on a fresh outbreak of jitters awaiting results from a pivotal trial of its most promising cancer treatment....",AstraZeneca,"JANUARY 27, 2017"
Smurfit Kappa hits record high on price hopes,https://www.ft.com/content/3f2684d0-df32-11e6-86ac-f253db7791c6,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...The setback increased uncertainty around AstraZeneca’s pivotal immunotherapy trial, known as Mystic, which is due in mid 2017....",AstraZeneca’s,"JANUARY 20, 2017"
GSK appoints AstraZeneca executive as global head of pharma,https://www.ft.com/content/43d049ae-de55-11e6-9d7c-be108f1c1dce,,https://www.ft.com/uk-companies,UK companies,...Her returned to AstraZeneca in 2014....,AstraZeneca,"JANUARY 19, 2017"
AstraZeneca exec appointed as GlaxoSmithKline global pharma president,https://www.ft.com/content/7d37de85-31c8-33fe-8492-fdaa1f2a7e5f,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,...The president of global pharmaceuticals at GlaxoSmithKline Abbas Hussain is to step down to be replaced by AstraZeneca’s Luke Miels....,AstraZeneca’s,"JANUARY 19, 2017"
AstraZeneca expands trials for key cancer drug,https://www.ft.com/content/a1086ce4-dc9f-11e6-9d7c-be108f1c1dce,,https://www.ft.com/european-companies,European companies,"...AstraZeneca has much riding on the drug, which analysts expect to deliver multibillion sales....",AstraZeneca,"JANUARY 17, 2017"
European pharma stocks fall after Trump targeting,https://www.ft.com/content/6e631a4f-9542-3334-9145-0f9ef3f5d719,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...Other major movers at publication time included: Astrazeneca: -1 per cent, £45.28.Indivior: -2.5 per cent, 297pGenmab: -2.4 per cent, DKr1259Novartis: -2 per cent, SFr72.9...",Astrazeneca,"JANUARY 12, 2017"
Corporate moments to look out for in 2017,https://www.ft.com/content/897737a8-c828-11e6-9043-7e34c07b46ef,,https://www.ft.com/retail-consumer,Retail & Consumer industry,"...Richard Waters in San Francisco

AstraZeneca’s immunotherapy drug

AstraZeneca is due to publish results in 2017 from a large trial of its immunotherapy medicine, which is designed to turn the human body...",AstraZeneca’s,"DECEMBER 30, 2016"
AstraZeneca chief says NHS drug approval process hurts patients,https://www.ft.com/content/5d196434-c854-11e6-8f29-9445cac8966f,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...AstraZeneca is developing an immunotherapy treatment that could rival Opdivo, known as durvalumab....",AstraZeneca,"DECEMBER 29, 2016"
Shell and BP’s UK dividend payments surge on weaker pound,https://www.ft.com/content/c8f06ce4-c8e9-11e6-8f29-9445cac8966f,,https://www.ft.com/currencies,Currencies,"...Shareholders in other UK multinationals, including HSBC and AstraZeneca, have benefited from a similar windfall since the Brexit vote in June sent the pound tumbling....",AstraZeneca,"DECEMBER 23, 2016"
AstraZeneca bags initial $550m from antibiotics sale,https://www.ft.com/content/6b5f7186-c681-3ef5-bebb-eed730be9d79,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...AstraZeneca has wrapped up the sale of rights to its small molecule antibiotics business to Pfizer, snagging $550m in an initial payment before further payments in the coming years....",AstraZeneca,"DECEMBER 23, 2016"
Ashtead retreats on warning over US demand,https://www.ft.com/content/b2170c58-c614-11e6-8f29-9445cac8966f,,https://www.ft.com/uk-equities,UK equities,"...AstraZeneca is due to publish results from a pivotal trial of durvalumab, its most promising cancer treatment, in early 2017....",AstraZeneca,"DECEMBER 19, 2016"
US regulator advances AstraZeneca’s application for cancer drug,https://www.ft.com/content/c174cb27-b98d-38b0-b96a-dbd0a2564343,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,...AstraZeneca has pinned hopes on durvalumab as a potential breakthrough treatment for several forms of cancer....,AstraZeneca,"DECEMBER 9, 2016"
"Investors Chronicle: Purplebricks, On the Beach, Stagecoach",https://www.ft.com/content/1afe5620-bbdb-11e6-8b45-b8b81dd5d080,,https://www.ft.com/investments,Investments,"...The shorts are: Capita, Fresnillo, Polymetal International, Mediclinic, Randgold Resources, Hikma Pharma, AstraZeneca, Whitbread, Imperial Brands, Travis Perkins....",AstraZeneca,"DECEMBER 9, 2016"
Smith & Nephew poaches Alvogen CFO,https://www.ft.com/content/20def6b4-99e3-38bc-bb23-431c5bc4b509,,https://www.ft.com/healthcare,Healthcare,"...Mr Baker, who will join the company from March, is currently chief financial officer at private equity-owned generic pharmaceuticals company Alvogen, and previously spent 20 years at AstraZeneca....",AstraZeneca,"NOVEMBER 30, 2016"
AstraZeneca climbs on new hopes for drugs pipeline,https://www.ft.com/content/de619772-b338-11e6-9c37-5787335499a0,,https://www.ft.com/uk-equities,UK equities,"...AstraZeneca was a gainer on Friday after Liberum argued that investors have already written off the group’s cancer drugs pipeline.

Liberum added AstraZeneca to its “buy” list with a £52 target....",AstraZeneca,"NOVEMBER 25, 2016"
AstraZeneca given green light to resume cancer drug trials,https://www.ft.com/content/be59f3c2-b0ca-11e6-a37c-f4a01f1b0fa1,,https://www.ft.com/uk-companies,UK companies,...AstraZeneca has pinned hopes on durvalumab as a potential breakthrough treatment for several forms of cancer....,AstraZeneca,"NOVEMBER 22, 2016"
Iron and copper miners fall as Trump trade slows,https://www.ft.com/content/cde64896-4834-34d2-9488-f9a7cfa6e9cd,,https://www.ft.com/uk-equities,UK equities,"...joined at the bottom of the FTSE 100 by some of the financial and pharmaceuticals groups that also gained in the immediate aftermath of the election, with RBS, Barclays, Prudential, Legal & General and AstraZeneca...",AstraZeneca,"NOVEMBER 15, 2016"
AstraZeneca: Trump lifts it up,https://www.ft.com/content/e73f4848-a740-11e6-8b69-02899e8bd9d1,,https://www.ft.com/us-companies,US & Canadian companies,"...AstraZeneca has plenty of other treatments in the pipeline, meanwhile. Some of these, such as Tagrisso for lung cancer, should sell well in China, where AstraZeneca is doing well....",AstraZeneca,"NOVEMBER 10, 2016"
AstraZeneca revenues dented by generic rivals,https://www.ft.com/content/953da3e6-a731-11e6-8b69-02899e8bd9d1,,https://www.ft.com/uk-companies,UK companies,"...AstraZeneca posted a drop in profits and weaker than expected sales in the third quarter despite advances in bringing new products to the market, as competition from generic rivals dragged down revenues...",AstraZeneca,"NOVEMBER 10, 2016"
Generic rivals weigh on AstraZeneca revenues,https://www.ft.com/content/5da1c2d7-2ca4-3835-979b-3b47482afbcf,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,...AstraZeneca chief executive Pascal Soriot has bet on new product development to help bring an end to five years of sales declines....,AstraZeneca,"NOVEMBER 10, 2016"
How Trump could make the City great again,https://www.ft.com/content/7c6c4ac0-a673-11e6-8898-79a99e2a4de6,,https://www.ft.com/jonathan-guthrie,Jonathan Guthrie,"...The immediate winners among quoted multinationals are gold miners, pharma giants such as GlaxoSmithKline and AstraZeneca, which could escape Clintonite price controls, and defence group BAE Systems....",AstraZeneca,"NOVEMBER 9, 2016"
AstraZeneca walks tightrope of drug trials,https://www.ft.com/content/626c73e0-a5a9-11e6-8b69-02899e8bd9d1,,https://www.ft.com/us-companies,US & Canadian companies,...AstraZeneca is due to update the market on its third-quarter performance on Thursday....,AstraZeneca,"NOVEMBER 9, 2016"
Smith & Nephew shares slip on jitters ahead of trading update,https://www.ft.com/content/8703deb6-a05c-11e6-86d5-4e36b35c3550,,https://www.ft.com/uk-equities,UK equities,"...AstraZeneca, which reports results on November 10, faded 1.7 per cent to £45.12 in tandem with Shire....",AstraZeneca,"NOVEMBER 1, 2016"
FDA deals blow to AstraZeneca cancer drug,https://www.ft.com/content/4c52afd6-9c6f-11e6-a6e4-8b8e77dd083a,,https://www.ft.com/us-companies,US & Canadian companies,...AstraZeneca has pinned hopes on durvalumab as a potential breakthrough treatment for several forms of cancer....,AstraZeneca,"OCTOBER 27, 2016"
AstraZeneca shares fall after trial setback for cancer drug,https://www.ft.com/content/fc0aa77f-32fa-304e-a2c7-f8e42de26d7e,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,...AstraZeneca has pinned hopes on durvalumab as a potential new breakthrough treatment for several forms of cancer....,AstraZeneca,"OCTOBER 27, 2016"
AstraZeneca slides after cancer drug trial partially on hold,https://www.ft.com/content/cac948d2-9c62-11e6-a6e4-8b8e77dd083a,https://www.ft.com/__origami/service/image/v2/images/raw/http%3A%2F%2Fprod-upp-image-read.ft.com%2F039f0cda-9c65-11e6-a6e4-8b8e77dd083a?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/uk-equities,UK equities,...AstraZeneca was a faller on Thursday on news it had placed partially on hold a trial of one of its most important pipeline drugs....,AstraZeneca,"OCTOBER 27, 2016"
"Pharma makes up half of UK’s £16.5bn R&D spending, survey says",https://www.ft.com/content/4eb0e046-9b6a-11e6-b8c6-568a43813464,,https://www.ft.com/uk-economy,UK economy,"...Two big pharmaceutical companies, GlaxoSmithKline and AstraZeneca, are behind almost all of the sector’s investment — £7.5bn of the £7.9bn spent....",AstraZeneca,"OCTOBER 27, 2016"
May and the case for vetting foreign deals,https://www.ft.com/content/80e0753a-8edc-11e6-8df8-d3778b55a923,,https://www.ft.com/uk-inward-investment,UK inward investment,"...One example of this was Pfizer’s unsuccessful hostile bid two years ago for AstraZeneca, the drugs group, which involved informal discussions around these themes between the bidder and the state....",AstraZeneca,"OCTOBER 10, 2016"
Sterling’s pain is UK blue-chips’ dividend gain,https://www.ft.com/content/d68ed738-8bcb-11e6-8cb7-e7ada1d123b1,,https://www.ft.com/currencies,Currencies,,,"OCTOBER 7, 2016"
Allergan to buy bowel disease drug from AstraZeneca,https://www.ft.com/content/1f23f2d2-896d-11e6-8cb7-e7ada1d123b1,,https://www.ft.com/us-companies,US & Canadian companies,"...Depending on whether the drug sells in sufficient quantities, Allergan will pay an additional $725m to AstraZeneca as well as various royalties....",AstraZeneca,"OCTOBER 3, 2016"
Allergan strikes deal with AstraZeneca over Crohn’s disease treatment,https://www.ft.com/content/799e9ba9-b7d5-30bf-98ce-bd09eb6ca6c8,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...As a result, AstraZeneca will pay Amgen one third of all of the payments received from Allergan for the drug....",AstraZeneca,"OCTOBER 3, 2016"
Zuckerberg health fund poaches AstraZeneca non-exec director,https://www.ft.com/content/2cec692b-e3cc-32e8-aa75-b7652cab7d0c,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...Leif Johansson, AstraZeneca chairman, said the company was “sorry to see her leave the AstraZeneca board but fully understand her decision to step down to focus on her new assignment”....",AstraZeneca,"SEPTEMBER 28, 2016"
Opinions split on Witty regime at GSK,https://www.ft.com/content/c759144a-7f2d-11e6-bc52-0c7211ef3198,,https://www.ft.com/uk-companies,UK companies,"...AstraZeneca, the second-biggest UK drugmaker, for example, has seen its shares increase 148 per cent in the same period....",AstraZeneca,"SEPTEMBER 20, 2016"
AstraZeneca climbs on cancer drugs pipeline hopes,https://www.ft.com/content/e3f3f256-790a-11e6-a0c6-39e2633162d5,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,...AstraZeneca dodged a London market sell-off on Monday on optimism that potential blockbusters in its cancer drugs pipeline can revive earnings growth....,AstraZeneca,"SEPTEMBER 13, 2016"
"Markets Live: Monday, 12th September, 2016",https://www.ft.com/content/62daeb66-0549-3aa8-9779-3b650bf36cb1,,https://www.ft.com/bryce-elder,Bryce Elder,,,"SEPTEMBER 12, 2016"
The plague of compulsory creativity may be dying out,https://www.ft.com/content/5fd3a6a0-75eb-11e6-b60a-de4532d5ea35,,https://www.ft.com/lucy-kellaway,Lucy Kellaway,"...AstraZeneca, which is looking for someone to plan its cash flow, boasts in the advertisement about an atmosphere in which people are “rewarded for their ideas and creativity”....",AstraZeneca,"SEPTEMBER 11, 2016"
Friends reunite for Barclays’ turnround attempt,https://www.ft.com/content/8430207a-735f-11e6-b60a-de4532d5ea35,,https://www.ft.com/retail,Retail sector,"...These include AstraZeneca, Unilever and HSBC. The only kid who cried wolf with the bite marks to show for it is easyJet....",AstraZeneca,"SEPTEMBER 5, 2016"
The FT’s City List: Baroness Shriti Vadera,https://www.ft.com/content/2aab2272-6b83-11e6-ae5b-a7cc5dd5a28c,,https://www.ft.com/magazine,FT Magazine,"...Non-executive director at AstraZeneca. I remain involved in issues relating to developing economies and communities.

What did you want to be when you were growing up?...",AstraZeneca,"SEPTEMBER 1, 2016"
AstraZeneca and Pfizer strike $1.6bn antibiotics deal,https://www.ft.com/content/c7ca348a-69e9-11e6-ae5b-a7cc5dd5a28c,,https://www.ft.com/us-companies,US & Canadian companies,...Anglo-Swedish pharmaceuticals group AstraZeneca has agreed to sell part of its antibiotics business to former US suitor Pfizer in a deal worth up to $1.6bn....,AstraZeneca,"AUGUST 24, 2016"
Opening Quote: Glencore; WPP; bookies; bacon rolls,https://www.ft.com/content/2fb9febd-1e37-3adf-94c7-87247aa7a452,,https://www.ft.com/fastft,fastFT,"...Elsewhere, AstraZeneca has struck a deal to sell the rights to its small molecule antibiotics business to Pfizer in a deal that could be worth over $1.5bn through a combination of staggered payments and...",AstraZeneca,"AUGUST 24, 2016"
AstraZeneca to sell antibiotics business to Pfizer,https://www.ft.com/content/e37c522b-55ff-3493-ba76-0c23b162cefb,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,...UK pharma giant AstraZeneca has struck a deal to sell the rights to its small molecule antibiotics business to Pfizer in a deal that could be worth over $1.5bn through a combination of staggered payments...,AstraZeneca,"AUGUST 24, 2016"
Pharmaceuticals: Staying power,https://www.ft.com/content/d7b1c59e-65fb-11e6-a08a-c7ac04ef00aa,,https://www.ft.com/the-big-read,The Big Read,"...A spokesperson for AstraZeneca says: “Now that generic rosuvastatin is available in the US, patients have additional options when filling their prescriptions....",AstraZeneca,"AUGUST 21, 2016"
AstraZeneca climbs to a record high,https://www.ft.com/content/2cdd5808-5b2a-11e6-9f70-badea1b336d4,,https://www.ft.com/uk-equities,UK equities,...A setback for a rival’s cancer treatment helped lift AstraZeneca to a record high on Friday....,AstraZeneca,"AUGUST 5, 2016"
Bristol-Myers Squibb shares drop after trial results,https://www.ft.com/content/c2b90ee9-8090-3be4-b87c-bade4b71c41b,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...that Opdivo has failed, and perhaps the biggest failure for the entire class of drugs, known as checkpoint inhibitors, which are being developed by several large drugmakers, including Pfizer, Roche and Astrazeneca...",Astrazeneca,"AUGUST 5, 2016"
HSBC hits 6-month high on shareholder payout hopes,https://www.ft.com/content/0094b44c-5a64-11e6-9f70-badea1b336d4,,https://www.ft.com/uk-equities,UK equities,"...AstraZeneca hit a record high, up 2.7 per cent to £51.53....",AstraZeneca,"AUGUST 4, 2016"
Sanofi Q2 profits fall as sales of Lantus insulin suffer,https://www.ft.com/content/8adb98d6-daf9-32b0-aab2-93fb107d4556,,https://www.ft.com/european-companies,European companies,"...Sanofi is, like many other big pharmaceuticals companies such as AstraZeneca, on the hunt for fresh sources of growth to replace sliding sales of best-selling products that have lost patent protection....",AstraZeneca,"JULY 29, 2016"
The Brexit reckoning: UK plc reports,https://www.ft.com/content/c8d44cbc-54e5-11e6-befd-2fc0c26b3c60,,https://www.ft.com/brexit,Brexit,"...While companies such as Veolia, GSK and AstraZeneca have announced plans to invest in the UK, others such as ITV, Flybe and Virgin Money have warned of a more uncertain future....",AstraZeneca,"JULY 28, 2016"
FT Opening Quote: Forex write-down hits Rolls-Royce,https://www.ft.com/content/7fecf8da-6849-33b4-8267-6a7e86615a56,,https://www.ft.com/financial-job-losses,Financial job losses,"...BAE Systems and Merlin Entertainment report positive half-year profits movements, while AstraZeneca has headed in the opposite direction.Anglo American has narrowed its six-month loss from $1.9bn to $364m...",AstraZeneca,"JULY 28, 2016"
AstraZeneca insists new drugs ‘advancing quickly’ as revenues drop,https://www.ft.com/content/b892698f-fa77-34e7-8717-7103660078ab,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,...Patent protection on Crestor drug in the US expired in May and AstraZeneca has since been defending against copycat versions....,AstraZeneca,"JULY 28, 2016"
New drugs aim to kill cancer cells by destabilising their DNA,https://www.ft.com/content/043439a8-502b-11e6-88c5-db83e98a590a,,https://www.ft.com/uk-economy,UK economy,...In exchange AstraZeneca will have first right to negotiate commercial development of any compounds that are discovered....,AstraZeneca,"JULY 24, 2016"
UK-exposed stocks sink on slowdown fears,https://www.ft.com/content/2dec8606-5021-11e6-88c5-db83e98a590a,https://www.ft.com/__origami/service/image/v2/images/raw/http%3A%2F%2Fprod-upp-image-read.ft.com%2F4db130f4-2254-11e6-9d4d-c11776a5124d?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,...AstraZeneca closed up 2 per cent   to £46.13 while GlaxoSmithKline rose by 1.3 per cent to finish at £16.60....,AstraZeneca,"JULY 22, 2016"
The unhappy story of British industrial strategy,https://www.ft.com/content/ec742b44-4e62-11e6-8172-e39ecd3b86fc,,https://www.ft.com/stream/ccfd9664-828d-4c02-bf03-1d07010dbb4d,Sir Geoffrey Owen,"...She went on to refer to the 2014 attempt by Pfizer of the US to take over AstraZeneca, one of the UK’s two big pharmaceuticals companies....",AstraZeneca,"JULY 20, 2016"
Sterling advance cools FTSE 100,https://www.ft.com/content/202d43ad-516a-399b-b80e-d3fcd3af03a9,,https://www.ft.com/stream/8eb5e6a0-1a05-34ab-9fa1-ba6e627cfa31,Joel Lewin,"...Leading the losses are the dollar earning miners and pharmaceutical groups that have benefited so handsomely from the weakness of the pound, with Fresnillo down 2 per cent, Astrazeneca off 1.7 per cent and...",Astrazeneca,"JULY 12, 2016"
Theresa May sets out vision for business,https://www.ft.com/content/b6442e26-4777-11e6-b387-64ab0a67014c,,https://www.ft.com/uk-industrial-strategy,UK industrial strategy,...There was a call for the government to take more powers to block predatory takeovers of key companies — citing Kraft’s takeover of Cadbury and Pfizer’s failed bid for AstraZeneca — and another promise to...,AstraZeneca,"JULY 11, 2016"
Poetic visions help companies reach more prosaic goals,https://www.ft.com/content/897e247e-3b78-11e6-9f2c-36b487ebd80a,,https://www.ft.com/andrew-hill,Andrew Hill,"...Pascal Soriot, chief executive of AstraZeneca, set a goal in 2013 of developing 10 entirely new medicines by 2020, and “[improving] the lives of 200m patients”....",AstraZeneca,"JULY 4, 2016"
AstraZeneca licenses skin drug to Denmark’s Leo Pharma,https://www.ft.com/content/f8010fe8-9021-3fd8-a33e-60263b0e4edf,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,...UK drugmaker AstraZeneca has secured a $115m global license agreement with Danish pharmaceutical group Leo Pharma for its news skin disease drug....,AstraZeneca,"JULY 1, 2016"
Database shines light on pharma payments to UK doctors,https://www.ft.com/content/b3e42806-3ec7-11e6-8716-a4a71e8140b0,,https://www.ft.com/uk-economy,UK economy,"...AstraZeneca is the company that paid most to healthcare professionals: a total of £42m in 2015 for research and non-research payments. The largest sum paid to an individual was £98,000....",AstraZeneca,"JUNE 30, 2016"
Housebuilders lead FTSE 100 Brexit slump,https://www.ft.com/content/bd4eb26e-3c86-11e6-9f2c-36b487ebd80a,,https://www.ft.com/brexit,Brexit,"...The FTSE 100 closed down 2.6 per cent, off 156.49 points at 5,982.20, thanks to dollar earners such as AstraZeneca, up 2.3 per cent to £41.26, and Unilever, up 1.4 per cent to £33.11....",AstraZeneca,"JUNE 27, 2016"
Few bright spots in UK traders’ sea of red,https://www.ft.com/content/ba663574-39fa-11e6-a780-b48ed7b6126f,,https://www.ft.com/energy,Energy sector,"...Shares in pharmaceutical companies AstraZeneca and GlaxoSmithKline, and those in Mediclinic, the international healthcare group, all rose in morning trading as investors sought companies that sold products...",AstraZeneca,"JUNE 24, 2016"
One in three FTSE 100 companies worries about tax,https://www.ft.com/content/5e757cbc-3157-11e6-bda0-04585c31b153,,https://www.ft.com/uk-economy,UK economy,"...Mr Irwin said that AstraZeneca, Barclays, BP, HSBC and Old Mutual stood out for the depth and breadth of their reporting of political risks....",AstraZeneca,"JUNE 13, 2016"
FT Opening Quote,https://www.ft.com/content/20834ee6-b7ac-3bc3-a267-a2a4ae27aab5,,https://www.ft.com/chris-nuttall,Chris Nuttall,"...FastFT has news from Argos, AstraZeneca, Flybe, PZ Cussons and Watkin Jones....",AstraZeneca,"JUNE 9, 2016"
AstraZeneca forges new deal on anaesthetics,https://www.ft.com/content/a49b03b9-c584-3973-a33b-2164ded19943,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,...AstraZeneca has struck a deal with Aspen for distributing seven brands of anaesthetics outside the US....,AstraZeneca,"JUNE 9, 2016"
President raises patient and business hope for cancer treatment,https://www.ft.com/content/e538e304-0d32-11e6-b41f-0beb7e589515,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...He highlights the approval last year of Tagrisso, an AstraZeneca drug which took two and a half years from first clinical trials to launch, compared with the decade or more the process has usually taken....",AstraZeneca,"JUNE 2, 2016"
M&A back on the table as ‘big pharma’ targets smaller rivals,https://www.ft.com/content/d6e5feb6-2832-11e6-8b18-91555f2f4fde,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...After failing to acquire AstraZeneca for $119bn in 2014 and Allergan for $160bn earlier this year, the New York-based group wasted little time before pursuing a fresh deal — last month it spent $5.2bn on...",AstraZeneca,"JUNE 2, 2016"
"Denys Henderson, industrialist who split up ICI, 1932-2016",https://www.ft.com/content/e65a20a6-2400-11e6-aa98-db1e01fabc0c,,https://www.ft.com/uk-companies,UK companies,...The units are now respectively part of Akzo Nobel and AstraZeneca....,AstraZeneca,"MAY 27, 2016"
Opening Quote: Playtech struggling to find a deal,https://www.ft.com/content/5726f6e1-dee0-340c-8756-6a29b0974b7a,,https://www.ft.com/mergers-acquisitions,Mergers & Acquisitions,"...Following decent results from trials of an asthma drug, AstraZeneca has reported that olaparib, an important cancer treatment, did not meet targets in tests against advanced gastric cancer....",AstraZeneca,"MAY 18, 2016"
FT Opening Quote,https://www.ft.com/content/779de6ab-b6e8-3c9a-9b88-80a3d4fdd5ea,,https://www.ft.com/chris-nuttall,Chris Nuttall,"...Following decent results from trials of an asthma drug, AstraZeneca has reported that olaparib, an important cancer treatment, did not meet targets in tests against advanced gastric cancer....",AstraZeneca,"MAY 18, 2016"
Epstein out as Novartis splits cancer from pharma unit,https://www.ft.com/content/ac903067-759e-3b80-b17a-1b6eaad2abb2,,https://www.ft.com/fastft,fastFT,"...Paul Hudson, a veteran executive at AstraZeneca will replace Mr Epstein as head of Novartis Pharmaceuticals, while Bruno Strigini will become CEO of Novartis Oncology....",AstraZeneca,"MAY 17, 2016"
AstraZeneca set to go head to head against GSK with asthma drug,https://www.ft.com/content/3753f086-1c18-11e6-b286-cddde55ca122,,https://www.ft.com/uk-companies,UK companies,...AstraZeneca is on course for a head-to-head battle with GlaxoSmithKline over a new generation of asthma drugs which are injected rather than inhaled....,AstraZeneca,"MAY 17, 2016"
Opening Quote: Premier Foods back in the black,https://www.ft.com/content/88325122-1d4c-3cdb-ae39-a4de97404a46,,https://www.ft.com/mergers-acquisitions,Mergers & Acquisitions,"...AstraZeneca reports that Benralizumab, an important new anti-asthma drug, has achieved good results in two Phase III trials, the tests that generally precede an application for marketing approval....",AstraZeneca,"MAY 17, 2016"
FT Opening Quote,https://www.ft.com/content/0741c22b-c853-3785-a1f8-5f2dce7949db,,https://www.ft.com/chris-nuttall,Chris Nuttall,"...AstraZeneca reports that Benralizumab, an important new anti-asthma drug, has achieved good results in two Phase III trials, the tests that generally precede an application for marketing approval....",AstraZeneca,"MAY 17, 2016"
FT Opening Quote,https://www.ft.com/content/a4c354e2-a4b9-3218-8d75-d0aa7c9c732f,,https://www.ft.com/chris-nuttall,Chris Nuttall,"...AstraZeneca has received US orphan drug designation for Selumetinib, a treatment for thyroid cancer. It’s a small market, inevitably....",AstraZeneca,"MAY 12, 2016"
Opening Quote: TalkTalk; ITV’s Brexit jitters; Carney time,https://www.ft.com/content/ff17c3e6-4a9a-3714-91f4-eee7277418fe,,https://www.ft.com/brexit,Brexit,"...AstraZeneca has received US orphan drug designation for Selumetinib, a treatment for thyroid cancer. It’s a small market, inevitably....",AstraZeneca,"MAY 12, 2016"
Euro credit: today it’s breakfast & doughnut bonds,https://www.ft.com/content/e8d2082c-a533-36ac-b898-63c5f8e68926,,https://www.ft.com/euro,Euro,"...Yesterday, corporate giants such as Shell, AstraZeneca and Airbus tapped the euro credit market with multi-billion euro deals, taking yesterday’s total to €5.45bn....",AstraZeneca,"MAY 10, 2016"
EasyJet bounces back from 18-month low,https://www.ft.com/content/4d24e704-1604-11e6-b197-a4af20d5575e,,https://www.ft.com/uk-equities,UK equities,"...Leading the FTSE 100 risers, AstraZeneca rose 3.8 per cent to £39.45 on word that it was marketing a €2.2bn bond issue....",AstraZeneca,"MAY 9, 2016"
France’s Total to make rare dip into hybrid debt,https://www.ft.com/content/53fef984-4a6d-3f2c-a16a-8a4c6d3f9750,,https://www.ft.com/private-equity,Private equity,"...The news of the bond sale comes as corporate bond markets gear up for a bumper week of issuance with Airbus, AstraZeneca and Shell all selling big euro-denominated bonds and AbbVie and Chevron launching...",AstraZeneca,"MAY 9, 2016"
‘Almost madness’: Companies pile into euro bonds,https://www.ft.com/content/b59f78f5-8a50-3cf4-bf6f-5af6edf09939,,https://www.ft.com/capital-markets,Capital markets,"...AstraZeneca has set initial price guidance at 0.5 per cent to 0.55 per cent for its 5-year bond, while both AstraZeneca and Shell are both looking to pay about 1.5 per cent to borrow for 12 years....",AstraZeneca,"MAY 9, 2016"
Financial PR spins a new global story,https://www.ft.com/content/e21a373e-137e-11e6-91da-096d89bd2173,,https://www.ft.com/public-relations,Public relations,...He has played an important role in many recent cross-border deals involving the UK including helping AstraZeneca fight off a bid from Pfizer....,AstraZeneca,"MAY 6, 2016"
How to survive the trauma of acquisition,https://www.ft.com/content/f93cd8f6-f11c-11e5-9f20-c3a047354386,,https://www.ft.com/recruitment,Recruitment,"...Even a change of company name can be upsetting, says Pascal Soriot, now chief executive of AstraZeneca, who in previous roles lived through several big mergers....",AstraZeneca,"MAY 4, 2016"
Medivation rejects Sanofi’s $9.3bn takeover offer,https://www.ft.com/content/9c8c8df7-e1b3-34c3-8049-9c4b2302a3b4,,https://www.ft.com/mergers-acquisitions,Mergers & Acquisitions,"...Andrew Baum, analyst at Citigroup, said he believed “it is likely that AstraZeneca is actively exploring the acquisition” of Medivation....",AstraZeneca,"APRIL 29, 2016"
AstraZeneca cuts costs for shift to cancer drugs,https://www.ft.com/content/2ebfeccc-0de5-11e6-b41f-0beb7e589515,,https://www.ft.com/uk-companies,UK companies,...Investors had been expecting big cost cuts at AstraZeneca in years ahead but analysts welcomed the increased detail....,AstraZeneca,"APRIL 29, 2016"
AstraZeneca’s revenues rise but profit hit by higher R&D,https://www.ft.com/content/6bdc8e23-3bef-3294-a70a-f378ed31290e,,https://www.ft.com/world,World,...AstraZeneca managed to increase revenues slightly in the first quarter but reported a drop in profits as it steps up investment in the new generation of cancer drugs upon which it is relying to revive growth...,AstraZeneca,"APRIL 29, 2016"
AstraZeneca slips on downgrade worries,https://www.ft.com/content/b44a5820-0bd1-11e6-9456-444ab5211a2f,,https://www.ft.com/uk-equities,UK equities,...AstraZeneca led the blue-chip fallers on Tuesday as a licensing deal stoked concerns that earnings due this week may trigger downgrades....,AstraZeneca,"APRIL 26, 2016"
AstraZeneca sells US rights to gout treatment for up to $265m,https://www.ft.com/content/af9ff55c-16ce-3e6b-ba03-66511702dce6,,https://www.ft.com/world,World,...UK drugmaker AstraZeneca is selling the US rights to its gout treatment Zurampic....,AstraZeneca,"APRIL 26, 2016"
Opening Quote: Whitbread gets a boost from Premier Inn,https://www.ft.com/content/1b3499b6-2c71-3a47-bce2-32a22667d202,,https://www.ft.com/world,World,"...AstraZeneca has announced that Bevespi Aerosphere, a bronchodilator product for patients with chronic obstructive pulmonary disease has received US marketing approval....",AstraZeneca,"APRIL 26, 2016"
FT Opening Quote,https://www.ft.com/content/266c3801-55f2-3078-a903-b30687f643c3,,https://www.ft.com/chris-nuttall,Chris Nuttall,"...AstraZeneca has announced that Bevespi Aerosphere, a bronchodilator product for patients with chronic obstructive pulmonary disease has received US marketing approval....",AstraZeneca,"APRIL 26, 2016"
Drug prices: Tweaking the formula,https://www.ft.com/content/b034a38e-0abf-11e6-9456-444ab5211a2f,,https://www.ft.com/the-big-read,The Big Read,"...“We need to stop looking at medicines as a cost and look at the value they can create for UK plc,” says Mr Thompson. He admits, though, that the industry will have to be realistic about pricing....",plc,"APRIL 25, 2016"
"Opening Quote: BHS blues, Rexam and Snoozebox",https://www.ft.com/content/9be6b914-a022-3e5d-b18c-83809f809a95,,https://www.ft.com/mergers-acquisitions,Mergers & Acquisitions,"...Protest votes are expected at drug businesses Shire and AstraZeneca over pay, and at Schroders....",AstraZeneca,"APRIL 25, 2016"
FT Opening Quote,https://www.ft.com/content/2ab897aa-b14e-309c-80e1-97e959149bd9,,https://www.ft.com/chris-nuttall,Chris Nuttall,"...Protest votes are expected at drug businesses Shire and AstraZeneca over pay, and at Schroders....",AstraZeneca,"APRIL 25, 2016"
AstraZeneca links with three partners to focus on genomics,https://www.ft.com/content/136523f0-07ca-11e6-876d-b823056b209b,,https://www.ft.com/us-companies,US & Canadian companies,...But Dr Venter said the AstraZeneca partnership would be more extensive....,AstraZeneca,"APRIL 21, 2016"
The secret of a world-class biotech sector,https://www.ft.com/content/02c2d702-061e-11e6-9b51-0fb5e65703ce,,https://www.ft.com/stream/ccfd9664-828d-4c02-bf03-1d07010dbb4d,Sir Geoffrey Owen,"...the UK there is a dearth not only of big biotechs but also of independent, medium-sized companies that would make the life sciences sector less reliant on the Big Pharma companies: GlaxoSmithKline and AstraZeneca...",AstraZeneca,"APRIL 19, 2016"
BP shareholders get sniffy over Dudley’s pay,https://www.ft.com/content/f4dbe810-0238-11e6-af1d-c47326021344,,https://www.ft.com/jonathan-guthrie,Jonathan Guthrie,"...How about Rakesh Kapoor at Reckitt Benckiser, Pascal Soriot at AstraZeneca or Mark Cutifani at Anglo American? It promises to be a lively spring voting season.

Corporate profits were weak in 2015....",AstraZeneca,"APRIL 14, 2016"
Next rebounds as broker calls retailer a value play,https://www.ft.com/content/9d613c2c-fc19-11e5-b3f6-11d5706b613b,,https://www.ft.com/uk-equities,UK equities,"...The FTSE 100 rose 1.2 per cent, up 70.4 points to 6,161.63, as AstraZeneca gained 4.5 per cent to £41.28....",AstraZeneca,"APRIL 6, 2016"
US Treasury shatters Pfizer chief Ian Read’s merger dreams,https://www.ft.com/content/7bccfb06-fbf0-11e5-b5f5-070dca6d0a0d,,https://www.ft.com/us-companies,US & Canadian companies,"...It marked the second such deal involving Pfizer to collapse since 2014, when a $100bn hostile takeover of AstraZeneca was thwarted by the UK group....",AstraZeneca,"APRIL 6, 2016"
Pfizer merger collapse is serious failure of management,https://www.ft.com/content/f45ffbba-fbee-11e5-8f41-df5bda8beb40,,https://www.ft.com/michael-skapinker,Michael Skapinker,"...In 2014, he failed to take over UK-based AstraZeneca. On that occasion, he managed to upset politicians not just on both sides of the US aisle, but on both sides of the Atlantic....",AstraZeneca,"APRIL 6, 2016"
Pfizer: plan C,https://www.ft.com/content/f70e91ca-fbe2-11e5-b3f6-11d5706b613b,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...The strategy has now failed twice, with AstraZeneca and Allergan. The growth problem remains....",AstraZeneca,"APRIL 6, 2016"
Medivation hires bankers to defend against takeover,https://www.ft.com/content/613305bf-15f4-363e-a34d-5ec0460c4aa2,,https://www.ft.com/mergers-acquisitions,Mergers & Acquisitions,...Other potential drugmakers who could be interested in acquiring Medivation include AstraZeneca and Roche....,AstraZeneca,"MARCH 30, 2016"
Opening Quote: BoE to publish stress test scenarios,https://www.ft.com/content/304fec79-cd98-3bf0-8c0d-ee589bebbd5a,,https://www.ft.com/central-banks,Central banks,...AstraZeneca has received Japanese marketing approval for the use of its Tagrisso drug for treating some forms of non-small cell lung cancer....,AstraZeneca,"MARCH 29, 2016"
FT Opening Quote,https://www.ft.com/content/beb83d69-504d-3ec2-9a52-e798cac8da68,,https://www.ft.com/chris-nuttall,Chris Nuttall,...AstraZeneca has received Japanese marketing approval for the use of its Tagrisso drug for treating some forms of non-small cell lung cancer....,AstraZeneca,"MARCH 29, 2016"
British drugmakers receive approvals in Japan,https://www.ft.com/content/6cede2b9-8df6-314f-b7b1-09118138435b,,https://www.ft.com/world,World,...UK pharmaceuticals giants AstraZeneca and GlaxoSmithKline have both received some good news from Japanese regulators today....,AstraZeneca,"MARCH 29, 2016"
Sanofi poaches immunology expert from AstraZeneca,https://www.ft.com/content/e8a11b6b-c04d-391d-84ff-36f9f41864a1,,https://www.ft.com/world,World,...Cambridge-based MedImmune accounts for neatly half of AstraZeneca’s overall R&D portfolio....,AstraZeneca’s,"MARCH 29, 2016"
Chi-Med taps Nasdaq for $100m to help break innovation drought,https://www.ft.com/content/d238dbd8-ee38-11e5-aff5-19b4e253664a,,https://www.ft.com/ipos,IPOs,"...Christian Hogg, Chi-Med chief executive, said the initial public offering, which was completed last week, would support work on two cancer drugs being developed in partnership with AstraZeneca and Eli Lilly...",AstraZeneca,"MARCH 29, 2016"
AstraZeneca heart drug hopes hit by clinical trial failure,https://www.ft.com/content/2bd98bd0-f0d5-11e5-9f20-c3a047354386,,https://www.ft.com/companies/byregion,Companies By Region,...AstraZeneca had hoped that positive results would open a new market for the drug beyond its current use in heart attack patients....,AstraZeneca,"MARCH 23, 2016"
Opening Quote: Candour from Sports Direct; Cheltenham rumbles bookies,https://www.ft.com/content/d9baa851-37df-3588-8321-9d1d1646b73d,,https://www.ft.com/mergers-acquisitions,Mergers & Acquisitions,"...Brilinta, an AstraZeneca heart drug, has failed to meet efficacy targets in a comparative trial with aspirin. The drug company needs good trial results to meet ambitious earnings targets....",AstraZeneca,"MARCH 23, 2016"
AstraZeneca’s latest trial for Brilinta drug ends in disappointment,https://www.ft.com/content/caf64268-999f-35e4-9d20-82c64a5c3ab9,,https://www.ft.com/world,World,...Probably not the outcome UK drugmaker AstraZeneca was hoping for....,AstraZeneca,"MARCH 23, 2016"
BT recruits former BG Group finance director Simon Lowth,https://www.ft.com/content/8a54ae62-1d55-3fed-a29a-e2e83fae0bba,,https://www.ft.com/mergers-acquisitions,Mergers & Acquisitions,"...He has been CFO of, and served on the boards of, BG Group, drugmaker AstraZeneca and utility group ScottishPower in the last 11 years. He is also a non-executive director at Standard Chartered....",AstraZeneca,"MARCH 18, 2016"
Miners keep FTSE in positive territory,https://www.ft.com/content/d6ea9b9a-ec43-11e5-888e-2eadd5fbc4a4,,https://www.ft.com/uk-equities,UK equities,"...Shire fell 2.4 per cent to 3,606.4p, AstraZeneca slipped 1.5 per cent to 3,963.1p and GlaxoSmithKline dropped 0.9 per cent to 1,403.0p....",AstraZeneca,"MARCH 17, 2016"
Pharma merger to create UK champion in respiratory medicines,https://www.ft.com/content/62322d88-eb6f-11e5-888e-2eadd5fbc4a4,,https://www.ft.com/uk-companies,UK companies,...A former senior executive at AstraZeneca is aiming to create a new UK champion in respiratory medicines after a £441m merger between Vectura and Skyepharma....,AstraZeneca,"MARCH 16, 2016"
Vectura and Skyepharma agree £441m merger,https://www.ft.com/content/4710f98f-0f5c-3818-90f0-d9b212421619,,https://www.ft.com/mergers-acquisitions,Mergers & Acquisitions,"...The enlarged company will be run by James Ward-Lilley, Vectura chief executive and a former senior AstraZeneca executive. Bruno Angelici, Vectura’s chairman, will also keep his role....",AstraZeneca,"MARCH 16, 2016"
WPP chief’s £60m pay set to spark anger,https://www.ft.com/content/ee434a84-e942-11e5-bb79-2303682345c8,,https://www.ft.com/uk-companies,UK companies,...The target to hit sales of $45bn by 2023 was a central part of AstraZeneca’s defence against a takeover approach from Pfizer in 2014....,AstraZeneca’s,"MARCH 13, 2016"
HSBC slips on fears of dividend decline,https://www.ft.com/content/25e443dc-df0f-11e5-b072-006d8d362ba3,,https://www.ft.com/uk-equities,UK equities,"...AstraZeneca lost 2.3 per cent to £41.07 after a trial of its lung cancer drug, tremelimumab, failed to show better survival rates than a placebo....",AstraZeneca,"FEBRUARY 29, 2016"
AstraZeneca agrees licensing deal for Plendil in China,https://www.ft.com/content/5e221d26-dee4-11e5-b072-006d8d362ba3,,https://www.ft.com/uk-companies,UK companies,...Monday’s deal marks a step towards meeting AstraZeneca’s target for a further increase in so-called externalisation revenue this year....,AstraZeneca’s,"FEBRUARY 29, 2016"
Governance veterans bow out,https://www.ft.com/content/e0d42174-d62e-11e5-829b-8564e7528e54,,https://www.ft.com/jonathan-guthrie,Jonathan Guthrie,"...Oustees during the acrimonious “Shareholder Spring” of 2012 included David Brennan of AstraZeneca, and Sly Bailey of Trinity Mirror....",AstraZeneca,"FEBRUARY 18, 2016"
Dividend cuts put strain on income funds,https://www.ft.com/content/71f0b9d8-d3dc-11e5-8887-98e7feb46f27,,https://www.ft.com/stream/27142330-e0bb-49c7-91e7-c51648f0ce68,FTfm,"...Groups such as GlaxoSmithKline and AstraZeneca, in the pharma sector, and tobacco’s British American Tobacco are among the 10 best dividend payers in the FTSE 100, in terms of total cash pay out, according...",AstraZeneca,"FEBRUARY 16, 2016"
Miner rally subsides as FTSE hits 2012 low,https://www.ft.com/content/0a0db2c2-cf58-11e5-92a1-c5e23ef99c77,,https://www.ft.com/uk-equities,UK equities,...AstraZeneca edged 0.2 per cent higher to £39.15 amid talk that it has been weighing up a US acquisition to expand its biotechnology portfolio....,AstraZeneca,"FEBRUARY 9, 2016"
AstraZeneca cancer drug presents breakthrough,https://www.ft.com/content/36c72a86-cd74-11e5-831d-09f7778e7377,,https://www.ft.com/uk-companies,UK companies,"...AstraZeneca recently scrapped plans to seek regulatory approval for durvalumab on its own, in favour of focusing on the combination with tremelimumab....",AstraZeneca,"FEBRUARY 7, 2016"
Numbers games and existential angst,https://www.ft.com/content/5139fe1a-cb6d-11e5-a8ef-ea66e967dd44,,https://www.ft.com/jonathan-guthrie,Jonathan Guthrie,...AstraZeneca recorded a mere 1 per cent decline to $6.9bn....,AstraZeneca,"FEBRUARY 4, 2016"
Mining stocks lead the FTSE bounce,https://www.ft.com/content/b751c790-cb69-11e5-a8ef-ea66e967dd44,,https://www.ft.com/mergers-acquisitions,Mergers & Acquisitions,...But AstraZeneca lost 6.1 per cent to £41.43 after 2015 core earnings missed consensus expectations and current-year guidance underwhelmed....,AstraZeneca,"FEBRUARY 4, 2016"
Hedge fund pioneer is force behind hotly tipped biotech companies,https://www.ft.com/content/eaa798fe-c425-11e5-808f-8231cd71622e,,https://www.ft.com/uk-companies,UK companies,"...Further trials of the drug are planned in combination with two Eli Lilly therapies and separate R&D partnerships are under way with AstraZeneca, GSK and Roche....",AstraZeneca,"FEBRUARY 4, 2016"
AstraZeneca warns of lower earnings ahead of patent losses,https://www.ft.com/content/d9d223bc-cb0c-11e5-be0b-b7ece4e953a0,,https://www.ft.com/companies/byregion,Companies By Region,...AstraZeneca has urged investors to keep focused on long-term growth after its shares were sent tumbling by a warning of lower earnings this year....,AstraZeneca,"FEBRUARY 4, 2016"
AstraZeneca shares hit as 2016 revenue forecast to fall,https://www.ft.com/content/0dd5ffd4-7cfd-3a2d-b42e-6bb9208c6d97,,https://www.ft.com/world,World,"...However, it was still the biggest contributor to AstraZeneca’s total product sales of $23.6bn.

Read more on the results here....",AstraZeneca’s,"FEBRUARY 4, 2016"
"Opening Quote: Shell protects divi, Compass ploughs on",https://www.ft.com/content/3de0f745-b895-3b7d-b4a7-56b451f54606,,https://www.ft.com/central-banks,Central banks,"...Shell’s profits have slumped with the oil price, AstraZeneca’s sales are stalling, the Bank of England is set to hold interest rates....",AstraZeneca’s,"FEBRUARY 4, 2016"
FT Opening Quote,https://www.ft.com/content/fdf75fd0-0e7d-380e-a5f8-f31c3a8f06f5,,https://www.ft.com/chris-nuttall,Chris Nuttall,"...Shell profits have slumped with the oil price, AstraZeneca sales are stalling, the Bank of England is set to hold interest rates....",AstraZeneca,"FEBRUARY 4, 2016"
"AstraZeneca warns of revenue, earnings drop this year",https://www.ft.com/content/c64ea5e5-32b4-3c71-ba29-3a37ab77146c,,https://www.ft.com/mergers-acquisitions,Mergers & Acquisitions,...The group says it expects to make particular progress with oncology treatments (see table below for details of AstraZeneca’s pipeline)....,AstraZeneca’s,"FEBRUARY 4, 2016"
Opening Quote: Hargreaves shrugs off difficult markets,https://www.ft.com/content/79eec333-8fe9-3caa-9417-fb102dd68325,,https://www.ft.com/uk-banks,UK banks,"...AstraZeneca, run by Frenchman Pascal Soriot, has scored a victory of its own with approval from the European Commission to market Tagrisso, a treatment for non-small cell lung cancer....",AstraZeneca,"FEBRUARY 3, 2016"
FT Opening Quote,https://www.ft.com/content/cab130c1-699d-301e-bd38-31977de0c228,,https://www.ft.com/chris-nuttall,Chris Nuttall,"...AstraZeneca, run by Frenchman Pascal Soriot (pictured), has scored a victory of its own with approval from the European Commission to market Tagrisso, a treatment for non-small cell lung cancer....",AstraZeneca,"FEBRUARY 3, 2016"
J&J and GSK join Medicxi’s European life sciences push,https://www.ft.com/content/10e91eac-c921-11e5-be0b-b7ece4e953a0,https://www.ft.com/__origami/service/image/v2/images/raw/http%3A%2F%2Fprod-upp-image-read.ft.com%2Fb4555454-b533-11e5-b147-e5e5bba42e51?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/us-companies,US & Canadian companies,"...J&J and GSK, along with AstraZeneca, were also part of a new £40m fund called Apollo Therapeutics announced last week to help commercialise academic research from Cambridge university, Imperial College London...",AstraZeneca,"FEBRUARY 2, 2016"
Investor calls for big pharma to slim down grow louder,https://www.ft.com/content/3609613a-c8ca-11e5-be0b-b7ece4e953a0,,https://www.ft.com/us-companies,US & Canadian companies,"...jettisoned its consumer healthcare business — with brands including Coppertone sunscreen and Dr Scholl’s footcare — to sharpen its competitive edge against “pure-play” drugmakers such as Bristol-Myers Squibb, AstraZeneca...",AstraZeneca,"FEBRUARY 1, 2016"
"Opening Quote: Smith & Nephew, BT, EU/sardines",https://www.ft.com/content/6862abe9-4a15-3685-82c0-c66584573565,,https://www.ft.com/eu-energy,EU energy,"...Earnings season gets fully under way this week with results from the likes of GSK, AstraZeneca, Shell and BP....",AstraZeneca,"FEBRUARY 1, 2016"
FT Opening Quote,https://www.ft.com/content/709c4de6-6df5-33fb-9494-5a209dd8cf90,,https://www.ft.com/chris-nuttall,Chris Nuttall,"...Earnings season gets fully under way this week with results from the likes of GSK, AstraZeneca, Shell and BP....",AstraZeneca,"FEBRUARY 1, 2016"
Gilead risks becoming victim of its own success,https://www.ft.com/content/ab14f1d6-c6d3-11e5-808f-8231cd71622e,,https://www.ft.com/us-companies,US & Canadian companies,"...The explosive growth has propelled the company into the ranks of the world’s largest drugmakers, with a market capitalisation of $126bn that is larger than more established names such as GlaxoSmithKline, AstraZeneca...",AstraZeneca,"JANUARY 31, 2016"
Opening Quote: Babcock’s CEO retires,https://www.ft.com/content/46a447a4-0e90-3cb0-ac43-82e59bb38b2d,,https://www.ft.com/mergers-acquisitions,Mergers & Acquisitions,"...A feather in the cap of AstraZeneca chief executive Pascal Soriot, who needs plenty more for giving would-be acquirer Pfizer the bum’s rush.

There’s a slew of trading statements this morning....",AstraZeneca,"JANUARY 28, 2016"
FT Opening Quote,https://www.ft.com/content/0d600f93-f001-33a8-a8ec-0375d8e89084,,https://www.ft.com/chris-nuttall,Chris Nuttall,"...A feather in the cap of AstraZeneca chief executive Pascal Soriot, who needs plenty more for giving would-be acquirer Pfizer the bum’s rush.

There’s a slew of trading statements this morning....",AstraZeneca,"JANUARY 28, 2016"
Global pharma groups reveal tie-up with universities,https://www.ft.com/content/7cb34d18-c0fe-11e5-9fdb-87b8d15baec2,,https://www.ft.com/uk-companies,UK companies,"...AstraZeneca, GSK and J&J will have first option to take assets backed by the fund into clinical development, with a bidding process among the trio to decide which gets the licence....",AstraZeneca,"JANUARY 25, 2016"
Pascal Soriot confident of AstraZeneca’s independent course,https://www.ft.com/content/d7883be2-c03e-11e5-846f-79b0e3d20eaf,,https://www.ft.com/uk-companies,UK companies,"...Mr Soriot says he is not implacably opposed to big mergers but prefers smaller bolt-on deals, such as AstraZeneca’s recent $2.7bn takeover of ZS Pharma....",AstraZeneca’s,"JANUARY 21, 2016"
Pascal Soriot on his rise to become CEO of AstraZeneca,https://www.ft.com/content/39020eb0-b627-11e5-b147-e5e5bba42e51,,https://www.ft.com/business-education,Business education,...These memories helped stiffen his resolve when Pfizer launched its raid on AstraZeneca in 2014....,AstraZeneca,"JANUARY 21, 2016"
Drugmakers call for collective action on superbugs,https://www.ft.com/content/3b82d910-bf6b-11e5-846f-79b0e3d20eaf,,https://www.ft.com/us-companies,US & Canadian companies,"...Others included AstraZeneca, GlaxoSmithKline and Sanofi, in a sign of growing consensus among “big pharma” over the need for new approaches to the development and marketing of antibiotics....",AstraZeneca,"JANUARY 21, 2016"
Big pharma joins forces to tackle cancer,https://www.ft.com/content/70448e52-b7e4-11e5-b151-8e15c9a029fb,,https://www.ft.com/us-companies,US & Canadian companies,"...Bristol-Myers Squibb and US-based Merck, which make the only approved immunotherapies, have not yet joined the initiative, and neither have those companies that hope to launch the next batch, such as AstraZeneca...",AstraZeneca,"JANUARY 11, 2016"
Aberdeen shares sink on worries over costs,https://www.ft.com/content/81215104-b3d6-11e5-8358-9a82b43f6b2f,,https://www.ft.com/uk-equities,UK equities,...Drug stocks were the main line of support with AstraZeneca climbing 1.9 per cent to £45.62 and GlaxoSmithKline ahead 1.6 per cent to £13.86....,AstraZeneca,"JANUARY 5, 2016"
GSK and AstraZeneca prescribe different treatments,https://www.ft.com/content/d70920b6-afd9-11e5-b46e-3ef837cafba3,,https://www.ft.com/uk-companies,UK companies,"...AstraZeneca

While GSK has diversified its business, AstraZeneca has placed all its bets on pharmaceuticals....",AstraZeneca,"JANUARY 3, 2016"
GSK chief fights back to regain investor faith,https://www.ft.com/content/f906dcdc-afe1-11e5-b46e-3ef837cafba3,,https://www.ft.com/us-companies,US & Canadian companies,"...Sir Andrew will be hoping for a similar boost to the strong share price rally enjoyed by AstraZeneca, the other big UK drugmaker, after its chief executive, Pascal Soriot, made an upbeat presentation at...",AstraZeneca,"JANUARY 3, 2016"
"Week in Review, December 19",https://www.ft.com/content/b62e15ca-a57c-11e5-a91e-162b86790c58,,https://www.ft.com/european-companies,European companies,"...AstraZeneca was also busy on the deals front. It agreed to pay up to $7bn for Acerta Pharma to secure a promising blood-cancer therapy, and $575m for respiratory medicines from Takeda of Japan....",AstraZeneca,"DECEMBER 18, 2015"
BoE’s Carney plays the game of two halves,https://www.ft.com/content/89bf004c-a4ed-11e5-a91e-162b86790c58,,https://www.ft.com/european-companies,European companies,...The cost of $7bn for the whole of Acerta would fall heavily even on AstraZeneca....,AstraZeneca,"DECEMBER 17, 2015"
AstraZeneca adds 55% Acerta Pharma stake to swath of deals,https://www.ft.com/content/6aa1c230-a48e-11e5-b73f-9545472cb784,,https://www.ft.com/companies/byregion,Companies By Region,"...People close to the situation said AstraZeneca had faced competition for the asset, with other interested parties including Merck & Co and Amgen....",AstraZeneca,"DECEMBER 17, 2015"
Opening Quote – Peppa in pink with Spielberg deal,https://www.ft.com/content/0fb3747b-f17b-3bd9-b835-d3bfe55f7690,,https://www.ft.com/mergers-acquisitions,Mergers & Acquisitions,"...Peppa Pig owner Entertainment One has made a deal with ET’s Steven Spielberg, AstraZeneca has revealed it will pay $4bn for Acerta Pharma....",AstraZeneca,"DECEMBER 17, 2015"
FT Opening Quote – Peppa in pink with Spielberg deal,https://www.ft.com/content/f2480bd3-2b30-3aa6-9315-b5707c5229e4,,https://www.ft.com/chris-nuttall,Chris Nuttall,"...Peppa Pig owner Entertainment One has made a deal with ET’s Steven Spielberg, AstraZeneca has revealed it will pay $4bn for Acerta Pharma....",AstraZeneca,"DECEMBER 17, 2015"
AstraZeneca buys Takeda’s respiratory business,https://www.ft.com/content/4ab04162-a3d1-11e5-b73f-9545472cb784,,https://www.ft.com/us-companies,US & Canadian companies,...AstraZeneca has taken another step to refill its depleted product pipeline by agreeing to pay $575m for the respiratory business of Takeda....,AstraZeneca,"DECEMBER 16, 2015"
AstraZeneca bolsters respiratory business with $575m acquisition,https://www.ft.com/content/1626b131-6c9e-38ef-b927-3de21eef5c1a,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,...UK drugmaker AstraZeneca has acquired the main respiratory business of Japanese rival Takeda for $575 million....,AstraZeneca,"DECEMBER 16, 2015"
AstraZeneca pours millions into China R&D,https://www.ft.com/content/d14235b6-a37a-11e5-a035-96e9dfdf9fff,,https://www.ft.com/chinese-corruption,Chinese corruption,"...AstraZeneca says it is confident of its compliance procedures.

China accounted for 11 per cent of group sales in the first nine months of this year — AstraZeneca’s second-biggest market after the US....",AstraZeneca,"DECEMBER 16, 2015"
AstraZeneca on fast track to companion diagnostics,https://www.ft.com/content/c1fed4c0-944c-11e5-bd82-c1fb87bef7af,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...AstraZeneca worked with the diagnostics arm of Roche, the Swiss pharma group, to develop a test for the mutant genes....",AstraZeneca,"DECEMBER 15, 2015"
AstraZeneca: in search of a blockbuster,https://www.ft.com/content/3396dab0-a27b-11e5-8d70-42b68cfae6e4,https://www.ft.com/__origami/service/image/v2/images/raw/http%3A%2F%2Fprod-upp-image-read.ft.com%2F41708964-52db-11e5-b029-b9d50a74fd14?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/uk-companies,UK companies,...Jimmy Carter can tell you why AstraZeneca is contemplating paying $5bn for an unquoted Dutch biotech company with a single product in phase III trials....,AstraZeneca,"DECEMBER 14, 2015"
Shell can claim BG despite burden of proof weighing on van Beurden,https://www.ft.com/content/b7b0a23c-a257-11e5-bc70-7ff6d4fd203a,,https://www.ft.com/jonathan-guthrie,Jonathan Guthrie,"...Last year, the prime minister talked of extending a public interest test to block Pfizer’s £70bn bid for AstraZeneca....",AstraZeneca,"DECEMBER 14, 2015"
AstraZeneca weighing up Acerta bid to secure blood cancer drug,https://www.ft.com/content/bbc02fd0-a25e-11e5-8d70-42b68cfae6e4,,https://www.ft.com/uk-companies,UK companies,"...AstraZeneca is aiming for a return to sales growth in 2017 after a dip next year, with a long-term goal of increasing revenues by three-quarters to $45bn by 2023....",AstraZeneca,"DECEMBER 14, 2015"
AstraZeneca ‘exploring strategic options’ with Dutch biotech,https://www.ft.com/content/73db185a-876d-3f43-b13d-fc7e4e506136,,https://www.ft.com/world,World,"...UK drugmaker AstraZeneca says it is “exploring potential strategic options” with Acerta Pharma, a biotechnology company based in the Netherlands....",AstraZeneca,"DECEMBER 14, 2015"
AstraZeneca achieves partial victory over NHS drug cost watchdog,https://www.ft.com/content/6b8d9cca-9f4b-11e5-8613-08e211ea5317,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...Lisa Anson, head of AstraZeneca in the UK, welcomed the decision but said NHS patients were losing out because of restrictions on cancer drugs....",AstraZeneca,"DECEMBER 11, 2015"
AstraZeneca and Wallenbergs join in biological drugs venture,https://www.ft.com/content/780af5c8-9f38-11e5-8613-08e211ea5317,,https://www.ft.com/european-companies,European companies,...Opposition from the Wallenbergs helped galvanise AstraZeneca’s successful resistance last year against a $100bn takeover by Pfizer....,AstraZeneca’s,"DECEMBER 11, 2015"
"Excitement rises over gene editing tool, but ethical doubts remain",https://www.ft.com/content/2d744ff2-9031-11e5-bd82-c1fb87bef7af,,https://www.ft.com/disrupters,Disrupters,"...For instance AstraZeneca, the UK-based drug company, announced four partnerships early this year “aimed at harnessing the power of Crispr across its entire discovery platform in the company’s key therapeutic...",AstraZeneca,"DECEMBER 6, 2015"
Relypsa: the next US biotech M&A target?,https://www.ft.com/content/8136f632-25c7-3657-a824-e6e0b281f172,,https://www.ft.com/bryce-elder,Bryce Elder,"...Astrazeneca agreed in November to buy ZS Pharma for $2.7bn cash.

Relypsa shares are up 20 per cent at pixel time, giving it a market value of $1.1bn. We’ll update this story as and when required....",Astrazeneca,"DECEMBER 4, 2015"
Pfizer to cut 120 jobs with closure of Cambridge R&D centre,https://www.ft.com/content/7ee22f58-99cd-11e5-987b-d6cdef1b205c,,https://www.ft.com/companies/byregion,Companies By Region,"...Pfizer is planning to close a research and development facility in Cambridge with the loss of up to 120 jobs, weakening its presence in the UK just over a year after its failed takeover bid for AstraZeneca...",AstraZeneca,"DECEMBER 3, 2015"
Shire leads drug stocks sector on FTSE,https://www.ft.com/content/52e22d08-991f-11e5-9228-87e603d47bdc,,https://www.ft.com/uk-equities,UK equities,"...AstraZeneca was up 1.4 per cent to £45.83 on an upgrade to “overweight” from Morgan Stanley, its joint house broker....",AstraZeneca,"DECEMBER 2, 2015"
Unhealthy drugs: Pharma struggles with its reputation,https://www.ft.com/content/f4eb2978-9132-11e5-bd82-c1fb87bef7af,,https://www.ft.com/recruitment,Recruitment,"...Johnson & Johnson of the US made the top 10, while Swiss Novartis and the UK’s AstraZeneca were among the top 30....",AstraZeneca,"NOVEMBER 26, 2015"
Social media is capitalism with a human face,https://www.ft.com/content/2a20d07a-872e-11e5-90de-f44762bf9896,,https://www.ft.com/social-media,Social Media,"...AstraZeneca (Biotech & Pharma)

27. BG (Oil & Gas)

28. EasyJet (Travel & Tourism)

29. Burberry (Retail)

30. Whole Foods Market (Retail)

31. InterContinental Hotels (Travel & Tourism)

32....",AstraZeneca,"NOVEMBER 26, 2015"
FT Opening Quote – Rolls-Royce restructures,https://www.ft.com/content/867d3fef-e59e-311d-83d0-395069ca027f,,https://www.ft.com/chris-nuttall,Chris Nuttall,"...He was frustrated by the failure of his bid for AstraZeneca, but has won Round Two....",AstraZeneca,"NOVEMBER 24, 2015"
AstraZeneca sells US rights for gastro drug to Perrigo for $380m,https://www.ft.com/content/f165f162-91d6-11e5-bd82-c1fb87bef7af,,https://www.ft.com/us-companies,US & Canadian companies,...Analysts expect AstraZeneca’s revenues to fall by single digits this year and continue declining until 2017....,AstraZeneca’s,"NOVEMBER 23, 2015"
Pfizer-Allergan tie-up would mark M&A high point,https://www.ft.com/content/838b69b4-8fa7-11e5-8be4-3506bf20cc2b,,https://www.ft.com/us-companies,US & Canadian companies,"...The same applies for AstraZeneca.

However, there are reasons to believe Pfizer-Allergan would most likely remain an exception....",AstraZeneca,"NOVEMBER 22, 2015"
Sanofi-AstraZeneca chemicals swap takes open route to R&D,https://www.ft.com/content/8cce6580-8f84-11e5-8be4-3506bf20cc2b,,https://www.ft.com/european-companies,European companies,...AstraZeneca said it has about 2m compounds in its library so the exchange with Sanofi will increase its volume by about a tenth....,AstraZeneca,"NOVEMBER 20, 2015"
Tesco gains on positive house broker view,https://www.ft.com/content/f3b78dde-8d55-11e5-a549-b89a1dfede9b,,https://www.ft.com/uk-equities,UK equities,"...Drugmakers gained, with AstraZeneca up 3.3 per cent to £43.97 and Shire 3.7 per cent firmer at £46.63....",AstraZeneca,"NOVEMBER 17, 2015"
GSK and the perils of prudence,https://www.ft.com/content/25610520-8c59-11e5-8be4-3506bf20cc2b,,https://www.ft.com/companies/inside-business,Inside Business,"...Despite underperforming European and world pharma indices over the past five years, GSK’s shares trade at more than 15 times next year’s earnings, ahead of peers such as Pfizer, Merck, Sanofi and AstraZeneca...",AstraZeneca,"NOVEMBER 17, 2015"
AstraZeneca gains from rival’s trial setback,https://www.ft.com/content/7f1690f0-8c89-11e5-a549-b89a1dfede9b,,https://www.ft.com/uk-equities,UK equities,...AstraZeneca rose 4 per cent to £42.58 in a resilient wider market....,AstraZeneca,"NOVEMBER 16, 2015"
AstraZeneca urges antibiotics investment shake-up,https://www.ft.com/content/7d3fd1de-8a08-11e5-90de-f44762bf9896,,https://www.ft.com/uk-companies,UK companies,...AstraZeneca has urged the government to develop a new model for incentivising investment in antibiotics and warned of the “terrible human cost” of the rise in drug-resistant infections....,AstraZeneca,"NOVEMBER 15, 2015"
S&P cuts AstraZeneca’s credit rating,https://www.ft.com/content/f3c1012a-87ba-11e5-8a12-b0ce506400af,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...Moody’s, meanwhile, affirmed its A2 rating for AstraZeneca’s debt but changed its outlook to negative....",AstraZeneca’s,"NOVEMBER 10, 2015"
Sanofi chief positive on new drugs as he warns on profits,https://www.ft.com/content/2b60c9d0-845f-11e5-9dc0-186bb1146746,,https://www.ft.com/currencies,Currencies,"...lamented how Sanofi had “made a series of mis-steps” that left it absent from an important new category of cancer drugs called immuno-oncology, which is being led by Merck, Bristol-Myers Squibb, Roche and AstraZeneca...",AstraZeneca,"NOVEMBER 8, 2015"
AstraZeneca boosts pipeline with $2.7bn acquisition,https://www.ft.com/content/6eb9c010-845a-11e5-8e80-1574112844fd,,https://www.ft.com/uk-companies,UK companies,...Shares in AstraZeneca fell slightly to £42.24 on Friday in line with the broader FTSE 100....,AstraZeneca,"NOVEMBER 6, 2015"
AstraZeneca raises full-year profit and sales forecasts,https://www.ft.com/content/69445dc0-838d-11e5-9dc0-186bb1146746,,https://www.ft.com/uk-companies,UK companies,...Mr Soriot said AstraZeneca was outperforming peers in China and now ranked number two in the market....,AstraZeneca,"NOVEMBER 5, 2015"
FT Opening Quote – BoE’s Super Thursday fireworks,https://www.ft.com/content/d89caffa-212e-3622-b781-c1fe21ed27fe,,https://www.ft.com/chris-nuttall,Chris Nuttall,...AstraZeneca has raised earnings per share guidance for the full year from a low single digit percentage increase to high single digits....,AstraZeneca,"NOVEMBER 5, 2015"
Pfizer spurned by GSK before Allergan talks,https://www.ft.com/content/3a26241c-81b0-11e5-8095-ed1a37d1e096,https://www.ft.com/__origami/service/image/v2/images/raw/http%3A%2F%2Fprod-upp-image-read.ft.com%2F256b4080-39ca-11e5-bbd1-b37bc06f590c?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/us-companies,US & Canadian companies,"...The US group’s interest in GSK, the UK’s biggest drugmaker by sales and market capitalisation, came 18 months after it failed in a £69.4bn hostile bid for the number two UK group, AstraZeneca....",AstraZeneca,"NOVEMBER 2, 2015"
Corporate diary: November 2 – November 6,https://www.ft.com/content/6a3e5b68-7c08-11e5-98fb-5a6d4728f74e,,https://www.ft.com/tobacco,Tobacco,"...Kana Inagaki

Pipeline progress at AstraZeneca

AstraZeneca, the Anglo-Swedish pharmaceutical group which was the target for Pfizer’s $118bn botched takeover attempt last year, reports third-quarter results...",AstraZeneca,"NOVEMBER 1, 2015"
Cineworld slides on ‘duller’ film outlook,https://www.ft.com/content/c1bf5b9c-7f2f-11e5-ae43-f6d4a22c5a1a,,https://www.ft.com/sport,Sport,"...Licensee Novartis paid $22.5m, having won US regulatory approval for two lung disease inhalers, and Sandoz paid Vectura a small fee linked to generic product in development, thought to be a version of AstraZeneca...",AstraZeneca,"OCTOBER 30, 2015"
Large pill to swallow for Pfizer in Allergan deal,https://www.ft.com/content/40e6adec-7e60-11e5-98fb-5a6d4728f74e,,https://www.ft.com/us-companies,US & Canadian companies,"...“Pfizer’s still burnt from the political backlash it faced in the UK when it tried to acquire AstraZeneca,” says the banker....",AstraZeneca,"OCTOBER 29, 2015"
Ovarian cancer drug proves effective among prostate patients,https://www.ft.com/content/1e0b09ee-7d7f-11e5-a1fe-567b37f80b64,,https://www.ft.com/uk-economy,UK economy,"...AstraZeneca says it is “extremely disappointed” by Nice’s initial rejection of the drug to treat patients with advanced ovarian cancer, though negotiations are still continuing....",AstraZeneca,"OCTOBER 28, 2015"
FT Opening Quote – Gala calls ‘house’ on bingo sale,https://www.ft.com/content/ff5611cc-52d2-343c-90fd-a918e410f626,,https://www.ft.com/chris-nuttall,Chris Nuttall,"...Meanwhile,Tongon, an Ivorian mine of top gold bug Randgold is ready to begin paying dividends and AstraZeneca has received approval from the US authorities to market lesinurad, a treatment for a condition...",AstraZeneca,"OCTOBER 26, 2015"
UK remains fertile ground for biotech fundraisings,https://www.ft.com/content/d5baf606-78a9-11e5-a95a-27d368e1ddf7,,https://www.ft.com/uk-companies,UK companies,"...They say success is crucial to reduce the country’s dependence on its two pharmaceuticals giants, GlaxoSmithKline and AstraZeneca, at a time when both are under pressure from falling sales of older drugs...",AstraZeneca,"OCTOBER 25, 2015"
Fat finger trades — Deutsche joins league of market mistakes,https://www.ft.com/content/097af19c-770d-11e5-933d-efcdc3c11c89,,https://www.ft.com/currencies,Currencies,"...approaching closing trade

A trader at Lehman Brothers, another defunct US bank (London office pictured at the height of the financial crisis), entered a sell order for shares in FTSE 100 heavyweights BP and AstraZeneca...",AstraZeneca,"OCTOBER 20, 2015"
Foreign groups eye scaling back Russian operations,https://www.ft.com/content/8d1d4cd8-7416-11e5-a129-3fcc4f641d98,,https://www.ft.com/european-companies,European companies,"...Pharmaceutical groups such as AstraZeneca are more upbeat, reporting strong sales growth in several product lines in the first half of the year....",AstraZeneca,"OCTOBER 18, 2015"
Burnt fingers keep merger arbs at bay,https://www.ft.com/content/c8750b68-727c-11e5-bdb1-e6e4767162cc,,https://www.ft.com/neil-collins,Neil Collins,...One plausible explanation is the burnt fingers from the failure of Pfizer’s bid for AstraZeneca. That deal had seemed to be following the pattern set by Kraft’s siege of Cadbury when it all fell apart....,AstraZeneca,"OCTOBER 16, 2015"
Takeover Panel rules help AB InBev agree speedy deal,https://www.ft.com/content/5489d528-71ad-11e5-9b9e-690fdae72044,,https://www.ft.com/jonathan-guthrie,Jonathan Guthrie,"...Some big City shareholders, including Schroders and Jupiter, wanted AstraZeneca to accept the offer....",AstraZeneca,"OCTOBER 13, 2015"
The week: September 21,https://www.ft.com/content/fea9b238-5b93-11e5-a28b-50226830d644,,https://www.ft.com/fund-management,Fund management,"...• The latest report
 from the UK’s National Association of Pension Funds on the annual general meeting season says shareholders in a dozen FTSE 350 companies — including AstraZeneca, BG Group, Investec...",AstraZeneca,"SEPTEMBER 20, 2015"
Reckitt Benckiser benefits from fresh target talk,https://www.ft.com/content/c6439218-5c94-11e5-9846-de406ccb37f2,,https://www.ft.com/mergers-acquisitions,Mergers & Acquisitions,"...Having last year had its takeover of AstraZeneca blocked, Pfizer has reportedly been investigating breaking up its business....",AstraZeneca,"SEPTEMBER 16, 2015"
Big UK companies halve provisions for disputed tax bills,https://www.ft.com/content/e6760e46-524c-11e5-8642-453585f2cfcd,,https://www.ft.com/uk-economy,UK economy,"...AstraZeneca, the pharmaceutical company, estimated its worldwide exposure to transfer pricing audits at $595m (£382m) at the end of 2014, up by $72m over the year....",AstraZeneca,"SEPTEMBER 6, 2015"
AstraZeneca: filling a hole,https://www.ft.com/content/3043fde8-5307-11e5-8642-453585f2cfcd,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...The company had very good news on Friday, when US regulators gave expanded approval to Brilinta, an anti-clotting drug that is one of the most crucial in AstraZeneca’s pipeline....",AstraZeneca’s,"SEPTEMBER 4, 2015"
AstraZeneca wins FDA approval for expanded use of blood thinner,https://www.ft.com/content/6409cde0-52cd-11e5-b029-b9d50a74fd14,,https://www.ft.com/uk-companies,UK companies,...But there was a chance for AstraZeneca to “change that perception in coming years”....,AstraZeneca,"SEPTEMBER 4, 2015"
FT Opening Quote – bwin recommends £1.1bn GVC bid,https://www.ft.com/content/d18924c3-a025-3e85-bde7-c567bbb97614,,https://www.ft.com/chris-nuttall,Chris Nuttall,"...The FDA has approved widened use of Brilinta, a flagship heart disease drug developed by AstraZeneca....",AstraZeneca,"SEPTEMBER 4, 2015"
Woodford trust to issue more shares,https://www.ft.com/content/a036ade0-4014-11e5-b98b-87c7270955cf,,https://www.ft.com/investments,Investments,"...It also holds big listed companies such as AstraZeneca, GlaxoSmithKline, Legal & General and Rolls-Royce....",AstraZeneca,"AUGUST 11, 2015"
AstraZeneca beats earnings expectations despite strong dollar,https://www.ft.com/content/da311cd4-3686-11e5-b05b-b01debd57852,,https://www.ft.com/uk-companies,UK companies,"...AstraZeneca’s results echoed those of GlaxoSmithKline, which on Wednesday reported second-quarter figures....",AstraZeneca’s,"JULY 30, 2015"
FT Opening Quote – Banks challenged on Super Thursday of results,https://www.ft.com/content/ddb57a0d-3f25-3334-b57a-c967c59c0a4c,,https://www.ft.com/chris-nuttall,Chris Nuttall,"...InBev, Santander, Deutsche Bank, Sanofi, Renault, Accor, Swiss Re and Lufthansa then moved on to the UK where RBS, Centrica, Shell, Rolls-Royce, BAE Systems, Intercontinental Hotels, Smith & Nephew and AstraZeneca...",AstraZeneca,"JULY 30, 2015"
Pfizer chief executive has ‘sufficient courage’ to pursue deals,https://www.ft.com/content/ee74e4e6-3541-11e5-bdbb-35e55cbae175,,https://www.ft.com/us-companies,US & Canadian companies,...Pfizer has been on the hunt for targets since its botched takeover attempt of AstraZeneca in 2014....,AstraZeneca,"JULY 28, 2015"
Allergan signals appetite for new mega deal after $41bn disposal,https://www.ft.com/content/2bd1061a-3495-11e5-bdbb-35e55cbae175,,https://www.ft.com/us-companies,US & Canadian companies,"...Some analysts noted that a cash-rich Allergan without generics could be an even more attractive target for Pfizer, which has been scouting for a deal since its botched pursuit of Britain’s AstraZeneca....",AstraZeneca,"JULY 27, 2015"
GlaxoSmithKline: dose of reality,https://www.ft.com/content/ed20b49a-3202-11e5-91ac-a5e17d9b4cff,,https://www.ft.com/uk-companies,UK companies,"...Putting the company up for sale is possible, but would be a political minefield — witness the furore around Pfizer’s bid for Glaxo’s UK rival AstraZeneca....",AstraZeneca,"JULY 24, 2015"
AstraZeneca suffers setback after drug fails to treat eye cancer,https://www.ft.com/content/b891cb34-308a-11e5-8873-775ba7c2ea3d,,https://www.ft.com/european-companies,European companies,...Analysts said at the time that AstraZeneca had little margin for error in its drug development pipeline if it were to stand any chance of meeting the goal....,AstraZeneca,"JULY 22, 2015"
Record fundraising bolster UK’s biotech challengers,https://www.ft.com/content/4e03c962-2f9e-11e5-91ac-a5e17d9b4cff,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...some such as Gilead, Biogen and Celgene with billions of dollars in annual revenues — the UK has had less success in expanding the sector beyond its two big pharmaceuticals groups, GlaxoSmithKline and AstraZeneca...",AstraZeneca,"JULY 21, 2015"
Pfizer ranked top foreign research partner for UK academics,https://www.ft.com/content/985be59e-2bb6-11e5-8613-e7aedbb7bdb7,https://www.ft.com/__origami/service/image/v2/images/raw/http%3A%2F%2Fprod-upp-image-read.ft.com%2F83a0fcd4-c356-11e4-8fa9-00144feab7de?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/us-companies,US & Canadian companies,"...BAESystems and Unilever were the only other UK companies in the top 10 besides GSK, Rolls-Royce and AstraZeneca....",AstraZeneca,"JULY 19, 2015"
Cautionary tale as Receptos benefits from buying frenzy,https://www.ft.com/content/82784d12-2b39-11e5-acfb-cbd2e1c81cca,,https://www.ft.com/us-companies,US & Canadian companies,"...It also has partnerships with AstraZeneca, GlaxoSmithKline and Roche....",AstraZeneca,"JULY 17, 2015"
Indefensible secrets on women’s pay,https://www.ft.com/content/d06282b2-2b03-11e5-acfb-cbd2e1c81cca,,https://www.ft.com/andrew-hill,Andrew Hill,"...The very few UK companies that are already publicising their gender pay gap — including PwC, AstraZeneca and Tesco — are doing the minimum necessary....",AstraZeneca,"JULY 17, 2015"
Immunocore in record European biotech raising,https://www.ft.com/content/12fe020a-2b12-11e5-acfb-cbd2e1c81cca,,https://www.ft.com/uk-companies,UK companies,"...Immunocore also has partnerships with AstraZeneca, GlaxoSmithKline and Roche but Mr Forster said the fundraising ensured the company would be able to keep developing its most valuable “crown jewels” itself...",AstraZeneca,"JULY 16, 2015"
"Sir John Buchanan, scientist and finance chief, 1943-2015",https://www.ft.com/content/1fea290a-2a43-11e5-8613-e7aedbb7bdb7,,https://www.ft.com/world,World,...At various points Buchanan was also deputy chairman at Vodafone and on the boards of AstraZeneca and Alliance Boots....,AstraZeneca,"JULY 14, 2015"
BP: Into uncharted waters,https://www.ft.com/content/0a71ce8c-24b9-11e5-9c4e-a775d2b173ca,,https://www.ft.com/the-big-read,The Big Read,"...Bruised by US drug group Pfizer’s bid for Anglo-Swedish AstraZeneca last year, when ministers promoted the deal only to find themselves on the wrong side of public opinion, Number 10 has let it be known...",AstraZeneca,"JULY 9, 2015"
AstraZeneca sells gastro drug for $215m to Swiss group Tillotts,https://www.ft.com/content/5d04506c-263e-11e5-9c4e-a775d2b173ca,,https://www.ft.com/uk-companies,UK companies,"...However, Alistair Campbell, analyst at Berenberg, wrote in a report this week that investors were underestimating AstraZeneca’s potential....",AstraZeneca’s,"JULY 9, 2015"
UK life sciences funding at 10-year high,https://www.ft.com/content/d477e87e-24d7-11e5-9c4e-a775d2b173ca,,https://www.ft.com/us-presidential-election,US presidential election,"...Entrepreneurs have long bemoaned a shortage of risk capital to help commercialise breakthroughs from the strong UK science base and reduce dependence on the country’s two big pharma groups, GlaxoSmithKline and AstraZeneca...",AstraZeneca,"JULY 8, 2015"
It’s 30m to One as watchdog breaks taboo and blames customers,https://www.ft.com/content/2e6fd36e-248d-11e5-9c4e-a775d2b173ca,,https://www.ft.com/jonathan-guthrie,Jonathan Guthrie,"...The Brit has deep contacts that help her reel in advisory mandates for the likes of AstraZeneca and BG. “She walks through brick walls for clients,” an acquaintance says....",AstraZeneca,"JULY 7, 2015"
European pharma groups paid $1.5bn to US doctors in 2014,https://www.ft.com/content/ddb63122-2101-11e5-aa5a-398b2169cf79,,https://www.ft.com/us-presidential-election,US presidential election,"...AstraZeneca’s spend of $184m was less than GSK’s overall, although it spent more than twice the amount, $74m, on non-research payments....",AstraZeneca’s,"JULY 5, 2015"
AstraZeneca rises on drug pipeline hopes,https://www.ft.com/content/7b566eee-20d8-11e5-ab0f-6bb9974f25d0,,https://www.ft.com/uk-equities,UK equities,...AstraZeneca was among the gainers on Thursday after Berenberg said the market had grown too pessimistic about its oncology pipeline....,AstraZeneca,"JULY 2, 2015"
Home Retail buoyed by broker upgrade,https://www.ft.com/content/d672c2d6-1f49-11e5-ab0f-6bb9974f25d0,,https://www.ft.com/uk-equities,UK equities,...AstraZeneca fell 1.9 per cent to £40.19 — its lowest level since last April when Pfizer first confirmed it had made a takeover offer that it raised a month later to £55 a share....,AstraZeneca,"JUNE 30, 2015"
Pharmaceutical pollution in India is bitter pill for Nordea,https://www.ft.com/content/b0121282-1679-11e5-b07f-00144feabdc0,,https://www.ft.com/fund-management,Fund management,"...AstraZeneca, Pfizer and others are not aware of the seriousness of it. They are quite ignorant.”

AstraZeneca and Pfizer declined to comment....",AstraZeneca,"JUNE 21, 2015"
US companies regain their appetite for tax inversion deals,https://www.ft.com/content/da02654e-12ad-11e5-8cd7-00144feabdc0,,https://www.ft.com/us-presidential-election,US presidential election,"...When asked in April about the possibility of Pfizer seeking another tax inversion deal after its unsuccessful attempts to buy the UK’s AstraZeneca last year, the company said it was focused on reducing its...",AstraZeneca,"JUNE 15, 2015"
FRC signals tougher guidelines on succession planning,https://www.ft.com/content/5032419e-0b92-11e5-8937-00144feabdc0,,https://www.ft.com/retail-consumer,Retail & Consumer industry,"...These include Pascal Soriot at AstraZeneca, Richard Cousins at Compass, Tony Habgood at Reed Elsevier and Moya Greene at Royal Mail....",AstraZeneca,"JUNE 7, 2015"
Cancer treatment: Healing powers,https://www.ft.com/content/db1f47c6-0b64-11e5-994d-00144feabdc0,,https://www.ft.com/the-big-read,The Big Read,"...Pascal Soriot, chief executive of AstraZeneca, one of the drug companies most active in oncology, captured the general mood. “I think what we see here is a transformational shift,” he says....",AstraZeneca,"JUNE 5, 2015"
The unhealthily high price of cancer drugs,https://www.ft.com/content/9033f5fc-09d6-11e5-b6bd-00144feabdc0,,https://www.ft.com/john-gapper,John Gapper,"...The National Institute for Health and Care Excellence (Nice) has rejected olaparib, an ovarian cancer treatment produced by AstraZeneca....",AstraZeneca,"JUNE 3, 2015"
AstraZeneca chief warns UK ‘falling behind’ in cancer care,https://www.ft.com/content/a93c33b2-08cc-11e5-b38c-00144feabdc0,,https://www.ft.com/uk-companies,UK companies,"...AstraZeneca’s chief executive has warned that the UK is “falling behind” in cancer care and questioned the government’s commitment to innovation, after an ovarian cancer drug developed by British scientists...",AstraZeneca’s,"JUNE 2, 2015"
Financial pressure is a mind-altering drug for NHS and AstraZeneca,https://www.ft.com/content/93812c02-08ff-11e5-881f-00144feabdc0,,https://www.ft.com/jonathan-guthrie,Jonathan Guthrie,"...With AstraZeneca’s shares now 21 per cent below Pfizer’s bid price, Mr Soriot needs to demonstrate better progress....",AstraZeneca’s,"JUNE 2, 2015"
Clinical trials show cancer drug combo boosts survival rate,https://www.ft.com/content/6703bf00-0742-11e5-80e7-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,"...A smaller, early-stage study of 100 patients tested a combination of two AstraZeneca immunotherapies in lung cancer patients....",AstraZeneca,"MAY 31, 2015"
Doctors hail new front in fight against cancer,https://www.ft.com/content/c130d30c-0556-11e5-8612-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,...AstraZeneca said on Friday it would carry out trials of its widely anticipated MEDI4736 immunotherapy in combination with an older drug from Eli Lilly....,AstraZeneca,"MAY 29, 2015"
Novel cancer drugs tipped to boost drug sales,https://www.ft.com/content/074c1b62-05c0-11e5-b676-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,"...Merck KGaA of Germany and Pfizer are also partnering to develop a PDL-1, while AstraZeneca is also testing a handful of promising immunotherapies....",AstraZeneca,"MAY 29, 2015"
Fifa: Grand Theft Football,https://www.ft.com/content/fc945dbc-0522-11e5-8612-00144feabdc0,,https://www.ft.com/jonathan-guthrie,Jonathan Guthrie,...A similar episode involving the UK Takeover Panel helped scupper Pfizer’s £70bn bid for AstraZeneca last year. The difference is that Aer Lingus has recommended IAG’s offer....,AstraZeneca,"MAY 28, 2015"
Pfizer and AstraZeneca: one year after deal that never was,https://www.ft.com/content/e8320ccc-0327-11e5-8333-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,...It is a year this week since Pfizer admitted defeat in its £69.4bn hostile pursuit of AstraZeneca....,AstraZeneca,"MAY 26, 2015"
First Solar’s shine dims on downgrade,https://www.ft.com/content/fffea3f8-03bb-11e5-a70f-00144feabdc0,,https://www.ft.com/us-equities,US equities,...AstraZeneca said it would announce its decision on the future development of the treatment as soon as possible....,AstraZeneca,"MAY 26, 2015"
GSK unmoved by broker talk of takeover,https://www.ft.com/content/a3146e3e-ff10-11e4-84b2-00144feabdc0,,https://www.ft.com/mergers-acquisitions,Mergers & Acquisitions,...“We anticipate that government resistance to preserve GSK as an independent listed company is materially higher than it was with AstraZeneca given the much larger UK infrastructure and GSK’s status as the...,AstraZeneca,"MAY 20, 2015"
Fund houses back the boss too often,https://www.ft.com/content/f01b1f7c-fb1c-11e4-9fe6-00144feab7de,,https://www.ft.com/fund-management,Fund management,...A significant proportion of investors (43 per cent) at AstraZeneca also rejected the re-election of Jean-Philippe Courtois as a board member after he failed to attend four of 11 board meetings....,AstraZeneca,"MAY 17, 2015"
The drugs to watch in fight against cancer,https://www.ft.com/content/2e3a038c-fa72-11e4-a41c-00144feab7de,,https://www.ft.com/us-companies,US & Canadian companies,"...Tremelimumab and MEDI4736 (AstraZeneca)

Compared to Bristol-Myers and Merck, AstraZeneca is a laggard in this race....",AstraZeneca,"MAY 15, 2015"
"Boardroom trades, May 9",https://www.ft.com/content/1f8f21f0-f4b4-11e4-8a42-00144feab7de,,https://www.ft.com/investments,Investments,...The board table at AstraZeneca is chock-full of non-executives: only two executive directors have places on the board at the blue-chip pharmaceutical group....,AstraZeneca,"MAY 8, 2015"
Global spending on cancer drugs surges to $100bn,https://www.ft.com/content/40d7c23c-f256-11e4-b914-00144feab7de,,https://www.ft.com/us-companies,US & Canadian companies,"...Merck & Co, Bristol-Myers Squibb, Roche and AstraZeneca are among those developing so-called cancer immunotherapies that harness the body’s immune system to fight tumours....",AstraZeneca,"MAY 5, 2015"
Centrica stands out as FTSE 100 falls 1%,https://www.ft.com/content/7651929c-edc6-11e4-987e-00144feab7de,,https://www.ft.com/mergers-acquisitions,Mergers & Acquisitions,"...Excluding diabetes patients with heart problems from AstraZeneca’s sales would trim 2020 earnings by 2 per cent, said Morgan Stanley....",AstraZeneca’s,"APRIL 28, 2015"
BP shareholders need protecting from David Cameron,https://www.ft.com/content/2c803100-ecc2-11e4-b82f-00144feab7de,,https://www.ft.com/jonathan-guthrie,Jonathan Guthrie,"...First, it is simpler than driving trespassers off with a spot of muckspreading mid-bid, as he did with Pfizer’s abortive tilt at AstraZeneca....",AstraZeneca,"APRIL 27, 2015"
No end in sight to wave of pharma dealmaking,https://www.ft.com/content/6aad8ebe-e9c0-11e4-b863-00144feab7de,,https://www.ft.com/us-companies,US & Canadian companies,"...If completed, the combined group would have annual revenues of about $30bn — placing it above AstraZeneca among the world’s top 10 drugmakers....",AstraZeneca,"APRIL 26, 2015"
UK government warns BP over potential takeover,https://www.ft.com/content/06a3207e-e901-11e4-87fe-00144feab7de,,https://www.ft.com/us-companies,US & Canadian companies,"...Conservative governments have pursued a laissez-faire approach to takeovers, but both parties toughened their stance last year following public, political and business concern over a bid by Pfizer for AstraZeneca...",AstraZeneca,"APRIL 26, 2015"
UK ministers make Gallic gesture to keep the British in BP,https://www.ft.com/content/68d541c4-e9c3-11e4-a687-00144feab7de,,https://www.ft.com/global-economy,Global Economy,"...But Mr Cameron and his ministers concluded that the political cost of laissez-faire in the case of AstraZeneca was too high. In the end, Downing Street’s list of demands helped scare off Pfizer....",AstraZeneca,"APRIL 26, 2015"
Aberdeen retreats on sell advice,https://www.ft.com/content/844d8c3e-eaa1-11e4-96ec-00144feab7de,,https://www.ft.com/uk-equities,UK equities,...AstraZeneca lost 1.7 per cent to £47.50 after its underlying earnings disappointed....,AstraZeneca,"APRIL 24, 2015"
AstraZeneca forced to defend cancer drug deal with Celgene,https://www.ft.com/content/531d053a-ea4d-11e4-a701-00144feab7de,,https://www.ft.com/uk-companies,UK companies,...AstraZeneca also announced an agreement to work on combination therapies involving MEDI4736 with Innate Pharma of France....,AstraZeneca,"APRIL 24, 2015"
Tullow extends winning streak on M&A speculation,https://www.ft.com/content/0131273e-e38f-11e4-b407-00144feab7de,,https://www.ft.com/uk-equities,UK equities,"...After the close, SocGen started coverage of AstraZeneca with a £66 target price.

Vesuvius, the ceramics engineer formerly known as Cookson, lost 6 per cent to 470.4p....",AstraZeneca,"APRIL 15, 2015"
Biotech: Making sense of the science,https://www.ft.com/content/fd99c020-e1b5-11e4-bb7f-00144feab7de,,https://www.ft.com/the-big-read,The Big Read,"...Gilead is bigger than many of the best-known names in pharma, including GlaxoSmithKline, Sanofi and Bristol-Myers Squibb, while Biogen is larger than AstraZeneca and Eli Lilly....",AstraZeneca,"APRIL 13, 2015"
Speed of Shell’s swoop for BG unusual,https://www.ft.com/content/1d9884ae-df5b-11e4-b6da-00144feab7de,,https://www.ft.com/european-companies,European companies,"...It feared a repetition of Pfizer’s failed bid for UK rival AstraZeneca last year, when the US drugmaker kept raising its offer but was still rejected by the Astra board....",AstraZeneca,"APRIL 10, 2015"
Robey Warshaw makes the big league with role in BG sale,https://www.ft.com/content/ee44af74-dec0-11e4-b9ec-00144feab7de,,https://www.ft.com/us-companies,US & Canadian companies,"...Founded by former Morgan Stanley dealmaker Simon Robey and ex-UBS adviser Simon Warshaw, Robey Warshaw featured prominently in high-profile takeover situations last year, including AstraZeneca’s defence...",AstraZeneca’s,"APRIL 9, 2015"
Big pharma turns to small biotechs for edge in cancer treatment,https://www.ft.com/content/7ae07ade-db61-11e4-b693-00144feab7de,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...Novartis, Roche and AstraZeneca all believe their greater breadth of existing cancer drugs combined with new immunotherapies will allow them to prevail in the long run....",AstraZeneca,"APRIL 7, 2015"
Pascal Soriot takes name off list of Tory business supporters,https://www.ft.com/content/f75fb2a4-d955-11e4-8ed9-00144feab7de,,https://www.ft.com/stream/2aa91da4-33e1-4461-8bd8-54ed0c2e81a2,US downturn,...But he added: “Neither I nor AstraZeneca endorse any political party and while I support such policies my name should not be used in the context of the letter.”...,AstraZeneca,"APRIL 2, 2015"
City accused of failing to back life sciences sector,https://www.ft.com/content/65ba63b8-d4db-11e4-a87e-00144feab7de,,https://www.ft.com/fund-management,Fund management,"...Immunocore has development partnerships for some of its drugs with GSK, AstraZeneca, Roche and Eli Lilly of the US....",AstraZeneca,"MARCH 29, 2015"
Drugs companies unite to mine genetic data,https://www.ft.com/content/4d1792fe-d2f1-11e4-b7a8-00144feab7de,,https://www.ft.com/uk-companies,UK companies,"...GlaxoSmithKline and AstraZeneca, the two biggest UK drugs groups, will team up with rivals, including Roche of Switzerland and AbbVie and Biogen of the US, to mine information from a government project to...",AstraZeneca,"MARCH 26, 2015"
Jon Moulton-backed biotech company to list on Aim,https://www.ft.com/content/9c4eaa7c-d2ee-11e4-b7a8-00144feab7de,,https://www.ft.com/ipos,IPOs,...The company has a partnership with AstraZeneca and aims to forge further deals....,AstraZeneca,"MARCH 26, 2015"
Pharma sector hails ‘sea change’ in heart disease treatment,https://www.ft.com/content/373194fc-cb31-11e4-8ad9-00144feab7de,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...AstraZeneca, meanwhile, is focusing on an existing medicine for those who have suffered heart attacks....",AstraZeneca,"MARCH 15, 2015"
AstraZeneca leads the way in drugmaker jump,https://www.ft.com/content/1630bb32-c8e0-11e4-b43b-00144feab7de,,https://www.ft.com/mergers-acquisitions,Mergers & Acquisitions,...Another surge higher for drug stocks put AstraZeneca at the top of the FTSE 100 leaderboard....,AstraZeneca,"MARCH 12, 2015"
Going the extra mile to win a $21bn deal,https://www.ft.com/content/c2f2fdba-c405-11e4-a02e-00144feab7de,,https://www.ft.com/us-companies,US & Canadian companies,"...Pfizer, too, was on the prowl after failing to acquire the UK’s AstraZeneca last year....",AstraZeneca,"MARCH 6, 2015"
AbbVie joins the pharma chain reaction,https://www.ft.com/content/77b037d2-c356-11e4-8fa9-00144feab7de,,https://www.ft.com/us-companies,US & Canadian companies,...Pfizer’s failed $110bn offer for AstraZeneca also showed that mergers among the biggest groups cannot be ruled out altogether....,AstraZeneca,"MARCH 6, 2015"
Hikma set to join pharma blue-chips in UK market,https://www.ft.com/content/c1d273ca-c194-11e4-8b74-00144feab7de,https://www.ft.com/__origami/service/image/v2/images/raw/http%3A%2F%2Fprod-upp-image-read.ft.com%2F30d716de-c1b0-11e4-bd24-00144feab7de?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...This will place Hikma alongside GlaxoSmithKline, AstraZeneca and Shire as a fourth blue-chip drugmaker in the UK market and highlight the rapid rise of a business founded by Mr Darwazah’s father, Samih,...",AstraZeneca,"MARCH 3, 2015"
Cutting-edge pharma is in Neil Woodford’s investment DNA,https://www.ft.com/content/94523b56-bcda-11e4-a917-00144feab7de,,https://www.ft.com/fund-management,Fund management,"...And the opportunity does not exist only among large, mature companies such as AstraZeneca and GlaxoSmithKline....",AstraZeneca,"MARCH 1, 2015"
Highlights from this week’s Investors Chronicle,https://www.ft.com/content/f2d45920-bd0c-11e4-9902-00144feab7de,,https://www.ft.com/retail-consumer,Retail & Consumer industry,"...The remaining 20 companies are as follows:

Catlin, Carillion, Inmarsat, BHP Billiton, Imperial Tobacco, AstraZeneca, British American Tobacco, Direct Line Insurance, Aberdeen Asset Management, Informa,...",AstraZeneca,"FEBRUARY 27, 2015"
AstraZeneca carves out antibiotic research,https://www.ft.com/content/fc2a56dc-be79-11e4-8036-00144feab7de,,https://www.ft.com/uk-companies,UK companies,"...Some of them would move to the new entity or to other roles, AstraZeneca said, without specifying a number....",AstraZeneca,"FEBRUARY 27, 2015"
"Week in Review, February 21",https://www.ft.com/content/37e9af72-b8fa-11e4-b8e6-00144feab7de,,https://www.ft.com/personal-household-goods,Personal & Household Goods,...● It seems the chiefs at AstraZeneca have adopted the wisdom of keeping friends close but their enemies closer....,AstraZeneca,"FEBRUARY 20, 2015"
Centrica leads FTSE lower after profit fall,https://www.ft.com/content/bd95e23a-b814-11e4-86bb-00144feab7de,,https://www.ft.com/oil,Oil,"...AstraZeneca added further weight to the downside, falling 2.5 per cent to £43.73 as the stock traded without rights to its latest dividend....",AstraZeneca,"FEBRUARY 19, 2015"
AstraZeneca lines up pharma critic for board,https://www.ft.com/content/0f2f50de-b6be-11e4-95dc-00144feab7de,,https://www.ft.com/corporate-governance,Corporate governance,"...I would bring that perspective to [AstraZeneca], if elected, or anywhere else.”...",AstraZeneca,"FEBRUARY 17, 2015"
London stocks hit by Greece woes,https://www.ft.com/content/64d5a61e-b682-11e4-a5f2-00144feab7de,,https://www.ft.com/uk-equities,UK equities,"...Diageo, the beverages group, rose 0.5 per cent to £18.48 and drugmaker AstraZeneca added 0.4 per cent to £44.84....",AstraZeneca,"FEBRUARY 17, 2015"
Compound sharing boosts drugs success,https://www.ft.com/content/97f5ac94-b19e-11e4-a830-00144feab7de,,https://www.ft.com/technology-sector,Technology sector,...AstraZeneca says the MRC route is just one of several ways in which researchers can access its compound library....,AstraZeneca,"FEBRUARY 16, 2015"
Gene editing comes of healthcare age,https://www.ft.com/content/544f152c-b070-11e4-a2cc-00144feab7de,,https://www.ft.com/technology-sector,Technology sector,"...In addition, AstraZeneca will provide cell lines to target with the Sanger Institute’s collection of guide-RNA libraries....",AstraZeneca,"FEBRUARY 16, 2015"
"Monday interview: Flemming Ornskov, Shire CEO",https://www.ft.com/content/b536b692-a733-11e4-b6bd-00144feab7de,,https://www.ft.com/monday-interview,The Monday Interview,"...But it remained a junior league player compared with GlaxoSmithKline and AstraZeneca, Britain’s biggest drugmakers....",AstraZeneca,"FEBRUARY 15, 2015"
Healthcare: The race to cure rising drug costs,https://www.ft.com/content/7e3571da-b08c-11e4-92b6-00144feab7de,,https://www.ft.com/the-big-read,The Big Read,"...“Without any doubt there is pressure on price in the US,” says Pascal Soriot, chief executive of AstraZeneca, which has been in a price battle over respiratory drugs with its UK rival GlaxoSmithKline....",AstraZeneca,"FEBRUARY 10, 2015"
Pharma takes a dose of sense from the deals doctor,https://www.ft.com/content/bb602500-ae07-11e4-919e-00144feab7de,,https://www.ft.com/us-companies,US & Canadian companies,...The US drug group’s $17bn acquisition of Hospira is not the game-changer that many investors had been expecting after Pfizer abandoned its ill-fated £69bn pursuit of AstraZeneca last year....,AstraZeneca,"FEBRUARY 6, 2015"
AstraZeneca / Sanofi: inversion,https://www.ft.com/content/07e2427e-ad53-11e4-a5c1-00144feab7de,,https://www.ft.com/european-companies,European companies,"...Perhaps there is some expectation, following Pfizer’s bid last year, that AstraZeneca will be bought....",AstraZeneca,"FEBRUARY 5, 2015"
Pfizer: only in America,https://www.ft.com/content/0d650b5a-ad58-11e4-97c1-00144feab7de,,https://www.ft.com/us-companies,US & Canadian companies,...But this deal may not be the end of the story — and AstraZeneca might not have been the last word on Pfizer’s efforts to avoid US taxes. AstraZeneca is off the table; a foreign address may not be....,AstraZeneca,"FEBRUARY 5, 2015"
Ocado hit by ‘limited potential’ broker note,https://www.ft.com/content/88bacc02-ad5f-11e4-a5c1-00144feab7de,,https://www.ft.com/uk-equities,UK equities,...AstraZeneca lost 3.4 per cent to £45.29 after its full-year earnings missed forecasts....,AstraZeneca,"FEBRUARY 5, 2015"
Pfizer’s $17bn Hospira buy could lead to break-up,https://www.ft.com/content/1b6788a8-ad54-11e4-a5c1-00144feab7de,,https://www.ft.com/us-companies,US & Canadian companies,...Hospira is not the transformational deal that many investors have been waiting since Pfizer abandoned its £69.4bn pursuit of AstraZeneca....,AstraZeneca,"FEBRUARY 5, 2015"
Lazard’s M&A advisory revenues top $1bn,https://www.ft.com/content/305dda48-ad48-11e4-a5c1-00144feab7de,,https://www.ft.com/us-companies,US & Canadian companies,"...had a strong start to the new year advising on three mega deals, including Pfizer’s $17bn acquisition of Hospira, the US pharmaceutical company’s first large transaction since it failed to buy the UK’s AstraZeneca...",AstraZeneca,"FEBRUARY 5, 2015"
AstraZeneca to pay $600m for Actavis respiratory drugs,https://www.ft.com/content/25d7329c-ad05-11e4-bfcf-00144feab7de,,https://www.ft.com/uk-companies,UK companies,"...But he remained bullish on long-term prospects, arguing that investors continued to underestimate the quality of AstraZeneca’s drugs pipeline....",AstraZeneca’s,"FEBRUARY 5, 2015"
Big pharmaceuticals groups faces biosimilars challenge,https://www.ft.com/content/866cd8c2-a9f0-11e4-9fa7-00144feab7de,,https://www.ft.com/us-companies,US & Canadian companies,"...Bristol-Myers Squibb and Eli Lilly have the strongest late-stage pipelines relative to existing revenues, while AstraZeneca has shown the greatest improvement over the past two years, says a report by credit...",AstraZeneca,"FEBRUARY 2, 2015"
Pfizer chief says big acquisition not required,https://www.ft.com/content/3fd88972-a64b-11e4-89e5-00144feab7de,,https://www.ft.com/us-companies,US & Canadian companies,"...Since abandoning its $120bn pursuit of AstraZeneca, Pfizer, the largest US drugmaker, has been linked to a long list of other pharma companies amid the widespread impression that Ian Read, chief executive...",AstraZeneca,"JANUARY 27, 2015"
Actavis and Valeant raise prospect of more pharma deals,https://www.ft.com/content/69783a1e-a175-11e4-8d19-00144feab7de,,https://www.ft.com/americas-companies,Americas companies,"...Pfizer, which tried to invert by buying UK-domiciled AstraZeneca but had to abandon that plan, has a tax rate of approximately 27 per cent....",AstraZeneca,"JANUARY 21, 2015"
"Peter Wallenberg, Swedish industrialist, 1926-2015",https://www.ft.com/content/0fdf33c6-9fcd-11e4-aa89-00144feab7de,,https://www.ft.com/family-businesses,Family businesses,"...His leadership spanned a period of great corporate change in Sweden, resulting in the creation of companies including ABB, the Swiss-Swedish engineering group, and AstraZeneca, the Anglo-Swedish pharmaceuticals...",AstraZeneca,"JANUARY 19, 2015"
AstraZeneca receives fillip from drug data,https://www.ft.com/content/52244d9e-9bd5-11e4-b6cc-00144feabdc0,,https://www.ft.com/uk-companies,UK companies,"...Many analysts remain sceptical about AstraZeneca’s growth forecasts, set during the heat of takeover battle with Pfizer....",AstraZeneca’s,"JANUARY 14, 2015"
Shire in $5.2bn deal for US biotech NPS,https://www.ft.com/content/3c56967e-99b5-11e4-93c1-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,"...Shire, which has a market capitalisation of £28.1bn and trails only GlaxoSmithKline and AstraZeneca by value on the UK stock market, will pay for the deal with cash from its balance sheet as well as by tapping...",AstraZeneca,"JANUARY 11, 2015"
Pharma takeover battles boost FTSE 100 performance,https://www.ft.com/content/12f8f1f2-9661-11e4-922f-00144feabdc0,,https://www.ft.com/mergers-acquisitions,Mergers & Acquisitions,...Pfizer abandoned its bid for AstraZeneca in May after the UK group rejected its offer....,AstraZeneca,"JANUARY 7, 2015"
Big pharma cashes in as M&A fever sweeps sector,https://www.ft.com/content/f742b876-8aa3-11e4-8e24-00144feabdc0,https://www.ft.com/__origami/service/image/v2/images/raw/http%3A%2F%2Fprod-upp-image-read.ft.com%2F68e77dc6-5864-11e4-b331-00144feab7de?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,...But AstraZeneca claimed vindication in September when President Barack Obama launched an attack on the “corporate deserters” attempting to cut their US tax bill by moving overseas....,AstraZeneca,"DECEMBER 26, 2014"
Salamander climbs on takeover hopes,https://www.ft.com/content/61ee5822-8ac9-11e4-82db-00144feabdc0,,https://www.ft.com/uk-equities,UK equities,"...Healthcare stocks, among the year’s best performers on M&A hopes, faded with Smith & Nephew down 1.7 per cent to £10.89 and AstraZeneca lower by 1.9 per cent to £45.17....",AstraZeneca,"DECEMBER 23, 2014"
Takeover volumes move to highest post-crisis levels,https://www.ft.com/content/0d62639e-894c-11e4-9b7f-00144feabdc0,,https://www.ft.com/americas-companies,Americas companies,...pharmaceuticals industry tackle the boom in biotechnology and the rise of challengers with tax-friendly corporate domiciles — the latter pressuring the US’s Pfizer and AbbVie to unsuccessfully pursue European rivals AstraZeneca...,AstraZeneca,"DECEMBER 22, 2014"
Drugmaker Hikma on lookout for acquisitions,https://www.ft.com/content/b5c63a6a-88f2-11e4-ad5b-00144feabdc0,,https://www.ft.com/uk-companies,UK companies,"...Hikma’s London listing makes it the fourth-biggest UK-listed drugmaker after GlaxoSmithKline, AstraZeneca and Shire, but most of its business is concentrated in the US, the Middle East and North Africa....",AstraZeneca,"DECEMBER 21, 2014"
Ex-minister Vadera to chair Santander UK,https://www.ft.com/content/5159c3f6-8214-11e4-b9d0-00144feabdc0,,https://www.ft.com/banks,Banks,"...She also joined the boards of BHP Billiton, the London-listed mining group, and AstraZeneca, the Anglo-Swedish pharmaceutical group....",AstraZeneca,"DECEMBER 12, 2014"
Old drugs put under the microscope,https://www.ft.com/content/a9eb782e-7d65-11e4-bb0a-00144feabdc0,,https://www.ft.com/uk-economy,UK economy,"...The agreement adds to a previous deal between the MRC and AstraZeneca, which has funded 15 research programmes involving 22 compounds....",AstraZeneca,"DECEMBER 8, 2014"
Britain’s champions need to up their game,https://www.ft.com/content/366edd86-7c8a-11e4-aa9c-00144feabdc0,,https://www.ft.com/uk-companies,UK companies,...The hostility triggered among politicians and media by the US group’s £69bn tilt at AstraZeneca earlier this year would be nothing to the fury inspired by an offer for the country’s largest drugs company...,AstraZeneca,"DECEMBER 7, 2014"
AstraZeneca wins ‘pay-for-delay’ ruling,https://www.ft.com/content/85de4838-7ca4-11e4-9a86-00144feabdc0,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,...AstraZeneca said it was “pleased with the jury’s verdict” and “always maintained that the plaintiffs’ allegations were without merit”....,AstraZeneca,"DECEMBER 5, 2014"
Water utilities boosted by takeover hopes,https://www.ft.com/content/4b5d51e6-7ca3-11e4-9a86-00144feabdc0,,https://www.ft.com/uk-equities,UK equities,"...AstraZeneca, up 0.9 per cent to £47.40, drifted back from £47.62 on widespread speculation that Pfizer might bid instead for Bristol-Myers Squibb....",AstraZeneca,"DECEMBER 5, 2014"
AstraZeneca comes into focus as Pfizer’s cooling-off period ends,https://www.ft.com/content/0dc9b498-7427-11e4-b444-00144feabdc0,,https://www.ft.com/uk-companies,UK companies,...Mr Mahjoubi says he has been impressed by AstraZeneca’s speed....,AstraZeneca’s,"NOVEMBER 25, 2014"
Who controls the City? UK’s top fund managers lined up,https://www.ft.com/content/e1bd0798-69b2-11e4-9f65-00144feabdc0,,https://www.ft.com/property-sector,Property sector,"...Mr Barnett’s high income fund has big positions in British American Tobacco, AstraZeneca and Roche, highlighting the defensive nature of his portfolio, which concentrates on some of the biggest industrial...",AstraZeneca,"NOVEMBER 25, 2014"
AstraZeneca fleshes out standalone strategy,https://www.ft.com/content/eeff34f6-6f13-11e4-b060-00144feabdc0,,https://www.ft.com/uk-companies,UK companies,"...Andrew Baum, analyst at Citigroup, said on Tuesday that he still saw “some residual probability of a Pfizer return [for AstraZeneca]”....",AstraZeneca,"NOVEMBER 18, 2014"
Allergan sees off Valeant by sealing $66bn deal with Actavis,https://www.ft.com/content/f7013a22-6e83-11e4-a65a-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,"...Unlike recent attempted deals in the sector, such as Abbvie’s £35bn failed takeover of Shire and Pfizer’s abortive £69bn bid for AstraZeneca, this deal is not structured as a tax inversion....",AstraZeneca,"NOVEMBER 17, 2014"
Oil’s fall hits shares in pumpmaker Weir,https://www.ft.com/content/5884c9f6-6e81-11e4-afe5-00144feabdc0,,https://www.ft.com/uk-equities,UK equities,...Fading takeover hopes meant AstraZeneca fell 1.3 per cent to £45.97....,AstraZeneca,"NOVEMBER 17, 2014"
Allergan-Actavis deal follows battle for soul of pharma,https://www.ft.com/content/f67c8dc4-6e36-11e4-bffb-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,"...Many of the biggest deals, such as Abbvie’s £35bn takeover of Shire and Pfizer’s abortive £69bn bid for AstraZeneca, have been torpedoed by the US government’s crackdown on tax inversions....",AstraZeneca,"NOVEMBER 17, 2014"
Actavis to pay $66bn for Allergan,https://www.ft.com/content/f47c8610-6dc2-11e4-bf80-00144feabdc0,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...Now that Abbvie’s £35bn bid for Shire has collapsed and the chances of Pfizer making a fresh £69bn bid for AstraZeneca have greatly diminished, a sale to Actavis would also be the biggest takeover deal of...",AstraZeneca,"NOVEMBER 17, 2014"
Tesco closes 2% higher on upgrade,https://www.ft.com/content/2eab0d4c-6c25-11e4-b939-00144feabdc0,,https://www.ft.com/uk-equities,UK equities,...AstraZeneca dropped 1.6 per cent to £44.66 after Reuters reported that Pfizer “appears unlikely” to make a fresh bid....,AstraZeneca,"NOVEMBER 14, 2014"
UCB caps week of pharma dealmaking,https://www.ft.com/content/af1e9b88-6685-11e4-8bf6-00144feabdc0,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,...AstraZeneca and Novartis have also offloaded peripheral businesses in recent days and GlaxoSmithKline is auctioning a portfolio of older drugs as the industry shuffles its assets in search of fresh growth...,AstraZeneca,"NOVEMBER 7, 2014"
AstraZeneca: priorities,https://www.ft.com/content/76fca490-65ca-11e4-a454-00144feabdc0,,https://www.ft.com/companies/byregion,Companies By Region,"...AstraZeneca’s dividend is $2.80; multiplying that by 1.5 makes $4.20. So, $4.20 is important. One should not exaggerate how important....",AstraZeneca’s,"NOVEMBER 6, 2014"
Morrison and M&S lead retailers higher,https://www.ft.com/content/8dea33c8-6595-11e4-aba7-00144feabdc0,,https://www.ft.com/uk-retail-results,UK retail results,"...AstraZeneca reported a better than expected rise in third quarter revenues to $6.54bn, but core earnings per share fell 8 per cent....",AstraZeneca,"NOVEMBER 6, 2014"
AstraZeneca aims to ward off Pfizer by highlighting ‘tax inversion’ risks,https://www.ft.com/content/9cb0ca98-6586-11e4-aba7-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,...Mr Soriot said AstraZeneca’s board would consider any fresh offer and do what was in the best interests of shareholders....,AstraZeneca’s,"NOVEMBER 6, 2014"
Ackman gains ground in fight to force Allergan to sell to Valeant,https://www.ft.com/content/3d8b1d32-6457-11e4-b219-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,"...Now that Abbvie’s £35bn bid for Shire has collapsed and the chances of Pfizer making a fresh £69bn bid for AstraZeneca have greatly diminished, it is also the sector’s biggest potential deal of the year....",AstraZeneca,"NOVEMBER 4, 2014"
AstraZeneca strikes deals on cancer drugs,https://www.ft.com/content/c8fd529c-641e-11e4-bac8-00144feabdc0,,https://www.ft.com/uk-companies,UK companies,...Tuesday’s deals came as investors prepare for an update on AstraZeneca’s recovery efforts when it announces third-quarter results on Thursday....,AstraZeneca’s,"NOVEMBER 4, 2014"
Pfizer chief: tax inversions still have ‘meaningful value’,https://www.ft.com/content/783202aa-5eb4-11e4-b81d-00144feabdc0,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,...He did not address a bid for AstraZeneca directly....,AstraZeneca,"OCTOBER 28, 2014"
Shire and AstraZeneca show standalone strength,https://www.ft.com/content/9b3a30ea-5b8c-11e4-b68a-00144feab7de,https://www.ft.com/__origami/service/image/v2/images/raw/http%3A%2F%2Fprod-upp-image-read.ft.com%2F74eda37a-0742-11e4-b1b0-00144feab7de?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/us-companies,US & Canadian companies,...Shares in AstraZeneca closed down less than 1 per cent at £43.27 – still well below the £55-a-share offer from Pfizer rejected in May....,AstraZeneca,"OCTOBER 24, 2014"
M&A deal failure at highest since 2008,https://www.ft.com/content/f2934894-5791-11e4-8493-00144feab7de,,https://www.ft.com/us-companies,US & Canadian companies,"...But the chances of Pfizer, the US pharma company, reviving its $120bn pursuit of the UK’s AstraZeneca have been greatly diminished as a result of AbbVie’s decision, several people close to the situation...",AstraZeneca,"OCTOBER 19, 2014"
Pfizer’s AstraZeneca pursuit knocked by Shire deal collapse,https://www.ft.com/content/d4581c70-563c-11e4-bbd6-00144feab7de,,https://www.ft.com/us-companies,US & Canadian companies,...Pfizer and AstraZeneca declined to comment....,AstraZeneca,"OCTOBER 17, 2014"
Inversions should not (hop) scotch healthy trend for tax competition,https://www.ft.com/content/c45ef706-544f-11e4-b2ea-00144feab7de,,https://www.ft.com/jonathan-guthrie,Jonathan Guthrie,"...Pfizer’s £70bn tilt at AstraZeneca of the UK was damaged by resistance from a UK elite that, for all its claims to the contrary, nurtures national champions....",AstraZeneca,"OCTOBER 15, 2014"
AbbVie drops £32bn bombshell on Shire,https://www.ft.com/content/e539c070-5484-11e4-bac2-00144feab7de,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...Covidien of Ireland, which is being bought by Medtronic, shed 4.26 per cent in early New York trading, while AstraZeneca, the UK pharmaceuticals group that was subject to an abortive offer from Pfizer, closed...",AstraZeneca,"OCTOBER 15, 2014"
Shire hit as FTSE 100 slides to 15-month low,https://www.ft.com/content/7e6c97b0-5488-11e4-b2ea-00144feab7de,,https://www.ft.com/uk-equities,UK equities,"...Among the other stocks marked as tax inversion targets, Smith & Nephew lost 5.4 per cent to 921.5p and AstraZeneca fell 3.2 per cent to £42.65....",AstraZeneca,"OCTOBER 15, 2014"
Pharma stocks slide on Shire deal doubts,https://www.ft.com/content/47d60e54-543b-11e4-84c6-00144feab7de,,https://www.ft.com/stream/2aa91da4-33e1-4461-8bd8-54ed0c2e81a2,US downturn,"...AstraZeneca, which fought off a £69.4bn bid from Pfizer earlier this year, fell 4 per cent to £42.34, while GlaxoSmithKline lost 0.9 per cent to £13.54....",AstraZeneca,"OCTOBER 15, 2014"
Steris makes UK tax leap with $1.9bn Synergy inversion deal,https://www.ft.com/content/7f67a526-52e2-11e4-9221-00144feab7de,,https://www.ft.com/us-companies,US & Canadian companies,"...Pfizer, the US drugmaker, is among those still looking for potential inversions after its failed £69.4bn approach for AstraZeneca of the UK in May....",AstraZeneca,"OCTOBER 13, 2014"
Renewed merger hopes boost AstraZeneca,https://www.ft.com/content/eb7d26ca-52f4-11e4-b917-00144feab7de,,https://www.ft.com/mergers-acquisitions,Mergers & Acquisitions,...Refreshed hopes of another approach from Pfizer put AstraZeneca back in demand on Monday....,AstraZeneca,"OCTOBER 13, 2014"
Fortune 500 companies spend more than $15bn on corporate responsibility,https://www.ft.com/content/95239a6e-4fe0-11e4-a0a4-00144feab7de,,https://www.ft.com/us-companies,US & Canadian companies,"...Drugs companies are particularly prominent in CSR activity, with Merck and Johnson & Johnson being among the six groups providing almost two-thirds of the US CSR spend, while London-listed AstraZeneca and...",AstraZeneca,"OCTOBER 12, 2014"
Liverpool School of Tropical Medicine is in a global fight against suffering,https://www.ft.com/content/399570cc-279b-11e4-ae44-00144feabdc0,,https://www.ft.com/world,World,"...Its Centre for NTDs leads the Anti-Wolbachia Consortium, which works with AstraZeneca to develop antibiotics to cure conditions caused by parasitic worms: river blindness and elephantiasis....",AstraZeneca,"OCTOBER 9, 2014"
Gabriel Baertschi’s search for new AstraZeneca premises in Japan,https://www.ft.com/content/3f2fae24-489a-11e4-9d04-00144feab7de,,https://www.ft.com/global-property,Global property,...We think AstraZeneca falls into that category....,AstraZeneca,"OCTOBER 5, 2014"
BD agrees to buy CareFusion for $12.2bn,https://www.ft.com/content/20ac1324-4cc9-11e4-a0d7-00144feab7de,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,...Pfizer’s $116bn abortive takeover of AstraZeneca would have been the largest deal so far this year....,AstraZeneca,"OCTOBER 5, 2014"
Multibillion cross-border deals make a return after five years,https://www.ft.com/content/49a2843a-484a-11e4-ac9f-00144feab7de,,https://www.ft.com/us-companies,US & Canadian companies,...Pfizer’s abortive $116bn bid for UK drugmaker AstraZeneca – the largest deal attempted in the year to date – was an attempt at such a deal....,AstraZeneca,"SEPTEMBER 30, 2014"
"UK is a land of liberté, égalité and opportunity for French execs",https://www.ft.com/content/69794438-489a-11e4-ad19-00144feab7de,,https://www.ft.com/jonathan-guthrie,Jonathan Guthrie,"...They include Olivier Bohuon at Smith & Nephew, Xavier Rolet at the London Stock Exchange, Pascal Soriot of AstraZeneca and Tidjane Thiam at Prudential who has dual nationality....",AstraZeneca,"SEPTEMBER 30, 2014"
"Bonus clawbacks will burnish City prestige, not tarnish it",https://www.ft.com/content/a1fc2394-47d6-11e4-be7b-00144feab7de,,https://www.ft.com/jonathan-guthrie,Jonathan Guthrie,...AstraZeneca is a typical deal-dodger. Its stock is 20 per cent below the last price offered by Pfizer before the US group abandoned attempts to strike a deal with its UK rival....,AstraZeneca,"SEPTEMBER 29, 2014"
Drugs groups trapped in tangled M&A web,https://www.ft.com/content/cac910de-4556-11e4-ab86-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,"...All this has implications for Pfizer, the biggest US drugmaker, which has been linked with Actavis as a potential alternative to AstraZeneca, which rebuffed its £69bn offer in May....",AstraZeneca,"SEPTEMBER 28, 2014"
Drug development: Big pharma back in the game it made,https://www.ft.com/content/83bf54da-1bcd-11e4-9db1-00144feabdc0,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...Bristol-Myers Squibb, Roche and AstraZeneca will also issue updates on their progress in various tumour types....",AstraZeneca,"SEPTEMBER 25, 2014"
Curbs on tax inversions fail to convince,https://www.ft.com/content/0d8444fa-4338-11e4-be3f-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,"...Those benefits will be sized up carefully by companies still considering inversions, such as Pfizer, which was in May rebuffed in a £69.4bn approach for the UK’s AstraZeneca....",AstraZeneca,"SEPTEMBER 23, 2014"
J Sainsbury hits six-year low on trading fears,https://www.ft.com/content/6d30799e-433f-11e4-be3f-00144feabdc0,,https://www.ft.com/retail-consumer,Retail & Consumer industry,"...The FTSE 100 ended 1.4 per cent lower, down 97.55 points at 6,676.08 as AstraZeneca dropped 3.6 per cent to £44.14 and Smith & Nephew fell 2.8 per cent to £10.38....",AstraZeneca,"SEPTEMBER 23, 2014"
CarMax sputters on disappointing sales,https://www.ft.com/content/8f23e3c0-4339-11e4-be3f-00144feabdc0,,https://www.ft.com/us-equities,US equities,"...Pfizer shares fell 0.5 per cent to $30.05, AstraZeneca declined 5 per cent to $71.13, GlaxoSmithKline dipped 1 per cent to $46.64 and AbbVie slipped 2 per cent to $57.56....",AstraZeneca,"SEPTEMBER 23, 2014"
US Treasury hopes to stand logic of tax inversion deals on head,https://www.ft.com/content/91ea274c-430f-11e4-9a58-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,"...So, shares in Shire and AstraZeneca shivered slightly – the first on worries that AbbVie might walk away from its £32bn cash and shares bid; and the second on fears that Pfizer might not now come back with...",AstraZeneca,"SEPTEMBER 23, 2014"
London stocks hit by US tax crackdown,https://www.ft.com/content/07f2de4a-42fa-11e4-8a43-00144feabdc0,,https://www.ft.com/mergers-acquisitions,Mergers & Acquisitions,"...AstraZeneca, which has recently been courted by Pfizer, lost 5.1 per cent to £43.43....",AstraZeneca,"SEPTEMBER 23, 2014"
Europe struggles to catch US biotech bulls,https://www.ft.com/content/3f389094-3f25-11e4-a861-00144feabdc0,,https://www.ft.com/european-companies,European companies,"...But the medicine was licensed to Abbott, of which AbbVie used to be part, and CAT was bought by AstraZeneca, creating a case study in how the spoils of drug innovation often land a long way from the laboratories...",AstraZeneca,"SEPTEMBER 18, 2014"
AstraZeneca swallows bittersweet pill with Eli Lilly Alzheimer’s deal,https://www.ft.com/content/30b65f54-3d7e-11e4-b782-00144feabdc0,,https://www.ft.com/jonathan-guthrie,Jonathan Guthrie,"...The paradox is embodied in the unpopularity of neuroscience among big drug companies, such as AstraZeneca....",AstraZeneca,"SEPTEMBER 16, 2014"
AstraZeneca and Eli Lilly to unite for Alzheimer’s drug challenge,https://www.ft.com/content/e5027484-3d8d-11e4-b782-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,...AstraZeneca has struck a deal to jointly develop a treatment for Alzheimer’s disease with Eli Lilly of the US in a partnership that promises to add momentum to industry efforts to tackle one of the biggest...,AstraZeneca,"SEPTEMBER 16, 2014"
Takeover Panel proposes tougher rules for deal promises,https://www.ft.com/content/2e177d76-3ccc-11e4-9733-00144feabdc0,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...Under current takeover rules, Pfizer cannot make a new public approach for AstraZeneca until November 25 – six months after it withdrew from talks after its final offer was rejected....",AstraZeneca,"SEPTEMBER 15, 2014"
Pfizer says ‘window still open’ for tax inversions,https://www.ft.com/content/f7f00654-39ca-11e4-83c4-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,...His comments will stir speculation about a possible renewed bid for AstraZeneca but Mr Anderson said Mr Read sounded cool on the idea....,AstraZeneca,"SEPTEMBER 11, 2014"
Why Woodford dumped his HSBC stake,https://www.ft.com/content/4d998fc4-3379-11e4-85f1-00144feabdc0,,https://www.ft.com/uk-banks,UK banks,"...No surprises here: old favourites such as AstraZeneca and BAE Systems are among the positions that have recently neem increased, along with power generator Drax and insurer Legal & General.

————————————...",AstraZeneca,"SEPTEMBER 5, 2014"
Scotland poll sends UK banks tumbling,https://www.ft.com/content/705c299a-32c0-11e4-b86e-00144feabdc0,,https://www.ft.com/european-banks,European banks,"...Separately, Suntrust Robinson predicted that Pfizer would come back with a £58.25 per share offer for AstraZeneca....",AstraZeneca,"SEPTEMBER 2, 2014"
Imperial College London’s new head welcomes political promotion of science,https://www.ft.com/content/006f43c4-30fe-11e4-8313-00144feabdc0,,https://www.ft.com/uk-politics,UK politics,"...In the heated debate that followed Pfizer’s attempted takeover of AstraZeneca earlier this year, the government’s attempts to protect the UK science base struck an unlikely chord on a campus in Pennsylvania...",AstraZeneca,"AUGUST 31, 2014"
AstraZeneca gains on renewed bid chatter,https://www.ft.com/content/e7166b86-2f82-11e4-83e4-00144feabdc0,,https://www.ft.com/retail-consumer,Retail & Consumer industry,...AstraZeneca was among the FTSE 100 leaders on Friday as bid chatter continued to prod the drug company’s shares higher....,AstraZeneca,"AUGUST 29, 2014"
Chi-Med draws on the past for the future,https://www.ft.com/content/4ac234a2-2c50-11e4-a0b6-00144feabdc0,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...Among its best prospects are fruquintinib, a colorectal cancer drug being co-developed with Eli Lilly of the US, and volitinib, for renal cell cancer, with AstraZeneca....",AstraZeneca,"AUGUST 25, 2014"
Pfizer weighs options on AstraZeneca bid,https://www.ft.com/content/ee806732-2b6d-11e4-b052-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,...Pfizer is considering its acquisition options as a potential path opens this week for the US drugmaker to renew its pursuit of AstraZeneca....,AstraZeneca,"AUGUST 24, 2014"
IG Group under pressure on volume concerns,https://www.ft.com/content/7a22b00e-2a1c-11e4-a068-00144feabdc0,,https://www.ft.com/uk-equities,UK equities,"...Similar stories went around earlier in the year, shortly before Pfizer went public with its approach for AstraZeneca....",AstraZeneca,"AUGUST 22, 2014"
"US TV takeovers threaten UK creative economy, says C4 chief",https://www.ft.com/content/ea73b848-2950-11e4-8b81-00144feabdc0,,https://www.ft.com/uk-economy,UK economy,...from AstraZeneca’s board and British politicians....,AstraZeneca’s,"AUGUST 21, 2014"
Drugmaker link-up puts Astra on top,https://www.ft.com/content/1e4c9492-2937-11e4-8b81-00144feabdc0,,https://www.ft.com/energy,Energy sector,...The UK’s two biggest drugmakers both made it on to the FTSE 100 leaderboard  after AstraZeneca developed a partnership that it hoped would speed up development of cancer treatments while GlaxoSmithKline...,AstraZeneca,"AUGUST 21, 2014"
Drugmakers help lift FTSE 100,https://www.ft.com/content/c27b21aa-290a-11e4-8b81-00144feabdc0,,https://www.ft.com/stream/2aa91da4-33e1-4461-8bd8-54ed0c2e81a2,US downturn,"...The FTSE 100’s two biggest drugmakers were on the leaderboard on Thursday after AstraZeneca developed a partnership it hoped would speed up development of cancer treatments, while GlaxoSmithKline had an...",AstraZeneca,"AUGUST 21, 2014"
SSP climbs despite conflicting broker advice,https://www.ft.com/content/230d6f22-288a-11e4-8bda-00144feabdc0,,https://www.ft.com/uk-equities,UK equities,"...AstraZeneca rose 1.1 per cent to £42.85, awaiting initial Takeover Panel offer restrictions on Pfizer expiring next week....",AstraZeneca,"AUGUST 20, 2014"
What next for M&A now the bubble has burst?,https://www.ft.com/content/311877de-278f-11e4-ae44-00144feabdc0,,https://www.ft.com/sarah-gordon,Sarah Gordon,...Pfizer’s move on AstraZeneca was a case in point. So is the oddly constructed merger between the Irish and US banana companies Fyffes and Chiquita....,AstraZeneca,"AUGUST 20, 2014"
DoJ closes AstraZeneca probe without bringing charges,https://www.ft.com/content/ecfe01f0-277e-11e4-be5a-00144feabdc0,,https://www.ft.com/uk-companies,UK companies,...Shares in AstraZeneca were up 0.6 per cent at £42.28 on Tuesday morning....,AstraZeneca,"AUGUST 19, 2014"
AstraZeneca tops FTSE 100,https://www.ft.com/content/402d83b4-2770-11e4-ae44-00144feabdc0,,https://www.ft.com/mergers-acquisitions,Mergers & Acquisitions,...AstraZeneca made the best single gain on the FTSE 100 on Tuesday after the drug company welcomed news that the US investigation into one of its clinical trials was being closed without further action against...,AstraZeneca,"AUGUST 19, 2014"
B&M backed by Goldman growth forecasts,https://www.ft.com/content/ba3e8dca-230a-11e4-a424-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,"...AstraZeneca , which was trading ex a 53p dividend, slipped 0.7 per cent to £41.02....",AstraZeneca,"AUGUST 13, 2014"
Viking raiders will bring Norse sense to company votes,https://www.ft.com/content/da9a500c-1e20-11e4-ab52-00144feabdc0,,https://www.ft.com/jonathan-guthrie,Jonathan Guthrie,"...It accordingly takes regular pops at US bank bosses, such as Lloyd Blankfein of Goldman Sachs, and has sent the likes of AstraZeneca away with fleas in their ears on pay....",AstraZeneca,"AUGUST 7, 2014"
Pharma shares slide on fears of ‘tax inversion’ clampdown,https://www.ft.com/content/d3c2843a-1d5c-11e4-8b03-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,"...AstraZeneca, the UK drugmaker which was the subject of a failed £69.4bn bid from Pfizer in May, was down 3.6 per cent, while Smith & Nephew, the UK medical devices maker considered to be another inversion...",AstraZeneca,"AUGUST 6, 2014"
Tesco at 10-year low on profit fears,https://www.ft.com/content/5e542208-1d89-11e4-8f0c-00144feabdc0,,https://www.ft.com/european-banks,European banks,"...AstraZeneca lost 3.6 per cent to £41.90 on fears that Pfizer might abandon its pursuit while Smith & Nephew, previously an inversion target for US peer Stryker, lost 4.1 per cent to £10.20....",AstraZeneca,"AUGUST 6, 2014"
FTSE 100 bid stocks lead broad losses,https://www.ft.com/content/b6f5a188-1d3f-11e4-b927-00144feabdc0,,https://www.ft.com/uk-equities,UK equities,"...AstraZeneca, which was the subject of a failed £69.4bn bid from Pfizer which would have included a tax inversion, fell 1.6 per cent to £42.75....",AstraZeneca,"AUGUST 6, 2014"
Corporate acquirors take early aim at their target’s investors,https://www.ft.com/content/19f3121c-1420-11e4-9acb-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,"...To stress the importance of their response, AbbVie pointed to the example of AstraZeneca, the UK pharmaceutical company that in May fought off attention from US rival Pfizer – and has faced disgruntled shareholders...",AstraZeneca,"AUGUST 5, 2014"
High cost to AstraZeneca independence,https://www.ft.com/content/4542ab38-1bf7-11e4-9db1-00144feabdc0,,https://www.ft.com/mergers-acquisitions,Mergers & Acquisitions,"...The cost of AstraZeneca remaining independent may be greater than investors think, according to Barclays analysts....",AstraZeneca,"AUGUST 4, 2014"
Bristol-Myers Squibb in venture to turn US research into drugs,https://www.ft.com/content/257facb4-1be4-11e4-9db1-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,"...AstraZeneca recently unveiled plans for its new research centre in Cambridge, moving headquarters from its base in London....",AstraZeneca,"AUGUST 4, 2014"
AstraZeneca chairman Leif Johansson defends Pfizer rebuff,https://www.ft.com/content/b69c8a70-1bab-11e4-adc7-00144feabdc0,https://www.ft.com/__origami/service/image/v2/images/raw/http%3A%2F%2Fprod-upp-image-read.ft.com%2F78beefd4-d099-11e3-9a81-00144feabdc0?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/us-companies,US & Canadian companies,...AstraZeneca is already big enough and super big may not be better.”...,AstraZeneca,"AUGUST 4, 2014"
Europe delivers earnings growth for the first time in three years,https://www.ft.com/content/d8e7a14a-18af-11e4-a51a-00144feabdc0,https://www.ft.com/__origami/service/image/v2/images/raw/http%3A%2F%2Fprod-upp-image-read.ft.com%2Fcf0ef45a-1aff-11e4-a633-00144feabdc0?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/european-companies,European companies,"...Eni, the Italian oil and gas group, announced a 51 per cent increase in its quarterly net profit, and AstraZeneca, the UK drugmaker that in May rejected a £69.4bn takeover from Pfizer, also beat analysts...",AstraZeneca,"AUGUST 3, 2014"
GlaxoSmithKline vulnerable to Pfizer bid after price slump,https://www.ft.com/content/adc5184e-199a-11e4-b06c-00144feabdc0,,https://www.ft.com/uk-equities,UK equities,"...AstraZeneca, meanwhile, was off 0.1 per cent to £43.39 even after its chairman and three non-executive directors added to their stakes....",AstraZeneca,"AUGUST 1, 2014"
Drug pricing: Bitter pill,https://www.ft.com/content/f3ede8ae-189c-11e4-933e-00144feabdc0,,https://www.ft.com/the-big-read,The Big Read,"...It is already bigger by market capitalisation, at $143bn, than some traditional pharma mainstays, including GlaxoSmithKline and AstraZeneca....",AstraZeneca,"JULY 31, 2014"
AstraZeneca raises full-year earnings guidance,https://www.ft.com/content/d6d17a6a-1883-11e4-a51a-00144feabdc0,,https://www.ft.com/uk-companies,UK companies,...Analysts said this suggested AstraZeneca was bracing for a fresh approach....,AstraZeneca,"JULY 31, 2014"
AstraZeneca to bolster respiratory drugs with Almirall deal,https://www.ft.com/content/c1c1e25a-17b5-11e4-b842-00144feabdc0,,https://www.ft.com/european-companies,European companies,"...The deal will also reinforce the challenge posed by AstraZeneca to GlaxoSmithKline, its UK rival, in the respiratory market....",AstraZeneca,"JULY 30, 2014"
GSK’s Witty fights back amid bribery scandal and profit warning,https://www.ft.com/content/f7869406-1564-11e4-ae2e-00144feabdc0,,https://www.ft.com/uk-companies,UK companies,...Pfizer walked away after AstraZeneca rejected what would have been the biggest foreign takeover of a UK company....,AstraZeneca,"JULY 27, 2014"
US warned of up to 25 groups eyeing foreign switch to cut tax,https://www.ft.com/content/69e69c42-11c0-11e4-8279-00144feabdc0,,https://www.ft.com/us-politics-policy,US politics & policy,...They were thrust into the spotlight by Pfizer’s $116bn attempt to buy UK rival AstraZeneca....,AstraZeneca,"JULY 22, 2014"
Shire chief’s $10m ‘golden hello’ at AbbVie,https://www.ft.com/content/aeb66b6c-0e97-11e4-a1ae-00144feabdc0,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...It is the second FTSE 100 drugmaker to be subjected to an unsolicited takeover attempt by a US rival this year, after Pfizer’s failed £69.4bn bid for AstraZeneca....",AstraZeneca,"JULY 18, 2014"
AbbVie rounds on US tax laws as it snares Shire,https://www.ft.com/content/c43aa6ce-0e60-11e4-a1ae-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,"...However, while the latter approach drew strong political opposition because of AstraZeneca’s importance to the UK science base, the proposed Shire takeover has proved much less controversial....",AstraZeneca’s,"JULY 18, 2014"
AstraZeneca unveils plans for £330m R&D centre in Cambridge,https://www.ft.com/content/e86805f6-0e64-11e4-b1c4-00144feabdc0,,https://www.ft.com/london-future,London fights for its future,...AstraZeneca’s commitment to UK science was at the heart of its defence against Pfizer’s £69bn takeover bid in May....,AstraZeneca’s,"JULY 18, 2014"
AbbVie set to unveil £31bn Shire takeover,https://www.ft.com/content/d324fa2e-0dcd-11e4-85ab-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,...Shire is the second FTSE 100 drugmaker to be subjected to an unsolicited takeover attempt by a US rival this year after Pfizer’s failed £69.4bn bid for AstraZeneca....,AstraZeneca,"JULY 17, 2014"
Eli Lilly joins forces with UK biotech to develop cancer drugs,https://www.ft.com/content/d2ea0274-0ccf-11e4-bf1e-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,"...The deal with Immunocore adds to the British company’s existing alliances with AstraZeneca, GlaxoSmithKline and Roche, marking it out as one of the most promising new names in the UK life science sector....",AstraZeneca,"JULY 16, 2014"
Experian suffers shareholder revolt over board reshuffle,https://www.ft.com/content/82cae036-0cc7-11e4-90fa-00144feabdc0,,https://www.ft.com/corporate-governance,Corporate governance,"...Barclays, AstraZeneca, Reckitt Benckiser, WPP and Pearson (owner of the Financial Times) have each endured notable rebellions over remuneration....",AstraZeneca,"JULY 16, 2014"
David Cameron moves to boost UK life sciences,https://www.ft.com/content/8bb3d4ac-0c52-11e4-943b-00144feabdc0,,https://www.ft.com/uk-inward-investment,UK inward investment,...appointment of George Freeman in a newly created life sciences role in Tuesday’s reshuffle marks the prime minister’s determination to strengthen oversight of the sector following Pfizer’s £69.4bn bid for AstraZeneca...,AstraZeneca,"JULY 16, 2014"
Sir John Peace in the line of fire at FTSE 100 groups,https://www.ft.com/content/fd88db6a-0be7-11e4-a096-00144feabdc0,,https://www.ft.com/corporate-governance,Corporate governance,"...Barclays, AstraZeneca, Pearson (which owns the Financial Times), WPP and HSBC have each suffered revolts amid renewed shareholder agitation....",AstraZeneca,"JULY 15, 2014"
AbbVie closes in on £31bn takeover of Shire,https://www.ft.com/content/c8fe1c14-0b1c-11e4-ae6b-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,...AbbVie looks set to succeed where Pfizer failed in its £69.4bn bid for AstraZeneca of the UK in May....,AstraZeneca,"JULY 14, 2014"
Quindell starts on long road back to favour,https://www.ft.com/content/32d9afe6-0b71-11e4-8693-00144feabdc0,,https://www.ft.com/kate-burgess,Kate Burgess,"...Pfizer’s tilt at AstraZeneca set teacups clattering a few months ago. By contrast, the mooted purchase of Shire by US pharmaceutical rival AbbVie has yet to trouble the pages of the populist press....",AstraZeneca,"JULY 14, 2014"
AbbVie/Shire – join us at 12 for a live discussion,https://www.ft.com/content/010f6536-2e7f-35a7-ba2f-15469dfc4856,,https://www.ft.com/joseph-cotterill,Joseph Cotterill,"...of AbbVie’s £53.20 a share offer would eventually lead to a similar clause…

The price is a 42 per cent premium to where Shire shares traded before AbbVie became involved (though after Pfizer’s bid for AstraZeneca...",AstraZeneca,"JULY 14, 2014"
Vince Cable plans to toughen up takeover rules,https://www.ft.com/content/a41dcbe8-0a71-11e4-ac2a-00144feabdc0,,https://www.ft.com/world,World,...The business secretary concluded that the existing rules were inadequate after Pfizer’s £69.4bn approach for AstraZeneca....,AstraZeneca,"JULY 13, 2014"
Myners must give independent advice on independents,https://www.ft.com/content/8b1358ae-0740-11e4-81c6-00144feab7de,,https://www.ft.com/jonathan-guthrie,Jonathan Guthrie,"...The £69bn bid that Pfizer, made for AstraZeneca unravelled in May after its own discussions with the City M&A watchdog....",AstraZeneca,"JULY 9, 2014"
AbbVie retraction shows panel has teeth,https://www.ft.com/content/0adb6e98-0753-11e4-b1b0-00144feab7de,,https://www.ft.com/us-companies,US & Canadian companies,...The increased scrutiny of the code during the Pfizer/AstraZeneca courtship sparked complaints that the rules were arcane and led to muddle and confusion....,AstraZeneca,"JULY 9, 2014"
Five examples of the UK Takeover Code in action,https://www.ft.com/content/c94eccf4-0757-11e4-b1b0-00144feab7de,,https://www.ft.com/uk-companies,UK companies,"...May 19 2014: Pfizer outlines “final” offer to AstraZeneca, saying that its offer will not be increased, “except in the circumstances set out below”....",AstraZeneca,"JULY 9, 2014"
UK Takeover Panel forces AbbVie to retract claims of Shire support,https://www.ft.com/content/f97218fe-0730-11e4-b1b0-00144feab7de,,https://www.ft.com/us-companies,US & Canadian companies,"...volte-face for the US suitor and a further sign of how closely the panel is policing the company’s public utterances, as it did with Pfizer’s attempts to acquire another FTSE 100 pharmaceuticals group, AstraZeneca...",AstraZeneca,"JULY 9, 2014"
Cable backtracks on move to protect science industry,https://www.ft.com/content/0c67a6ee-06c4-11e4-b0d3-00144feab7de,,https://www.ft.com/world,World,...Pfizer walked away from AstraZeneca after the Anglo-Swedish company rebuffed its advances....,AstraZeneca,"JULY 8, 2014"
AstraZeneca chairman Leif Johansson defends Pfizer rebuff,https://www.ft.com/content/b69c8a70-1bab-11e4-adc7-00144feabdc0,https://www.ft.com/__origami/service/image/v2/images/raw/http%3A%2F%2Fprod-upp-image-read.ft.com%2F78beefd4-d099-11e3-9a81-00144feabdc0?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/us-companies,US & Canadian companies,...AstraZeneca is already big enough and super big may not be better.”...,AstraZeneca,"AUGUST 4, 2014"
Europe delivers earnings growth for the first time in three years,https://www.ft.com/content/d8e7a14a-18af-11e4-a51a-00144feabdc0,https://www.ft.com/__origami/service/image/v2/images/raw/http%3A%2F%2Fprod-upp-image-read.ft.com%2Fcf0ef45a-1aff-11e4-a633-00144feabdc0?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/european-companies,European companies,"...Eni, the Italian oil and gas group, announced a 51 per cent increase in its quarterly net profit, and AstraZeneca, the UK drugmaker that in May rejected a £69.4bn takeover from Pfizer, also beat analysts...",AstraZeneca,"AUGUST 3, 2014"
GlaxoSmithKline vulnerable to Pfizer bid after price slump,https://www.ft.com/content/adc5184e-199a-11e4-b06c-00144feabdc0,,https://www.ft.com/uk-equities,UK equities,"...AstraZeneca, meanwhile, was off 0.1 per cent to £43.39 even after its chairman and three non-executive directors added to their stakes....",AstraZeneca,"AUGUST 1, 2014"
Drug pricing: Bitter pill,https://www.ft.com/content/f3ede8ae-189c-11e4-933e-00144feabdc0,,https://www.ft.com/the-big-read,The Big Read,"...It is already bigger by market capitalisation, at $143bn, than some traditional pharma mainstays, including GlaxoSmithKline and AstraZeneca....",AstraZeneca,"JULY 31, 2014"
AstraZeneca raises full-year earnings guidance,https://www.ft.com/content/d6d17a6a-1883-11e4-a51a-00144feabdc0,,https://www.ft.com/uk-companies,UK companies,...Analysts said this suggested AstraZeneca was bracing for a fresh approach....,AstraZeneca,"JULY 31, 2014"
AstraZeneca to bolster respiratory drugs with Almirall deal,https://www.ft.com/content/c1c1e25a-17b5-11e4-b842-00144feabdc0,,https://www.ft.com/european-companies,European companies,"...The deal will also reinforce the challenge posed by AstraZeneca to GlaxoSmithKline, its UK rival, in the respiratory market....",AstraZeneca,"JULY 30, 2014"
GSK’s Witty fights back amid bribery scandal and profit warning,https://www.ft.com/content/f7869406-1564-11e4-ae2e-00144feabdc0,,https://www.ft.com/uk-companies,UK companies,...Pfizer walked away after AstraZeneca rejected what would have been the biggest foreign takeover of a UK company....,AstraZeneca,"JULY 27, 2014"
US warned of up to 25 groups eyeing foreign switch to cut tax,https://www.ft.com/content/69e69c42-11c0-11e4-8279-00144feabdc0,,https://www.ft.com/us-politics-policy,US politics & policy,...They were thrust into the spotlight by Pfizer’s $116bn attempt to buy UK rival AstraZeneca....,AstraZeneca,"JULY 22, 2014"
Shire chief’s $10m ‘golden hello’ at AbbVie,https://www.ft.com/content/aeb66b6c-0e97-11e4-a1ae-00144feabdc0,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...It is the second FTSE 100 drugmaker to be subjected to an unsolicited takeover attempt by a US rival this year, after Pfizer’s failed £69.4bn bid for AstraZeneca....",AstraZeneca,"JULY 18, 2014"
AbbVie rounds on US tax laws as it snares Shire,https://www.ft.com/content/c43aa6ce-0e60-11e4-a1ae-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,"...However, while the latter approach drew strong political opposition because of AstraZeneca’s importance to the UK science base, the proposed Shire takeover has proved much less controversial....",AstraZeneca’s,"JULY 18, 2014"
AstraZeneca unveils plans for £330m R&D centre in Cambridge,https://www.ft.com/content/e86805f6-0e64-11e4-b1c4-00144feabdc0,,https://www.ft.com/london-future,London fights for its future,...AstraZeneca’s commitment to UK science was at the heart of its defence against Pfizer’s £69bn takeover bid in May....,AstraZeneca’s,"JULY 18, 2014"
AbbVie set to unveil £31bn Shire takeover,https://www.ft.com/content/d324fa2e-0dcd-11e4-85ab-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,...Shire is the second FTSE 100 drugmaker to be subjected to an unsolicited takeover attempt by a US rival this year after Pfizer’s failed £69.4bn bid for AstraZeneca....,AstraZeneca,"JULY 17, 2014"
Eli Lilly joins forces with UK biotech to develop cancer drugs,https://www.ft.com/content/d2ea0274-0ccf-11e4-bf1e-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,"...The deal with Immunocore adds to the British company’s existing alliances with AstraZeneca, GlaxoSmithKline and Roche, marking it out as one of the most promising new names in the UK life science sector....",AstraZeneca,"JULY 16, 2014"
Experian suffers shareholder revolt over board reshuffle,https://www.ft.com/content/82cae036-0cc7-11e4-90fa-00144feabdc0,,https://www.ft.com/corporate-governance,Corporate governance,"...Barclays, AstraZeneca, Reckitt Benckiser, WPP and Pearson (owner of the Financial Times) have each endured notable rebellions over remuneration....",AstraZeneca,"JULY 16, 2014"
David Cameron moves to boost UK life sciences,https://www.ft.com/content/8bb3d4ac-0c52-11e4-943b-00144feabdc0,,https://www.ft.com/uk-inward-investment,UK inward investment,...appointment of George Freeman in a newly created life sciences role in Tuesday’s reshuffle marks the prime minister’s determination to strengthen oversight of the sector following Pfizer’s £69.4bn bid for AstraZeneca...,AstraZeneca,"JULY 16, 2014"
Sir John Peace in the line of fire at FTSE 100 groups,https://www.ft.com/content/fd88db6a-0be7-11e4-a096-00144feabdc0,,https://www.ft.com/corporate-governance,Corporate governance,"...Barclays, AstraZeneca, Pearson (which owns the Financial Times), WPP and HSBC have each suffered revolts amid renewed shareholder agitation....",AstraZeneca,"JULY 15, 2014"
AbbVie closes in on £31bn takeover of Shire,https://www.ft.com/content/c8fe1c14-0b1c-11e4-ae6b-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,...AbbVie looks set to succeed where Pfizer failed in its £69.4bn bid for AstraZeneca of the UK in May....,AstraZeneca,"JULY 14, 2014"
Quindell starts on long road back to favour,https://www.ft.com/content/32d9afe6-0b71-11e4-8693-00144feabdc0,,https://www.ft.com/kate-burgess,Kate Burgess,"...Pfizer’s tilt at AstraZeneca set teacups clattering a few months ago. By contrast, the mooted purchase of Shire by US pharmaceutical rival AbbVie has yet to trouble the pages of the populist press....",AstraZeneca,"JULY 14, 2014"
AbbVie/Shire – join us at 12 for a live discussion,https://www.ft.com/content/010f6536-2e7f-35a7-ba2f-15469dfc4856,,https://www.ft.com/joseph-cotterill,Joseph Cotterill,"...of AbbVie’s £53.20 a share offer would eventually lead to a similar clause…

The price is a 42 per cent premium to where Shire shares traded before AbbVie became involved (though after Pfizer’s bid for AstraZeneca...",AstraZeneca,"JULY 14, 2014"
Vince Cable plans to toughen up takeover rules,https://www.ft.com/content/a41dcbe8-0a71-11e4-ac2a-00144feabdc0,,https://www.ft.com/world,World,...The business secretary concluded that the existing rules were inadequate after Pfizer’s £69.4bn approach for AstraZeneca....,AstraZeneca,"JULY 13, 2014"
Myners must give independent advice on independents,https://www.ft.com/content/8b1358ae-0740-11e4-81c6-00144feab7de,,https://www.ft.com/jonathan-guthrie,Jonathan Guthrie,"...The £69bn bid that Pfizer, made for AstraZeneca unravelled in May after its own discussions with the City M&A watchdog....",AstraZeneca,"JULY 9, 2014"
AbbVie retraction shows panel has teeth,https://www.ft.com/content/0adb6e98-0753-11e4-b1b0-00144feab7de,,https://www.ft.com/us-companies,US & Canadian companies,...The increased scrutiny of the code during the Pfizer/AstraZeneca courtship sparked complaints that the rules were arcane and led to muddle and confusion....,AstraZeneca,"JULY 9, 2014"
Five examples of the UK Takeover Code in action,https://www.ft.com/content/c94eccf4-0757-11e4-b1b0-00144feab7de,,https://www.ft.com/uk-companies,UK companies,"...May 19 2014: Pfizer outlines “final” offer to AstraZeneca, saying that its offer will not be increased, “except in the circumstances set out below”....",AstraZeneca,"JULY 9, 2014"
UK Takeover Panel forces AbbVie to retract claims of Shire support,https://www.ft.com/content/f97218fe-0730-11e4-b1b0-00144feab7de,,https://www.ft.com/us-companies,US & Canadian companies,"...volte-face for the US suitor and a further sign of how closely the panel is policing the company’s public utterances, as it did with Pfizer’s attempts to acquire another FTSE 100 pharmaceuticals group, AstraZeneca...",AstraZeneca,"JULY 9, 2014"
Cable backtracks on move to protect science industry,https://www.ft.com/content/0c67a6ee-06c4-11e4-b0d3-00144feab7de,,https://www.ft.com/world,World,...Pfizer walked away from AstraZeneca after the Anglo-Swedish company rebuffed its advances....,AstraZeneca,"JULY 8, 2014"
AstraZeneca chairman Leif Johansson defends Pfizer rebuff,https://www.ft.com/content/b69c8a70-1bab-11e4-adc7-00144feabdc0,https://www.ft.com/__origami/service/image/v2/images/raw/http%3A%2F%2Fprod-upp-image-read.ft.com%2F78beefd4-d099-11e3-9a81-00144feabdc0?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/us-companies,US & Canadian companies,...AstraZeneca is already big enough and super big may not be better.”...,AstraZeneca,"AUGUST 4, 2014"
Europe delivers earnings growth for the first time in three years,https://www.ft.com/content/d8e7a14a-18af-11e4-a51a-00144feabdc0,https://www.ft.com/__origami/service/image/v2/images/raw/http%3A%2F%2Fprod-upp-image-read.ft.com%2Fcf0ef45a-1aff-11e4-a633-00144feabdc0?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/european-companies,European companies,"...Eni, the Italian oil and gas group, announced a 51 per cent increase in its quarterly net profit, and AstraZeneca, the UK drugmaker that in May rejected a £69.4bn takeover from Pfizer, also beat analysts...",AstraZeneca,"AUGUST 3, 2014"
GlaxoSmithKline vulnerable to Pfizer bid after price slump,https://www.ft.com/content/adc5184e-199a-11e4-b06c-00144feabdc0,,https://www.ft.com/uk-equities,UK equities,"...AstraZeneca, meanwhile, was off 0.1 per cent to £43.39 even after its chairman and three non-executive directors added to their stakes....",AstraZeneca,"AUGUST 1, 2014"
Drug pricing: Bitter pill,https://www.ft.com/content/f3ede8ae-189c-11e4-933e-00144feabdc0,,https://www.ft.com/the-big-read,The Big Read,"...It is already bigger by market capitalisation, at $143bn, than some traditional pharma mainstays, including GlaxoSmithKline and AstraZeneca....",AstraZeneca,"JULY 31, 2014"
AstraZeneca raises full-year earnings guidance,https://www.ft.com/content/d6d17a6a-1883-11e4-a51a-00144feabdc0,,https://www.ft.com/uk-companies,UK companies,...Analysts said this suggested AstraZeneca was bracing for a fresh approach....,AstraZeneca,"JULY 31, 2014"
AstraZeneca to bolster respiratory drugs with Almirall deal,https://www.ft.com/content/c1c1e25a-17b5-11e4-b842-00144feabdc0,,https://www.ft.com/european-companies,European companies,"...The deal will also reinforce the challenge posed by AstraZeneca to GlaxoSmithKline, its UK rival, in the respiratory market....",AstraZeneca,"JULY 30, 2014"
GSK’s Witty fights back amid bribery scandal and profit warning,https://www.ft.com/content/f7869406-1564-11e4-ae2e-00144feabdc0,,https://www.ft.com/uk-companies,UK companies,...Pfizer walked away after AstraZeneca rejected what would have been the biggest foreign takeover of a UK company....,AstraZeneca,"JULY 27, 2014"
US warned of up to 25 groups eyeing foreign switch to cut tax,https://www.ft.com/content/69e69c42-11c0-11e4-8279-00144feabdc0,,https://www.ft.com/us-politics-policy,US politics & policy,...They were thrust into the spotlight by Pfizer’s $116bn attempt to buy UK rival AstraZeneca....,AstraZeneca,"JULY 22, 2014"
Shire chief’s $10m ‘golden hello’ at AbbVie,https://www.ft.com/content/aeb66b6c-0e97-11e4-a1ae-00144feabdc0,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...It is the second FTSE 100 drugmaker to be subjected to an unsolicited takeover attempt by a US rival this year, after Pfizer’s failed £69.4bn bid for AstraZeneca....",AstraZeneca,"JULY 18, 2014"
AbbVie rounds on US tax laws as it snares Shire,https://www.ft.com/content/c43aa6ce-0e60-11e4-a1ae-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,"...However, while the latter approach drew strong political opposition because of AstraZeneca’s importance to the UK science base, the proposed Shire takeover has proved much less controversial....",AstraZeneca’s,"JULY 18, 2014"
AstraZeneca unveils plans for £330m R&D centre in Cambridge,https://www.ft.com/content/e86805f6-0e64-11e4-b1c4-00144feabdc0,,https://www.ft.com/london-future,London fights for its future,...AstraZeneca’s commitment to UK science was at the heart of its defence against Pfizer’s £69bn takeover bid in May....,AstraZeneca’s,"JULY 18, 2014"
AbbVie set to unveil £31bn Shire takeover,https://www.ft.com/content/d324fa2e-0dcd-11e4-85ab-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,...Shire is the second FTSE 100 drugmaker to be subjected to an unsolicited takeover attempt by a US rival this year after Pfizer’s failed £69.4bn bid for AstraZeneca....,AstraZeneca,"JULY 17, 2014"
Eli Lilly joins forces with UK biotech to develop cancer drugs,https://www.ft.com/content/d2ea0274-0ccf-11e4-bf1e-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,"...The deal with Immunocore adds to the British company’s existing alliances with AstraZeneca, GlaxoSmithKline and Roche, marking it out as one of the most promising new names in the UK life science sector....",AstraZeneca,"JULY 16, 2014"
Experian suffers shareholder revolt over board reshuffle,https://www.ft.com/content/82cae036-0cc7-11e4-90fa-00144feabdc0,,https://www.ft.com/corporate-governance,Corporate governance,"...Barclays, AstraZeneca, Reckitt Benckiser, WPP and Pearson (owner of the Financial Times) have each endured notable rebellions over remuneration....",AstraZeneca,"JULY 16, 2014"
David Cameron moves to boost UK life sciences,https://www.ft.com/content/8bb3d4ac-0c52-11e4-943b-00144feabdc0,,https://www.ft.com/uk-inward-investment,UK inward investment,...appointment of George Freeman in a newly created life sciences role in Tuesday’s reshuffle marks the prime minister’s determination to strengthen oversight of the sector following Pfizer’s £69.4bn bid for AstraZeneca...,AstraZeneca,"JULY 16, 2014"
Sir John Peace in the line of fire at FTSE 100 groups,https://www.ft.com/content/fd88db6a-0be7-11e4-a096-00144feabdc0,,https://www.ft.com/corporate-governance,Corporate governance,"...Barclays, AstraZeneca, Pearson (which owns the Financial Times), WPP and HSBC have each suffered revolts amid renewed shareholder agitation....",AstraZeneca,"JULY 15, 2014"
AbbVie closes in on £31bn takeover of Shire,https://www.ft.com/content/c8fe1c14-0b1c-11e4-ae6b-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,...AbbVie looks set to succeed where Pfizer failed in its £69.4bn bid for AstraZeneca of the UK in May....,AstraZeneca,"JULY 14, 2014"
Quindell starts on long road back to favour,https://www.ft.com/content/32d9afe6-0b71-11e4-8693-00144feabdc0,,https://www.ft.com/kate-burgess,Kate Burgess,"...Pfizer’s tilt at AstraZeneca set teacups clattering a few months ago. By contrast, the mooted purchase of Shire by US pharmaceutical rival AbbVie has yet to trouble the pages of the populist press....",AstraZeneca,"JULY 14, 2014"
AbbVie/Shire – join us at 12 for a live discussion,https://www.ft.com/content/010f6536-2e7f-35a7-ba2f-15469dfc4856,,https://www.ft.com/joseph-cotterill,Joseph Cotterill,"...of AbbVie’s £53.20 a share offer would eventually lead to a similar clause…

The price is a 42 per cent premium to where Shire shares traded before AbbVie became involved (though after Pfizer’s bid for AstraZeneca...",AstraZeneca,"JULY 14, 2014"
Vince Cable plans to toughen up takeover rules,https://www.ft.com/content/a41dcbe8-0a71-11e4-ac2a-00144feabdc0,,https://www.ft.com/world,World,...The business secretary concluded that the existing rules were inadequate after Pfizer’s £69.4bn approach for AstraZeneca....,AstraZeneca,"JULY 13, 2014"
Myners must give independent advice on independents,https://www.ft.com/content/8b1358ae-0740-11e4-81c6-00144feab7de,,https://www.ft.com/jonathan-guthrie,Jonathan Guthrie,"...The £69bn bid that Pfizer, made for AstraZeneca unravelled in May after its own discussions with the City M&A watchdog....",AstraZeneca,"JULY 9, 2014"
AbbVie retraction shows panel has teeth,https://www.ft.com/content/0adb6e98-0753-11e4-b1b0-00144feab7de,,https://www.ft.com/us-companies,US & Canadian companies,...The increased scrutiny of the code during the Pfizer/AstraZeneca courtship sparked complaints that the rules were arcane and led to muddle and confusion....,AstraZeneca,"JULY 9, 2014"
Five examples of the UK Takeover Code in action,https://www.ft.com/content/c94eccf4-0757-11e4-b1b0-00144feab7de,,https://www.ft.com/uk-companies,UK companies,"...May 19 2014: Pfizer outlines “final” offer to AstraZeneca, saying that its offer will not be increased, “except in the circumstances set out below”....",AstraZeneca,"JULY 9, 2014"
UK Takeover Panel forces AbbVie to retract claims of Shire support,https://www.ft.com/content/f97218fe-0730-11e4-b1b0-00144feab7de,,https://www.ft.com/us-companies,US & Canadian companies,"...volte-face for the US suitor and a further sign of how closely the panel is policing the company’s public utterances, as it did with Pfizer’s attempts to acquire another FTSE 100 pharmaceuticals group, AstraZeneca...",AstraZeneca,"JULY 9, 2014"
Cable backtracks on move to protect science industry,https://www.ft.com/content/0c67a6ee-06c4-11e4-b0d3-00144feab7de,,https://www.ft.com/world,World,...Pfizer walked away from AstraZeneca after the Anglo-Swedish company rebuffed its advances....,AstraZeneca,"JULY 8, 2014"
AstraZeneca chairman Leif Johansson defends Pfizer rebuff,https://www.ft.com/content/b69c8a70-1bab-11e4-adc7-00144feabdc0,https://www.ft.com/__origami/service/image/v2/images/raw/http%3A%2F%2Fprod-upp-image-read.ft.com%2F78beefd4-d099-11e3-9a81-00144feabdc0?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/us-companies,US & Canadian companies,...AstraZeneca is already big enough and super big may not be better.”...,AstraZeneca,"AUGUST 4, 2014"
Europe delivers earnings growth for the first time in three years,https://www.ft.com/content/d8e7a14a-18af-11e4-a51a-00144feabdc0,https://www.ft.com/__origami/service/image/v2/images/raw/http%3A%2F%2Fprod-upp-image-read.ft.com%2Fcf0ef45a-1aff-11e4-a633-00144feabdc0?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/european-companies,European companies,"...Eni, the Italian oil and gas group, announced a 51 per cent increase in its quarterly net profit, and AstraZeneca, the UK drugmaker that in May rejected a £69.4bn takeover from Pfizer, also beat analysts...",AstraZeneca,"AUGUST 3, 2014"
GlaxoSmithKline vulnerable to Pfizer bid after price slump,https://www.ft.com/content/adc5184e-199a-11e4-b06c-00144feabdc0,,https://www.ft.com/uk-equities,UK equities,"...AstraZeneca, meanwhile, was off 0.1 per cent to £43.39 even after its chairman and three non-executive directors added to their stakes....",AstraZeneca,"AUGUST 1, 2014"
Drug pricing: Bitter pill,https://www.ft.com/content/f3ede8ae-189c-11e4-933e-00144feabdc0,,https://www.ft.com/the-big-read,The Big Read,"...It is already bigger by market capitalisation, at $143bn, than some traditional pharma mainstays, including GlaxoSmithKline and AstraZeneca....",AstraZeneca,"JULY 31, 2014"
AstraZeneca raises full-year earnings guidance,https://www.ft.com/content/d6d17a6a-1883-11e4-a51a-00144feabdc0,,https://www.ft.com/uk-companies,UK companies,...Analysts said this suggested AstraZeneca was bracing for a fresh approach....,AstraZeneca,"JULY 31, 2014"
AstraZeneca to bolster respiratory drugs with Almirall deal,https://www.ft.com/content/c1c1e25a-17b5-11e4-b842-00144feabdc0,,https://www.ft.com/european-companies,European companies,"...The deal will also reinforce the challenge posed by AstraZeneca to GlaxoSmithKline, its UK rival, in the respiratory market....",AstraZeneca,"JULY 30, 2014"
GSK’s Witty fights back amid bribery scandal and profit warning,https://www.ft.com/content/f7869406-1564-11e4-ae2e-00144feabdc0,,https://www.ft.com/uk-companies,UK companies,...Pfizer walked away after AstraZeneca rejected what would have been the biggest foreign takeover of a UK company....,AstraZeneca,"JULY 27, 2014"
US warned of up to 25 groups eyeing foreign switch to cut tax,https://www.ft.com/content/69e69c42-11c0-11e4-8279-00144feabdc0,,https://www.ft.com/us-politics-policy,US politics & policy,...They were thrust into the spotlight by Pfizer’s $116bn attempt to buy UK rival AstraZeneca....,AstraZeneca,"JULY 22, 2014"
Shire chief’s $10m ‘golden hello’ at AbbVie,https://www.ft.com/content/aeb66b6c-0e97-11e4-a1ae-00144feabdc0,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...It is the second FTSE 100 drugmaker to be subjected to an unsolicited takeover attempt by a US rival this year, after Pfizer’s failed £69.4bn bid for AstraZeneca....",AstraZeneca,"JULY 18, 2014"
AbbVie rounds on US tax laws as it snares Shire,https://www.ft.com/content/c43aa6ce-0e60-11e4-a1ae-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,"...However, while the latter approach drew strong political opposition because of AstraZeneca’s importance to the UK science base, the proposed Shire takeover has proved much less controversial....",AstraZeneca’s,"JULY 18, 2014"
AstraZeneca unveils plans for £330m R&D centre in Cambridge,https://www.ft.com/content/e86805f6-0e64-11e4-b1c4-00144feabdc0,,https://www.ft.com/london-future,London fights for its future,...AstraZeneca’s commitment to UK science was at the heart of its defence against Pfizer’s £69bn takeover bid in May....,AstraZeneca’s,"JULY 18, 2014"
AbbVie set to unveil £31bn Shire takeover,https://www.ft.com/content/d324fa2e-0dcd-11e4-85ab-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,...Shire is the second FTSE 100 drugmaker to be subjected to an unsolicited takeover attempt by a US rival this year after Pfizer’s failed £69.4bn bid for AstraZeneca....,AstraZeneca,"JULY 17, 2014"
Eli Lilly joins forces with UK biotech to develop cancer drugs,https://www.ft.com/content/d2ea0274-0ccf-11e4-bf1e-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,"...The deal with Immunocore adds to the British company’s existing alliances with AstraZeneca, GlaxoSmithKline and Roche, marking it out as one of the most promising new names in the UK life science sector....",AstraZeneca,"JULY 16, 2014"
Experian suffers shareholder revolt over board reshuffle,https://www.ft.com/content/82cae036-0cc7-11e4-90fa-00144feabdc0,,https://www.ft.com/corporate-governance,Corporate governance,"...Barclays, AstraZeneca, Reckitt Benckiser, WPP and Pearson (owner of the Financial Times) have each endured notable rebellions over remuneration....",AstraZeneca,"JULY 16, 2014"
David Cameron moves to boost UK life sciences,https://www.ft.com/content/8bb3d4ac-0c52-11e4-943b-00144feabdc0,,https://www.ft.com/uk-inward-investment,UK inward investment,...appointment of George Freeman in a newly created life sciences role in Tuesday’s reshuffle marks the prime minister’s determination to strengthen oversight of the sector following Pfizer’s £69.4bn bid for AstraZeneca...,AstraZeneca,"JULY 16, 2014"
Sir John Peace in the line of fire at FTSE 100 groups,https://www.ft.com/content/fd88db6a-0be7-11e4-a096-00144feabdc0,,https://www.ft.com/corporate-governance,Corporate governance,"...Barclays, AstraZeneca, Pearson (which owns the Financial Times), WPP and HSBC have each suffered revolts amid renewed shareholder agitation....",AstraZeneca,"JULY 15, 2014"
AbbVie closes in on £31bn takeover of Shire,https://www.ft.com/content/c8fe1c14-0b1c-11e4-ae6b-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,...AbbVie looks set to succeed where Pfizer failed in its £69.4bn bid for AstraZeneca of the UK in May....,AstraZeneca,"JULY 14, 2014"
Quindell starts on long road back to favour,https://www.ft.com/content/32d9afe6-0b71-11e4-8693-00144feabdc0,,https://www.ft.com/kate-burgess,Kate Burgess,"...Pfizer’s tilt at AstraZeneca set teacups clattering a few months ago. By contrast, the mooted purchase of Shire by US pharmaceutical rival AbbVie has yet to trouble the pages of the populist press....",AstraZeneca,"JULY 14, 2014"
AbbVie/Shire – join us at 12 for a live discussion,https://www.ft.com/content/010f6536-2e7f-35a7-ba2f-15469dfc4856,,https://www.ft.com/joseph-cotterill,Joseph Cotterill,"...of AbbVie’s £53.20 a share offer would eventually lead to a similar clause…

The price is a 42 per cent premium to where Shire shares traded before AbbVie became involved (though after Pfizer’s bid for AstraZeneca...",AstraZeneca,"JULY 14, 2014"
Vince Cable plans to toughen up takeover rules,https://www.ft.com/content/a41dcbe8-0a71-11e4-ac2a-00144feabdc0,,https://www.ft.com/world,World,...The business secretary concluded that the existing rules were inadequate after Pfizer’s £69.4bn approach for AstraZeneca....,AstraZeneca,"JULY 13, 2014"
Myners must give independent advice on independents,https://www.ft.com/content/8b1358ae-0740-11e4-81c6-00144feab7de,,https://www.ft.com/jonathan-guthrie,Jonathan Guthrie,"...The £69bn bid that Pfizer, made for AstraZeneca unravelled in May after its own discussions with the City M&A watchdog....",AstraZeneca,"JULY 9, 2014"
AbbVie retraction shows panel has teeth,https://www.ft.com/content/0adb6e98-0753-11e4-b1b0-00144feab7de,,https://www.ft.com/us-companies,US & Canadian companies,...The increased scrutiny of the code during the Pfizer/AstraZeneca courtship sparked complaints that the rules were arcane and led to muddle and confusion....,AstraZeneca,"JULY 9, 2014"
Five examples of the UK Takeover Code in action,https://www.ft.com/content/c94eccf4-0757-11e4-b1b0-00144feab7de,,https://www.ft.com/uk-companies,UK companies,"...May 19 2014: Pfizer outlines “final” offer to AstraZeneca, saying that its offer will not be increased, “except in the circumstances set out below”....",AstraZeneca,"JULY 9, 2014"
UK Takeover Panel forces AbbVie to retract claims of Shire support,https://www.ft.com/content/f97218fe-0730-11e4-b1b0-00144feab7de,,https://www.ft.com/us-companies,US & Canadian companies,"...volte-face for the US suitor and a further sign of how closely the panel is policing the company’s public utterances, as it did with Pfizer’s attempts to acquire another FTSE 100 pharmaceuticals group, AstraZeneca...",AstraZeneca,"JULY 9, 2014"
Cable backtracks on move to protect science industry,https://www.ft.com/content/0c67a6ee-06c4-11e4-b0d3-00144feab7de,,https://www.ft.com/world,World,...Pfizer walked away from AstraZeneca after the Anglo-Swedish company rebuffed its advances....,AstraZeneca,"JULY 8, 2014"
AstraZeneca chairman Leif Johansson defends Pfizer rebuff,https://www.ft.com/content/b69c8a70-1bab-11e4-adc7-00144feabdc0,https://www.ft.com/__origami/service/image/v2/images/raw/http%3A%2F%2Fprod-upp-image-read.ft.com%2F78beefd4-d099-11e3-9a81-00144feabdc0?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/us-companies,US & Canadian companies,...AstraZeneca is already big enough and super big may not be better.”...,AstraZeneca,"AUGUST 4, 2014"
Europe delivers earnings growth for the first time in three years,https://www.ft.com/content/d8e7a14a-18af-11e4-a51a-00144feabdc0,https://www.ft.com/__origami/service/image/v2/images/raw/http%3A%2F%2Fprod-upp-image-read.ft.com%2Fcf0ef45a-1aff-11e4-a633-00144feabdc0?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/european-companies,European companies,"...Eni, the Italian oil and gas group, announced a 51 per cent increase in its quarterly net profit, and AstraZeneca, the UK drugmaker that in May rejected a £69.4bn takeover from Pfizer, also beat analysts...",AstraZeneca,"AUGUST 3, 2014"
GlaxoSmithKline vulnerable to Pfizer bid after price slump,https://www.ft.com/content/adc5184e-199a-11e4-b06c-00144feabdc0,,https://www.ft.com/uk-equities,UK equities,"...AstraZeneca, meanwhile, was off 0.1 per cent to £43.39 even after its chairman and three non-executive directors added to their stakes....",AstraZeneca,"AUGUST 1, 2014"
Drug pricing: Bitter pill,https://www.ft.com/content/f3ede8ae-189c-11e4-933e-00144feabdc0,,https://www.ft.com/the-big-read,The Big Read,"...It is already bigger by market capitalisation, at $143bn, than some traditional pharma mainstays, including GlaxoSmithKline and AstraZeneca....",AstraZeneca,"JULY 31, 2014"
AstraZeneca raises full-year earnings guidance,https://www.ft.com/content/d6d17a6a-1883-11e4-a51a-00144feabdc0,,https://www.ft.com/uk-companies,UK companies,...Analysts said this suggested AstraZeneca was bracing for a fresh approach....,AstraZeneca,"JULY 31, 2014"
AstraZeneca to bolster respiratory drugs with Almirall deal,https://www.ft.com/content/c1c1e25a-17b5-11e4-b842-00144feabdc0,,https://www.ft.com/european-companies,European companies,"...The deal will also reinforce the challenge posed by AstraZeneca to GlaxoSmithKline, its UK rival, in the respiratory market....",AstraZeneca,"JULY 30, 2014"
GSK’s Witty fights back amid bribery scandal and profit warning,https://www.ft.com/content/f7869406-1564-11e4-ae2e-00144feabdc0,,https://www.ft.com/uk-companies,UK companies,...Pfizer walked away after AstraZeneca rejected what would have been the biggest foreign takeover of a UK company....,AstraZeneca,"JULY 27, 2014"
US warned of up to 25 groups eyeing foreign switch to cut tax,https://www.ft.com/content/69e69c42-11c0-11e4-8279-00144feabdc0,,https://www.ft.com/us-politics-policy,US politics & policy,...They were thrust into the spotlight by Pfizer’s $116bn attempt to buy UK rival AstraZeneca....,AstraZeneca,"JULY 22, 2014"
Shire chief’s $10m ‘golden hello’ at AbbVie,https://www.ft.com/content/aeb66b6c-0e97-11e4-a1ae-00144feabdc0,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...It is the second FTSE 100 drugmaker to be subjected to an unsolicited takeover attempt by a US rival this year, after Pfizer’s failed £69.4bn bid for AstraZeneca....",AstraZeneca,"JULY 18, 2014"
AbbVie rounds on US tax laws as it snares Shire,https://www.ft.com/content/c43aa6ce-0e60-11e4-a1ae-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,"...However, while the latter approach drew strong political opposition because of AstraZeneca’s importance to the UK science base, the proposed Shire takeover has proved much less controversial....",AstraZeneca’s,"JULY 18, 2014"
AstraZeneca unveils plans for £330m R&D centre in Cambridge,https://www.ft.com/content/e86805f6-0e64-11e4-b1c4-00144feabdc0,,https://www.ft.com/london-future,London fights for its future,...AstraZeneca’s commitment to UK science was at the heart of its defence against Pfizer’s £69bn takeover bid in May....,AstraZeneca’s,"JULY 18, 2014"
AbbVie set to unveil £31bn Shire takeover,https://www.ft.com/content/d324fa2e-0dcd-11e4-85ab-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,...Shire is the second FTSE 100 drugmaker to be subjected to an unsolicited takeover attempt by a US rival this year after Pfizer’s failed £69.4bn bid for AstraZeneca....,AstraZeneca,"JULY 17, 2014"
Eli Lilly joins forces with UK biotech to develop cancer drugs,https://www.ft.com/content/d2ea0274-0ccf-11e4-bf1e-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,"...The deal with Immunocore adds to the British company’s existing alliances with AstraZeneca, GlaxoSmithKline and Roche, marking it out as one of the most promising new names in the UK life science sector....",AstraZeneca,"JULY 16, 2014"
Experian suffers shareholder revolt over board reshuffle,https://www.ft.com/content/82cae036-0cc7-11e4-90fa-00144feabdc0,,https://www.ft.com/corporate-governance,Corporate governance,"...Barclays, AstraZeneca, Reckitt Benckiser, WPP and Pearson (owner of the Financial Times) have each endured notable rebellions over remuneration....",AstraZeneca,"JULY 16, 2014"
David Cameron moves to boost UK life sciences,https://www.ft.com/content/8bb3d4ac-0c52-11e4-943b-00144feabdc0,,https://www.ft.com/uk-inward-investment,UK inward investment,...appointment of George Freeman in a newly created life sciences role in Tuesday’s reshuffle marks the prime minister’s determination to strengthen oversight of the sector following Pfizer’s £69.4bn bid for AstraZeneca...,AstraZeneca,"JULY 16, 2014"
Sir John Peace in the line of fire at FTSE 100 groups,https://www.ft.com/content/fd88db6a-0be7-11e4-a096-00144feabdc0,,https://www.ft.com/corporate-governance,Corporate governance,"...Barclays, AstraZeneca, Pearson (which owns the Financial Times), WPP and HSBC have each suffered revolts amid renewed shareholder agitation....",AstraZeneca,"JULY 15, 2014"
AbbVie closes in on £31bn takeover of Shire,https://www.ft.com/content/c8fe1c14-0b1c-11e4-ae6b-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,...AbbVie looks set to succeed where Pfizer failed in its £69.4bn bid for AstraZeneca of the UK in May....,AstraZeneca,"JULY 14, 2014"
Quindell starts on long road back to favour,https://www.ft.com/content/32d9afe6-0b71-11e4-8693-00144feabdc0,,https://www.ft.com/kate-burgess,Kate Burgess,"...Pfizer’s tilt at AstraZeneca set teacups clattering a few months ago. By contrast, the mooted purchase of Shire by US pharmaceutical rival AbbVie has yet to trouble the pages of the populist press....",AstraZeneca,"JULY 14, 2014"
AbbVie/Shire – join us at 12 for a live discussion,https://www.ft.com/content/010f6536-2e7f-35a7-ba2f-15469dfc4856,,https://www.ft.com/joseph-cotterill,Joseph Cotterill,"...of AbbVie’s £53.20 a share offer would eventually lead to a similar clause…

The price is a 42 per cent premium to where Shire shares traded before AbbVie became involved (though after Pfizer’s bid for AstraZeneca...",AstraZeneca,"JULY 14, 2014"
Vince Cable plans to toughen up takeover rules,https://www.ft.com/content/a41dcbe8-0a71-11e4-ac2a-00144feabdc0,,https://www.ft.com/world,World,...The business secretary concluded that the existing rules were inadequate after Pfizer’s £69.4bn approach for AstraZeneca....,AstraZeneca,"JULY 13, 2014"
Myners must give independent advice on independents,https://www.ft.com/content/8b1358ae-0740-11e4-81c6-00144feab7de,,https://www.ft.com/jonathan-guthrie,Jonathan Guthrie,"...The £69bn bid that Pfizer, made for AstraZeneca unravelled in May after its own discussions with the City M&A watchdog....",AstraZeneca,"JULY 9, 2014"
AbbVie retraction shows panel has teeth,https://www.ft.com/content/0adb6e98-0753-11e4-b1b0-00144feab7de,,https://www.ft.com/us-companies,US & Canadian companies,...The increased scrutiny of the code during the Pfizer/AstraZeneca courtship sparked complaints that the rules were arcane and led to muddle and confusion....,AstraZeneca,"JULY 9, 2014"
Five examples of the UK Takeover Code in action,https://www.ft.com/content/c94eccf4-0757-11e4-b1b0-00144feab7de,,https://www.ft.com/uk-companies,UK companies,"...May 19 2014: Pfizer outlines “final” offer to AstraZeneca, saying that its offer will not be increased, “except in the circumstances set out below”....",AstraZeneca,"JULY 9, 2014"
UK Takeover Panel forces AbbVie to retract claims of Shire support,https://www.ft.com/content/f97218fe-0730-11e4-b1b0-00144feab7de,,https://www.ft.com/us-companies,US & Canadian companies,"...volte-face for the US suitor and a further sign of how closely the panel is policing the company’s public utterances, as it did with Pfizer’s attempts to acquire another FTSE 100 pharmaceuticals group, AstraZeneca...",AstraZeneca,"JULY 9, 2014"
Cable backtracks on move to protect science industry,https://www.ft.com/content/0c67a6ee-06c4-11e4-b0d3-00144feab7de,,https://www.ft.com/world,World,...Pfizer walked away from AstraZeneca after the Anglo-Swedish company rebuffed its advances....,AstraZeneca,"JULY 8, 2014"
AstraZeneca chairman Leif Johansson defends Pfizer rebuff,https://www.ft.com/content/b69c8a70-1bab-11e4-adc7-00144feabdc0,https://www.ft.com/__origami/service/image/v2/images/raw/http%3A%2F%2Fprod-upp-image-read.ft.com%2F78beefd4-d099-11e3-9a81-00144feabdc0?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/us-companies,US & Canadian companies,...AstraZeneca is already big enough and super big may not be better.”...,AstraZeneca,"AUGUST 4, 2014"
Europe delivers earnings growth for the first time in three years,https://www.ft.com/content/d8e7a14a-18af-11e4-a51a-00144feabdc0,https://www.ft.com/__origami/service/image/v2/images/raw/http%3A%2F%2Fprod-upp-image-read.ft.com%2Fcf0ef45a-1aff-11e4-a633-00144feabdc0?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/european-companies,European companies,"...Eni, the Italian oil and gas group, announced a 51 per cent increase in its quarterly net profit, and AstraZeneca, the UK drugmaker that in May rejected a £69.4bn takeover from Pfizer, also beat analysts...",AstraZeneca,"AUGUST 3, 2014"
GlaxoSmithKline vulnerable to Pfizer bid after price slump,https://www.ft.com/content/adc5184e-199a-11e4-b06c-00144feabdc0,,https://www.ft.com/uk-equities,UK equities,"...AstraZeneca, meanwhile, was off 0.1 per cent to £43.39 even after its chairman and three non-executive directors added to their stakes....",AstraZeneca,"AUGUST 1, 2014"
Drug pricing: Bitter pill,https://www.ft.com/content/f3ede8ae-189c-11e4-933e-00144feabdc0,,https://www.ft.com/the-big-read,The Big Read,"...It is already bigger by market capitalisation, at $143bn, than some traditional pharma mainstays, including GlaxoSmithKline and AstraZeneca....",AstraZeneca,"JULY 31, 2014"
AstraZeneca raises full-year earnings guidance,https://www.ft.com/content/d6d17a6a-1883-11e4-a51a-00144feabdc0,,https://www.ft.com/uk-companies,UK companies,...Analysts said this suggested AstraZeneca was bracing for a fresh approach....,AstraZeneca,"JULY 31, 2014"
AstraZeneca to bolster respiratory drugs with Almirall deal,https://www.ft.com/content/c1c1e25a-17b5-11e4-b842-00144feabdc0,,https://www.ft.com/european-companies,European companies,"...The deal will also reinforce the challenge posed by AstraZeneca to GlaxoSmithKline, its UK rival, in the respiratory market....",AstraZeneca,"JULY 30, 2014"
GSK’s Witty fights back amid bribery scandal and profit warning,https://www.ft.com/content/f7869406-1564-11e4-ae2e-00144feabdc0,,https://www.ft.com/uk-companies,UK companies,...Pfizer walked away after AstraZeneca rejected what would have been the biggest foreign takeover of a UK company....,AstraZeneca,"JULY 27, 2014"
US warned of up to 25 groups eyeing foreign switch to cut tax,https://www.ft.com/content/69e69c42-11c0-11e4-8279-00144feabdc0,,https://www.ft.com/us-politics-policy,US politics & policy,...They were thrust into the spotlight by Pfizer’s $116bn attempt to buy UK rival AstraZeneca....,AstraZeneca,"JULY 22, 2014"
Shire chief’s $10m ‘golden hello’ at AbbVie,https://www.ft.com/content/aeb66b6c-0e97-11e4-a1ae-00144feabdc0,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...It is the second FTSE 100 drugmaker to be subjected to an unsolicited takeover attempt by a US rival this year, after Pfizer’s failed £69.4bn bid for AstraZeneca....",AstraZeneca,"JULY 18, 2014"
AbbVie rounds on US tax laws as it snares Shire,https://www.ft.com/content/c43aa6ce-0e60-11e4-a1ae-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,"...However, while the latter approach drew strong political opposition because of AstraZeneca’s importance to the UK science base, the proposed Shire takeover has proved much less controversial....",AstraZeneca’s,"JULY 18, 2014"
AstraZeneca unveils plans for £330m R&D centre in Cambridge,https://www.ft.com/content/e86805f6-0e64-11e4-b1c4-00144feabdc0,,https://www.ft.com/london-future,London fights for its future,...AstraZeneca’s commitment to UK science was at the heart of its defence against Pfizer’s £69bn takeover bid in May....,AstraZeneca’s,"JULY 18, 2014"
AbbVie set to unveil £31bn Shire takeover,https://www.ft.com/content/d324fa2e-0dcd-11e4-85ab-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,...Shire is the second FTSE 100 drugmaker to be subjected to an unsolicited takeover attempt by a US rival this year after Pfizer’s failed £69.4bn bid for AstraZeneca....,AstraZeneca,"JULY 17, 2014"
Eli Lilly joins forces with UK biotech to develop cancer drugs,https://www.ft.com/content/d2ea0274-0ccf-11e4-bf1e-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,"...The deal with Immunocore adds to the British company’s existing alliances with AstraZeneca, GlaxoSmithKline and Roche, marking it out as one of the most promising new names in the UK life science sector....",AstraZeneca,"JULY 16, 2014"
Experian suffers shareholder revolt over board reshuffle,https://www.ft.com/content/82cae036-0cc7-11e4-90fa-00144feabdc0,,https://www.ft.com/corporate-governance,Corporate governance,"...Barclays, AstraZeneca, Reckitt Benckiser, WPP and Pearson (owner of the Financial Times) have each endured notable rebellions over remuneration....",AstraZeneca,"JULY 16, 2014"
David Cameron moves to boost UK life sciences,https://www.ft.com/content/8bb3d4ac-0c52-11e4-943b-00144feabdc0,,https://www.ft.com/uk-inward-investment,UK inward investment,...appointment of George Freeman in a newly created life sciences role in Tuesday’s reshuffle marks the prime minister’s determination to strengthen oversight of the sector following Pfizer’s £69.4bn bid for AstraZeneca...,AstraZeneca,"JULY 16, 2014"
Sir John Peace in the line of fire at FTSE 100 groups,https://www.ft.com/content/fd88db6a-0be7-11e4-a096-00144feabdc0,,https://www.ft.com/corporate-governance,Corporate governance,"...Barclays, AstraZeneca, Pearson (which owns the Financial Times), WPP and HSBC have each suffered revolts amid renewed shareholder agitation....",AstraZeneca,"JULY 15, 2014"
AbbVie closes in on £31bn takeover of Shire,https://www.ft.com/content/c8fe1c14-0b1c-11e4-ae6b-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,...AbbVie looks set to succeed where Pfizer failed in its £69.4bn bid for AstraZeneca of the UK in May....,AstraZeneca,"JULY 14, 2014"
Quindell starts on long road back to favour,https://www.ft.com/content/32d9afe6-0b71-11e4-8693-00144feabdc0,,https://www.ft.com/kate-burgess,Kate Burgess,"...Pfizer’s tilt at AstraZeneca set teacups clattering a few months ago. By contrast, the mooted purchase of Shire by US pharmaceutical rival AbbVie has yet to trouble the pages of the populist press....",AstraZeneca,"JULY 14, 2014"
AbbVie/Shire – join us at 12 for a live discussion,https://www.ft.com/content/010f6536-2e7f-35a7-ba2f-15469dfc4856,,https://www.ft.com/joseph-cotterill,Joseph Cotterill,"...of AbbVie’s £53.20 a share offer would eventually lead to a similar clause…

The price is a 42 per cent premium to where Shire shares traded before AbbVie became involved (though after Pfizer’s bid for AstraZeneca...",AstraZeneca,"JULY 14, 2014"
Vince Cable plans to toughen up takeover rules,https://www.ft.com/content/a41dcbe8-0a71-11e4-ac2a-00144feabdc0,,https://www.ft.com/world,World,...The business secretary concluded that the existing rules were inadequate after Pfizer’s £69.4bn approach for AstraZeneca....,AstraZeneca,"JULY 13, 2014"
Myners must give independent advice on independents,https://www.ft.com/content/8b1358ae-0740-11e4-81c6-00144feab7de,,https://www.ft.com/jonathan-guthrie,Jonathan Guthrie,"...The £69bn bid that Pfizer, made for AstraZeneca unravelled in May after its own discussions with the City M&A watchdog....",AstraZeneca,"JULY 9, 2014"
AbbVie retraction shows panel has teeth,https://www.ft.com/content/0adb6e98-0753-11e4-b1b0-00144feab7de,,https://www.ft.com/us-companies,US & Canadian companies,...The increased scrutiny of the code during the Pfizer/AstraZeneca courtship sparked complaints that the rules were arcane and led to muddle and confusion....,AstraZeneca,"JULY 9, 2014"
Five examples of the UK Takeover Code in action,https://www.ft.com/content/c94eccf4-0757-11e4-b1b0-00144feab7de,,https://www.ft.com/uk-companies,UK companies,"...May 19 2014: Pfizer outlines “final” offer to AstraZeneca, saying that its offer will not be increased, “except in the circumstances set out below”....",AstraZeneca,"JULY 9, 2014"
UK Takeover Panel forces AbbVie to retract claims of Shire support,https://www.ft.com/content/f97218fe-0730-11e4-b1b0-00144feab7de,,https://www.ft.com/us-companies,US & Canadian companies,"...volte-face for the US suitor and a further sign of how closely the panel is policing the company’s public utterances, as it did with Pfizer’s attempts to acquire another FTSE 100 pharmaceuticals group, AstraZeneca...",AstraZeneca,"JULY 9, 2014"
Cable backtracks on move to protect science industry,https://www.ft.com/content/0c67a6ee-06c4-11e4-b0d3-00144feab7de,,https://www.ft.com/world,World,...Pfizer walked away from AstraZeneca after the Anglo-Swedish company rebuffed its advances....,AstraZeneca,"JULY 8, 2014"
AstraZeneca chairman Leif Johansson defends Pfizer rebuff,https://www.ft.com/content/b69c8a70-1bab-11e4-adc7-00144feabdc0,https://www.ft.com/__origami/service/image/v2/images/raw/http%3A%2F%2Fprod-upp-image-read.ft.com%2F78beefd4-d099-11e3-9a81-00144feabdc0?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/us-companies,US & Canadian companies,...AstraZeneca is already big enough and super big may not be better.”...,AstraZeneca,"AUGUST 4, 2014"
Europe delivers earnings growth for the first time in three years,https://www.ft.com/content/d8e7a14a-18af-11e4-a51a-00144feabdc0,https://www.ft.com/__origami/service/image/v2/images/raw/http%3A%2F%2Fprod-upp-image-read.ft.com%2Fcf0ef45a-1aff-11e4-a633-00144feabdc0?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/european-companies,European companies,"...Eni, the Italian oil and gas group, announced a 51 per cent increase in its quarterly net profit, and AstraZeneca, the UK drugmaker that in May rejected a £69.4bn takeover from Pfizer, also beat analysts...",AstraZeneca,"AUGUST 3, 2014"
GlaxoSmithKline vulnerable to Pfizer bid after price slump,https://www.ft.com/content/adc5184e-199a-11e4-b06c-00144feabdc0,,https://www.ft.com/uk-equities,UK equities,"...AstraZeneca, meanwhile, was off 0.1 per cent to £43.39 even after its chairman and three non-executive directors added to their stakes....",AstraZeneca,"AUGUST 1, 2014"
Drug pricing: Bitter pill,https://www.ft.com/content/f3ede8ae-189c-11e4-933e-00144feabdc0,,https://www.ft.com/the-big-read,The Big Read,"...It is already bigger by market capitalisation, at $143bn, than some traditional pharma mainstays, including GlaxoSmithKline and AstraZeneca....",AstraZeneca,"JULY 31, 2014"
AstraZeneca raises full-year earnings guidance,https://www.ft.com/content/d6d17a6a-1883-11e4-a51a-00144feabdc0,,https://www.ft.com/uk-companies,UK companies,...Analysts said this suggested AstraZeneca was bracing for a fresh approach....,AstraZeneca,"JULY 31, 2014"
AstraZeneca to bolster respiratory drugs with Almirall deal,https://www.ft.com/content/c1c1e25a-17b5-11e4-b842-00144feabdc0,,https://www.ft.com/european-companies,European companies,"...The deal will also reinforce the challenge posed by AstraZeneca to GlaxoSmithKline, its UK rival, in the respiratory market....",AstraZeneca,"JULY 30, 2014"
GSK’s Witty fights back amid bribery scandal and profit warning,https://www.ft.com/content/f7869406-1564-11e4-ae2e-00144feabdc0,,https://www.ft.com/uk-companies,UK companies,...Pfizer walked away after AstraZeneca rejected what would have been the biggest foreign takeover of a UK company....,AstraZeneca,"JULY 27, 2014"
US warned of up to 25 groups eyeing foreign switch to cut tax,https://www.ft.com/content/69e69c42-11c0-11e4-8279-00144feabdc0,,https://www.ft.com/us-politics-policy,US politics & policy,...They were thrust into the spotlight by Pfizer’s $116bn attempt to buy UK rival AstraZeneca....,AstraZeneca,"JULY 22, 2014"
Shire chief’s $10m ‘golden hello’ at AbbVie,https://www.ft.com/content/aeb66b6c-0e97-11e4-a1ae-00144feabdc0,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...It is the second FTSE 100 drugmaker to be subjected to an unsolicited takeover attempt by a US rival this year, after Pfizer’s failed £69.4bn bid for AstraZeneca....",AstraZeneca,"JULY 18, 2014"
AbbVie rounds on US tax laws as it snares Shire,https://www.ft.com/content/c43aa6ce-0e60-11e4-a1ae-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,"...However, while the latter approach drew strong political opposition because of AstraZeneca’s importance to the UK science base, the proposed Shire takeover has proved much less controversial....",AstraZeneca’s,"JULY 18, 2014"
AstraZeneca unveils plans for £330m R&D centre in Cambridge,https://www.ft.com/content/e86805f6-0e64-11e4-b1c4-00144feabdc0,,https://www.ft.com/london-future,London fights for its future,...AstraZeneca’s commitment to UK science was at the heart of its defence against Pfizer’s £69bn takeover bid in May....,AstraZeneca’s,"JULY 18, 2014"
AbbVie set to unveil £31bn Shire takeover,https://www.ft.com/content/d324fa2e-0dcd-11e4-85ab-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,...Shire is the second FTSE 100 drugmaker to be subjected to an unsolicited takeover attempt by a US rival this year after Pfizer’s failed £69.4bn bid for AstraZeneca....,AstraZeneca,"JULY 17, 2014"
Eli Lilly joins forces with UK biotech to develop cancer drugs,https://www.ft.com/content/d2ea0274-0ccf-11e4-bf1e-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,"...The deal with Immunocore adds to the British company’s existing alliances with AstraZeneca, GlaxoSmithKline and Roche, marking it out as one of the most promising new names in the UK life science sector....",AstraZeneca,"JULY 16, 2014"
Experian suffers shareholder revolt over board reshuffle,https://www.ft.com/content/82cae036-0cc7-11e4-90fa-00144feabdc0,,https://www.ft.com/corporate-governance,Corporate governance,"...Barclays, AstraZeneca, Reckitt Benckiser, WPP and Pearson (owner of the Financial Times) have each endured notable rebellions over remuneration....",AstraZeneca,"JULY 16, 2014"
David Cameron moves to boost UK life sciences,https://www.ft.com/content/8bb3d4ac-0c52-11e4-943b-00144feabdc0,,https://www.ft.com/uk-inward-investment,UK inward investment,...appointment of George Freeman in a newly created life sciences role in Tuesday’s reshuffle marks the prime minister’s determination to strengthen oversight of the sector following Pfizer’s £69.4bn bid for AstraZeneca...,AstraZeneca,"JULY 16, 2014"
Sir John Peace in the line of fire at FTSE 100 groups,https://www.ft.com/content/fd88db6a-0be7-11e4-a096-00144feabdc0,,https://www.ft.com/corporate-governance,Corporate governance,"...Barclays, AstraZeneca, Pearson (which owns the Financial Times), WPP and HSBC have each suffered revolts amid renewed shareholder agitation....",AstraZeneca,"JULY 15, 2014"
AbbVie closes in on £31bn takeover of Shire,https://www.ft.com/content/c8fe1c14-0b1c-11e4-ae6b-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,...AbbVie looks set to succeed where Pfizer failed in its £69.4bn bid for AstraZeneca of the UK in May....,AstraZeneca,"JULY 14, 2014"
Quindell starts on long road back to favour,https://www.ft.com/content/32d9afe6-0b71-11e4-8693-00144feabdc0,,https://www.ft.com/kate-burgess,Kate Burgess,"...Pfizer’s tilt at AstraZeneca set teacups clattering a few months ago. By contrast, the mooted purchase of Shire by US pharmaceutical rival AbbVie has yet to trouble the pages of the populist press....",AstraZeneca,"JULY 14, 2014"
AbbVie/Shire – join us at 12 for a live discussion,https://www.ft.com/content/010f6536-2e7f-35a7-ba2f-15469dfc4856,,https://www.ft.com/joseph-cotterill,Joseph Cotterill,"...of AbbVie’s £53.20 a share offer would eventually lead to a similar clause…

The price is a 42 per cent premium to where Shire shares traded before AbbVie became involved (though after Pfizer’s bid for AstraZeneca...",AstraZeneca,"JULY 14, 2014"
Vince Cable plans to toughen up takeover rules,https://www.ft.com/content/a41dcbe8-0a71-11e4-ac2a-00144feabdc0,,https://www.ft.com/world,World,...The business secretary concluded that the existing rules were inadequate after Pfizer’s £69.4bn approach for AstraZeneca....,AstraZeneca,"JULY 13, 2014"
Myners must give independent advice on independents,https://www.ft.com/content/8b1358ae-0740-11e4-81c6-00144feab7de,,https://www.ft.com/jonathan-guthrie,Jonathan Guthrie,"...The £69bn bid that Pfizer, made for AstraZeneca unravelled in May after its own discussions with the City M&A watchdog....",AstraZeneca,"JULY 9, 2014"
AbbVie retraction shows panel has teeth,https://www.ft.com/content/0adb6e98-0753-11e4-b1b0-00144feab7de,,https://www.ft.com/us-companies,US & Canadian companies,...The increased scrutiny of the code during the Pfizer/AstraZeneca courtship sparked complaints that the rules were arcane and led to muddle and confusion....,AstraZeneca,"JULY 9, 2014"
Five examples of the UK Takeover Code in action,https://www.ft.com/content/c94eccf4-0757-11e4-b1b0-00144feab7de,,https://www.ft.com/uk-companies,UK companies,"...May 19 2014: Pfizer outlines “final” offer to AstraZeneca, saying that its offer will not be increased, “except in the circumstances set out below”....",AstraZeneca,"JULY 9, 2014"
UK Takeover Panel forces AbbVie to retract claims of Shire support,https://www.ft.com/content/f97218fe-0730-11e4-b1b0-00144feab7de,,https://www.ft.com/us-companies,US & Canadian companies,"...volte-face for the US suitor and a further sign of how closely the panel is policing the company’s public utterances, as it did with Pfizer’s attempts to acquire another FTSE 100 pharmaceuticals group, AstraZeneca...",AstraZeneca,"JULY 9, 2014"
Cable backtracks on move to protect science industry,https://www.ft.com/content/0c67a6ee-06c4-11e4-b0d3-00144feab7de,,https://www.ft.com/world,World,...Pfizer walked away from AstraZeneca after the Anglo-Swedish company rebuffed its advances....,AstraZeneca,"JULY 8, 2014"
AstraZeneca chairman Leif Johansson defends Pfizer rebuff,https://www.ft.com/content/b69c8a70-1bab-11e4-adc7-00144feabdc0,https://www.ft.com/__origami/service/image/v2/images/raw/http%3A%2F%2Fprod-upp-image-read.ft.com%2F78beefd4-d099-11e3-9a81-00144feabdc0?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/us-companies,US & Canadian companies,...AstraZeneca is already big enough and super big may not be better.”...,AstraZeneca,"AUGUST 4, 2014"
Europe delivers earnings growth for the first time in three years,https://www.ft.com/content/d8e7a14a-18af-11e4-a51a-00144feabdc0,https://www.ft.com/__origami/service/image/v2/images/raw/http%3A%2F%2Fprod-upp-image-read.ft.com%2Fcf0ef45a-1aff-11e4-a633-00144feabdc0?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/european-companies,European companies,"...Eni, the Italian oil and gas group, announced a 51 per cent increase in its quarterly net profit, and AstraZeneca, the UK drugmaker that in May rejected a £69.4bn takeover from Pfizer, also beat analysts...",AstraZeneca,"AUGUST 3, 2014"
GlaxoSmithKline vulnerable to Pfizer bid after price slump,https://www.ft.com/content/adc5184e-199a-11e4-b06c-00144feabdc0,,https://www.ft.com/uk-equities,UK equities,"...AstraZeneca, meanwhile, was off 0.1 per cent to £43.39 even after its chairman and three non-executive directors added to their stakes....",AstraZeneca,"AUGUST 1, 2014"
Drug pricing: Bitter pill,https://www.ft.com/content/f3ede8ae-189c-11e4-933e-00144feabdc0,,https://www.ft.com/the-big-read,The Big Read,"...It is already bigger by market capitalisation, at $143bn, than some traditional pharma mainstays, including GlaxoSmithKline and AstraZeneca....",AstraZeneca,"JULY 31, 2014"
AstraZeneca raises full-year earnings guidance,https://www.ft.com/content/d6d17a6a-1883-11e4-a51a-00144feabdc0,,https://www.ft.com/uk-companies,UK companies,...Analysts said this suggested AstraZeneca was bracing for a fresh approach....,AstraZeneca,"JULY 31, 2014"
AstraZeneca to bolster respiratory drugs with Almirall deal,https://www.ft.com/content/c1c1e25a-17b5-11e4-b842-00144feabdc0,,https://www.ft.com/european-companies,European companies,"...The deal will also reinforce the challenge posed by AstraZeneca to GlaxoSmithKline, its UK rival, in the respiratory market....",AstraZeneca,"JULY 30, 2014"
GSK’s Witty fights back amid bribery scandal and profit warning,https://www.ft.com/content/f7869406-1564-11e4-ae2e-00144feabdc0,,https://www.ft.com/uk-companies,UK companies,...Pfizer walked away after AstraZeneca rejected what would have been the biggest foreign takeover of a UK company....,AstraZeneca,"JULY 27, 2014"
US warned of up to 25 groups eyeing foreign switch to cut tax,https://www.ft.com/content/69e69c42-11c0-11e4-8279-00144feabdc0,,https://www.ft.com/us-politics-policy,US politics & policy,...They were thrust into the spotlight by Pfizer’s $116bn attempt to buy UK rival AstraZeneca....,AstraZeneca,"JULY 22, 2014"
Shire chief’s $10m ‘golden hello’ at AbbVie,https://www.ft.com/content/aeb66b6c-0e97-11e4-a1ae-00144feabdc0,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...It is the second FTSE 100 drugmaker to be subjected to an unsolicited takeover attempt by a US rival this year, after Pfizer’s failed £69.4bn bid for AstraZeneca....",AstraZeneca,"JULY 18, 2014"
AbbVie rounds on US tax laws as it snares Shire,https://www.ft.com/content/c43aa6ce-0e60-11e4-a1ae-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,"...However, while the latter approach drew strong political opposition because of AstraZeneca’s importance to the UK science base, the proposed Shire takeover has proved much less controversial....",AstraZeneca’s,"JULY 18, 2014"
AstraZeneca unveils plans for £330m R&D centre in Cambridge,https://www.ft.com/content/e86805f6-0e64-11e4-b1c4-00144feabdc0,,https://www.ft.com/london-future,London fights for its future,...AstraZeneca’s commitment to UK science was at the heart of its defence against Pfizer’s £69bn takeover bid in May....,AstraZeneca’s,"JULY 18, 2014"
AbbVie set to unveil £31bn Shire takeover,https://www.ft.com/content/d324fa2e-0dcd-11e4-85ab-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,...Shire is the second FTSE 100 drugmaker to be subjected to an unsolicited takeover attempt by a US rival this year after Pfizer’s failed £69.4bn bid for AstraZeneca....,AstraZeneca,"JULY 17, 2014"
Eli Lilly joins forces with UK biotech to develop cancer drugs,https://www.ft.com/content/d2ea0274-0ccf-11e4-bf1e-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,"...The deal with Immunocore adds to the British company’s existing alliances with AstraZeneca, GlaxoSmithKline and Roche, marking it out as one of the most promising new names in the UK life science sector....",AstraZeneca,"JULY 16, 2014"
Experian suffers shareholder revolt over board reshuffle,https://www.ft.com/content/82cae036-0cc7-11e4-90fa-00144feabdc0,,https://www.ft.com/corporate-governance,Corporate governance,"...Barclays, AstraZeneca, Reckitt Benckiser, WPP and Pearson (owner of the Financial Times) have each endured notable rebellions over remuneration....",AstraZeneca,"JULY 16, 2014"
David Cameron moves to boost UK life sciences,https://www.ft.com/content/8bb3d4ac-0c52-11e4-943b-00144feabdc0,,https://www.ft.com/uk-inward-investment,UK inward investment,...appointment of George Freeman in a newly created life sciences role in Tuesday’s reshuffle marks the prime minister’s determination to strengthen oversight of the sector following Pfizer’s £69.4bn bid for AstraZeneca...,AstraZeneca,"JULY 16, 2014"
Sir John Peace in the line of fire at FTSE 100 groups,https://www.ft.com/content/fd88db6a-0be7-11e4-a096-00144feabdc0,,https://www.ft.com/corporate-governance,Corporate governance,"...Barclays, AstraZeneca, Pearson (which owns the Financial Times), WPP and HSBC have each suffered revolts amid renewed shareholder agitation....",AstraZeneca,"JULY 15, 2014"
AbbVie closes in on £31bn takeover of Shire,https://www.ft.com/content/c8fe1c14-0b1c-11e4-ae6b-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,...AbbVie looks set to succeed where Pfizer failed in its £69.4bn bid for AstraZeneca of the UK in May....,AstraZeneca,"JULY 14, 2014"
Quindell starts on long road back to favour,https://www.ft.com/content/32d9afe6-0b71-11e4-8693-00144feabdc0,,https://www.ft.com/kate-burgess,Kate Burgess,"...Pfizer’s tilt at AstraZeneca set teacups clattering a few months ago. By contrast, the mooted purchase of Shire by US pharmaceutical rival AbbVie has yet to trouble the pages of the populist press....",AstraZeneca,"JULY 14, 2014"
AbbVie/Shire – join us at 12 for a live discussion,https://www.ft.com/content/010f6536-2e7f-35a7-ba2f-15469dfc4856,,https://www.ft.com/joseph-cotterill,Joseph Cotterill,"...of AbbVie’s £53.20 a share offer would eventually lead to a similar clause…

The price is a 42 per cent premium to where Shire shares traded before AbbVie became involved (though after Pfizer’s bid for AstraZeneca...",AstraZeneca,"JULY 14, 2014"
Vince Cable plans to toughen up takeover rules,https://www.ft.com/content/a41dcbe8-0a71-11e4-ac2a-00144feabdc0,,https://www.ft.com/world,World,...The business secretary concluded that the existing rules were inadequate after Pfizer’s £69.4bn approach for AstraZeneca....,AstraZeneca,"JULY 13, 2014"
Myners must give independent advice on independents,https://www.ft.com/content/8b1358ae-0740-11e4-81c6-00144feab7de,,https://www.ft.com/jonathan-guthrie,Jonathan Guthrie,"...The £69bn bid that Pfizer, made for AstraZeneca unravelled in May after its own discussions with the City M&A watchdog....",AstraZeneca,"JULY 9, 2014"
AbbVie retraction shows panel has teeth,https://www.ft.com/content/0adb6e98-0753-11e4-b1b0-00144feab7de,,https://www.ft.com/us-companies,US & Canadian companies,...The increased scrutiny of the code during the Pfizer/AstraZeneca courtship sparked complaints that the rules were arcane and led to muddle and confusion....,AstraZeneca,"JULY 9, 2014"
Five examples of the UK Takeover Code in action,https://www.ft.com/content/c94eccf4-0757-11e4-b1b0-00144feab7de,,https://www.ft.com/uk-companies,UK companies,"...May 19 2014: Pfizer outlines “final” offer to AstraZeneca, saying that its offer will not be increased, “except in the circumstances set out below”....",AstraZeneca,"JULY 9, 2014"
UK Takeover Panel forces AbbVie to retract claims of Shire support,https://www.ft.com/content/f97218fe-0730-11e4-b1b0-00144feab7de,,https://www.ft.com/us-companies,US & Canadian companies,"...volte-face for the US suitor and a further sign of how closely the panel is policing the company’s public utterances, as it did with Pfizer’s attempts to acquire another FTSE 100 pharmaceuticals group, AstraZeneca...",AstraZeneca,"JULY 9, 2014"
Cable backtracks on move to protect science industry,https://www.ft.com/content/0c67a6ee-06c4-11e4-b0d3-00144feab7de,,https://www.ft.com/world,World,...Pfizer walked away from AstraZeneca after the Anglo-Swedish company rebuffed its advances....,AstraZeneca,"JULY 8, 2014"
AstraZeneca chairman Leif Johansson defends Pfizer rebuff,https://www.ft.com/content/b69c8a70-1bab-11e4-adc7-00144feabdc0,https://www.ft.com/__origami/service/image/v2/images/raw/http%3A%2F%2Fprod-upp-image-read.ft.com%2F78beefd4-d099-11e3-9a81-00144feabdc0?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/us-companies,US & Canadian companies,...AstraZeneca is already big enough and super big may not be better.”...,AstraZeneca,"AUGUST 4, 2014"
Europe delivers earnings growth for the first time in three years,https://www.ft.com/content/d8e7a14a-18af-11e4-a51a-00144feabdc0,https://www.ft.com/__origami/service/image/v2/images/raw/http%3A%2F%2Fprod-upp-image-read.ft.com%2Fcf0ef45a-1aff-11e4-a633-00144feabdc0?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/european-companies,European companies,"...Eni, the Italian oil and gas group, announced a 51 per cent increase in its quarterly net profit, and AstraZeneca, the UK drugmaker that in May rejected a £69.4bn takeover from Pfizer, also beat analysts...",AstraZeneca,"AUGUST 3, 2014"
GlaxoSmithKline vulnerable to Pfizer bid after price slump,https://www.ft.com/content/adc5184e-199a-11e4-b06c-00144feabdc0,,https://www.ft.com/uk-equities,UK equities,"...AstraZeneca, meanwhile, was off 0.1 per cent to £43.39 even after its chairman and three non-executive directors added to their stakes....",AstraZeneca,"AUGUST 1, 2014"
Drug pricing: Bitter pill,https://www.ft.com/content/f3ede8ae-189c-11e4-933e-00144feabdc0,,https://www.ft.com/the-big-read,The Big Read,"...It is already bigger by market capitalisation, at $143bn, than some traditional pharma mainstays, including GlaxoSmithKline and AstraZeneca....",AstraZeneca,"JULY 31, 2014"
AstraZeneca raises full-year earnings guidance,https://www.ft.com/content/d6d17a6a-1883-11e4-a51a-00144feabdc0,,https://www.ft.com/uk-companies,UK companies,...Analysts said this suggested AstraZeneca was bracing for a fresh approach....,AstraZeneca,"JULY 31, 2014"
AstraZeneca to bolster respiratory drugs with Almirall deal,https://www.ft.com/content/c1c1e25a-17b5-11e4-b842-00144feabdc0,,https://www.ft.com/european-companies,European companies,"...The deal will also reinforce the challenge posed by AstraZeneca to GlaxoSmithKline, its UK rival, in the respiratory market....",AstraZeneca,"JULY 30, 2014"
GSK’s Witty fights back amid bribery scandal and profit warning,https://www.ft.com/content/f7869406-1564-11e4-ae2e-00144feabdc0,,https://www.ft.com/uk-companies,UK companies,...Pfizer walked away after AstraZeneca rejected what would have been the biggest foreign takeover of a UK company....,AstraZeneca,"JULY 27, 2014"
US warned of up to 25 groups eyeing foreign switch to cut tax,https://www.ft.com/content/69e69c42-11c0-11e4-8279-00144feabdc0,,https://www.ft.com/us-politics-policy,US politics & policy,...They were thrust into the spotlight by Pfizer’s $116bn attempt to buy UK rival AstraZeneca....,AstraZeneca,"JULY 22, 2014"
Shire chief’s $10m ‘golden hello’ at AbbVie,https://www.ft.com/content/aeb66b6c-0e97-11e4-a1ae-00144feabdc0,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...It is the second FTSE 100 drugmaker to be subjected to an unsolicited takeover attempt by a US rival this year, after Pfizer’s failed £69.4bn bid for AstraZeneca....",AstraZeneca,"JULY 18, 2014"
AbbVie rounds on US tax laws as it snares Shire,https://www.ft.com/content/c43aa6ce-0e60-11e4-a1ae-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,"...However, while the latter approach drew strong political opposition because of AstraZeneca’s importance to the UK science base, the proposed Shire takeover has proved much less controversial....",AstraZeneca’s,"JULY 18, 2014"
AstraZeneca unveils plans for £330m R&D centre in Cambridge,https://www.ft.com/content/e86805f6-0e64-11e4-b1c4-00144feabdc0,,https://www.ft.com/london-future,London fights for its future,...AstraZeneca’s commitment to UK science was at the heart of its defence against Pfizer’s £69bn takeover bid in May....,AstraZeneca’s,"JULY 18, 2014"
AbbVie set to unveil £31bn Shire takeover,https://www.ft.com/content/d324fa2e-0dcd-11e4-85ab-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,...Shire is the second FTSE 100 drugmaker to be subjected to an unsolicited takeover attempt by a US rival this year after Pfizer’s failed £69.4bn bid for AstraZeneca....,AstraZeneca,"JULY 17, 2014"
Eli Lilly joins forces with UK biotech to develop cancer drugs,https://www.ft.com/content/d2ea0274-0ccf-11e4-bf1e-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,"...The deal with Immunocore adds to the British company’s existing alliances with AstraZeneca, GlaxoSmithKline and Roche, marking it out as one of the most promising new names in the UK life science sector....",AstraZeneca,"JULY 16, 2014"
Experian suffers shareholder revolt over board reshuffle,https://www.ft.com/content/82cae036-0cc7-11e4-90fa-00144feabdc0,,https://www.ft.com/corporate-governance,Corporate governance,"...Barclays, AstraZeneca, Reckitt Benckiser, WPP and Pearson (owner of the Financial Times) have each endured notable rebellions over remuneration....",AstraZeneca,"JULY 16, 2014"
David Cameron moves to boost UK life sciences,https://www.ft.com/content/8bb3d4ac-0c52-11e4-943b-00144feabdc0,,https://www.ft.com/uk-inward-investment,UK inward investment,...appointment of George Freeman in a newly created life sciences role in Tuesday’s reshuffle marks the prime minister’s determination to strengthen oversight of the sector following Pfizer’s £69.4bn bid for AstraZeneca...,AstraZeneca,"JULY 16, 2014"
Sir John Peace in the line of fire at FTSE 100 groups,https://www.ft.com/content/fd88db6a-0be7-11e4-a096-00144feabdc0,,https://www.ft.com/corporate-governance,Corporate governance,"...Barclays, AstraZeneca, Pearson (which owns the Financial Times), WPP and HSBC have each suffered revolts amid renewed shareholder agitation....",AstraZeneca,"JULY 15, 2014"
AbbVie closes in on £31bn takeover of Shire,https://www.ft.com/content/c8fe1c14-0b1c-11e4-ae6b-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,...AbbVie looks set to succeed where Pfizer failed in its £69.4bn bid for AstraZeneca of the UK in May....,AstraZeneca,"JULY 14, 2014"
Quindell starts on long road back to favour,https://www.ft.com/content/32d9afe6-0b71-11e4-8693-00144feabdc0,,https://www.ft.com/kate-burgess,Kate Burgess,"...Pfizer’s tilt at AstraZeneca set teacups clattering a few months ago. By contrast, the mooted purchase of Shire by US pharmaceutical rival AbbVie has yet to trouble the pages of the populist press....",AstraZeneca,"JULY 14, 2014"
AbbVie/Shire – join us at 12 for a live discussion,https://www.ft.com/content/010f6536-2e7f-35a7-ba2f-15469dfc4856,,https://www.ft.com/joseph-cotterill,Joseph Cotterill,"...of AbbVie’s £53.20 a share offer would eventually lead to a similar clause…

The price is a 42 per cent premium to where Shire shares traded before AbbVie became involved (though after Pfizer’s bid for AstraZeneca...",AstraZeneca,"JULY 14, 2014"
Vince Cable plans to toughen up takeover rules,https://www.ft.com/content/a41dcbe8-0a71-11e4-ac2a-00144feabdc0,,https://www.ft.com/world,World,...The business secretary concluded that the existing rules were inadequate after Pfizer’s £69.4bn approach for AstraZeneca....,AstraZeneca,"JULY 13, 2014"
Myners must give independent advice on independents,https://www.ft.com/content/8b1358ae-0740-11e4-81c6-00144feab7de,,https://www.ft.com/jonathan-guthrie,Jonathan Guthrie,"...The £69bn bid that Pfizer, made for AstraZeneca unravelled in May after its own discussions with the City M&A watchdog....",AstraZeneca,"JULY 9, 2014"
AbbVie retraction shows panel has teeth,https://www.ft.com/content/0adb6e98-0753-11e4-b1b0-00144feab7de,,https://www.ft.com/us-companies,US & Canadian companies,...The increased scrutiny of the code during the Pfizer/AstraZeneca courtship sparked complaints that the rules were arcane and led to muddle and confusion....,AstraZeneca,"JULY 9, 2014"
Five examples of the UK Takeover Code in action,https://www.ft.com/content/c94eccf4-0757-11e4-b1b0-00144feab7de,,https://www.ft.com/uk-companies,UK companies,"...May 19 2014: Pfizer outlines “final” offer to AstraZeneca, saying that its offer will not be increased, “except in the circumstances set out below”....",AstraZeneca,"JULY 9, 2014"
UK Takeover Panel forces AbbVie to retract claims of Shire support,https://www.ft.com/content/f97218fe-0730-11e4-b1b0-00144feab7de,,https://www.ft.com/us-companies,US & Canadian companies,"...volte-face for the US suitor and a further sign of how closely the panel is policing the company’s public utterances, as it did with Pfizer’s attempts to acquire another FTSE 100 pharmaceuticals group, AstraZeneca...",AstraZeneca,"JULY 9, 2014"
Cable backtracks on move to protect science industry,https://www.ft.com/content/0c67a6ee-06c4-11e4-b0d3-00144feab7de,,https://www.ft.com/world,World,...Pfizer walked away from AstraZeneca after the Anglo-Swedish company rebuffed its advances....,AstraZeneca,"JULY 8, 2014"
AstraZeneca chairman Leif Johansson defends Pfizer rebuff,https://www.ft.com/content/b69c8a70-1bab-11e4-adc7-00144feabdc0,https://www.ft.com/__origami/service/image/v2/images/raw/http%3A%2F%2Fprod-upp-image-read.ft.com%2F78beefd4-d099-11e3-9a81-00144feabdc0?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/us-companies,US & Canadian companies,...AstraZeneca is already big enough and super big may not be better.”...,AstraZeneca,"AUGUST 4, 2014"
Europe delivers earnings growth for the first time in three years,https://www.ft.com/content/d8e7a14a-18af-11e4-a51a-00144feabdc0,https://www.ft.com/__origami/service/image/v2/images/raw/http%3A%2F%2Fprod-upp-image-read.ft.com%2Fcf0ef45a-1aff-11e4-a633-00144feabdc0?source=next&fit=scale-down&dpr=2&width=240,https://www.ft.com/european-companies,European companies,"...Eni, the Italian oil and gas group, announced a 51 per cent increase in its quarterly net profit, and AstraZeneca, the UK drugmaker that in May rejected a £69.4bn takeover from Pfizer, also beat analysts...",AstraZeneca,"AUGUST 3, 2014"
GlaxoSmithKline vulnerable to Pfizer bid after price slump,https://www.ft.com/content/adc5184e-199a-11e4-b06c-00144feabdc0,,https://www.ft.com/uk-equities,UK equities,"...AstraZeneca, meanwhile, was off 0.1 per cent to £43.39 even after its chairman and three non-executive directors added to their stakes....",AstraZeneca,"AUGUST 1, 2014"
Drug pricing: Bitter pill,https://www.ft.com/content/f3ede8ae-189c-11e4-933e-00144feabdc0,,https://www.ft.com/the-big-read,The Big Read,"...It is already bigger by market capitalisation, at $143bn, than some traditional pharma mainstays, including GlaxoSmithKline and AstraZeneca....",AstraZeneca,"JULY 31, 2014"
AstraZeneca raises full-year earnings guidance,https://www.ft.com/content/d6d17a6a-1883-11e4-a51a-00144feabdc0,,https://www.ft.com/uk-companies,UK companies,...Analysts said this suggested AstraZeneca was bracing for a fresh approach....,AstraZeneca,"JULY 31, 2014"
AstraZeneca to bolster respiratory drugs with Almirall deal,https://www.ft.com/content/c1c1e25a-17b5-11e4-b842-00144feabdc0,,https://www.ft.com/european-companies,European companies,"...The deal will also reinforce the challenge posed by AstraZeneca to GlaxoSmithKline, its UK rival, in the respiratory market....",AstraZeneca,"JULY 30, 2014"
GSK’s Witty fights back amid bribery scandal and profit warning,https://www.ft.com/content/f7869406-1564-11e4-ae2e-00144feabdc0,,https://www.ft.com/uk-companies,UK companies,...Pfizer walked away after AstraZeneca rejected what would have been the biggest foreign takeover of a UK company....,AstraZeneca,"JULY 27, 2014"
US warned of up to 25 groups eyeing foreign switch to cut tax,https://www.ft.com/content/69e69c42-11c0-11e4-8279-00144feabdc0,,https://www.ft.com/us-politics-policy,US politics & policy,...They were thrust into the spotlight by Pfizer’s $116bn attempt to buy UK rival AstraZeneca....,AstraZeneca,"JULY 22, 2014"
Shire chief’s $10m ‘golden hello’ at AbbVie,https://www.ft.com/content/aeb66b6c-0e97-11e4-a1ae-00144feabdc0,,https://www.ft.com/pharmaceuticals,Pharmaceuticals sector,"...It is the second FTSE 100 drugmaker to be subjected to an unsolicited takeover attempt by a US rival this year, after Pfizer’s failed £69.4bn bid for AstraZeneca....",AstraZeneca,"JULY 18, 2014"
AbbVie rounds on US tax laws as it snares Shire,https://www.ft.com/content/c43aa6ce-0e60-11e4-a1ae-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,"...However, while the latter approach drew strong political opposition because of AstraZeneca’s importance to the UK science base, the proposed Shire takeover has proved much less controversial....",AstraZeneca’s,"JULY 18, 2014"
AstraZeneca unveils plans for £330m R&D centre in Cambridge,https://www.ft.com/content/e86805f6-0e64-11e4-b1c4-00144feabdc0,,https://www.ft.com/london-future,London fights for its future,...AstraZeneca’s commitment to UK science was at the heart of its defence against Pfizer’s £69bn takeover bid in May....,AstraZeneca’s,"JULY 18, 2014"
AbbVie set to unveil £31bn Shire takeover,https://www.ft.com/content/d324fa2e-0dcd-11e4-85ab-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,...Shire is the second FTSE 100 drugmaker to be subjected to an unsolicited takeover attempt by a US rival this year after Pfizer’s failed £69.4bn bid for AstraZeneca....,AstraZeneca,"JULY 17, 2014"
Eli Lilly joins forces with UK biotech to develop cancer drugs,https://www.ft.com/content/d2ea0274-0ccf-11e4-bf1e-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,"...The deal with Immunocore adds to the British company’s existing alliances with AstraZeneca, GlaxoSmithKline and Roche, marking it out as one of the most promising new names in the UK life science sector....",AstraZeneca,"JULY 16, 2014"
Experian suffers shareholder revolt over board reshuffle,https://www.ft.com/content/82cae036-0cc7-11e4-90fa-00144feabdc0,,https://www.ft.com/corporate-governance,Corporate governance,"...Barclays, AstraZeneca, Reckitt Benckiser, WPP and Pearson (owner of the Financial Times) have each endured notable rebellions over remuneration....",AstraZeneca,"JULY 16, 2014"
David Cameron moves to boost UK life sciences,https://www.ft.com/content/8bb3d4ac-0c52-11e4-943b-00144feabdc0,,https://www.ft.com/uk-inward-investment,UK inward investment,...appointment of George Freeman in a newly created life sciences role in Tuesday’s reshuffle marks the prime minister’s determination to strengthen oversight of the sector following Pfizer’s £69.4bn bid for AstraZeneca...,AstraZeneca,"JULY 16, 2014"
Sir John Peace in the line of fire at FTSE 100 groups,https://www.ft.com/content/fd88db6a-0be7-11e4-a096-00144feabdc0,,https://www.ft.com/corporate-governance,Corporate governance,"...Barclays, AstraZeneca, Pearson (which owns the Financial Times), WPP and HSBC have each suffered revolts amid renewed shareholder agitation....",AstraZeneca,"JULY 15, 2014"
AbbVie closes in on £31bn takeover of Shire,https://www.ft.com/content/c8fe1c14-0b1c-11e4-ae6b-00144feabdc0,,https://www.ft.com/us-companies,US & Canadian companies,...AbbVie looks set to succeed where Pfizer failed in its £69.4bn bid for AstraZeneca of the UK in May....,AstraZeneca,"JULY 14, 2014"
Quindell starts on long road back to favour,https://www.ft.com/content/32d9afe6-0b71-11e4-8693-00144feabdc0,,https://www.ft.com/kate-burgess,Kate Burgess,"...Pfizer’s tilt at AstraZeneca set teacups clattering a few months ago. By contrast, the mooted purchase of Shire by US pharmaceutical rival AbbVie has yet to trouble the pages of the populist press....",AstraZeneca,"JULY 14, 2014"
AbbVie/Shire – join us at 12 for a live discussion,https://www.ft.com/content/010f6536-2e7f-35a7-ba2f-15469dfc4856,,https://www.ft.com/joseph-cotterill,Joseph Cotterill,"...of AbbVie’s £53.20 a share offer would eventually lead to a similar clause…

The price is a 42 per cent premium to where Shire shares traded before AbbVie became involved (though after Pfizer’s bid for AstraZeneca...",AstraZeneca,"JULY 14, 2014"
Vince Cable plans to toughen up takeover rules,https://www.ft.com/content/a41dcbe8-0a71-11e4-ac2a-00144feabdc0,,https://www.ft.com/world,World,...The business secretary concluded that the existing rules were inadequate after Pfizer’s £69.4bn approach for AstraZeneca....,AstraZeneca,"JULY 13, 2014"
Myners must give independent advice on independents,https://www.ft.com/content/8b1358ae-0740-11e4-81c6-00144feab7de,,https://www.ft.com/jonathan-guthrie,Jonathan Guthrie,"...The £69bn bid that Pfizer, made for AstraZeneca unravelled in May after its own discussions with the City M&A watchdog....",AstraZeneca,"JULY 9, 2014"
AbbVie retraction shows panel has teeth,https://www.ft.com/content/0adb6e98-0753-11e4-b1b0-00144feab7de,,https://www.ft.com/us-companies,US & Canadian companies,...The increased scrutiny of the code during the Pfizer/AstraZeneca courtship sparked complaints that the rules were arcane and led to muddle and confusion....,AstraZeneca,"JULY 9, 2014"
Five examples of the UK Takeover Code in action,https://www.ft.com/content/c94eccf4-0757-11e4-b1b0-00144feab7de,,https://www.ft.com/uk-companies,UK companies,"...May 19 2014: Pfizer outlines “final” offer to AstraZeneca, saying that its offer will not be increased, “except in the circumstances set out below”....",AstraZeneca,"JULY 9, 2014"
UK Takeover Panel forces AbbVie to retract claims of Shire support,https://www.ft.com/content/f97218fe-0730-11e4-b1b0-00144feab7de,,https://www.ft.com/us-companies,US & Canadian companies,"...volte-face for the US suitor and a further sign of how closely the panel is policing the company’s public utterances, as it did with Pfizer’s attempts to acquire another FTSE 100 pharmaceuticals group, AstraZeneca...",AstraZeneca,"JULY 9, 2014"
Cable backtracks on move to protect science industry,https://www.ft.com/content/0c67a6ee-06c4-11e4-b0d3-00144feab7de,,https://www.ft.com/world,World,...Pfizer walked away from AstraZeneca after the Anglo-Swedish company rebuffed its advances....,AstraZeneca,"JULY 8, 2014"
